cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.8433336280749586
NCI-H522,613000,2.2856040748624347,2.493921047726236
YAPC,16038120,1.926562361021756,0.9550467086102405
NCI-H292,9935249,3.8808310590786,3.140122448663667
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-1.2509028460200695
NCI-H522,9908783,5.043768225694569,4.999044058795543
JM-1,11175137,0.9157477453434189,2.0155545867375086
NCI-H522,5287620,-2.19230412457559,-2.036941262542307
MDA-MB-453,4917,2.8920757434762203,3.1485435449230414
DMS 273,135421197,2.3407622077730035,1.7143247650678226
SNU-449,BRD-K55473186,5.1406225681359174,4.039837499275336
SNU-61,4521392,3.90812104829802,4.333958894848691
G-401,9549297,1.736191202159007,1.925927558370292
NCI-H146,89183176,1.451528120959232,3.775631317249381
LOU-NH91,5287620,-1.52867963951729,-2.0299942559355246
FTC-133,123631,3.8044847524269865,2.116795603418605
KMRC-1,5291,3.811670367299954,3.7207783517435864
A-673,9823820,4.6435125645675095,3.6239913267372543
FU-OV-1,168313047,2.3973799381416208,2.367269695096671
Panc 04.03,44462760,4.978463894781355,3.80191433846513
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,2.847934754370026
OPM-2,445091,3.996829176942573,4.1843711120375975
ONS-76,5746,1.4703359849180313,1.0636629046563415
NCI-H661,3025944,3.908905198351104,4.241009015912686
A4/Fukuda,107970,1.5574682195612295,2.1557329066984314
CAL-51,49850262,3.6300011952383584,3.630078722040295
NCI-H460,2858523,3.1665522277325575,3.0607290097805917
G-401,6184667,2.5094508901292487,2.978976646070061
NCI-H661,44607531,1.139733733680255,1.5447197839376345
SNU-81,6917907,-6.2756065511253185,-5.551884088856938
MSTO-211H,54678924,1.5146991125566602,2.163765072393168
FTC-133,10127622,5.496386107928154,4.2105346020197185
EFO-27,11977753,-1.8189065225127747,-1.5433065786456248
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.4255107757107357
MSTO-211H,19582717,3.17062921236116,4.049864257636353
KMRC-1,53392493,3.2185750963739026,2.6850402608382216
OPM-2,2749,1.7313419667612246,1.4856543987651336
NCI-H460,5351362,3.0809857123464037,1.7931175351286055
SNU-449,56949517,4.374997906660537,4.439118715284567
NCI-H146,1716436,1.8968095332546364,2.91182766497737
MSTO-211H,9884685,-1.5007126123703023,0.5161900313845488
CA46,46926350,-5.311040218420036,-4.324890646092207
BxPC-3,72193861,-0.2425633398981322,1.924176737828661
NCI-H522,24180719,4.104291025168841,3.6198437417780385
NCI-H292,16038120,0.8772093711483475,1.1168390850178291
NCI-H2171,11364421,-5.769988570724398,-1.6634611926619758
LOU-NH91,71304818,3.9209078908272703,2.364274145031098
NCI-H2009,71466380,3.950405172838994,4.53804675110862
EFO-27,44607530,2.237032971856772,1.8409489334236722
CAL-51,3136844,4.799885860604426,4.153161702236214
MSTO-211H,9936388,-4.464575449065994,-0.8435717271655951
A2780,66577038,2.715796351675557,2.7726054367828987
G-401,24779724,6.361263224396382,4.563429347134935
OPM-2,5470400,-0.1217933569770787,-0.20268846228162135
HCC1143,36314,1.6197332159913502,-1.1814314779648347
SW1463,54143018,1.6932952952144893,0.47177647454155713
JM-1,1317464,3.8125649173872938,3.0663296218494414
DMS 273,46907787,0.4735517334159472,1.6550356091100997
MDA-MB-453,46843906,1.4379824902109608,2.7770060597503643
YAPC,6252,1.451992868069142,-0.15152467864261013
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.4202882205454828
CA46,46943432,1.2105530921386296,1.2484850610045108
NCI-H292,24785538,2.1095024536235374,1.8576117584783782
NCI-H292,3038522,3.811290582208577,3.118441783026899
NCI-H460,54454,2.7807551042334935,2.6828087272530095
NCI-H661,9911463,3.595935737335879,3.8258868602141387
BT-549,4261,1.9217340769001163,1.8017667352677762
FTC-133,16013152,4.199465293191842,4.155696730059738
MDA-MB-453,54618305,5.448966988850886,4.369084596018884
LOU-NH91,56946209,-2.032751224257796,-4.468207429342114
KMRC-1,16659841,4.161446951047465,4.097270691032311
LXF 289,66577038,2.7615792990535937,3.0454679218660994
A-673,2871966,-2.1375369153988597,0.47764188488294274
EFO-27,4788,6.204062284318603,5.715571553476784
FTC-133,5281321,-2.4880366458953196,-1.4297410321505881
JM-1,613753,2.4959303189076376,2.830642098595092
CAL-51,168312962,1.4117577594763937,1.7005299444852227
OPM-2,6450551,0.7106995413225735,1.8979860581199899
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,3.633759886050305
EFO-27,26596,4.577324640946523,-1.2030040837617684
LoVo,656346,0.766025679375412,0.6170618622027331
NCI-H522,4477,0.4448521837298123,0.42542164309704367
NCI-H727,9936388,1.6432072244848812,-1.3662915234631448
FTC-133,104842,-5.8581546696404,-2.387108400635208
EFO-27,7326481,5.957065585898912,3.050568451870739
NCI-H460,11222830,2.8861636193629323,1.687408862371893
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,3.825032789037942
NCI-H460,54618771,1.6853262233131374,1.2415922083733557
JM-1,52947716,1.780956269613054,-1.8006608275973657
OPM-2,9444,2.5095115053941557,3.319627120489355
NCI-H146,60700,-4.723399126949256,-0.5587045098990778
BxPC-3,9911830,2.611582201474507,2.7780007888712714
NCI-H146,16038120,1.7989248875403512,0.8788885461112269
LXF 289,51037431,5.679407317259089,3.1438540216064705
HCC1143,44589607,1.260451666530297,2.913883704172345
CA46,5281321,-3.5082232289526663,-1.7512712225236025
BxPC-3,3815108,3.682439325637505,3.029423127779347
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.5483864359171258
BxPC-3,3552672,2.73628551508051,2.955908522045166
SCC-9,3081361,1.719146178558617,2.4340040340225784
SCC-9,135875424,4.9754653396039314,4.009894935548138
LoVo,1716436,2.86184708699294,2.8602086377595297
MDA-MB-157,9884685,1.398372779004129,0.4109456106389438
NCI-H292,9911463,4.207043029649759,3.922271916268099
G-401,54626689,4.421186382617726,4.377590545369728
NCI-H460,6917907,-4.956095121428261,-3.759428345768183
CA46,25062766,1.483751377697603,1.7781176013937765
LXF 289,44241473,4.688676931788039,4.955374069919373
EFO-27,71680916,4.9682795090816185,4.66764550757635
SW1463,11152667,-0.1903484351781526,-0.6113048599964492
NCI-H292,73707398,0.96137499748578,1.338334392864177
NCI-H2009,16725315,3.943728055015544,4.204717287928432
SNU-61,135440466,2.760100648324382,2.268117949158604
A2780,451668,4.676838081876032,1.7386065832045465
JM-1,46191454,-0.7072965876905944,1.0284008717712416
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.497468906474982
SNU-449,2733526,4.280379959685792,3.921770582337118
JM-1,10302451,3.097435274235228,2.828273179361653
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.4294983726409598
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.0331608154229333
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.375252131467733
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.2144701862831446
OPM-2,52912189,-3.1407059889083424,0.8209008147885285
SCC-9,9549297,5.273243325738832,2.255341209958496
A-673,375860,-0.5094320760358009,-0.3156657957987728
SNU-449,15983966,0.8926749279922188,-1.026896723045069
SNU-449,135440466,2.7536019754154375,2.3573702799366636
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.6127064713715364
NCI-H522,73707398,0.7434005611154502,1.316888292225611
NCI-H1623,72376,-0.6301176586270604,-1.7004854001814054
SCC-9,24901704,4.548877009949327,3.3771118672036176
HSC-4,448949,2.25928901468022,2.0864239657708876
SCC-9,25102847,2.571358625043281,2.272323132421049
FTC-133,135411,0.6572104898559208,0.7128467586327014
DMS 273,445643,4.452334519038606,4.004498923702189
HSC-4,24771867,2.9499855440491243,2.428659469966617
BxPC-3,2841722,6.186043735824486,4.364378705319639
MDA-MB-157,52947716,2.709287320485668,-1.2367860635382046
HSC-4,46224516,3.389129888163455,2.349742120475731
NCI-H146,400769,-1.4971487301951925,-0.6237824636947522
LOU-NH91,387447,-3.4249375140388247,-4.282671692243578
CA46,6610216,4.017162804005507,3.8693506207649535
LoVo,375860,-0.1162329718395109,-0.33445720938597195
FU-OV-1,9911830,2.8434321082933773,2.399774829034943
LoVo,9840324,5.061772266378942,5.8362623651852985
MSTO-211H,56649450,2.845391743702004,2.963157399766388
HSC-4,9935249,3.700870290975298,2.9038948601138603
BT-549,44486219,4.179253703467884,4.2773556764110685
SNU-449,24901704,3.9093934632949616,3.205937968502043
FTC-133,44589607,3.1305768616958085,2.5257922436756415
LOU-NH91,42642645,0.5799169530603235,1.0063990895756172
KYSE-70,51037431,6.2873914521382765,3.0847945367336695
KMRC-1,1566236,3.0378094444517645,2.4512928233261153
Panc 04.03,42642645,1.6619965718360328,0.9901754451709242
CAL-51,3689413,0.5709426612715743,-0.5763460473871403
NCI-H522,44487872,5.4176039717063915,4.55473046529828
NCI-H2009,16722836,0.9347693241342916,1.664783970415145
NCI-H522,11222830,1.4433136379668847,1.5814867818894571
CA46,72193861,0.1338517787347367,0.7497955015437282
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,0.6927835043492685
LoVo,119607,4.4096130331744865,5.009962218676525
MDA-MB-453,1566236,2.5975650319928434,2.1024885214577043
ONS-76,11152667,-0.1692604119623072,-0.6763320021961431
G-401,24748573,1.6686206591324024,1.7720560920800796
A2780,176870,3.0464675702719655,3.175789615989505
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,0.9667156109962685
OPM-2,3385,3.5898560550490837,3.054410499780656
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.582347052563952
NOMO-1,53495165,-0.0338576092201104,-0.6390179862541575
LoVo,46191454,2.275591949439888,1.6836733672040458
A4/Fukuda,4096211,1.2598455852625392,1.6774116358197577
NCI-H522,25126798,3.91575296607237,3.8668254501592116
FU-OV-1,135411,0.8541212220651947,0.789523885818481
KYSE-70,10113978,1.960067513789881,3.1708406427735536
FU-OV-1,24856436,0.8416503079264269,0.46878707168257727
A-498,10026128,4.231838396167064,3.8600295619158516
JM-1,11626560,-0.1801568688824005,0.8411954814388791
NCI-H460,9911830,3.1326305509826824,2.5780585904708015
A-673,9911830,1.9751375507094395,2.5000798769675994
Panc 04.03,71751553,4.683117627568525,4.437573011846484
LXF 289,6450551,1.9915066986525345,3.0312897317483998
NCI-H522,156414,0.937566519659893,1.332506365461353
MDA-MB-453,6610355,3.820285868995436,4.4985783130537875
FU-OV-1,46843906,0.6915308493256752,2.791544120340419
NCI-H522,42642645,1.4297074042386375,0.6630923185339209
SCC-9,4917,3.683292695011318,2.9859009146843984
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9544098018494228
SBC-5,54649381,4.189343649803657,3.7566653741770155
NCI-H1623,6918837,-3.3974396350468674,-2.8651401543754016
KMRC-1,10184653,1.755388017214173,1.5991815231177051
LXF 289,9967941,3.6599941581067057,3.5472716896923333
FTC-133,57519531,1.7209799050566308,2.5313349526138307
NCI-H661,19582717,3.3132894226769056,4.0225527999351245
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.7824337902332403
LoVo,71466578,1.8530080227063717,4.007555796953581
NCI-H2009,46907787,0.5680124512944033,2.2259521408249183
DMS 273,49793307,-3.720971975288363,-3.5641775113605156
NCI-H522,135659046,3.4944475458884012,3.672375556684731
FTC-133,5351362,2.946320615286136,1.5551497718135576
JM-1,208908,1.8689748302954872,2.054380556283985
Panc 04.03,216239,3.3806837686851923,2.378604335333385
NOMO-1,71466445,1.8310961714544176,2.665331119992046
NCI-H522,71680916,3.6078643166976896,4.557830536148279
EFO-27,2126,5.846579140474247,4.655201101361909
ONS-76,5284616,3.539643222518188,2.808851887031283
SCC-9,16736978,3.1048488109971664,1.4851325556535955
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-4.1330369407335255
A4/Fukuda,23582824,-0.7377224087572002,0.7569863444450212
NCI-H661,53325874,4.390083123893945,4.45921433633256
SNU-61,4096211,1.05462843518756,1.897995324845221
CAL-51,675434,4.354107922133551,4.597158240780125
NOMO-1,11175137,1.3676050257567425,1.8336684348415033
NCI-H2171,5335621,4.282845813975702,4.266572887633498
SNU-449,11647372,1.9881649315547345,1.465092116459261
NCI-H522,3503,2.0960599148243557,2.2652430233727063
NCI-H2171,52947716,1.4567314464455066,0.42656235269660764
NOMO-1,5291,3.5817896511091862,2.683563540203337
NCI-H522,46843906,2.3044802452603967,2.9651971659598013
OPM-2,11494412,0.3054873199299708,0.7527129334844648
A-673,53495165,-1.305348317827654,-0.08768546527149373
KYSE-70,54618771,1.1170424016733127,1.3626839107236548
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.073974139101641
SCC-9,3062316,1.318086870144001,1.0479089011824096
LoVo,387447,-3.727342469020989,-4.155680565708289
MSTO-211H,73707386,2.8647689708389943,2.9541259558244075
FTC-133,54613361,1.5430217136639572,0.07644705716449107
SNU-61,12001922,2.043150446887516,1.8421421262865743
DMS 273,374536,2.442253811681885,2.072612736559521
LXF 289,10302451,1.735451917587997,3.2843647394810898
CAL-51,2858523,3.1959449804225524,3.1451100270472834
Panc 04.03,23582824,1.118403221753994,0.9714363500397049
KMRC-1,6505803,1.455434702084088,-0.4303766822500277
CAL-51,4261,2.4552246887350417,1.4093463360480194
SCC-9,5746,1.774962232755205,1.2079904027299144
NCI-H661,71466578,3.739107690689307,4.303872106039599
ONS-76,54619267,4.0364090976663,4.025235626512476
NCI-H522,100016,6.692385014202011,5.9097370735438925
G-401,11719255,3.853695059500007,3.2958927064852843
HSC-4,3815108,3.178044313970192,2.8293323188262165
NCI-H2171,5287620,-0.0573950216422359,-1.88186970198458
A4/Fukuda,5311,-0.1264358008137528,0.9313397510428358
NCI-H292,387447,-4.003442188855186,-4.368108817029485
OPM-2,148124,-6.3849256320012575,-3.773081365653989
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,0.32530818575393156
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.838507439101416
CA46,9967941,3.699441503938977,3.219656480487447
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,1.0891606950993387
LXF 289,387447,-4.093727880786265,-4.316370730050769
CAL-51,5113032,4.55807021159329,4.829851520278222
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,2.068685812494603
OPM-2,241158,1.7102591321182437,2.9398795571678464
ONS-76,16741245,1.9308546797770672,3.9184999031749004
Panc 04.03,322968,5.075488138121087,3.7347578056344304
BT-549,135875424,3.804392758634582,3.8355946388862554
A-673,54626689,4.6393725921997415,4.614756581683893
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.3322653137234315
HCC1143,3543504,4.280043771428645,4.304905972399072
BxPC-3,107970,2.2592769610294448,2.32543870220427
ONS-76,51037431,1.0002101292366832,2.8877163482493153
G-401,24785538,-1.0602782345595374,1.4485637128867221
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.3110066957252755
FTC-133,676352,3.9949531967924297,1.9809437619684394
NOMO-1,53232,3.2414615649348772,2.598869868495654
LoVo,11625818,2.0848313295223844,4.325587218633698
A4/Fukuda,702558,5.147225783500614,4.944750984958734
NOMO-1,11455910,0.2303469505827257,0.6603894491896278
SNU-81,4096211,1.97800800333133,1.6193481881338616
NCI-H522,676352,1.6559488811299496,1.9545188105309004
YAPC,60750,-4.781219880342373,-2.1306458393266734
Panc 04.03,11612883,3.751429287253437,2.928245423555525
NCI-H661,67156097,-3.370555704228358,-1.0530685884651125
SNU-449,4705,3.898593282840832,3.2309785177181336
MDA-MB-157,9952709,2.6586157499418444,3.1837137394881965
NCI-H522,16038120,0.9671280612186928,0.6959814857136957
A4/Fukuda,4259181,-0.5702867723998835,-0.19147407302309194
LoVo,135398744,6.330186357549225,6.456376875475899
OPM-2,637858,0.8070227403937857,1.2150644588740658
SCC-9,3038522,1.9571402343301385,3.0511524802003107
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.8850324488140376
A4/Fukuda,10127622,0.8035335483112384,3.2563424846722477
Panc 04.03,4378219,5.53220646065493,2.33278524169487
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.1267345952305121
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,1.442569955282922
EFO-27,11396600,3.826824277303455,3.787606442565771
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,0.9912318610985617
NCI-H2171,7251185,0.8673768610035957,2.3777954972727606
NCI-H1623,5311281,4.903104817913162,2.317910101549977
OPM-2,11317348,2.0151792351474755,2.2428002065462587
OPM-2,100016,3.804278037815123,5.674850434532085
LoVo,46224516,4.94892102130723,2.4926930418999422
A4/Fukuda,9826308,-1.4955537783248567,-0.14037720767558537
LoVo,15547703,1.4569683263207862,2.645881936529299
LoVo,227681,3.064150517180394,3.1648344604112104
NCI-H727,5460769,4.510942150258337,2.946019952189384
NCI-H292,6918837,-2.538558148903755,-2.813077610004317
A2780,132971,2.947129832610188,3.071503774848391
FTC-133,4788,5.605324981437421,5.654302173906425
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,2.6452491531033315
A-498,23582824,2.0595934555669886,0.6828639048949634
SNU-61,8515,5.6731171982359365,3.7296356389691696
MDA-MB-453,23582824,0.0198148722876335,0.7772073278795143
DMS 273,5329102,2.038563375095403,1.9752792998798514
NCI-H460,72193861,2.1658883750752844,1.8432524494852636
MDA-MB-157,6610355,3.680589360872168,4.497694513952545
Panc 04.03,56649450,4.182465283011193,3.1270923239246087
NCI-H727,124202324,2.79148434895864,2.2554103439186486
MSTO-211H,24772860,-3.3585393605141824,-2.1114225093108114
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.5410572505833462
CAL-51,20959075,-3.1196535578382987,-3.115300838891652
OPM-2,322968,0.7466819505545055,2.7007807303264433
CA46,984333,-2.431082434536014,-0.024009807363054497
JM-1,1242560,2.356943306915098,2.992022024849654
NOMO-1,25126798,3.9519848152055848,3.560152489828173
MDA-MB-453,5738263,2.9414099779046934,3.2945487171231953
OVISE,10074640,3.3556303567674064,3.147196695282978
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,0.6724138738392252
MSTO-211H,159324,-0.971759723426381,3.172272220720444
Panc 04.03,46191454,2.0071895522726377,1.7567966622921931
SBC-5,9826308,0.1778598819423294,0.1130710027697303
BxPC-3,1641662,3.0109567862503654,3.591145695489465
NCI-H460,2708,4.613368759945332,4.8854348391383215
MDA-MB-453,2746,1.6853152695376463,2.979771746384374
NCI-H292,2858523,3.0406792249868633,3.01158908820287
LoVo,52912189,0.3784309245329977,1.6198454186500486
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-0.5372347309940091
NCI-H460,9936388,2.3098343611543415,-1.0281299632194045
A4/Fukuda,176870,1.9874765150136215,2.8160024480208943
LOU-NH91,49793307,0.2442451207819767,-3.1832777388066593
MDA-MB-453,2945648,2.145365576847094,2.721284049543298
SNU-449,54596490,5.440438718305218,4.733608696188437
NCI-H2171,9927531,3.1501077196413783,4.781168486731775
CAL-51,25150857,2.2346870378683934,2.4189108591116555
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,1.823153369639717
NCI-H727,9444,4.415864627267573,4.076578470123613
CA46,71466578,1.7711352492213497,2.9088621415514124
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.251951307617002
G-401,11507802,0.4930201538787991,1.1482580336236685
OVISE,11214940,-0.1911189695405239,1.9196094849729086
MDA-MB-453,135999136,4.2113637134750395,3.7431470748955102
CA46,445455,4.357290874085763,4.060407389376275
KMRC-1,5335621,6.052276706579308,4.414242412702766
Panc 04.03,36462,3.526332093717117,2.6351559124472397
SBC-5,56963564,-0.838635946263744,-0.034790214560416956
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.197811451554071
NCI-H727,46224516,2.477743379244975,2.2936704630363915
NCI-H292,11222830,1.205012148013641,1.5371646865999766
MDA-MB-453,24771867,4.091824937074987,2.5574345937415806
NCI-H460,72376,-0.5460239014371263,-1.4650861242587365
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,0.947342286499363
LXF 289,9911830,2.045852319971143,2.685024515879151
LoVo,1242560,3.2639930925900305,3.5928711271607456
NCI-H292,6918736,3.734181331597608,-1.8453018588890386
G-401,11717001,3.7897150646045863,4.042050222498697
ONS-76,46398810,2.9642978938134004,2.5198932102436165
NCI-H522,1242560,4.210520049105227,3.446253645416741
EFO-27,3081361,2.362036241237279,2.3527913197056796
SBC-5,11222830,1.4112085967579189,1.3826249488662807
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.142631313057018
CA46,11213558,2.4131379110887496,1.0967280772904118
FU-OV-1,6918837,-4.1157354170673495,-2.828250950928458
A4/Fukuda,56946209,-6.395954164738885,-4.4797919519343425
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-0.5451877134074897
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,0.8330571209542533
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,1.1747155352599123
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.1063703211435163
A4/Fukuda,216239,1.5760740052804734,2.140783392384446
FTC-133,4578,5.173307644971936,4.397044879257148
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.1623264695546727
NCI-H460,54618164,4.49670945938676,4.089877563755588
CAL-51,42642645,0.4324607401831485,0.8312756295575534
BxPC-3,24771867,1.9124988819938955,2.453855388053576
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,2.0533678561742494
NCI-H460,15953870,5.00315267734786,3.6386635961917477
A2780,24964624,-0.4628922796959323,2.040970412665119
CAL-51,654092,0.82886283906252,-0.4601928621300256
G-401,5281321,-2.57337969869382,-1.7294381293399095
MDA-MB-157,3634881,2.7842407118999852,3.2548812377881244
MDA-MB-453,42642645,1.5292302084545462,0.9979877914603709
BT-549,54618164,4.423974096662665,4.115617489935669
A4/Fukuda,16741245,4.963846947143099,3.758689928437882
BxPC-3,44632017,0.4026385498906549,1.4553756053464566
ONS-76,9911830,2.941904202808556,2.539464901319431
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.9005719786392367
ONS-76,4477,-0.2351585842599584,0.6751460891901437
JM-1,44493528,3.997956862382446,4.300477942644753
NCI-H146,5702613,3.149923076768629,3.031072506164873
NOMO-1,25150857,2.063048355345986,1.9608620574650428
LoVo,24856436,-0.7244956111709783,0.15565534783671123
OPM-2,53481919,3.0492738202957206,3.1868557996482765
BxPC-3,44507138,1.658490789748868,2.6996236384333603
FU-OV-1,2113511,4.466585490981426,5.272264202376082
NCI-H661,2749,0.7713739826565964,1.8065833605937383
NCI-H1623,53495165,-0.5563852526996439,0.18755059856619624
NCI-H522,6610216,4.154510920860766,4.309975264330024
BxPC-3,148198,-2.171424706341701,-3.2694816770326374
MSTO-211H,4788,5.119342350142264,5.606888803427995
A-498,1750826,-1.7479882416802337,-1.5787629004327945
HSC-4,136227924,4.2199200707906845,2.96740492225578
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,2.747677560828031
LoVo,54618771,0.7060685526757626,0.6451332394208503
DMS 273,10322450,3.6367733537116167,3.6965437661496447
ONS-76,1750826,-1.6505794475434372,-1.6013390720792182
MDA-MB-157,135440466,3.174924928897617,2.320906587419087
NCI-H727,241158,6.115461447477091,3.947254628061598
HCC1143,46398810,2.1694021244377333,2.544984662416753
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,1.3611500701088182
SNU-449,3062316,-1.3612378425924234,0.497662210966798
SNU-449,11977753,-2.005546044599541,-1.8830148084053908
JM-1,24771867,-4.48997165682624,0.32442737569690894
NCI-H2009,11507802,1.1556617167312242,1.8095336583073816
HSC-4,11964036,1.64347500999081,1.302213326979498
Panc 04.03,5479543,4.112837907412102,3.4665760188029653
ONS-76,439501,-2.2755976390662163,-2.3242334768192645
JM-1,54639126,4.392955654749798,3.0423806845708494
CA46,11167602,1.6890466560929325,1.9343065135521005
CA46,135411,0.0331424760277949,0.399846249200341
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,1.68496408204813
Panc 04.03,11625818,5.081289492721679,4.374546903531121
NCI-H292,12001922,1.805770236255338,2.007923678715426
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.9468357933688893
MDA-MB-453,5278396,3.602107220771141,3.5375034547706097
NCI-H522,6438330,2.681865372615506,2.0284679496491633
A-673,71466445,2.638210082463498,3.41514578764813
MDA-MB-453,25105715,3.2581724710849778,3.5318463386232564
A2780,17759555,2.3500586644289165,3.6330761412590493
YAPC,124202324,3.68667481758741,2.3707824032393203
NCI-H522,25227462,-0.4562280137645088,0.104600766526831
KYSE-70,10074640,3.109810551584267,3.060276424344741
HCC1143,5278396,2.995823973274505,3.327279677793355
HSC-4,5479543,4.052409111099337,3.4111193065820165
NCI-H661,446155,0.1985182541705634,2.6545090316227293
YAPC,53495165,-1.0203233667221312,0.5116474331269107
FU-OV-1,11719255,3.4823701199113097,3.4117231597131106
NCI-H2171,5278396,3.2627520221828115,3.3871534427055217
MDA-MB-157,9911830,0.0801478348660684,2.6693178000541553
OPM-2,9911463,3.091122447781221,3.280979612903897
LoVo,25126798,3.7423562181337338,3.7887705383298202
EFO-27,9911463,4.361076045114702,3.850103263748933
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-3.8088222509416165
A2780,5280436,2.9198027340920434,3.0238797578878946
SCC-9,5311037,3.6943722712183007,3.9341180406992997
ONS-76,5978,-2.168221630618191,-2.1242532247808557
A-673,44819697,-3.745571155852308,-0.6618437358870441
CA46,24785538,1.2011715151517115,0.7723516105719619
HSC-4,9936388,2.361545024779824,-1.777517120089405
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,1.7663855630672205
NCI-H460,49793307,0.4479933662320887,-2.581986787344072
A2780,64971,1.607646338152048,2.585348371201854
JM-1,72193861,0.5763432020354632,1.2175625623588542
NOMO-1,11625818,1.7683333213472852,4.094739430677982
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.6647747937411106
MSTO-211H,11507802,-2.113337212450165,1.7462530517417818
NCI-H661,53232,0.4849867031297817,2.4530434554707328
YAPC,16720766,-1.1916244870670316,0.8529658266522553
NCI-H522,208908,1.8410391152152548,2.2948476539616394
MDA-MB-157,5284616,2.798393493195082,2.4858600297894378
MSTO-211H,6505803,-0.0669493563910609,-0.5481679038419519
NOMO-1,56649450,3.0749194455734012,2.641682841725014
NCI-H727,9967941,3.73486297967426,3.617568560488424
SW1463,15547703,3.1824451623977312,3.190569856169461
FTC-133,24951314,1.987520160616717,1.3245820757749625
MDA-MB-157,24772860,-2.2599749907314175,-2.0339552614607603
G-401,2749,1.3663456978729704,1.6880805037496942
BT-549,16065773,1.5788570773866877,2.3484457517579798
OPM-2,11955716,-2.9191891869850015,-1.9727328197316205
NCI-H661,176870,2.3474624932942207,3.3571155484651585
NCI-H292,66577038,2.9683700205355765,3.0384858000399184
MSTO-211H,54143018,-0.309857947329572,0.6212030302930635
OPM-2,3634881,2.0291765129520467,2.7703723055053495
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.3876366039531527
A-498,44607531,1.7098722083353044,1.549190262644195
KMRC-1,2749,2.412459730094544,1.9064759507202311
NCI-H292,57519531,1.7489075965122454,2.3260067746822215
NCI-H727,11404337,0.8145711342672778,-0.4714150813392893
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.902184354570318
SNU-81,107985,-4.076050447844214,-3.6172602229450233
SNU-61,24785538,1.5668080683488936,1.4946551342174528
SNU-449,56946209,-2.472995255165521,-4.17085648942067
KYSE-70,452548,2.3575041584151637,-0.006401892605311322
BxPC-3,5280436,3.644569175052812,3.4426135477953226
JM-1,409805,3.649428990507172,4.432330535392221
SNU-81,17755052,-1.02795410661762,1.6417430359227334
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.380854009687146
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,1.9592061802996925
G-401,54618771,0.8582285882331511,0.9386433831911742
LoVo,4788,4.577300245187766,5.57261068015774
A2780,24771867,-2.9740519428749055,1.8499393045016785
NCI-H292,4261,1.3935441456482582,1.610048190725847
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,0.9266805828127292
NCI-H522,2729026,3.0595997973682043,2.61868507979382
MSTO-211H,448949,1.6774063902575909,2.1351564710869138
BxPC-3,9825149,2.348819386499172,2.33442448228171
NCI-H522,44607531,1.4505766804532754,1.4052161890427277
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.7854509054803498
A-498,1285940,4.242355519484504,3.6022281513931307
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.029588054142963
NCI-H661,44543605,4.030509034099432,4.138276462305573
CAL-51,12003241,-1.2189714227076325,-1.45719613173675
A4/Fukuda,135411,0.1560078623072997,0.42924328861181815
HCC1143,675434,4.285446752444937,4.561703489883723
CA46,11719255,3.04595311036835,2.9776541126014253
BxPC-3,654092,-0.3546902897816355,-0.05352481048502848
NCI-H292,11238147,1.7384499640365698,2.7356093857896595
LoVo,285033,-2.045623665035502,-2.294389215122417
NCI-H1623,136227924,2.959018127447204,3.06064304578204
OPM-2,5329102,0.9197947820907424,1.4772157019851093
OPM-2,208908,1.37961789198716,2.0818497032831194
MSTO-211H,124202324,2.766151060695559,2.4668113160750003
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,1.9163756259322247
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,2.538394318885633
SNU-81,55508,3.0035688840672767,2.8579305923672806
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.42695933741069103
A-498,24821094,3.8657770123239574,3.2852844469282245
DMS 273,6918736,-3.620580414510608,-1.8583277239313665
JM-1,3062316,-0.5573937765637444,0.8017694465249366
JM-1,56649450,3.7062904943567263,2.4629843440735324
SBC-5,24856436,0.2896075356546521,0.09002326849549305
BT-549,285033,-1.3520552126123144,-2.0280247858652865
OPM-2,5746,0.8583790934138843,0.47651750414364985
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,3.8598686003994693
G-401,6914657,-5.660532663542792,-4.358654733615995
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.8881686031472786
HSC-4,2858523,3.1192513569149245,3.0917602150300443
NCI-H522,675434,4.236381328267226,4.516630660400662
CAL-51,25183872,-0.1080661998677032,-0.7394005245441236
BT-549,4259181,2.4625999028961743,0.02201657510513885
NCI-H522,11455910,0.4156799864056491,0.9841945953904877
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,0.3277805156695739
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,1.6138318678030945
NCI-H460,3543504,4.388423548450019,4.4983031387900505
LOU-NH91,11626560,1.802766880846386,1.7927655017080226
NCI-H522,2871966,1.782445654343025,0.2940294365858965
G-401,135440466,1.822823734742602,1.950616564653857
A-673,10172275,4.325815901444083,3.516551777186322
LoVo,3385,1.4948122184820352,3.6366335508789023
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.092439568652067
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-0.6884948027958074
A-673,637858,0.7164978632133837,1.7406080664138224
OPM-2,4915,5.457147549775398,3.7208455578971935
CAL-51,11626560,0.7349282975065881,1.861307241831879
NCI-H661,2729026,2.3445725854556696,2.64599118475794
KMRC-1,25126798,3.86147373401716,3.8553094187774586
KMRC-1,107970,3.035071998795665,2.373441862276217
MDA-MB-157,16219061,1.3123257474603047,3.306470492801297
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,1.9306738511124746
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,3.301569440234833
NCI-H2009,24964624,2.271229049936602,2.6805449375348496
NCI-H522,7251185,1.2190943442977031,2.4340425064731765
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4715398744761363
G-401,52912189,0.0594470173160698,1.408037876245769
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,2.3176196828583118
OVISE,702558,5.699669356311473,5.163811475654569
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.6658186511928068
EFO-27,54678924,2.818156902929417,2.068107519036612
LOU-NH91,44607530,2.1348137775706646,1.7939664776948374
EFO-27,24180125,3.663788732934096,3.003786524116693
NCI-H661,135421197,1.0600684669241136,1.657465682243712
MDA-MB-157,56963564,-0.5852778857487072,0.0617430331030109
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.8529715814278497
LXF 289,6505803,-2.367756082461904,-0.8610531038373384
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-1.2076498624773542
A-673,5278396,3.572368012209165,3.440890611526155
MDA-MB-453,135421197,0.8806711164351635,1.8916712149241033
NCI-H661,11396600,4.301216087095742,3.3582456407313783
G-401,148124,-6.018913106580182,-3.116098426208041
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.3278222182686754
SNU-61,208908,2.000237947522829,2.2050826548006546
NCI-H661,5329102,2.676948448482624,1.8456995625298211
NCI-H146,148124,-0.9007997951548676,-2.838855894505099
HSC-4,446155,4.1145986724492865,2.7074334014486747
NCI-H661,3825829,3.711058317012711,4.079056896603222
OPM-2,135411,1.0006691045824918,0.2526847897625746
CAL-51,3815108,3.0623029951861396,2.8470940345596847
NCI-H522,2858523,2.9817407099898676,3.0218567690436853
YAPC,2708,5.2324194580289065,4.599442818931124
Panc 04.03,4917,3.7974030923782274,3.058044738065772
KMRC-1,51039095,3.0507646213845008,2.909868868567779
MDA-MB-157,44632017,-0.0621812067979977,1.27078156872152
KYSE-70,613753,3.646356391333843,2.9780003012158716
OPM-2,11364421,-7.162542415885671,-3.72392667587785
KYSE-70,11964036,0.6479741930424838,1.3585174520103802
EFO-27,9915743,1.432055126276498,0.8633672754750645
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.3194563547762193
A2780,9935249,1.4583070792637778,2.8074837811245756
NCI-H292,25105715,3.507158893285561,3.5217664736624865
JM-1,5566,2.903571956440186,2.691895698106281
NCI-H460,16722836,2.818869820371906,1.623111013358061
MDA-MB-453,71466380,3.4268898477848784,4.475230173820885
MSTO-211H,24753719,3.2448003358152286,4.221646499913791
JM-1,637858,0.5231851777275447,1.281162282533732
MDA-MB-453,11152667,-1.4808178636693017,0.11128255750387553
HCC1143,44185566,2.5224843451498273,2.466407945268279
SBC-5,53481919,4.872311947173971,3.6209375607589145
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,2.0185862250521853
LoVo,3038522,4.270533501697307,3.2414843886523164
OPM-2,5280436,1.5288125622159816,2.834815019597391
A-673,71680916,4.0499723530429295,4.554263330651037
LOU-NH91,6610355,5.077923698507978,4.29639002474508
SW1463,10127622,-0.1211197806374188,2.8984274656237368
ONS-76,2126,3.999900921085769,4.554751750853223
NCI-H522,53301938,4.938312106360689,2.1168885459384152
NCI-H2171,3552672,1.63504499488054,3.0022331993103926
SNU-449,375860,2.655390537146391,-0.4177267584106001
MDA-MB-157,54626689,4.568687551235484,4.7334923347769715
KMRC-1,5746,2.0919022066371484,1.3006958678337524
CAL-51,24964624,1.6704816041215405,2.516417419924062
EFO-27,46199207,3.7203826311454096,3.1560764465259017
A2780,439501,-2.4090624878410316,-2.275790612768146
LoVo,89183176,4.107889784939482,3.884803004764871
NCI-H661,24772860,-4.399665014096174,-2.081767330673644
NOMO-1,46224516,2.27353152393119,1.7403740773497347
NCI-H460,5281672,4.99885948312363,4.6250032565883625
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.5484275528363378
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.6026597515655558
NCI-H460,9967941,4.030885542149613,3.940810633902895
NCI-H292,44819697,-0.5623825720804246,-0.5288484043839994
OPM-2,216468,0.7655721379939343,1.8261756019131417
ONS-76,60700,0.0915142349819345,-0.18487845654221707
YAPC,17755052,3.2330221121257874,2.124561898581291
EFO-27,444795,5.488221670965637,4.349426054386857
YAPC,24797083,1.6153709299916277,1.391416670568811
NCI-H661,51039095,3.3700376717556315,2.3365812137067166
MDA-MB-453,25154868,3.2796937080857296,4.34996955310312
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,0.6809957984098882
KMRC-1,9911463,4.4126092990485395,3.9432069692368685
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,1.151796766362178
G-401,107970,2.0352708529532824,2.0801085540966433
FU-OV-1,25195348,3.3767609447508846,3.131794069091258
NCI-H1623,11234052,4.315313421055944,4.031406932182564
MDA-MB-157,151289,0.3130009139891556,0.8203699632890762
EFO-27,56973724,4.318199286965652,2.9535855415882435
NCI-H460,5328940,3.322075361136407,1.8006338309885657
NCI-H2171,11964036,0.8555185627034467,1.2405065031822609
Panc 04.03,24821094,4.144896314615952,3.132689333611909
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.1548038780528502
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,2.489745546908314
FTC-133,5280436,3.005172717589714,3.1767250502132716
NCI-H292,49766530,5.348764781206105,-0.49420979139092025
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,3.1340957286390516
FTC-133,219104,4.114698267906641,3.360527084323995
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.2305925996703744
ONS-76,6918736,-1.0728340962982743,-2.197102770850388
A4/Fukuda,16065773,1.900447949816596,2.2443809156008148
FU-OV-1,25126798,3.715640842708804,3.7841009811426884
NCI-H460,6505803,-0.4074860596498978,-0.6894008651564905
ONS-76,44491742,4.314760532803232,4.134882110007227
MSTO-211H,6914657,-1.9341273237470331,-4.053144780417207
G-401,136227924,2.3105932180874365,2.78595284896716
Panc 04.03,148198,-3.912302089259141,-3.3705794960569193
CAL-51,23725625,3.781531245600544,4.896630624049336
NCI-H1623,7251185,3.63742147878688,2.699744557814924
A2780,44589607,1.4452328541597397,2.6333140283308283
A-673,675434,3.949120496105267,4.445944599239532
KMRC-1,25227462,1.6145893273286742,0.45716826773127783
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.666647012117986
HSC-4,2749,1.8453067540575636,1.5644941607901037
DMS 273,6438330,2.6669951536881182,1.9574337089406149
KMRC-1,44491742,6.09620831621162,4.536972169345847
MDA-MB-453,3465537,1.8912554302439897,2.403141698228719
SNU-61,156414,1.6812768260110038,1.0267747764989559
YAPC,11625818,4.8006567630911094,4.215535049718363
CAL-51,9911463,4.251278022142156,3.6799041667016015
MSTO-211H,68056272,2.8034566103574825,3.691200855444018
OVISE,9911830,4.830872688345326,2.507122037422619
MDA-MB-453,6917907,3.1299164846836796,-5.160482109253103
SNU-449,9444,4.238096768887569,3.9484867136094848
SNU-61,3062316,1.255261088163193,1.181572705302805
A2780,11178236,-3.658526043242797,-3.5098878276950956
MSTO-211H,219104,2.9811404214526136,3.5916068724907673
CA46,11364421,-6.636542851208846,-3.5228753210644768
NCI-H1623,3689413,0.664737487618683,-0.1080777213059908
YAPC,9907093,4.959151627500645,4.203828194502318
ONS-76,19582717,4.438276624405871,3.9867841216246727
LoVo,446155,3.732759169917468,2.7396099526151123
G-401,5566,2.967754959970698,3.0179321582063054
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,1.5885547299532519
HSC-4,9884685,0.6492053944574516,0.48033323218725227
CA46,4788,4.772802977698259,5.254562212967182
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,3.2714869700449225
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.3174005702278089
Panc 04.03,6918837,-2.8853122799888085,-2.802230936920281
NCI-H460,71466380,4.4879606530616725,4.406325998306404
CA46,25183872,-1.226882585953409,-1.8883683350028395
NCI-H146,12001922,1.0892970499924846,1.7823082996385318
SBC-5,11625818,4.225517908096314,3.9704771051023524
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,0.6282934259251842
LoVo,2708,4.2308362163689415,4.630350300127983
OVISE,72193861,4.281646205908775,1.5909659607446158
NCI-H460,16720766,0.8258921674033131,0.769079605114927
LoVo,4378219,2.040258922351895,2.185658710458079
MSTO-211H,24901704,1.657456360567008,3.2383513325406454
A4/Fukuda,4477,0.5783674149898913,0.49202231380481765
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,2.769526274374988
CA46,107985,-3.181693098398671,-3.8831808895305726
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,1.031238280960641
EFO-27,19582717,3.374407024388894,4.202102697741409
NCI-H1623,15953870,1.9962949386047493,3.34594768580254
FU-OV-1,46199207,3.737847668041784,3.1319924272257462
A2780,11213558,0.737897067491707,1.4825317202956843
NCI-H460,9926054,2.081701465030928,1.9413983054348602
NCI-H460,11404337,1.7201854837770862,-0.191594304671769
NCI-H2171,2749,1.9442537074322577,1.678161272971065
HSC-4,49846579,1.975916395804951,0.8605265245306002
NCI-H2009,56963564,-0.2763231945711286,0.7213063855163214
Panc 04.03,3825829,5.002168928220905,4.137525329420764
HSC-4,5738263,3.918173826320675,3.288941018079305
MDA-MB-157,9926054,2.0716850398098368,1.9258333986968637
OPM-2,50905018,4.056598853615348,3.8727981790904216
BxPC-3,9915743,0.4274244099837221,0.6838551147618581
HSC-4,16725315,4.164866459292326,4.233206452434201
SCC-9,11175137,3.431057653368815,2.6013365440691545
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,4.340936980294717
NCI-H146,107985,-3.379993708562796,-3.4702530936087737
SNU-61,3689413,-2.128463404187725,0.09514880470175097
KMRC-1,9903786,4.024109374851969,3.0318857801773733
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,1.6638166847608136
SNU-61,73707386,3.625444775073466,3.0812772751847906
ONS-76,11238147,3.0900457426442864,2.621431716141304
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,3.4038831140595254
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,0.9055676172457496
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.941605083589125
OPM-2,44607531,0.9426576866563848,1.293552851108405
BT-549,409805,3.826135579342285,4.8991368966549995
G-401,6505803,-2.085126737120111,-0.7271235033547839
ONS-76,9866186,2.0020907987509657,0.9179769700366444
BT-549,1641662,3.5282995747020514,3.4830508221623937
MSTO-211H,3384730,2.0695323326007387,2.908954576738076
NCI-H292,439501,-2.469830491210978,-2.3413737932174454
NCI-H2009,11964036,0.3874991337590915,1.4608199750872919
Panc 04.03,9840324,5.85151623174837,5.795489698954237
NCI-H522,5311,1.356899837189567,1.3862764641430845
ONS-76,5311,1.4287655491580966,1.291781146972092
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,0.5586538397398997
EFO-27,24775005,4.127014722833266,3.766475389553772
NCI-H460,5278396,3.885794996406102,3.639131174871788
NCI-H2009,23725625,3.8804106674125713,5.162174977145533
NCI-H146,25102847,3.053262776547781,2.5488597577757712
JM-1,11396600,1.6173586604508372,2.7808414286770087
SBC-5,168312962,-2.5718885882949896,1.4645487140696323
DMS 273,46215462,1.755765775691153,1.6686797300469238
YAPC,107985,-3.02393363080246,-3.762963734577545
KYSE-70,5566,3.0340425256076813,2.9476315163560436
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,4.014078147807536
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.7837930243946385
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.7508104779793604
CAL-51,11404337,-1.4033364127444676,-0.23618947082084446
A4/Fukuda,25183872,-2.565081518812491,-1.812442622663427
SNU-61,3815108,2.973673139417603,2.755335098000628
KYSE-70,11507802,1.463595053056406,1.3287255599999925
A2780,10296883,3.5268945611299927,3.7844757432219565
FTC-133,24797083,1.5806228477994335,1.4161856410354055
MDA-MB-157,122327,5.563359607134461,4.810869740226817
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.6861897745814324
NCI-H146,4378219,1.8118272794434884,2.686815190113864
SNU-81,54143018,-0.9079963072010888,0.26754879936315357
NCI-H2009,49850262,3.4451640543988233,3.800535564281243
KMRC-1,54143018,1.481383467839363,0.5498789371133899
NCI-H522,11507802,0.900021964921284,1.181528121548278
A2780,6438330,0.9178294762259074,2.0360204529816675
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,3.3123397437589204
SW1463,82146,3.98984472956996,3.6269166899823198
BxPC-3,135984461,1.8776729747018608,4.001053839180102
NCI-H2171,56946209,-6.55665845628197,-4.348841122839247
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,2.58380318464925
HCC1143,54619267,5.25191473393144,4.069385551704647
NCI-H2171,46907787,0.7633638606493435,1.554755694709646
NCI-H1623,216468,3.833399887526913,3.2987254217223363
MDA-MB-453,9803433,3.6839578739817935,4.598251166466376
SCC-9,11955716,-2.333323067647372,-1.9919775518083391
A4/Fukuda,54619267,3.184419267966046,3.818745568877156
KYSE-70,387447,-2.8804562370412765,-4.135198566912166
FTC-133,135398744,6.510037604259866,6.4830035043342615
CA46,2842253,3.7037662444842696,4.573870106062792
BT-549,12001922,2.460799936977109,2.047598348307889
LoVo,107970,2.0597080136849795,2.3419775007167534
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,3.7529860619522126
CAL-51,3385,3.064238699960593,3.7146648531517865
CAL-51,375860,-0.3577134594482877,-0.40127935345681487
OPM-2,3025944,3.8735985412418943,4.152933496139564
NCI-H522,53325874,4.347038439567835,4.429424888307061
MSTO-211H,216239,0.7405720543436254,2.3688909617993326
CAL-51,9868037,3.5441777448678615,3.235497764192366
A-673,49836020,4.096681472773702,3.4341669326261774
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,2.437404125945059
LoVo,49836020,1.6927786584323,3.4112534137465627
OPM-2,5291,3.3293230980723254,3.3343589921148062
LOU-NH91,9884685,4.047485572984955,0.566387756347222
HSC-4,36462,0.7755986988683452,2.2025967366992814
SNU-61,46907787,2.0753699666277936,1.5574800313510786
NCI-H522,5951923,5.621144710124551,4.290545687021294
SBC-5,445091,4.3721050746953845,4.2331867076747605
MSTO-211H,6252,0.7966303392140095,0.835495420464263
MSTO-211H,6610355,3.5448971464264507,4.504816423534969
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,2.2712758360695564
CAL-51,15953870,3.220977372988981,3.3086519008642368
NCI-H460,25150857,3.536831166282903,2.3494814449692885
DMS 273,3854666,0.530051590236263,1.605868517026095
LXF 289,9825149,1.6285560242869113,2.2913610924318863
NCI-H522,67156097,-2.1513446238308656,-1.0944662930213827
MSTO-211H,3062316,0.3213577633457804,1.2332384701328878
LXF 289,11485656,2.2610473771175847,2.398132054528119
BT-549,4477,0.6326595549350394,0.6277903687263999
NCI-H2009,54454,1.843451372115344,2.6154756190925377
SNU-449,16013152,4.866412327860677,4.217882905865293
SBC-5,16115403,-4.662279180425711,-4.533257605417477
A2780,2842253,3.957240977141399,5.02040802175189
MSTO-211H,135398516,-0.6247457561994184,2.312818266651421
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-0.7764958157887787
YAPC,702558,5.05880400043124,4.973921728268762
MDA-MB-453,409805,5.496183153122164,4.712961625052637
G-401,25161177,2.410029759496817,4.068692144035707
A4/Fukuda,3025944,3.254701794903189,4.10238637684957
NOMO-1,126941,-2.339513844414448,-3.3799513134022785
FU-OV-1,159324,3.7929038817112746,2.982657641432015
MSTO-211H,2113511,3.4014041807223228,5.613081516703111
A4/Fukuda,1242560,1.4412010240031818,3.402123904761597
OPM-2,327653,2.4944005218311984,2.8747553651780238
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.7023380532755129
KYSE-70,46398810,2.5990171625416916,2.4371710144219803
MSTO-211H,44486219,3.5621328730435216,4.35297702070209
MDA-MB-453,6450551,2.407686053683273,2.48536784296115
A4/Fukuda,24180719,2.900503133545593,3.2615023226402284
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.5188715579658132
A4/Fukuda,11234052,3.83864189929063,3.501610677835641
ONS-76,10231331,-2.145918525616272,1.8574505459085484
JM-1,11656518,1.5501827619920003,0.9703959131470262
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.8309804244933341
EFO-27,16741245,5.191473652546265,3.680884244971744
DMS 273,216468,1.1199955960897896,2.390751676253435
MSTO-211H,3689413,-2.1873545800685865,-0.30974124931682867
NCI-H727,10074640,3.0722260002613697,3.231404241417829
BxPC-3,66577038,2.7392816080167117,2.85649027093958
OPM-2,44489675,4.196628172603179,3.875146631485167
A-673,1239801,2.654695998337671,3.9041484583868957
G-401,9444,5.739332402240228,4.164000602870624
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-1.6491725628237517
KYSE-70,71466380,5.08916461895765,4.464004245635417
NCI-H460,3025944,5.476008686130055,4.300557277211372
OPM-2,375860,-0.7230228450862618,-0.6712941900341057
G-401,262093,2.911602765721858,2.489627243736705
OPM-2,12001922,1.1641343868089369,1.741147291828347
SCC-9,9903786,2.6448761987997917,2.8372943154152823
YAPC,1750826,2.252131937951327,-1.2370923721455707
JM-1,9840324,5.823306366003189,5.839742312536001
SNU-61,4705,2.600761934037586,2.781794741527957
HCC1143,24821094,3.095995819095247,2.933760360610745
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.6766775353755519
HSC-4,15983966,0.1445652725334258,-1.7420376244492117
MDA-MB-157,9887053,3.277628039368057,3.5831138079623304
KYSE-70,969516,2.5944329315988552,2.838639240645173
CAL-51,135421197,1.6266864976107616,1.800550106530915
LOU-NH91,11175137,1.9157928307161511,2.5689317462929906
NCI-H661,168313047,3.0111797961595523,2.201891633935214
Panc 04.03,16659841,4.736684370351261,3.968662892117341
KYSE-70,16720766,1.38091635176305,0.8604129879782124
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.3800378484968685
NCI-H2009,9911463,4.220122302208283,3.8500590424220102
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,1.5787613109723484
MDA-MB-157,44491742,3.772080854170876,4.315407583421444
A-673,216239,1.7434495050319987,2.3200519300528892
MSTO-211H,9967941,1.8027522151796112,3.5751469268437006
YAPC,3815108,3.3369752363492315,3.132362559569914
MSTO-211H,73707398,0.6990065379334892,1.4396398129629042
NCI-H727,4788,5.448581481072406,5.6491194700302705
A2780,9911830,1.8386970616579583,2.2724113024317547
JM-1,3038522,1.6953465924304043,2.892721996764006
FTC-133,107985,-2.14591043360211,-3.5673436388040276
NCI-H727,3503,3.7902677592538265,2.198180249329739
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,1.736970450741142
KMRC-1,24771867,5.5206603877823275,2.9081322258885405
KYSE-70,3634881,3.4536977245329363,3.1944867770459457
SBC-5,119607,3.910029744126627,5.054542648283485
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.1231032511402903
Panc 04.03,5329102,2.9853977590279075,2.060859506789641
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,1.6954646110309435
A2780,9826308,-0.0101157672837292,0.13569065525862167
HSC-4,135440466,2.2202939224472655,2.243471663730395
NCI-H727,6917907,-5.56846167215282,-3.556132636613359
MDA-MB-157,123631,3.9412563374531864,2.4113126184063587
MSTO-211H,11640390,2.078497045728262,3.3569504607425915
OVISE,54649381,4.33420809644373,3.8553374080436633
MDA-MB-157,9868037,3.2071579521245823,3.158342526067188
A4/Fukuda,67291369,-0.3870993856905487,1.3767765856434468
A4/Fukuda,10113978,1.900139268592958,2.865247663019726
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-0.8919692357764138
A2780,46199207,2.4758344041689093,3.1978977974661995
NCI-H2009,151289,0.8401149520435854,1.1213499783576355
DMS 273,4477,0.2378478748071137,0.601214614053143
HCC1143,6852167,2.667487538311212,2.6238061720968284
NCI-H460,5335621,5.645903220513178,4.427303778954935
NCI-H460,54613361,2.8642714411834502,0.11519880049861683
A2780,6852167,1.374383856311773,2.7292519086647213
SCC-9,11707110,2.5707994933885736,-0.21436128743617255
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,2.07119549622798
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.6530148747324626
EFO-27,6610355,3.735872349212987,4.386220646999919
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.2386354543292364
OPM-2,16038120,-1.581922980476964,0.280023708965324
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,2.053991417868394
HCC1143,10410894,4.771687149558392,3.26710105549312
YAPC,54454,3.200830039856186,2.8748321688400296
DMS 273,6252,1.7538621935564394,0.11799756617583394
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-1.0202565124371388
G-401,44491742,3.951665256591854,3.9933713806845
DMS 273,11625818,4.382645377089847,4.292635126165249
LOU-NH91,3503,2.9647844947930397,2.1431258645505324
G-401,446155,3.2535633304842144,2.329659207622689
DMS 273,675434,4.24768091674901,4.520640009177128
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.0468772170240914
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.5704077043270984
Panc 04.03,168313016,6.087789512449841,4.641231866070138
NCI-H1623,24856436,0.944997546799197,0.47566742195017947
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.6477312651212853
LoVo,3025986,-0.1762115912359206,-1.0763042476814073
A-673,10184653,1.446453264453446,0.9488885964234869
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,1.8028748249589899
LoVo,66577038,2.852951614414874,2.9443919096025355
NCI-H522,3136844,3.3827652175643577,4.19192612120638
A-673,3676137,4.749608800479587,4.477360979821354
SCC-9,409805,5.497565328609373,4.684644062983366
DMS 273,6918328,-1.955094157059326,-0.23862181338387106
LXF 289,4259181,0.8555931132792622,0.33829667306911404
OVISE,448949,2.233154508177948,2.143268223334852
JM-1,675434,3.7844228868956296,4.174542975410644
NCI-H292,5566,3.044146869319611,3.1484747883373223
EFO-27,227681,1.958013080406725,3.150841604254684
EFO-27,65064,5.385038331959097,5.029354136894291
A-498,9907093,3.786767310891997,4.244423893272856
SNU-61,676352,2.4274144006766893,1.9723967369229032
MDA-MB-157,135421197,1.265960780615991,1.9285059502023836
NCI-H460,10074640,3.83137833519258,3.2938366673921875
BxPC-3,46199207,2.8626203608628416,3.1118618474093243
CAL-51,387447,-3.720200693098244,-4.398953071353473
NCI-H146,56946209,-6.937271673290349,-4.289687988697221
EFO-27,46907787,4.067144836646944,1.9216352349564518
NCI-H292,2729026,2.9142630754738037,2.8593233210790276
LOU-NH91,1716436,1.3649900096390022,3.032995406521891
KMRC-1,8515,4.713762602344707,4.147440726455522
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,2.005063336397199
SNU-449,448949,1.5810053045793695,2.022674209079472
SBC-5,4096211,1.588189246491771,1.7310582401179875
NCI-H661,26596,-0.5563822784391794,-1.5930978557159938
A4/Fukuda,51037431,0.9928208538339424,3.205013175365092
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-1.2224457416451546
OVISE,5311,2.608797421965248,1.414567698412042
A2780,11238147,1.47132390494783,2.5297298580407412
NCI-H1623,676352,1.987229853680802,2.1501344297461458
Panc 04.03,126941,-1.1535511280443094,-2.079454767191855
NCI-H727,9926054,2.0492739470784445,1.959937552001771
LoVo,65064,4.389937632551182,4.869325538009537
SNU-449,52947716,1.9936156354056855,-0.014462496982229612
Panc 04.03,5351362,1.307383541492636,1.578496230088369
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.0130401227614416
NOMO-1,44493952,3.580250185381126,3.151491067200088
A-498,676352,1.77005199556574,2.2789529721911315
Panc 04.03,5280436,1.6844699655115762,3.2503777313958886
CAL-51,16736978,0.375988055286384,1.6169051136655437
MDA-MB-157,54618771,3.1146330047846877,1.0484044954330114
NOMO-1,6450551,1.2307950565416117,1.5828317649142818
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,4.54323115293185
G-401,25105715,3.9034348367564258,3.402672150037477
BxPC-3,151289,0.5689607060021993,1.0464061818428814
NCI-H727,44543605,4.300237824274415,3.9078275128506847
SNU-81,2907,6.641268536629272,2.7559430284877227
SNU-81,613753,2.2388707005796507,2.935656716145879
JM-1,168312962,1.22629450044224,1.395819670578035
LOU-NH91,168313200,3.810508485111527,3.1284668831255193
NCI-H146,3854666,1.3221451848305394,1.9104892618132059
KYSE-70,322968,3.381611542483835,3.4702691920672835
ONS-76,241158,4.846225597872182,3.668391634561315
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,2.7854978236058843
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,1.2775053108273373
CAL-51,5291,4.8235616489491635,3.688488240967186
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.6439591605810804
MDA-MB-453,168313016,4.163913885489913,4.554909647508869
A-498,60700,2.2087582051541257,0.05037011781637332
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,4.840024657657483
HSC-4,6918878,5.2813290465493505,2.5637412623124884
MDA-MB-453,9884685,-1.4419247946131482,0.5327251754499742
A2780,2746,1.939184711313242,2.9446770576449652
NCI-H661,148198,-4.235070372495308,-3.2802746544496997
HSC-4,54678924,3.092091974621669,1.996365638079937
A-673,2113511,4.0082027727586,5.386205040238439
A4/Fukuda,5287620,-3.30087759062066,-2.4562010138661172
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.3479117372604916
LOU-NH91,6918328,0.1478473020386815,0.04023051909274335
BxPC-3,3385,3.820290029267426,4.55947677667222
MDA-MB-453,44185566,2.487729821066063,2.583737285682634
LXF 289,46907787,-0.1426698074457199,2.623040869362537
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,2.0159609694552616
EFO-27,9887053,4.025142225668377,3.9480281009030307
BxPC-3,4259181,0.1397018777458316,0.20684625324906264
SCC-9,10184653,-0.319006591471168,0.5943870510888277
SNU-449,53232,1.6560937312011326,2.7816044848199204
BxPC-3,53232,2.859321527409702,2.8772382947646515
NCI-H460,71304818,2.359856693071434,2.5093267844212512
NCI-H2009,11178236,-2.605718631753464,-2.985697254875509
FU-OV-1,400769,0.1189863997269066,-0.46825543680116705
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.1957314731706754
FTC-133,72376,-0.3430893294901544,-1.686636589366313
LOU-NH91,2858523,2.98680776080117,3.0781353161676153
LoVo,6918837,-3.586713596901602,-3.4035778415807316
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,3.1852333910290245
CAL-51,6918837,-3.0563476396929703,-2.9553209826254965
NCI-H292,676352,2.616071543582294,2.0762867816193675
NCI-H522,11626560,2.464867345362881,1.9253463870353
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-1.6160141691160208
A-673,11167602,2.442600782118551,2.3193014307512163
OPM-2,11222830,0.0961911151739945,1.2845154289421785
A4/Fukuda,7251185,1.076285820033946,1.9404043104137556
OPM-2,24978538,1.9225155298388676,0.39660935441072753
CAL-51,135411,0.595745817277345,0.5942573061968056
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.4835342996276264
HSC-4,3025986,-1.9523671858491285,-0.9538292986446889
BT-549,54618771,1.4883156908959423,1.3553218620778167
DMS 273,1239801,5.369367906855259,4.1616763891540085
SNU-449,374536,4.370390285639732,2.0224157769243085
MDA-MB-157,168313016,4.249309770188466,4.8800500678131495
NCI-H522,446155,3.2752737209903504,2.4791483346907524
BxPC-3,9935249,3.9268263105803727,3.209726330631347
A2780,16725315,3.2354385253964253,3.9157813974018922
NCI-H522,11647372,2.460433695225771,0.9794207651996635
MDA-MB-157,3689413,-1.567220624306923,0.04655734496235905
NOMO-1,36314,1.6795260413615891,-1.8658231296562693
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.4064288748285763
ONS-76,46199207,3.062888044588984,3.215492969928822
HSC-4,2746,3.845189406581069,3.2510387335836346
A-673,126941,-4.88778992999732,-2.8614551325308377
A4/Fukuda,2874250,4.0164309105299685,4.728998772533611
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,0.6222131988792562
Panc 04.03,3136844,4.698465140769799,4.140398725056374
KYSE-70,53232,3.7067207893488017,2.5231634491330746
CAL-51,24180125,2.8082301472193203,3.0173917970507342
Panc 04.03,9884685,1.6842032304446288,0.63649076561614
NCI-H460,11626560,2.497647926194901,1.9856950599613115
SNU-449,168312962,3.745202246753347,1.5055079640810272
HCC1143,9935249,3.8757786370374303,2.829443923288915
SNU-449,613753,3.229445182846538,3.1931067908618256
OPM-2,44491742,3.727542800888903,4.118989466017903
KYSE-70,9936388,-4.915846401119174,-1.2859611713218824
CAL-51,654092,0.82886283906252,-0.4601928621300256
SBC-5,448949,2.9920694717704204,1.9657490708990903
OPM-2,46843906,-0.5330027912440064,1.9983291069183862
CAL-51,5566,3.271951139375183,3.059974116874821
KMRC-1,53232,3.79650380515527,2.6054837129530823
CAL-51,11228183,3.6770505489909007,1.975249526224233
SW1463,24785538,0.6322996420886741,1.3218424155483817
A4/Fukuda,119182,-4.160589878424858,-1.6905900353343708
A-498,107970,3.0044685679861054,2.361194408343991
CAL-51,11612883,1.9359641259018452,2.646059490995201
A-498,11317348,4.2355090436144875,2.9678796957859164
LoVo,67291369,1.4516021942624118,1.7775777420978573
A2780,11222830,0.6433638933511314,1.4766140297108346
BxPC-3,241158,3.755569293331497,4.007972996290091
SCC-9,6610216,4.4695629784882795,4.174968196373578
CAL-51,374536,3.1977545561189347,2.320850243997084
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.356418508677538
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.7368271079532702
SNU-449,72376,1.1438392823146497,-1.5914672639868608
A-673,4259181,-0.6373852614685119,-0.15526109369936156
DMS 273,168313200,2.725135044490621,2.7990267127388897
NCI-H460,9911463,4.421747687015995,3.844223717548226
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,3.9882563930669472
YAPC,119182,-1.6155541294016968,-1.2254689069176414
SBC-5,6184667,2.5027552360756946,2.9382368891035147
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.5802017079612056
G-401,2858523,3.0226653633513,3.0460410897373977
MDA-MB-157,10184653,0.5581112583171038,1.3348476431012304
A4/Fukuda,19582717,0.7629696429231957,3.3880256903488406
NCI-H460,53392493,4.733063337287369,2.692693709905318
OPM-2,72193861,0.7906161175639799,0.7004207693871016
NCI-H146,44491742,2.6808030102351323,4.424156340319429
NOMO-1,46398810,2.1682472320454504,1.7386823646526357
DMS 273,16736978,0.9096800466601204,1.5766344954301588
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,1.3784686310872463
CAL-51,16741245,4.222373420591208,3.932252736249592
MDA-MB-157,10074640,3.629475203970288,3.2619340051081145
SNU-449,2828334,6.138780539354761,6.087409139491874
HSC-4,9823820,4.434899642824078,4.202438171362727
A-673,11238147,1.6374380314183412,2.596578469734711
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.520936773572765
A4/Fukuda,4915,4.811112690158961,3.674737377843025
JM-1,42642645,-0.9084434189288264,0.4158816933665998
MDA-MB-157,3854666,0.668628762558335,1.9296715559694722
SBC-5,2841722,4.592516057239796,4.106987033160182
BxPC-3,2742550,6.208235416241253,3.9744724299339196
NCI-H2171,168313200,1.615164123973231,2.721795482528737
LOU-NH91,46843906,2.60442098689998,2.673688431962225
DMS 273,54619267,3.628421853226673,3.9778445072373456
CAL-51,16725315,3.2794500362302,4.1652294390327205
MDA-MB-157,10127622,3.2546864424502076,4.032193485699507
NCI-H2171,16725315,3.053630151756443,3.862526495577053
SCC-9,9935249,4.690276947265519,2.8666675802697488
NCI-H460,44507138,4.578042897326484,2.6518605742725816
NCI-H1623,5282054,3.865413044747809,3.7479157234615634
HCC1143,984333,-0.0539665216618622,0.6056313717060737
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,3.2479429252894567
MDA-MB-453,9840324,6.873328025428986,5.789913347647686
Panc 04.03,176870,4.897846724128431,3.5332066833552647
NOMO-1,11640390,1.5691640408186416,2.9501237982580766
Panc 04.03,409805,5.536204895331733,4.793056281746704
MSTO-211H,71466445,2.2675767772231024,3.843982711500975
NCI-H2171,9915743,0.832341910278816,1.0097525194960435
A4/Fukuda,5281672,3.917758560865086,4.379299393998072
LXF 289,11427553,2.4541082171467368,2.955897826919197
Panc 04.03,7251185,3.2944683029692237,2.755502056733428
NCI-H522,9933475,1.020852520604034,1.976874596488
JM-1,24180719,3.5833576580940005,3.0137417236478385
SCC-9,15953870,4.1491811794097995,3.436575309692076
Panc 04.03,56946209,-4.443392589569815,-4.0786477444030735
BT-549,6918837,-1.3661230802503712,-2.81773301585069
ONS-76,56946209,-3.559106939272703,-4.436027359817229
OVISE,44507138,4.185704551553473,2.681947112538331
NCI-H292,441298,3.4530013870499037,2.601537670597525
EFO-27,374536,3.468329704237433,1.758661300694881
NCI-H292,568763,1.0095796953036382,0.3721041981787935
NCI-H522,122327,3.7548997428021904,4.774033243098374
FTC-133,409805,6.0297974484260655,4.136362567811479
KMRC-1,3384730,3.706671423221143,2.6401640160684616
HSC-4,5351362,1.6988999536887646,1.4162257584990872
BT-549,448949,1.6914375683866394,2.112789718126063
JM-1,753704,3.307600856766594,4.491248948209473
CAL-51,25195348,5.6667768045179905,3.207506278985138
CAL-51,3025986,-1.0834382414923172,-1.0426730730823712
HCC1143,15547703,3.062266000318877,2.9780714302228217
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,1.5707827300320643
CAL-51,135999136,4.2132345103647015,3.388333527795469
ONS-76,55283,0.3588409196586273,2.557139592840026
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.1769362873279792
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.227558119941075
SW1463,25262965,-1.5690747748042335,-1.531295738814938
FTC-133,241158,4.091507154193835,3.437236167543631
KMRC-1,23582824,0.9449566223543509,1.04641019622518
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,0.815784819946088
FU-OV-1,16013152,4.2048953133679765,4.082952570743691
MDA-MB-453,613000,0.0740651651217389,2.3521427751726236
MDA-MB-157,24797083,0.6098010922803769,1.3843996373361238
NCI-H460,10074640,3.83137833519258,3.2938366673921875
CAL-51,16722836,0.8083581946159574,1.6700862887541856
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.932826322075037
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,2.0081635709272647
G-401,10322450,4.220475308231234,3.6539224441686677
G-401,15983966,-4.354524639754001,-2.886454100985416
CA46,9887053,1.048475441216289,2.8304506076530784
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.235472135802421
NCI-H1623,11152667,-0.7587975819891684,-0.6947510976932719
HSC-4,11609586,5.018303752842559,2.8165495309202897
OPM-2,67156097,-3.031514601372161,-1.9188968933661954
G-401,984333,0.0612358592539302,0.6177909204220468
LXF 289,9908783,5.689655754809611,4.83492464158367
SCC-9,5329102,2.2394800798474677,2.0050789992531897
NCI-H661,17759555,2.3282310316349935,3.8723848938396346
LXF 289,24856436,0.8419130403195528,0.38308866672959974
SBC-5,159324,3.4028835437957112,2.636137197676532
JM-1,6184667,1.7187669889057045,2.534716446419549
MDA-MB-157,11396600,3.7386973485738424,3.4853225852858354
BxPC-3,216239,2.4917493719892274,2.203573060003686
MDA-MB-453,72193861,1.6700607918257404,1.7043432238580252
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.9183098156235365
KMRC-1,9915743,1.4003501061845525,1.3139149160744241
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.3440578788655242
A-673,12001922,0.9671300191794728,1.6393402028395352
A-673,1323703,5.495685082034704,1.9428553466867904
SCC-9,2729026,3.0647326637868573,2.7170231823982296
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.1071385148652693
NCI-H2171,3503,1.152076889590999,2.301595173870358
JM-1,252682,6.042634536055517,6.541094092343851
CA46,44137675,2.206940954689562,3.057356237027408
CAL-51,11152667,-1.203722258692511,-0.7307913141570788
LXF 289,135984461,4.539632657840611,3.7851581990347034
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-2.75245611714378
SW1463,11507802,1.438199099446833,1.4049299732695022
BxPC-3,25062766,1.590701824067561,1.8726289354468793
EFO-27,45279963,4.232301991437958,3.6543030535428134
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,1.9182673091327385
NCI-H2009,42642645,0.1491359953679814,0.8936727076977056
FTC-133,53495165,1.6157050027500164,0.1772704555162206
NCI-H292,11640390,3.2514062698758015,3.6079310701630414
A-673,135423438,2.29660224903782,2.1420342007405813
SBC-5,9911830,3.21689826570876,2.544809035414656
MDA-MB-157,36314,-4.695989096441824,-0.820818548589151
NCI-H1623,5328940,1.639592653942716,1.7299949236275163
SNU-61,135999136,5.618921387112628,3.7013052025843303
CAL-51,25102847,1.94226811064499,2.5079221700720473
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.5132637504325923
A2780,68056272,2.2410901197134923,3.2130938476795707
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.6004512947775302
KYSE-70,24856436,0.5719980221753466,0.4020404060447508
CAL-51,46398810,2.084696284876613,2.5537936233538563
NCI-H661,16720766,3.873672796747104,0.5669892498094053
LXF 289,11234052,4.719623128458786,4.111645882936439
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.514669586299086
MSTO-211H,107970,1.929708493397844,2.425814787454865
MDA-MB-453,9929138,5.862527790185705,5.1317942611676095
G-401,285033,-4.902412101243927,-2.5897744178862165
OPM-2,6852167,1.7172653102666242,1.9040914771491493
EFO-27,11228183,3.371245966973651,2.290952766672923
CAL-51,17759555,3.5733302595078182,3.8027220915730147
SCC-9,24785538,2.4612574042553432,1.5531144823010188
KMRC-1,11364421,1.724167601186248,-2.053089245960097
MDA-MB-453,24748573,1.9919110400088051,2.0195537832728836
EFO-27,5460769,4.47484627366887,2.7314711111927052
HCC1143,49850262,3.2153342375189533,3.4028554897203906
Panc 04.03,66577038,3.1738099516277667,3.065269625635091
NCI-H661,11238147,3.129195095759777,2.6499305008724705
SNU-61,6623618,1.73773822434396,2.414032520254272
EFO-27,16720766,3.656433318818957,0.7998691927648636
BxPC-3,969516,1.4378873066513898,3.026847030233873
JM-1,54596558,3.768195826371459,4.300631516047943
LOU-NH91,5738263,3.7277759973822726,3.457338738761294
JM-1,25183872,-4.29494207596009,-1.7001656225473452
NCI-H292,89928392,1.456532385863884,1.4887155163725097
NCI-H460,119607,4.735621464768821,5.3832247411211185
NCI-H460,322968,5.369771337760045,3.8473104226093215
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,1.698609839424778
CAL-51,9907093,3.7886359098281783,4.348754703996215
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.46472920415297
LoVo,123631,1.2882244486240189,2.054216910683375
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,1.7004358451377264
MDA-MB-453,15983966,1.8434310309669164,-1.3358594768861034
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.438391954673263
HCC1143,135440466,2.588436572703006,2.0984362888976746
NCI-H146,9926054,1.7480459470636802,2.0724507526560103
KMRC-1,5278396,3.6212610119500783,3.5252533690804673
A2780,46191454,-1.192769752942619,1.4021405769186612
A4/Fukuda,25062766,1.3929374396347198,1.9976793986110866
NCI-H292,53232,1.814131755875953,2.6810578277067583
ONS-76,24771867,4.286887453999452,2.4438611016933502
FU-OV-1,31703,-1.7023718917237094,-0.9999430783092425
A4/Fukuda,66577038,2.118562328013949,2.986748277443187
NOMO-1,445455,4.303833401854377,4.129045648957332
NCI-H2009,12003241,-1.6852069192913937,-0.9025050656565196
LXF 289,42642645,0.485507292149712,0.8083733331312528
NOMO-1,46199207,2.5514936314753434,3.0915555040687988
NCI-H460,322968,5.369771337760045,3.8473104226093215
Panc 04.03,5328940,2.517395347800957,1.5493011775410357
SNU-61,9936388,-6.308071034865157,-2.4116078408515484
LoVo,4261,-0.8211989197292223,1.3771055117071542
A2780,136227924,2.141563547945887,2.944436215211184
DMS 273,11175137,1.5448586489611442,2.429767499306707
LoVo,44202524,1.5416570481285088,1.8104456101983515
HCC1143,9907093,3.794716934303189,4.327677810306072
NCI-H292,6610216,4.846288432835765,4.2589594150929715
BxPC-3,11178236,-3.5754762678880567,-2.9289862479220306
MDA-MB-453,5978,-2.563797038396111,-2.2342848717405626
NCI-H146,5460769,1.8747395178404,2.6957694674178208
CA46,11238147,1.5462987380530164,2.2865673933905004
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.1683949352291374
LoVo,2828334,5.515630519838643,6.104744466725759
KMRC-1,5287969,-1.8174868244268352,-1.7384193895898787
NCI-H460,676352,2.985829219207002,2.172389888849909
SNU-61,23635314,-2.2430318809352556,-1.595901546463728
NCI-H460,11612883,2.88158995470921,2.8326630254861915
HCC1143,24951314,0.9489239510798212,1.1469577678177332
OVISE,387447,-4.037756707187744,-4.1469795824697
JM-1,568763,-0.4685251193741573,0.3514168319132287
SNU-449,9907093,4.078651849005814,4.148161601442595
BT-549,53392493,1.9491955503491856,2.4349597119585518
MSTO-211H,24180719,1.9210037149309027,3.435819861732841
NCI-H1623,23635314,-3.504391783968502,-2.1668755166532008
MDA-MB-157,135875424,2.7117106005077276,3.9078307026358137
NCI-H661,54678924,1.9600004323573317,1.9482513464255726
DMS 273,25105715,3.6490952941772496,3.496505786702214
NCI-H1623,216345,4.517328735854535,4.157197358887926
SNU-61,5282054,3.0015154117441996,3.489629018950377
SNU-61,10302451,2.848073588995495,2.818440994989459
CAL-51,16720766,0.5416929462446769,0.468348391557266
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,1.7654285160028416
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,1.7226056801780283
NCI-H522,46398810,2.2314734558486053,2.4466834481165822
JM-1,67156097,-2.627968736143573,-1.0306678612358673
LXF 289,60700,2.2902498510351528,-0.6341158324430076
BxPC-3,2945648,3.219283504871713,3.005315328855678
A4/Fukuda,65064,3.1077716650538707,4.242269729840171
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.9106633441711217
BxPC-3,10077130,4.243605425717339,3.1271910667621587
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,1.9321928027845956
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,1.9509544557849194
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.2438288583327917
LoVo,168312962,0.7059894109575258,1.6016851824858005
G-401,65064,5.209946412003188,4.697846084196538
NCI-H146,148198,-5.323171419653744,-3.479317821322379
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.478034273801739
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,1.1948903870295664
HCC1143,2746,1.9419289545652112,3.1373657762923
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,3.0313174935535767
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,1.2969474378151673
NCI-H2009,10385095,0.2451756361843044,1.3497984765237416
OPM-2,11167602,1.1745103577473592,1.997054403005733
CAL-51,26596,-1.4638590943230956,-1.5017767702191833
NCI-H460,1716436,4.318712917611328,2.9767884028571387
ONS-76,71304818,2.469307822454373,2.429031466374075
BxPC-3,11626560,1.2674200020854305,1.899101858267515
CAL-51,104842,-3.020036586723177,-2.555808602150251
NCI-H460,49793307,0.4479933662320887,-2.581986787344072
FTC-133,5284373,3.681008384459256,2.9003762094995658
SBC-5,11455910,0.8715920005264659,0.710269332619389
MSTO-211H,49850262,3.597717946429448,3.4611001824466854
DMS 273,2871966,0.6484564569530932,0.3178536218030472
OPM-2,2729026,2.502425703285658,2.296374678388185
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.9847322480832003
NCI-H292,9840324,5.8141064790381884,5.784217226312784
NCI-H661,375860,0.2037463104187888,-0.41818558874091627
NOMO-1,6918328,-2.206625897840938,-0.7551591382056935
NCI-H522,54143018,0.2801073306793095,0.5082730229655759
OPM-2,23635314,-4.85335222903722,-2.500377173347353
NCI-H1623,1716436,2.729344651836522,3.073456217543442
CA46,60700,-1.6899904219212585,-1.1751599227675678
SNU-81,10077130,-1.1742608263747976,3.017767422439178
MSTO-211H,9907093,3.5779290533064856,3.9618821217213998
CA46,2126,3.4622152695614767,4.025976422679077
CAL-51,49766530,0.4609697007955676,-0.9043892609464297
CAL-51,6438330,3.884194225982375,2.2603332030636802
KYSE-70,68056272,3.571583007543391,3.4594296305682275
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.1746499189326
EFO-27,68056272,3.9995237189063784,3.387476081272878
SCC-9,241158,3.962823581088113,3.972559371210795
NOMO-1,5746,1.3002002606442051,0.020643482263492587
MSTO-211H,44202524,1.4972222665959742,2.2203848416233867
NCI-H727,49793307,-2.322611372156632,-2.2954326936537384
NCI-H146,4578,4.154543455900732,4.423822325615955
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.8296556193422429
LoVo,107985,-3.583734032756361,-3.5915885517056605
YAPC,984333,0.9591784056691972,0.4862509849403985
SW1463,1750826,-6.63000221324875,-1.801564223831961
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,1.9515604935444246
HSC-4,9866186,0.7177643600632182,0.9439810228820603
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.1093086736203384
ONS-76,135398516,1.9151603507117831,2.1255019567442615
LoVo,11964036,-0.4950100771581299,1.0486273841555478
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.9660393791777127
CAL-51,11964036,0.7531640395115359,1.2447746276758505
SBC-5,5328940,3.016318294707136,1.391549479357615
SNU-61,9444,4.091366887299019,3.982563199083984
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.670717939639984
A2780,676352,1.788840905955693,1.9147820490594172
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,1.1799997286580766
JM-1,7251185,0.7253388444333596,2.072761915668253
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,0.8653884898747402
NCI-H460,52947716,-4.997624319891589,-0.692748606366326
NCI-H2009,6505803,-0.1719772058921901,-0.1634287374345979
OVISE,25126798,4.262747569123806,3.905768268793599
G-401,54678924,1.6253720221899297,1.8760729960006222
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,2.2635816350393476
A2780,135421197,1.3895584306244824,1.6064127179330785
EFO-27,25126798,3.692256603979053,3.914504468805794
DMS 273,73707398,1.2764695344106731,0.994869376632101
MSTO-211H,10296883,3.6762481855456985,3.869879320330563
LOU-NH91,60700,-0.2604526525302556,-0.5456730075635327
Panc 04.03,8515,4.900392472396633,4.0710462727242085
A4/Fukuda,216345,2.739557201577506,3.653220146806346
A-673,24978538,2.0217931845087596,0.09843104629177558
SBC-5,11152667,-0.3838978082878119,-0.9884559553887395
NCI-H460,15983966,-0.5601417251503862,-1.5389172014520474
EFO-27,400769,-0.0834796845468066,-0.35591458775677004
YAPC,2858523,3.168058012530131,3.0673845950168332
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,1.3158873590988334
NCI-H2171,227681,1.8296199533038344,2.922308235926618
NCI-H460,11455910,1.4134750909778395,1.3543055145628349
G-401,44566777,-0.9568944013200004,0.5075337621973081
NCI-H292,5328940,1.2067364026743148,1.7257630894858058
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,1.602686534957026
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-2.510335455881106
JM-1,25154868,2.919888649987432,4.262052624057525
LoVo,44185566,1.1715497148164364,2.1686545986206704
ONS-76,54618164,4.167815792355048,4.073334827584485
NOMO-1,151289,1.0922355572005962,0.5713060339592659
G-401,44493528,4.310857122389352,4.189839977081983
KYSE-70,89928392,5.113782206339635,1.2437219634854995
NCI-H661,89928392,1.5970967591597882,1.362002655587694
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-3.7276274387977733
KMRC-1,3503,2.6706031423305845,2.227245821529897
G-401,11455910,1.3171347053017213,0.7683850533154206
SNU-449,208908,2.01293579360495,2.3718626370180704
G-401,57519531,1.5783303012871783,2.033452714589057
MDA-MB-453,11427553,2.8599395215861567,2.868425037387039
LOU-NH91,241158,4.097895358021133,3.9912590134797843
G-401,24951314,0.7541386929645643,1.1639927314008505
MDA-MB-453,208908,1.869724740513474,2.1156530697348304
YAPC,46398810,3.0625661294812216,2.6852037155207467
LOU-NH91,1750826,-0.8784962447018205,-1.7971259226798757
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.48384913182504335
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,1.5402147266450197
MDA-MB-157,100016,3.517936084480814,6.17006931910789
HCC1143,60750,-4.413462787403808,-2.0954888369459366
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,4.032553262443619
HCC1143,159324,3.533344711636858,2.829443923288915
JM-1,1750826,-4.271139507623605,-2.0901786990585016
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,0.3550002404847266
A-673,11396600,2.723776149104898,3.293779253775789
NCI-H1623,24964624,2.070631930148384,2.6405581377979463
MDA-MB-453,104842,-3.389911854354977,-2.4377115377701455
SNU-81,49793307,-4.215972202332142,-3.5755346215560646
A4/Fukuda,54618164,3.3817410387547575,3.8526098796023085
NCI-H2171,26596,-1.7584148860978708,-1.3854172898580794
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.6351555753059273
ONS-76,676352,2.5309673509494535,2.0762461680598165
SCC-9,4378219,1.9931327421657885,2.337692358903239
CAL-51,613753,3.3238399640193177,3.1406767322595344
Panc 04.03,49867926,4.237506736984018,4.271801513720294
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,5.046833986761463
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,1.478582763334932
MSTO-211H,3543504,4.118160915221066,4.366587854194069
NCI-H460,6252,1.4342703041264255,0.39014306985669633
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-1.2337298559778342
NCI-H727,3825829,4.725008182252989,4.072263473059602
OPM-2,119182,-0.8289962289267476,-1.5905761207864573
LoVo,54613361,-1.4267659732177436,-0.1455312097431809
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,1.6637422221036566
A4/Fukuda,126941,-4.18863393868508,-2.4311508458497584
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.3224161190583337
NCI-H460,136227924,3.925006850615035,3.019448751215001
NCI-H727,3136844,6.195563862298742,4.406843858418783
MDA-MB-453,136227924,2.410345496671846,2.99400211158187
SNU-61,51037431,3.7250627983577513,2.8583455241034703
SNU-61,3384730,2.3184170398790154,2.4666358899677427
Panc 04.03,24753719,4.39873379823384,4.279758508331932
SNU-81,5978,-4.726956734092058,-2.463772960391345
SNU-61,9967941,2.1294940171884043,3.3015922919172316
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,1.75099409403284
ONS-76,5470400,1.68546701619173,-0.055588940069504905
JM-1,52912189,-1.1165299764243126,1.4480169258504318
NOMO-1,52947716,-3.339302012338735,-2.311140399522631
JM-1,26596,-2.491901301923365,-1.9945970086685005
NCI-H661,445455,5.2176896422295025,4.43550755716137
SBC-5,216468,3.330480208625043,1.9298749956497352
NCI-H292,5311,1.7806932533505695,1.4450983608815764
Panc 04.03,9935249,3.3873751996630177,2.9316368351349507
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-0.852565234499494
CA46,25262965,-5.196703638661911,-2.2584387520703113
NCI-H460,11626560,2.497647926194901,1.9856950599613115
CAL-51,54686904,4.850424917483252,3.415942243592846
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,1.041834847730434
NCI-H2171,6918328,-2.9240080597430813,-0.46501660087182195
CAL-51,3825829,3.9510679995615257,3.968284102369523
SNU-61,65064,4.771880102821997,4.77756090203617
CAL-51,124202324,2.033990287468598,2.4474953574104714
NCI-H1623,11494412,1.2552972437851018,1.6528961382767222
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,-0.9394861271845494
JM-1,135398516,1.8505892369708832,1.5420748945151879
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,3.681159288806951
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,1.9573754164872068
LoVo,1641662,3.111662868893329,3.286091562397421
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.2888432801343388
HCC1143,24856436,0.4052757500096688,0.5913664101722351
YAPC,73707398,1.1307339717786768,1.279534232917559
FU-OV-1,24771867,2.3744516407985485,2.0775530882347537
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,2.068788577794283
SNU-61,2749,1.958913212534665,1.897451568744977
CAL-51,20959075,-3.1196535578382987,-3.115300838891652
A-673,6918878,1.2344260030899934,1.8625368450950548
LOU-NH91,73707398,1.1540810865513749,1.2850190410455926
NCI-H2171,107985,-3.896160678794096,-3.6261175864278794
KYSE-70,12003241,-1.4257688129039825,-0.7164508651487392
MDA-MB-453,10296883,4.2989687155614735,3.8629075849275423
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,2.437288339465679
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.26789969618918
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.3329496612208955
NCI-H661,4259181,-1.4326329693308524,-0.01346097620301153
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.755747346894232
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.9270556786356222
SCC-9,25183872,-1.5689686359020558,-0.7621802693221639
NCI-H727,6438394,3.7246032061112553,1.8944095428485292
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.6447787672819578
Panc 04.03,9911463,4.4327726522455855,3.9704608085850954
ONS-76,2733487,6.718347537986806,6.341732307683905
MDA-MB-453,25062766,1.9156877669914651,2.113488534838799
NCI-H1623,36314,1.7259264714185265,-1.2712420665493316
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.197662878379985
MDA-MB-453,11234052,3.3366002038414493,3.9803616799368347
NCI-H661,54143018,-0.94518686271758,0.3805001794737275
NOMO-1,72376,-3.881755374018637,-2.3548949245744843
NCI-H1623,104842,-3.8091356035642434,-2.1505750233338783
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.375252131467733
JM-1,71466445,1.831003524042788,2.8385789088990823
EFO-27,49766530,-2.657964166176686,-0.9337769908433531
NCI-H661,753704,5.093119647973415,4.8165123436267745
OPM-2,11175137,1.4890519960627426,2.1725305962378214
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,2.243737574214697
A4/Fukuda,5746,-1.1009867615741116,0.3187868843891167
SNU-449,44489675,3.6193477306301927,3.9153815063194806
NCI-H661,12001922,2.629031416850278,1.8312365245830244
DMS 273,11640390,3.3173332454053717,3.5144682500613955
SNU-449,4259181,0.6587440570439733,0.24999273272003045
EFO-27,24964624,2.939505532014586,2.48499997163985
LoVo,4096211,0.5868958804653562,1.8268357137477509
A2780,2841722,4.258280317113099,4.074242133970399
CAL-51,24771867,-0.5018492111736887,2.130339933318148
G-401,46907787,-0.0293884143124787,1.5724483009671124
JM-1,24772860,-4.004711239665373,-2.609758312724233
MDA-MB-453,71680916,4.8348560692055695,4.728965424944207
JM-1,11507802,0.223918960474334,0.9949744677652019
A-673,462382,-0.040658639847304,0.6684146118238459
NCI-H661,216345,4.176204855685743,4.089171808598792
BxPC-3,9907093,4.5613416209155755,4.323998420158119
HSC-4,216468,2.5769925673594227,2.827673913162948
NOMO-1,60700,-1.0021705320646457,-0.9908783170213792
YAPC,11455910,1.8317787914833017,1.210795051005479
SNU-449,11175137,3.183352091664916,2.691050115205889
A2780,2113511,4.588817591987419,5.114147438567332
NCI-H146,613753,2.6314812615131222,3.310583895732409
SNU-81,10231331,-2.370371712203436,1.4115176869474195
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-4.264482599561591
NCI-H661,168313016,5.326553105852446,4.710270539005356
CAL-51,25126798,3.926975819986009,3.8160786551313373
Panc 04.03,1716436,3.048029385411991,3.1228778310299283
EFO-27,11625818,4.615590718074381,4.478850366702883
A-498,44495899,4.223152889477574,3.202340054423989
A2780,3825829,2.5427924978442467,3.829271432701128
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.345683805016937
NCI-H1623,2858523,3.2758661507497115,3.0969717106392
A-673,49793307,-5.444897343264971,-2.990158608239028
MDA-MB-453,9935249,2.561550169446695,3.0336954791804738
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.5084108549343855
LXF 289,3062316,-3.851151802003845,1.3933676796576404
MDA-MB-157,2874250,4.29768331905581,4.588577479355786
HSC-4,4521392,4.744801099229743,4.243858206412419
EFO-27,23725625,5.484413053531449,4.773554506485253
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.7725290478995642
NCI-H2009,5460769,1.3316086312624285,2.7515889088370193
LOU-NH91,654092,0.641619390442256,-0.1697182329485525
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,2.92296197787789
SNU-449,9887053,4.621717664819675,4.002319787210125
LOU-NH91,54618164,4.244208934703923,4.082076559354158
MDA-MB-157,24951314,0.2652102931153908,1.3134957372835112
SCC-9,4261,1.568262163612179,1.3686662039393749
CAL-51,262093,2.862241975448649,3.001538339893101
DMS 273,100016,5.677769516399485,6.181097032595031
A2780,44137675,1.3252793631369038,3.5646040450818974
DMS 273,71466578,4.37241227128359,4.24818062124255
A4/Fukuda,1566236,1.4071330472860828,1.8416781078881066
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-0.929621886888645
NCI-H2171,25102847,1.8897460049958847,2.3820882890311648
MDA-MB-453,60700,-1.6006047446684224,-0.0877580140588182
A-498,11404337,2.25955984981305,-0.10367310536652093
NCI-H2171,10302451,3.986494326049399,3.0476618659948436
YAPC,10184653,0.1561987566095487,1.4223075140793633
NCI-H661,9967941,4.170813203069281,3.4267270862511356
BT-549,24901704,3.7794480452342,3.428593850074272
A2780,3038522,3.0311112283818864,2.949014138281405
NCI-H522,67291369,2.1338291538877514,2.3662110629268702
HSC-4,753704,4.983094182740762,4.739605667709122
G-401,44607530,1.0217800111575093,1.5102043245184598
OPM-2,19582717,1.9960397366001383,2.989892118219541
NCI-H2009,104741,-5.941055510927969,3.6322643533370824
OVISE,9936388,2.6758567859836826,-1.268758740384981
NCI-H1623,11178236,-2.2917099582879144,-3.067438218163907
CAL-51,5746,-0.6872762444946757,0.6182045779657872
JM-1,3503,1.2397121319894746,2.113075976561543
LoVo,26596,-4.043483931746528,-1.2339692063877978
ONS-76,44486219,4.293725912166159,4.215837845639615
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,0.5958795700148627
NCI-H460,24964624,3.5490884182562565,2.4619086686981704
A2780,448949,1.9574027813966313,2.1028085934702863
G-401,6918878,1.5849207586223315,2.3667091539695413
EFO-27,123631,3.2705036111065957,2.303003175746203
NCI-H460,71466380,4.4879606530616725,4.406325998306404
NCI-H146,126941,0.4535750644224253,-2.3180439805747697
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,0.865692346008857
JM-1,25062766,0.7257031347370316,2.03888063739291
BxPC-3,44819697,-0.5900667288519075,-0.19507861771914958
DMS 273,49766530,-1.3487399530522592,-0.9185822814364585
G-401,6918837,-4.518653911968971,-3.152805156784767
FTC-133,25195348,4.144583358862902,3.4089153953501836
BT-549,5281321,-3.0037540013163433,-1.5550714642336587
Panc 04.03,44241473,4.425072929332434,4.818368838893827
YAPC,5278396,4.010893890545004,3.6360116376882647
ONS-76,5287620,-2.6985711183159573,-2.128577688437006
SBC-5,11612883,3.4240653421197877,2.6394580871999103
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-1.3484551990856806
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.167956042354621
SBC-5,219104,3.745930190487188,3.255041781988612
SNU-61,176870,2.732721688120773,2.9478857970969257
CAL-51,36314,1.3238047725901672,-1.0711158023694454
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.2487734264122627
DMS 273,71751553,4.31191978803821,4.356083058717747
NCI-H2171,400769,-1.2297634018381476,-0.6282688852778434
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,4.77261829173413
NCI-H727,71304818,2.536891878991305,2.494740541130243
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.831931704896913
CA46,135398516,0.7680931483587626,1.5394088520321225
MSTO-211H,100016,4.243846732059744,6.211642366879366
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.413371718941547
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,3.3760022843413786
SW1463,25183872,-1.2446986167158185,-0.8777713195935215
EFO-27,122327,4.8281000238128,4.488966058401968
MDA-MB-157,11222830,0.6776847499576403,1.5457136886423566
NCI-H2009,25150857,2.992056775880064,2.582915226228269
NOMO-1,216468,1.212023833941809,2.0293109712151245
JM-1,11152667,-1.617053586455527,-1.3928647637714082
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.7667492805875593
A-673,25126798,3.569829443135804,3.9984729954436786
DMS 273,148198,-4.27913692458833,-3.6176539833130175
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.7460349470977103
LXF 289,5329102,1.6667075021580833,2.2288630483464136
HSC-4,53495165,1.6708694504220498,0.07236233504323245
CAL-51,969516,2.948027689121256,2.80015374254067
NCI-H661,5746,2.052034109930783,1.0262926397766752
A4/Fukuda,9967941,2.4411204768161983,3.385196938774465
MDA-MB-157,89928392,-0.9485630303355488,1.3635632134830253
NCI-H460,12001922,2.3574763109101253,1.9169572089280664
SNU-81,327653,3.5323829695882267,2.983599615406095
NCI-H661,124202324,2.0891928025286943,2.265835037741169
BxPC-3,42642645,0.6313588777440967,0.6110372913735522
NCI-H2009,24772860,-3.0306018162615342,-1.6926433658475875
A-673,6610355,3.502413574243847,4.504302468658974
SNU-61,57330099,3.603690788773508,4.206703346597314
NCI-H522,2749,2.969505400884835,1.8327185077153498
NCI-H661,57519531,4.09429699672183,2.2630753261066134
MSTO-211H,2126,4.496176254172968,4.706075858345407
KMRC-1,10410894,3.4812991400934585,3.3495625107346103
EFO-27,44237094,3.2066908421034332,3.0958142178345542
LoVo,16725315,3.2447595903434627,4.228381245319581
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.6222497301999454
MDA-MB-453,2842253,6.29942483998937,5.181763698696537
A-498,135875424,4.978423270774445,3.8992313219016217
Panc 04.03,9903786,4.611047286699123,2.8694345979700575
SCC-9,54639665,4.512228528266098,3.3632421379844333
JM-1,24856436,-2.211637583066154,-0.002446946151959599
A4/Fukuda,5311037,4.577970147235868,3.701993913339164
NCI-H522,66577038,3.0388231599187017,3.105221372550838
BT-549,25154868,5.818557590138654,4.41985748690233
KYSE-70,6505803,-1.025033993677824,-0.14742955576704073
LXF 289,11396600,4.152956454399736,3.8374306401893286
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,1.1861197731815722
SBC-5,126941,-0.8684780314881991,-2.828625337290399
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.603850920501248
OPM-2,9933475,-1.3895511853659537,1.5792063587155396
YAPC,11214940,1.707662344700129,1.8696415680186573
EFO-27,4259181,1.8274060730963064,0.08528825276627688
NCI-H460,446155,3.79922347841428,2.7461156483734173
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,3.0573060295056522
A4/Fukuda,3634881,2.7004024711225596,2.805809574051594
NCI-H661,1566236,3.2299922345410006,2.30477280160477
MDA-MB-157,6450551,1.4635370045174534,2.622540903047766
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,3.1190319211234323
BT-549,6918328,0.6487197523295809,-0.016922019765074472
NCI-H727,11175137,3.085433657363398,2.7660992856140827
NCI-H460,3854666,3.1385110084048065,2.190087331291705
LoVo,44241473,4.10673515965005,4.699200681524434
G-401,10074640,2.6430496317806957,2.9978805914871614
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,0.9544658064236533
SBC-5,2126,4.14698296213378,4.417399460672916
ONS-76,3503,2.5109588721491938,2.2030400057133877
SNU-61,5470400,-1.745187092277687,-0.6687723314403526
NCI-H661,36314,-4.592945905020296,-1.474712679172419
JM-1,451668,-4.255879556837535,0.5450479999579297
NCI-H1623,5978,-1.0298747552622975,-2.0959150640241457
DMS 273,136227924,2.538513279360657,2.95492405641934
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.718108933674927
A4/Fukuda,6918638,-1.9449982869755031,-0.03310390341148981
HCC1143,16038120,0.5509172721588973,1.035170275700879
BxPC-3,44185566,1.4327209520395616,2.616913233167171
ONS-76,2858523,2.9452513130208975,3.058528028999766
NOMO-1,46191454,0.6880471005756411,0.9567342671532824
NCI-H292,216239,2.858200088172953,2.256518520517692
DMS 273,11178236,-4.200581603954177,-3.3521410807708314
OPM-2,10074640,2.1693178922200813,2.919317737197344
ONS-76,5566,3.1751487050742804,3.0271948931811665
BxPC-3,10385095,1.8732992891777025,1.5584175212636537
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.7972842052365008
MDA-MB-453,675434,4.221225816741011,4.5296748661648545
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.8177226665662797
CA46,9825149,2.310107059064329,1.9377807274318932
MDA-MB-453,12003241,-0.9610578830621354,-0.8755709515897842
A-673,613753,2.7839803669097134,3.1578144316560706
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.8880679826267994
NCI-H460,3062316,3.704520183651484,1.199575229112319
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,1.0803409782260684
A2780,11427553,1.40474333506403,2.5295071796408384
CAL-51,5287620,-2.338247824560234,-2.0627533076916578
KMRC-1,11640390,3.901360175468555,3.621292960038304
EFO-27,16219061,3.8100949831762296,3.477435119262584
A2780,31703,-4.480868228272363,-1.0784107882760843
Panc 04.03,135440466,2.8713092707831116,2.3787833280371
SCC-9,16065773,3.2014379284662864,2.5326633354595725
SNU-449,148198,-4.785889264279132,-3.4273154607597047
OPM-2,2949965,2.476405976050771,2.564532981745231
ONS-76,44489367,4.840464292002439,4.60225058578763
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,1.086439562525612
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,1.1359270220733728
MDA-MB-453,135411,0.2962177293375728,0.5903027781826519
DMS 273,123631,3.074313122611396,2.519251515259258
CA46,19582717,2.2741322004032716,3.1680658203026595
A2780,3676137,3.624330330130062,4.279985322871286
BxPC-3,11964036,0.7144816609502266,1.5187630646137358
G-401,71466445,3.182548969694367,3.6951341155683086
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.8017356708154793
A-673,49766530,-3.0139632371957705,-0.461991315831251
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.4832777892487173
SNU-449,11609586,3.2368097564340546,2.9870086082501457
G-401,46199207,3.084348249789013,3.1897440206236207
A2780,11612883,1.284093973133662,2.5250128212955043
KMRC-1,2708,5.927603665606935,4.738465982477432
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-1.5557937084917746
DMS 273,135875424,3.231864587804135,3.753705229810505
Panc 04.03,2749,3.2242301239764184,2.025525123972449
G-401,675434,4.2282934242266235,4.200326612188812
G-401,72734382,4.843742106159305,4.074225553461171
SNU-81,72376,-4.141271855112041,-2.698656758397653
LXF 289,208908,1.975389940693236,2.1339768876153684
EFO-27,11175137,3.0704812268942296,2.6107564165653026
HCC1143,16736978,2.2332113551174415,1.5216315026107796
LoVo,24821094,2.523288695365458,2.5377100534316255
A4/Fukuda,10322450,2.3588003127389277,3.6250568274266057
EFO-27,11152667,1.7712187839859168,-0.42048027895864964
A2780,6918736,-1.942572837589071,-1.8303949060438913
FU-OV-1,285033,0.0377877938075082,-1.8687017813881115
KYSE-70,11626560,2.028097573065789,1.71604803358358
CAL-51,400769,-0.1641693790968544,-0.39637379118597954
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,1.6351417135294222
CA46,11507802,0.4399982092061076,0.7869373850406315
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.200627711196914
SNU-61,44607531,1.8838139804325664,1.258162238949712
MDA-MB-157,135984461,1.8807242402896556,3.7788496271174403
YAPC,68056272,3.685228443179594,3.3231699576832243
KMRC-1,3025986,0.2913922358554936,-0.671508699400716
G-401,11656518,0.9589948119457968,1.2209941250480194
CAL-51,25262965,-2.904292987251918,-1.6794046265320963
NCI-H727,31703,0.5895859224805655,-0.6150670651037251
FTC-133,3025986,2.6500554516402515,-0.5056999103715872
OPM-2,11404337,-1.9830798838769188,-0.6161795092574064
NOMO-1,54649381,4.1030759428324455,3.4975445813606454
OPM-2,45279963,2.6394525890823335,3.1277444706852666
G-401,54619267,3.6389956680017495,3.9847684760347253
SCC-9,613753,3.4469207135602904,3.130467123486848
FTC-133,3825829,4.910712910753543,3.63687242253929
NCI-H727,6918328,2.020699769993763,0.07449228647144839
JM-1,3384730,1.783412153965406,1.862086329844816
OPM-2,5335621,3.731372916139424,4.274002392071546
NCI-H727,46199207,3.049846279584177,3.2325963995776283
NCI-H2009,100016,6.24887408197215,6.029828395380191
OPM-2,2742550,2.8639715022070713,3.4090157331451754
A-673,56649450,2.339222019664337,3.176396231568465
LoVo,135928012,4.12079355273469,4.030965690706021
SNU-449,46215462,1.6240369462021291,1.9310661904003936
EFO-27,10385095,0.896347771716858,1.3699153584720134
BT-549,6917907,-5.828237871920148,-5.316759703610287
A-673,262093,2.1198375376891705,2.532764028819488
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,1.8675602501613309
G-401,2871966,-1.4998546935779766,0.13668981492537083
NCI-H460,6610355,4.949206869720499,4.423694609604406
NCI-H292,56946209,-3.439063202171596,-4.361551472486076
MDA-MB-453,46907787,-0.524764523127372,1.866132467746919
NCI-H661,9935249,3.279757521015836,2.8686383806894082
Panc 04.03,5311281,5.064761813982229,2.450077298926101
EFO-27,54765302,4.904683382842226,4.143856856338879
OVISE,24964624,2.347879134584806,2.596859557651431
MSTO-211H,6918878,2.3677965777112653,2.5716370427282196
KMRC-1,1641662,3.91383049133015,3.6095596843400455
NOMO-1,3025944,3.969971169930392,4.089798335872401
MDA-MB-453,10322450,5.853812101119735,3.7195510560873233
A-498,675434,6.195396019607132,4.565877644084898
JM-1,16736978,2.465148690257062,1.32191134538629
HCC1143,400769,-0.895432113907658,-0.6867014851758895
JM-1,5328940,0.4457439228433418,1.0589032261469928
NCI-H522,156422,4.012108454967305,4.170123274393055
DMS 273,135999136,4.8097980755766505,3.5979988187569374
A2780,44607530,1.3884091000724437,1.558286890954406
KMRC-1,10302451,2.629362111325239,3.3358830492266827
SNU-61,6918736,-1.624439463390885,-1.501649716898853
BT-549,135999136,1.9798336492119424,3.5071349456060767
NCI-H1623,9926054,1.7409203229588674,1.8642598580664405
JM-1,16722836,0.523497579231149,1.0443600625404583
MSTO-211H,613753,2.697490548990984,2.953684560885232
NOMO-1,16725315,4.952538276899841,3.7976979808721008
KMRC-1,16736978,2.1404631421072975,1.6799894804134925
A-498,123631,3.2458168084526564,2.6018112900208568
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,2.993883483916526
NCI-H1623,24951314,1.0133274480783143,1.4959246811679148
NCI-H661,11228183,4.275001578251326,1.9893386237152166
FTC-133,5479543,4.4305420476204205,3.42305308948032
NCI-H292,136227924,3.1886204590132654,2.8760417008674852
A2780,6184667,2.4201329833494705,3.031257699566656
SCC-9,5278396,3.934746070394729,3.572559904527894
OPM-2,5743,-3.6176009576451142,-1.1073444176254348
DMS 273,66577038,3.0260629384717443,2.9561935795310443
SBC-5,151289,0.3068057764327633,0.6868798189711377
A4/Fukuda,44491742,3.3943913096556444,4.149816412444124
MDA-MB-453,135928012,3.1518499848728534,4.063806273559501
A-673,2828334,5.945698490544337,6.197035144569672
OVISE,44185566,3.1371413376940724,2.482346353464327
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.46870045446575226
KYSE-70,5460769,2.831605222646697,2.7029817467652943
EFO-27,60700,0.0275300045157078,-0.6038166419902925
SNU-449,2871966,0.0642629453363792,0.3562078779007208
A-498,135411,0.9450284346401692,0.6736778831546977
CAL-51,151289,0.6583498849401344,0.7918607039502916
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8702988150046584
NCI-H292,54454,1.5363763322568371,2.7345300992450836
MDA-MB-453,984333,1.2010378495759917,0.549025361641398
A2780,1242560,2.8030380184252346,3.4685304156213737
G-401,11625818,3.256149300060542,4.207155182338587
EFO-27,2729026,3.178460421270277,2.8034216610251526
CAL-51,54454,2.240351559744082,2.6197363445508177
SNU-81,5470400,-5.232383325772668,-0.9805969301062529
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,2.457961636838649
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-0.4426248152661439
LoVo,51037431,2.9518330914759043,2.8173848262747145
NCI-H1623,57519531,2.253772853853667,2.4917719933008593
BxPC-3,6918837,-2.8801990347910045,-2.6428402656989034
SNU-81,452548,-0.1759999006209261,-0.15766569650974296
BT-549,327653,2.9888914918454854,2.7792818097039014
CA46,46199207,1.8825158344658808,3.0104263120610972
MDA-MB-157,10410894,1.6628456414259642,3.313100272844125
SCC-9,66577038,2.999012470787333,2.9878883401695986
NOMO-1,6918878,0.4522523514749809,0.6644216321531577
SNU-61,5281321,-1.743716860572046,-1.410495073036148
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.6260204685810762
HCC1143,9840324,5.44269474449066,5.751625615618241
CA46,11234052,2.4794836109026077,3.4195117559077617
CA46,11609586,1.0102139081655188,1.8984742369518286
NCI-H460,10385095,2.2920897819597896,1.3424414559506928
BT-549,11625818,5.0921701677816875,4.216556233965955
SW1463,400769,-0.5224692496950973,-0.5509909610906613
Panc 04.03,10113978,5.097338218314276,3.0286375776420287
JM-1,9907093,3.962832886035932,3.679212546659021
CAL-51,23582824,1.0413279539794644,0.8104966318549819
Panc 04.03,135398738,4.347297256699442,3.5788008505579567
G-401,3038522,2.1905688095022215,3.022923752694558
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.692700648305346
NCI-H146,4261,-1.8051480987265105,1.3486333323538875
DMS 273,2729026,2.67706862921606,2.5626148520906225
SNU-81,1750826,0.9975547695410114,-1.5561670719702958
CA46,168313200,1.9493207867170304,2.829761741041786
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.1886700240500567
A2780,57519531,1.3251208810116586,2.2245047114184913
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.7635977945942218
A4/Fukuda,11717001,3.8123333180630103,3.731781572907
LOU-NH91,3634881,3.4323223488487593,3.267385641201655
JM-1,11485656,1.6613246077420758,1.4251123777049661
SNU-61,107985,-3.1587785808489297,-3.4974592516350524
FTC-133,2729026,3.353273516564875,2.836772332286068
ONS-76,159324,2.5690437216419677,3.077119673143248
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.8944954848834765
G-401,9927531,4.9703255494446035,4.447023304992053
LOU-NH91,25105715,3.511519280721543,3.514631394445938
SNU-61,15953870,3.2687219409332657,3.4931933506068087
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-0.9863967346675285
EFO-27,24951314,0.9989426715403756,1.5346016525771373
MSTO-211H,5311,0.950405781568164,1.4261571741889705
A-673,9444,4.054770941664931,3.729574804134618
MDA-MB-453,6852167,1.219966928776707,2.810831466788419
DMS 273,3384730,2.794672653243152,2.410459286579246
NCI-H522,24964624,3.0091798278143003,2.6160097991787454
DMS 273,6918878,0.6913807013381441,2.4629625763938185
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,3.221577785896892
CAL-51,5311,1.4183219405835503,1.4876304647237597
SNU-449,3136844,4.333259755823753,4.271615122346434
SNU-61,10074640,3.0465009012673923,3.060193788071429
NCI-H292,5738263,3.605646843776872,3.5201010649265125
NCI-H2009,135440466,0.1778924686528867,2.30469200143636
SBC-5,387447,-4.42204631831661,-4.252196621161559
HSC-4,60700,-2.3901041148359,-0.4270930551368024
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,1.506287673375127
BxPC-3,322968,4.585795478380971,3.871680108144845
CA46,24821094,1.9467424475066963,2.9422901598656956
SNU-449,5282054,4.57557530009064,3.60456833056076
CAL-51,11625818,4.1129054868405905,4.374876013711795
A2780,16038120,0.4203115446628392,0.5819079089911066
MDA-MB-453,44484893,4.218904183145372,4.024265347440191
YAPC,969516,2.7207948170212894,3.165735986192207
SCC-9,6914657,-2.6898440352771704,-4.057836137331454
BT-549,156414,4.402880659642667,1.3112901541903252
A2780,10410894,2.69442494781606,3.2753900746824285
HSC-4,1566236,1.9723291328750472,2.2173072432715415
CAL-51,53232,2.8018516258833395,2.811138731950899
NCI-H522,73707371,4.918377506073214,4.802397521725926
FTC-133,2858523,3.137647378022636,3.015838020122735
NCI-H146,2949965,2.1998257096859235,2.9040138951647942
A2780,5291,3.6974106280730767,3.5091172226273475
A-673,11317348,1.5484644948233677,2.569571253688913
CA46,5284616,-8.167802056045408,1.304085645431493
FU-OV-1,9840324,7.491199941931371,5.68563002600929
NCI-H292,17759555,3.476208496969499,3.9106233271861597
NCI-H2009,6918837,-3.78935135271195,-2.7315895127142733
NCI-H460,216345,3.827300936034388,3.642152090978483
BxPC-3,54143018,-0.804639103071218,0.6853396693831233
SNU-449,11612883,3.957753067546404,2.8747743115210085
DMS 273,49867930,4.404291499076759,4.684935028543566
FTC-133,15953870,4.441911294632587,3.2904583140502264
NCI-H522,11612883,3.3366707819202666,2.7445422967203386
A2780,9444,3.815396075990075,3.785192097429802
NCI-H460,54619267,4.901891634717457,4.082198780121467
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,4.724027311686908
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-0.9250623266023921
A4/Fukuda,4521392,3.820585335578038,4.0862454953164296
CA46,5328940,1.1838617633473132,1.211872726783747
NCI-H460,452548,0.6919333948360032,0.30837133716659726
YAPC,25126798,3.983335704988987,3.9276895443927593
SNU-449,322968,4.603056923598163,3.7907805312352405
SNU-61,54618164,4.021673833793196,4.08189753572122
NCI-H661,400769,-1.492892337104586,-0.5396010295907806
G-401,24964624,1.4880998129973728,2.2795918865286238
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.0999480372672235
OVISE,2945648,2.8352179600513367,2.9450758363905094
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.282295284175446
BxPC-3,984333,0.8836461068661873,0.7129436841699348
NCI-H1623,42642645,0.9313727170286358,1.2099352444540903
BxPC-3,71466445,4.819923879864087,4.123925397250711
MSTO-211H,126941,-2.2791548116201987,-2.3920200362507273
MSTO-211H,20959075,-3.222615813929693,-2.7398724159349173
BxPC-3,16741245,5.048799679028713,3.431444436100419
OVISE,12001922,2.261742632923514,1.8901224886840717
NCI-H2171,135440466,1.9220793929810305,2.297692910218874
BT-549,119182,-0.6766164524597643,-0.22330108894383444
KMRC-1,65064,5.386842832596526,5.0811769557826025
ONS-76,16725315,4.104726960292652,3.891888120292801
ONS-76,6505803,1.3937943977095182,-0.7622958610187597
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.4823454086210424
FU-OV-1,25062766,2.359728819743937,2.099489878838554
KMRC-1,5566,3.18269246163038,3.1172669927129073
NCI-H460,6438330,3.783082395235063,2.304540205780148
CAL-51,135440466,2.9511327404143755,2.1800070666204316
DMS 273,23582824,1.3511796414129456,0.6806713012987002
CAL-51,56946209,-4.496983035262223,-4.282441980754465
OVISE,176870,4.342841287056181,3.159960592529351
KMRC-1,11494412,2.978505743964039,1.5962417528104702
A4/Fukuda,54454,2.014078017992857,2.5144247092725482
MDA-MB-453,2733526,2.894784526555574,3.954740123165251
HSC-4,11625818,4.485436042124793,4.365941671809369
NCI-H727,2733487,6.440431233061491,6.4847162605071995
HSC-4,54618771,2.9865797342969564,0.9845497306286195
CAL-51,12003241,-1.2189714227076325,-1.45719613173675
A4/Fukuda,52912189,-0.8285591911559074,1.1240051132169784
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.3715420461725834
CAL-51,6610355,4.388066889778601,4.469270474705888
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,-0.1125632712850651
NCI-H1623,56649450,-0.2540238687607088,3.493710253622553
A4/Fukuda,9444,3.1818692272898423,3.8011331825594543
NCI-H2171,55508,1.786136919471965,3.1201070275568306
NCI-H522,9840324,6.2981118504366735,5.882842061164902
DMS 273,409805,3.6932334728164826,4.502164328567376
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.7772129033696826
NCI-H727,16722836,1.5817712487099789,1.5730718000730568
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.3768609594212076
G-401,5281672,4.259815588040996,4.615898222574835
FTC-133,4917,3.819256860929221,3.04304263364047
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,2.91072553213376
JM-1,10113978,2.290370569955518,2.609612095967255
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-5.51421882890151
EFO-27,675434,4.38679148408465,4.472172390954137
SNU-81,5460769,-2.0941921209529575,2.090450518337797
BxPC-3,5282054,3.885649252328735,3.6472602816686917
OVISE,6184667,4.390472676016808,3.154272747006282
G-401,16659841,2.2879294183156396,3.4205022688312483
HSC-4,19582717,4.479728463380205,3.9605510613371497
KYSE-70,1750826,1.0050628158627442,-1.4064897277238038
LOU-NH91,135659046,3.4412725013745336,3.4872440050770472
HSC-4,11396600,3.0766488056466104,3.6450670977575577
KMRC-1,11964036,1.816670768699429,1.5844019375289056
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,1.155352267720059
HCC1143,54618771,1.714955024233068,1.3014729671904748
A2780,8515,1.754639935244518,3.6961230823986067
FU-OV-1,36462,2.321134275550796,2.204392945427257
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,3.2197389238990213
YAPC,216345,4.822006863531136,3.983454909717159
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.257444423378098
LOU-NH91,72193861,1.0473212139197163,1.6797662126130553
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.9798076414390968
CA46,54618164,3.845436645537388,3.734936062875444
NCI-H292,446155,1.4424758906582096,2.638274565308429
HCC1143,9936388,-6.988875343339418,-1.6375960737056916
NCI-H727,9907093,4.262034183201205,4.198247312545701
ONS-76,126941,-2.856353430413947,-2.129830065477447
A2780,11455910,-0.8495199814745813,0.7285330312942441
A2780,73707398,0.6651600447827565,1.0963071513180827
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,-0.04082612420910037
MDA-MB-157,24856436,-0.6830375019554852,0.31058074930813523
LoVo,1750826,-1.736017877496402,-1.1197700948588025
NCI-H146,49766530,4.81095512251176,-0.31317037788669466
HCC1143,409805,4.31745443409651,4.672230665808252
OVISE,159324,4.206537691518507,2.9527963147357825
SNU-81,10302451,3.60256279960024,2.237147077895913
EFO-27,5282054,3.999430083075576,3.633270101521899
LOU-NH91,4917,3.4124252266322297,3.08609278391603
SCC-9,5328940,1.568072217369216,1.6158976980175135
OVISE,637858,1.8122421616924396,2.2242581511320787
NCI-H2171,44607531,0.7654225162387793,1.3881847718944809
SBC-5,7326481,1.449700392659346,2.7941026381823817
LXF 289,9907093,2.975231625485398,4.163407857463457
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-1.5852086589886574
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.6864515289442754
KYSE-70,159324,1.7590392520862297,2.579856118656029
NCI-H2009,3025944,4.548991530576528,4.381432788701085
SNU-81,135398516,1.5373988209241822,1.6155585216082873
A-673,9911463,3.7053308577681583,3.7626188770553894
CAL-51,9826308,0.5677925602140103,0.14477261403283204
SNU-449,10074640,3.65403010435808,3.1771646950401538
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,2.4768739778862585
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-2.1773503005953687
JM-1,11213558,1.11781575024048,1.5492628372441524
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.22987426211402298
DMS 273,11396600,2.9821670224503025,3.453956980810692
CAL-51,2742550,4.689941422286605,3.7576966445394726
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,4.94781797880498
NOMO-1,24856436,-0.4465471145990737,-0.18203514054311826
BxPC-3,54454,2.2110977916594945,2.5634633783366634
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,3.4950609587187382
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,4.083015910264717
LoVo,54678924,0.9602640778132784,1.8374209163624078
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.0700914099100602
NCI-H460,9911463,4.421747687015995,3.844223717548226
CAL-51,3062316,-2.5625958708444205,1.207599952306453
G-401,11404337,0.5096427987118028,-0.2504238286244263
A4/Fukuda,107985,-4.34456564276242,-3.773872187105991
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.7484736901700664
SNU-61,9956119,3.7156714580567063,3.6793305125643014
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-0.9935649502885066
EFO-27,53301938,6.290465616373669,2.0155763850883996
NCI-H727,17759555,3.180616959518291,3.900075950295098
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.511185010174915
SNU-61,44819697,3.53302657640718,-0.09355843332930562
FTC-133,16065773,0.3113531910395277,2.2841785670564843
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.815636697254158
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.9149909762934769
NCI-H2009,107985,-3.3237358160703843,-3.544088539192595
NCI-H146,3676137,4.978597159303883,4.457623591591635
NCI-H146,16065773,1.505871551892472,2.076870137042615
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.6169789300398896
NCI-H661,60700,0.4833445990508663,-0.07546320018103637
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,3.2962246436912856
MDA-MB-453,44491742,4.088527945953042,4.291302758427318
NCI-H661,2945648,2.4705894827529984,2.820296053239967
FU-OV-1,12001922,2.2107336164209586,1.9224551944256536
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.6927316301412776
FTC-133,168312962,3.97521401805193,1.799512980357677
NCI-H2009,24951314,0.5822698862930126,1.4590105136814229
Panc 04.03,3552672,4.635312487107652,2.875841979356768
HCC1143,16725315,4.684699585721338,4.161924264765685
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,1.7581023943686074
A4/Fukuda,67156097,-3.3575882698535526,-1.5018347099324485
NCI-H460,44507138,4.578042897326484,2.6518605742725816
BT-549,262093,3.1295246575488354,2.8864176876388394
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.3596134015401296
LOU-NH91,23635314,-2.2216361010230545,-2.049236530344918
HSC-4,11485656,2.41592786996926,2.268062230440178
Panc 04.03,2858523,3.1704472292667245,3.0768000158690154
CAL-51,31703,-2.726607914110417,-0.8816982361769645
SCC-9,11485656,3.6663619913543446,2.345241450602391
EFO-27,11234052,4.354926990140025,4.006797233127097
NOMO-1,11977753,-1.9426292333262003,-1.9635988438785779
NCI-H146,5280436,1.6778415991784894,3.261967818295864
SCC-9,44589607,3.476138487776652,2.767413713690422
YAPC,1716436,3.308380745751715,3.059599483859996
MSTO-211H,72376,-3.945669301292739,-1.5573296880586338
CA46,6438330,0.8057128440407828,1.4263826981678784
SNU-81,46907787,-1.0582449369350613,0.6805531821206816
ONS-76,53232,1.9476307600046912,2.6155942127257372
SCC-9,51037431,5.108150298111964,3.136291431747873
SNU-61,11719255,3.5581483316812275,3.0872176443582147
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,2.0221039631366473
NCI-H522,8515,4.67214972936148,3.7752623397595433
A2780,104842,-8.58016789938804,-2.9468287429793003
KYSE-70,56946209,-4.444419695204879,-3.964183296045229
NCI-H2171,46191454,1.782184086758524,1.5026159648436073
NCI-H292,54618305,4.4370648491662195,4.637660884059786
A-498,16725315,5.296109915632034,4.294951717316339
A-498,11494412,3.741733086313002,1.718912078080855
JM-1,36314,-7.745176622378906,-2.1632060476672845
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,0.9589905676718299
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,1.5477407518471236
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,3.077557453524605
BxPC-3,72734382,5.457836982387995,4.681157960047669
NCI-H2009,72734382,3.739945681050146,4.423513756782446
CAL-51,65064,3.306239750209062,4.771836972031958
A4/Fukuda,6252,-3.645065834912594,0.302522162870703
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-4.082859557503316
A-673,36462,-0.225010248526114,0.8577304284895138
BT-549,25195348,2.629764497852918,2.9752764229095208
ONS-76,3385,3.2517912405561784,3.5224162139083095
A-498,73707398,1.745059470984177,1.4991674879247139
A-673,56963564,0.0212663307031236,0.3418736512466927
NCI-H522,984333,-0.7488997443424653,0.632638506898758
NCI-H292,452548,1.0483210578903834,-0.05766054189475344
NCI-H661,57330099,4.147264508988866,4.23650896752527
KMRC-1,11167602,5.704956856257104,2.379107969742412
YAPC,25150857,2.3485140693919178,2.5773618330177444
LoVo,6918878,0.5506920931363443,1.7067895775228414
LoVo,5282054,3.3404837473565077,3.763297234199251
G-401,445643,3.8388087856424,3.832890603399254
Panc 04.03,31703,0.9238663549391216,-0.4982627595277232
KMRC-1,25150857,2.932634990579502,2.593022709443375
LXF 289,9903786,1.8485652979864533,2.7845010002076793
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-0.7875996452072996
Panc 04.03,25227462,1.6849134644206611,0.22254279936178836
LoVo,5328940,0.1711764774474706,1.4588339913692554
SNU-81,49850262,-1.5447601433950633,3.387711759604178
CA46,46215462,1.3062506059575565,1.395519681681003
MDA-MB-157,219104,2.454471278072077,3.478001152606887
MSTO-211H,168313047,1.6297190097298295,2.3631439712433004
NCI-H522,16722836,1.5816295407965617,1.7583500769578082
OPM-2,54626689,3.88605573030338,4.400256682390971
DMS 273,60700,-0.3389173956036069,-0.8796762248066947
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,1.1911057044068445
SNU-81,9826308,-1.744878476856413,-0.12240633244871237
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.7213593678432653
NCI-H292,72734382,4.432039940054941,4.475060519625151
NCI-H661,11507802,0.3336368123539006,1.1631709672191102
Panc 04.03,676352,2.180457258433582,2.1387256205216594
FTC-133,322968,4.798855030018761,3.4818262634262154
G-401,16720766,1.0481135004094,0.4287930562981784
G-401,462382,0.38796721763981,0.5402040805466162
MSTO-211H,25062766,2.0532887481804605,2.0458341717078614
A2780,16736978,-0.7643928517553599,1.730041732071556
NCI-H727,2729026,3.015864992302643,2.6865520518125527
CAL-51,135440466,2.9511327404143755,2.1800070666204316
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.24914952856234
BT-549,72376,-0.6560931555152002,-1.6068455445764198
A-673,9933475,1.583729012108943,1.8728538823602572
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-1.7238882753779836
EFO-27,135875424,4.6207788215281465,3.9028380782857295
A-673,24785538,-1.1944412082957694,1.4524471260884615
CA46,135659046,2.986085914123542,3.356400403321726
CA46,3038522,1.2076902647573031,2.8914931631032643
MSTO-211H,54626689,2.3486455994654767,4.609905127794995
SNU-61,44241473,4.262106100814371,4.460406001630126
MDA-MB-157,25126798,2.9199314308838327,3.874695005921156
SNU-449,10410894,3.985550363358928,3.3886300502569746
LXF 289,53232,1.5859701947912777,2.660282763796437
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,0.9016297317985899
DMS 273,11234052,4.3748762471871725,4.013431466719526
A2780,107985,-4.859396565896689,-3.574385835420683
Panc 04.03,44202524,4.489701680422056,2.1168635999452468
LOU-NH91,44185566,3.062522771292805,2.6502638648692516
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.314002393305761
EFO-27,36462,3.079082429258617,2.1121771968791165
JM-1,24821094,1.723225199642946,2.476091692117714
KMRC-1,216345,4.164305633353381,4.08686604726083
NOMO-1,168313047,1.7455342513633885,1.9222383042242313
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.0193066431340223
NCI-H522,5282054,2.516149277526254,3.4085427721498864
SNU-81,26596,-2.2143193215677925,-1.5864712944108161
LOU-NH91,135875424,2.9424536382603215,3.866118472983722
HCC1143,446155,3.993343592958968,2.656759084364859
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,3.3910650049874658
LXF 289,3081361,2.235375481166719,2.4995995890458884
Panc 04.03,6918638,0.956445062850862,0.6287283557049177
ONS-76,46907787,2.0367347893242247,1.7126566227952569
FTC-133,5470400,2.075616738071143,-0.2545713497875899
SNU-449,9884685,0.40134732620175,0.725121353638742
FTC-133,44566777,0.1715240988601806,0.9018136722464586
KMRC-1,9911830,2.7576147713752532,2.691567180893083
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.9117026319292006
SNU-61,119607,4.552023022199627,5.151002368961407
FU-OV-1,2945648,2.6612648927829348,2.9205826926193508
CAL-51,5282054,3.552468823116285,3.587358620723771
A-673,1750826,-4.326827801164573,-1.9203465465265876
NCI-H661,23582824,0.4459994130921247,0.6422521653539809
A4/Fukuda,208908,1.6750686900112284,2.050306341205557
LXF 289,24180719,2.719444673565486,3.7407508820422817
MDA-MB-453,11647372,0.3935032395331521,1.080819320102277
NOMO-1,54454,3.4949720971193083,2.4339796938581957
SBC-5,1750826,-0.5333690682178334,-1.5096568957924745
SNU-449,11234052,5.346874708028275,4.085790729270446
LXF 289,159324,2.685439807189008,3.210231228990583
A-498,11964036,1.806054574855834,1.3818118524065153
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-2.2448781952638304
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,2.0257820886079183
NOMO-1,11178236,-2.492998231075174,-3.3557088063165295
BxPC-3,3503,1.5238678808710824,2.3418859619894645
A2780,5281672,4.494440141018236,4.425864165655992
NCI-H460,57519531,1.7606196796007008,2.690454911489439
NCI-H146,3038522,1.5824622735127496,2.9808658618201362
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,0.008384204254456105
A2780,7251185,3.0282253021168835,2.1367281881472833
NCI-H2009,54143018,-0.2798924220132643,0.7268540427853535
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-1.153254262270921
A-673,50905018,4.224820228350104,4.125276768534128
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.4172808155383623
A2780,11640390,3.511086163886132,3.2661807659566517
NOMO-1,984333,-1.7512214516120577,0.038570387942777694
NCI-H292,3062316,0.0480521305272509,1.7349940111426798
NCI-H1623,25183872,0.2518729007636168,-0.6026670772904232
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,1.54302962399426
DMS 273,11647372,0.2469617170644157,1.074051311776229
KMRC-1,12001922,2.9414276180440884,2.064109890783219
A2780,54143018,-1.3409986451592475,0.19194472660250647
YAPC,49793307,-4.348408449857898,-2.486679628716839
CA46,1716436,3.005257864158129,2.5042639993102562
HSC-4,676352,2.328446260179327,1.9706377346908277
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.6878820108324986
YAPC,12001922,1.7591466639310227,2.0361430089820036
MSTO-211H,5460769,-2.0887143253822615,2.7541943150938426
CA46,3384730,2.283076300956678,1.7903249323914374
JM-1,9911830,1.0886367976495992,1.9715665241869007
BxPC-3,1242560,2.823718248478356,3.4399847273756587
G-401,44237094,3.2290132612915325,2.847576506266129
BxPC-3,16736978,1.696086021540879,1.5604931842551937
SNU-61,46191454,1.739312628335972,1.7270232449542546
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,2.011156177887413
NCI-H460,5329102,3.240160570329804,2.253273433572855
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.1342017488355447
LXF 289,216468,2.2889797638929683,3.217686176653627
SCC-9,44819697,0.1293575980749295,-0.564228414920196
Panc 04.03,675434,5.243078667682196,4.5209397082567255
HCC1143,135398516,2.188515967576281,1.9607201690484048
ONS-76,25262965,-0.7369683376858831,-1.4631523038317054
A4/Fukuda,53392493,1.8640822641046917,2.0773614241626888
A-673,2130404,3.217416760546526,2.9422270767855165
NCI-H661,72193861,0.3965882674238952,1.3120790571501326
CA46,119607,3.9558807366301374,4.8692332112037455
CAL-51,24856436,-0.3083697359271743,0.32937269379495765
NCI-H2009,2828334,6.796615650463657,6.17797862439709
JM-1,135398738,1.1596934849395544,3.0463885682088825
CAL-51,49793307,-3.2015156477281193,-2.848186133495196
HSC-4,10410894,2.7401570440851155,3.184666880689408
KYSE-70,46843906,3.5210263801871498,2.6108195841155806
KYSE-70,11178236,-1.2639965798928303,-3.096832444098067
EFO-27,6610216,4.772563131438148,4.326758780982653
JM-1,135659046,3.550517545140938,3.405079016929623
A4/Fukuda,3136844,3.333855932915555,4.071524725948317
KYSE-70,53495165,0.5494520653774981,-0.21583185752747866
EFO-27,9926054,1.857839666788878,1.9897855456981548
NCI-H460,16741245,2.175171044948558,3.8506598282687197
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,4.2786180707525965
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.295127434634782
NCI-H661,107970,2.2398777867932473,2.386841267381294
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,2.41703785620256
SNU-61,51039095,2.128467827492616,2.7637614272497144
YAPC,104842,-2.4249346234244302,-2.7384859364665974
EFO-27,11364421,0.0539420857608272,-1.8972108732824224
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.3719041536507772
HSC-4,5284616,2.67117659303102,2.47348961843942
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,1.2848591943337397
KMRC-1,100016,6.458679548763862,6.040073164103474
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.6978278483246012
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,0.7723479581101493
LXF 289,10184653,0.2846387514020494,1.5035680383534893
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-3.699297186238612
ONS-76,73707438,3.6763163562039103,4.295253559882356
CA46,10113978,2.0547387812543425,2.5084724598638606
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,3.8824892087710325
MDA-MB-453,9444,3.890114397090033,3.890184884247849
DMS 273,462382,0.1050500144131629,0.44328987111200213
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.6185627829439053
SNU-449,327653,3.836895463512291,3.3308077943138166
JM-1,4917,2.618606210388543,2.6652715671792375
A-673,7326481,2.3948672158707027,3.006010384297614
LoVo,3543504,4.109477120593384,4.356040524824824
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-2.2908217390883068
FU-OV-1,322968,2.943455676205593,3.73435416454339
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.240686124043168
NCI-H522,10172275,5.332939953657848,3.4167734394945732
FU-OV-1,11175137,4.687876560675478,2.5759062349850637
NCI-H292,702558,5.809534673466565,5.327189144618716
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,0.5588767368925162
FTC-133,4378219,2.0024564120700874,2.3001108767699567
A-673,322968,2.685664332943325,3.2857395075113573
A4/Fukuda,11175137,1.0544671313881684,2.2204157967966007
NCI-H522,9907093,4.234502914187168,4.035598490912588
NCI-H460,73707398,3.251551904382877,1.4542429875562923
NCI-H1623,11625818,3.770410958253076,4.367777382255219
NCI-H2171,3384730,2.17478810564445,2.7152815952793152
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-1.0644499885132088
BxPC-3,135398516,1.0474106677719497,1.860214833583187
YAPC,6852167,3.757016833172803,3.055377941515325
HCC1143,11178236,-3.0622306456236728,-3.3741713907700137
LoVo,168313047,1.791039731088859,2.1073467765963305
CA46,9915743,0.7447060154867644,0.6205215061957705
CA46,16065773,1.8844207098737984,2.0965856788149124
DMS 273,2749,1.7681499736943271,1.8336287176038846
OPM-2,9549297,1.1861201303789202,1.8856131219546362
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.8962183560556154
G-401,3136844,3.887156631896907,4.0079480753134415
NCI-H727,24901704,2.771852034083143,3.2569433602077464
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.0271180369239072
ONS-76,36314,-4.67770988102335,-1.5012359772074302
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.9829455438256238
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-1.1863649550369515
NCI-H146,54618771,0.1782763900918093,1.3708894358031636
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.8565660174226322
BT-549,1750826,-1.15792790160721,-1.3978650822396779
A-673,4521392,3.83212246390289,4.174046412137753
A-498,10127622,2.6897842830613934,3.698450392230088
NCI-H146,24951314,0.0243539025761212,1.2812655672987379
LXF 289,11404337,0.1273620702572638,-0.12724738159171817
CAL-51,72376,-2.938334648898351,-2.456953701238588
HSC-4,56946209,-4.10163917558625,-4.0458728546723
OPM-2,11719255,1.0053781432887028,2.8634190964059076
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.23558079904432
OPM-2,54765302,3.66991118627716,3.9725450702676004
YAPC,107970,2.510985201601563,2.4702936258020687
A4/Fukuda,6505803,0.0348674492980193,-0.7445264952654018
NCI-H146,421610,3.280213272702812,2.967014037286112
CA46,10427712,3.800630662833656,3.9167379765874055
Panc 04.03,42611257,4.903884607697216,3.5370589796558045
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.2223217558177633
SBC-5,54618771,0.9612938071948806,0.6646875333397846
NOMO-1,44819697,-3.3724853213010895,-1.1414368242137345
SNU-449,46843906,3.9850337221839074,2.8935111074859403
A-673,2733526,4.173930306540303,3.6234371612681975
Panc 04.03,387447,-4.060832381569581,-4.391841943896051
ONS-76,16038120,1.944596111088229,1.2756520379047656
Panc 04.03,12001922,2.0215480430072588,1.942413747533293
EFO-27,56946209,-4.24663912291577,-3.936624119457983
A4/Fukuda,15983966,4.102938700353478,-3.092241919548066
NCI-H522,10322450,3.5945001970925787,3.7999405051506305
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.7023219038758635
BT-549,16038120,1.0292862217749383,1.1373989177762078
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,0.5178718424057598
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.1478310921183765
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,-2.217926240212245
OPM-2,10302451,3.176323712036339,2.7530067891393823
BT-549,5291,3.9626748190842167,3.656686892255443
A4/Fukuda,54143018,0.5698360241890451,-0.04027780848613428
CAL-51,5113032,4.55807021159329,4.829851520278222
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,0.7396800113818764
KMRC-1,15983966,1.4470823508624893,-1.7434910006421283
SBC-5,409805,5.881004535625117,4.594561253612628
MSTO-211H,11717001,4.186640197436745,4.025346985147795
MSTO-211H,5351362,0.1292531164344693,1.7238733598348173
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,0.8419274797514602
A-673,135398738,4.1394757023123505,3.542245642337893
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.5384048233959282
NCI-H2009,12001922,2.0619007134450524,1.8737446357853578
CAL-51,3634881,3.319714226315486,3.2673572100322947
SCC-9,5282054,4.577178009511458,3.568943928407018
SNU-449,6610355,5.42598000328545,4.605995964140921
JM-1,100016,5.094244415703564,5.750976618928033
DMS 273,16720766,1.3424969772091375,0.5599536086522324
MDA-MB-453,82146,5.197355724890258,3.800369723512184
NCI-H727,219104,4.385991256377306,3.7301567671328852
G-401,387447,-4.890417311710873,-4.502978599890945
SNU-61,445643,4.910443238015828,3.960366464905038
G-401,445091,4.490925944707375,4.351764908236821
Panc 04.03,10074640,3.644812120140466,3.080921919070941
KYSE-70,3038522,4.319477989558539,2.8619966251377127
NCI-H727,5311281,4.417954223041409,2.200094765664834
OPM-2,24889392,2.046562304125139,3.8788895230582194
OPM-2,9866186,1.7779199456036283,0.31318726054158674
NCI-H292,65628,4.3235700442832625,4.49282063283491
JM-1,5284329,3.614100674193798,2.7953397334943357
LoVo,49850262,2.4887252685350227,3.6504722060724277
BxPC-3,24785538,1.143761767664292,2.0456173577794434
LoVo,176870,1.1282563754131285,2.945480903827179
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.215631688661202
EFO-27,73707398,1.1269975883077623,1.1950952320346888
CAL-51,49850262,3.6300011952383584,3.630078722040295
NCI-H2009,1750826,0.0733322198534379,-1.5928975031026231
LOU-NH91,9903786,3.184012464559237,2.5634791907070906
NOMO-1,9911463,3.1879476164010243,3.3755682305559422
A2780,16722836,0.6661441985838381,1.5176946398160944
MDA-MB-453,11238147,2.2482376857817856,2.7907890842167076
NCI-H2009,11626560,0.9059448501577204,1.9514538301622195
LoVo,2746,2.3133613771451524,2.9563063690017306
NCI-H661,9840324,5.7754199175322825,5.6725181192229535
SNU-61,10385095,2.7560205308704044,1.2375341882498752
A4/Fukuda,24771867,-3.7385177445932585,0.9017932702362806
NCI-H727,654092,0.4388886539996767,-0.22533585053416164
NCI-H661,44507138,1.7319125686737762,2.331614359633714
EFO-27,16013152,4.523705738143722,4.118326127760636
CAL-51,4259181,-0.5132501801478601,0.16406076746560483
A4/Fukuda,2746,1.0000278581130588,2.609853379826167
NOMO-1,10184653,1.080224838410231,0.9062034210698379
Panc 04.03,135398516,3.776050709281408,1.981447156634529
YAPC,3038522,4.3203914817087234,2.925449638177001
NCI-H292,9926054,1.8794077191249725,1.9874046341694482
NCI-H661,5278396,2.727600530538007,3.508370048725401
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,1.9720395683914007
A2780,9803433,4.475774001896097,4.664587339245352
MDA-MB-157,11178236,-4.597953573249134,-2.918154473852476
ONS-76,44137675,3.612845962454732,3.6420426048589327
LoVo,51039095,1.8047028032602028,2.862870133703835
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-0.5988801560234552
SNU-61,25183872,0.0265852822027559,-0.7465102582478335
NCI-H661,10410894,2.079430431888453,3.239149096362989
NCI-H1623,11497983,5.112351206162292,3.643919457015392
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-2.3316736056953014
NCI-H522,6184667,2.532079714436212,2.9728826013855056
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,1.7773289261209824
NCI-H2009,44589607,3.679148722712513,2.9708904517899093
EFO-27,44137675,3.925812188621705,3.8198102347638327
FTC-133,5328940,3.204514542529291,1.5992017370776614
FTC-133,2708,3.4116435244290773,4.308211113946166
NCI-H661,24901704,2.3315866691701395,3.0962064908655482
MSTO-211H,11719255,2.56955632094912,2.937716871090537
OVISE,11626560,2.348997135596899,1.9184488985287849
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,0.14112312300550048
CAL-51,9868037,3.5441777448678615,3.235497764192366
MDA-MB-157,5328940,1.5742504795877947,1.7262435188597636
BxPC-3,19582717,4.685369750995796,4.275979907873793
MSTO-211H,6852167,2.890925130180435,2.4752222999436473
CAL-51,5746,-0.6872762444946757,0.6182045779657872
OVISE,17759555,4.197708618199663,3.880067341823673
EFO-27,6918638,-0.5643283195590469,0.6673870853613295
JM-1,439501,-5.872076466297635,-2.736564151575491
NCI-H522,44486219,4.336787525166091,4.430011886366751
SNU-449,11167602,2.762483283064935,2.750712002572807
NCI-H661,11640390,3.9877189690607993,3.3039126563990946
SNU-449,216239,2.7953722371364473,2.602570133511037
NOMO-1,17755052,-0.2814114025249274,1.3209965067087253
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,1.442994821176345
A-498,54618771,1.1394352833671273,1.0322029313071643
CAL-51,176870,2.9999818119422175,3.3827010559502577
NCI-H292,11404337,-1.5117614396305947,-0.13431365105462142
HSC-4,9911463,3.832706037448295,3.8262163199197796
DMS 273,5470400,-1.1243568241206934,0.012277414140405086
OPM-2,25183872,-4.3499490255982085,-1.9209453684639632
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-0.5572801216261926
LOU-NH91,31703,0.5806868540812907,-0.9671067906629308
NCI-H661,44493528,5.823125515558819,4.229989590052543
SCC-9,10074640,3.673307032160535,3.0821335545636597
A4/Fukuda,11427553,0.0702382308883879,1.927445478265984
SBC-5,568763,0.2965266090010964,0.5184811403286611
BT-549,25126798,3.990115132251306,4.070897730919099
SNU-449,9933475,1.8242814161965168,1.9429783728202108
BT-549,2113511,7.745487386721322,5.5795625820383545
SCC-9,969516,2.533129063350548,2.7653273899492548
A-498,11178236,-0.0767055613398424,-3.2670358032909577
YAPC,1242560,3.336355906074855,3.712950695773482
YAPC,54626689,5.597039319211252,4.796460247640134
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,1.8417552882542712
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.560820478479199
HSC-4,6918837,-1.8301723200742368,-3.078338827978761
YAPC,656346,3.528875898488543,1.0892127054568366
LXF 289,5470400,3.745756378340341,-0.5271869088146884
NCI-H2171,168312962,2.801787293375821,1.331632807341832
MDA-MB-453,6918638,-1.2403270134347248,0.5516216411325346
NCI-H522,1566236,1.6835491869847783,2.1907918643424678
NCI-H661,24964624,2.8216778680067836,2.4897041536778066
NCI-H2009,5281672,4.642324044569225,4.458854524562896
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,-0.9217780870907797
NCI-H1623,16065773,2.4078381094703456,2.3797392226473746
CAL-51,46398810,2.084696284876613,2.5537936233538563
OPM-2,54143018,-0.7196855693728514,-0.1994448932729486
SCC-9,15547703,2.91115041464476,3.058171804430898
DMS 273,6914657,-3.971712341208325,-3.9284743766605743
OPM-2,3676137,3.169610101166173,4.335836033022938
OVISE,3025944,5.5857056433387235,4.281346833461949
Panc 04.03,4259181,1.0934261994249337,0.3705294798175823
A2780,11683005,3.0394905793504963,3.10336596278834
HCC1143,5328940,1.7305674649682683,1.6901350944838311
NCI-H2009,72193861,0.2482611586799762,1.9037172749168974
NCI-H292,6914657,-3.659053204598075,-4.074399852357739
NCI-H522,46199207,1.8719788650663136,3.3116910445143897
CA46,53481919,3.755788894439918,3.19584763248296
LoVo,444795,4.8141558651213145,4.290848769271108
FTC-133,9823820,4.816748988305079,3.7256062054269217
KMRC-1,6918837,-1.4377118656295438,-2.461386376194397
HSC-4,44486219,5.375029781512573,4.255058616322985
NCI-H292,54613361,2.8419740491204957,0.053373295466834794
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.7439765527781533
CAL-51,11234052,5.18044926966805,4.045121836761078
SNU-449,387447,-3.8386512960067862,-4.224440809842772
SNU-61,53232,3.65751057839411,2.684105896329163
LoVo,16038120,0.8839921956645777,1.06398970810342
BxPC-3,219104,3.7528053800812615,3.965414406326028
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,0.2532867255288147
SNU-81,24748573,1.8214275246808207,1.6048794028939226
MSTO-211H,16725315,3.290115596802182,3.8895824737460067
SNU-61,25154868,4.341936394973705,4.245159881432659
MDA-MB-453,1716436,1.6727209102312437,3.0240470817440293
G-401,5329102,1.4807949874052762,1.8572882608268022
BxPC-3,6610216,4.298723179439111,4.316274934428912
ONS-76,5738263,4.146346761655981,3.2626885500227085
A2780,51037431,1.9184867581168112,2.931872292143552
CA46,46398810,1.9636985074186508,2.097814157497489
BxPC-3,9936388,-5.112429278661846,-1.6795960478039265
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.4943593781585014
MSTO-211H,637858,1.3984482263345202,1.9563936654388856
A-673,5284373,2.9730764803314496,2.877762181871026
JM-1,5284616,2.861882362083186,0.18601599081995945
A-673,64971,3.704564654457452,2.6202706281324795
ONS-76,6918289,2.669224964930956,2.8024792157796954
HSC-4,11167602,1.6360881716966182,2.3565377871038193
NCI-H661,3689413,0.5447440822016135,-0.7511382535740089
A4/Fukuda,12003241,-4.192136354440014,-1.5676271899745615
LoVo,10231331,-0.6826574775964468,1.5829715981459425
NCI-H292,219104,4.068792108053485,3.857545161768414
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.3966443086147575
NCI-H460,216468,4.763843832635099,3.193602964839768
SBC-5,322968,4.849411960208385,3.4543017840709918
MDA-MB-157,135411,-1.5273896245850724,0.837005416745866
A-498,6918837,-1.461997313484149,-2.800968147677761
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,1.524366323566501
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-1.144059156939461
FTC-133,36314,-6.239918298117373,-0.8048006125589262
CAL-51,23635314,-2.261837237964324,-2.1696074408732016
NCI-H292,126941,-3.055153146808903,-2.512617844284947
A4/Fukuda,23725625,4.971593284778653,4.375453706807559
A2780,25105715,3.052833826388835,3.443299657304957
JM-1,9903786,1.587415218469425,2.3082784420931843
NCI-H460,5566,3.3663694984335533,3.004494113293611
OVISE,262093,2.7343448368987597,2.948752274202771
CAL-51,25262965,-2.904292987251918,-1.6794046265320963
SNU-61,448949,2.574317813231787,2.0780163577157635
SCC-9,24180125,3.671852734769843,2.9233457240372815
HSC-4,42611257,3.4394582921614933,3.354680520450356
EFO-27,46174525,4.9061854461465435,4.212689681726615
G-401,3384730,2.1525913455039474,2.38889495556966
G-401,3825829,3.962498358217521,3.8194841358902023
A2780,53232,-0.3956468617212337,2.8685969712817716
YAPC,54618164,4.31457100114165,4.192476835155993
SNU-449,54765302,4.743565917095417,3.926541506038557
NCI-H460,24951314,1.96669984187411,1.4151721180837002
FTC-133,11364421,1.174405518858428,-2.180008937995029
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,2.7666286001317353
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,0.8038187516791118
NCI-H2171,24771867,-2.6220866978549444,2.021201444383409
A-498,11427553,3.7697046176741185,2.9410297436324635
MDA-MB-157,5394,4.303334925677516,4.084730051293642
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,2.529503448982178
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.2680371324952904
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.8175978537002824
SNU-61,15983966,-2.103596771317332,-1.2426819694497362
A2780,9927531,3.2712332494904226,4.650191073776208
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.409614931164838
NCI-H661,168312962,0.9705864877614524,1.9235271057943562
OPM-2,135440466,0.016624870652288,1.9704301844040648
NCI-H727,44486219,4.75896405378265,4.320180647780916
NOMO-1,637858,1.0893367728071195,1.2117307254138203
NCI-H727,23725625,5.500914308976136,4.973112536151203
NCI-H661,444795,4.831383676329662,4.216003251831077
NCI-H1623,10427712,4.824592613381889,4.287187921772084
CAL-51,11507802,1.2528060552922216,1.3601550544160788
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-1.1909284526518342
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.6179454331539282
A-673,2949965,2.43157797191215,2.7960374006082005
FTC-133,46907787,3.491897677971775,1.8518031632039418
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.4491215054143667
JM-1,12003241,0.2073989775302392,-1.457036280550738
DMS 273,72376,-2.307681046282287,-1.9625610483887679
A-673,3025986,-4.4852998426095985,-0.8663563882331811
A2780,9823820,2.6289512031423836,3.5452953149417477
HCC1143,11152667,-1.9901975183751028,-0.36025124718546275
A2780,119607,4.019563194528792,5.023419052330275
MSTO-211H,136227924,2.717505566177341,2.6576561158961005
A-673,3025944,3.970835118137527,4.157865818207653
NCI-H146,11222830,0.9953145616857674,1.4778481357955044
NCI-H146,1750826,0.7822669653178473,-1.4116894367920019
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,2.354554584003932
BxPC-3,1750826,-1.1292189334445044,-0.7685090244988595
CA46,6450551,1.1375422858810305,1.8051168001085198
NCI-H1623,46191454,1.8980276717062192,1.800207874732561
CAL-51,24797083,1.5666479073716466,1.296420955615163
CA46,448949,1.4123991312197492,1.651138600625848
OVISE,135999136,4.426271635938179,3.635101065925534
HSC-4,2742550,4.46855499399167,3.9086358406888477
NCI-H460,168313200,3.91056508525232,3.113555530846869
NCI-H292,1750826,1.4118366921158176,-1.6517381948997667
HCC1143,452548,1.7974899966046338,0.29606758771207503
SCC-9,53325874,4.533787552290022,4.365474237904044
CA46,24771867,-0.8036362931877258,0.5977579784274011
A2780,72199292,-0.0351373222218005,0.8866039811267221
MDA-MB-157,216468,1.0474678727125786,2.8622403453398313
SNU-449,65064,5.2463646910054536,4.879296709026617
NCI-H292,9952709,2.799114874088216,2.8979021613605322
LOU-NH91,24964624,2.935669445800335,2.5150412705871816
MSTO-211H,5566,3.048712391825719,3.1218090127143734
MDA-MB-157,3384730,2.532514051685687,2.5769459373431944
BxPC-3,753704,5.46289082133378,4.896217203969545
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-1.6549870807489995
SCC-9,12003241,-1.125345709331217,-0.6309802098762597
HCC1143,285033,-0.1452813325821209,-1.6674649700872382
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.1225486094438275
FTC-133,9956119,4.526890245155382,3.561729947787719
SNU-61,3854666,2.8565665342705735,2.067871256638245
G-401,16065773,1.1067048318222386,2.2569894996512203
G-401,11214940,0.8244141998238856,1.5580517740423487
HCC1143,54618164,3.885707225557291,4.146862620263318
MDA-MB-453,16013152,4.031304285322853,3.972197837226042
SBC-5,24951314,1.1707148737631825,1.0607784531926812
FTC-133,135398516,3.4482633492568913,2.1241636547473197
KYSE-70,11625818,4.1356453826336965,3.98603194404136
BT-549,16722836,2.2023880033470893,1.749345255087893
MDA-MB-157,54678924,0.1283777680712135,1.9690947977474746
SNU-81,10410894,4.450607476297739,3.049835192968761
KYSE-70,9926054,2.326174845830733,1.8493339146261598
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-1.382572207542177
EFO-27,25102847,3.020723568572887,2.4699035439605455
MDA-MB-453,5351362,1.2969167061447922,1.5101005778794356
LoVo,9926054,1.9069881185353632,2.0213363584247257
NCI-H1623,46926350,-4.300601402935136,-4.133225623688403
SNU-61,16065773,0.792903808301444,2.552797432339506
A-673,5287620,-2.2582011832849824,-2.117813543775087
NCI-H727,9903786,3.725485605999375,2.7700164180026756
KMRC-1,72376,-0.8386976675707333,-2.009141207008483
JM-1,11640390,2.558073354039076,2.420760757894358
A-498,104842,-1.4921326822698753,-2.396030486306845
LoVo,10127622,2.21220618035224,2.7755828157504627
LoVo,11364421,-3.7348040522268624,-2.1788261562372018
FU-OV-1,57519531,3.042184872303348,2.481606562710386
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.9234756774066588
DMS 273,6917907,-5.615473283892677,-5.220932952185266
MDA-MB-453,2828334,5.6655606940020755,6.159837506761262
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.336164408803331
A2780,3025944,3.330273751246369,4.26994058094926
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.0830941463094677
Panc 04.03,11152667,-0.1106415062306802,-0.45016748559018693
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,3.487677509260576
SBC-5,374536,0.1871414147839566,1.9012406566623563
NCI-H661,11222830,1.6760341955617937,1.5247973667459283
BxPC-3,89183176,5.843393871566337,4.287639358125869
JM-1,135999136,3.9281924738089016,3.3341346994366234
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,2.814137337127391
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.6573113402127104
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,0.9414922262249356
SBC-5,56946209,0.800516243447007,-4.5799649112597045
NCI-H2009,5328940,1.7426808664178373,1.6872955685092856
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-0.8840783403009911
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,1.3904894305857636
SNU-449,9911463,3.778924364931394,3.8865692055388013
HCC1143,3025944,4.170847171640537,4.375954140752333
JM-1,969516,2.095061675415332,2.664496167324396
NCI-H460,3384730,3.247736649900264,2.9845920187211745
LOU-NH91,135411,2.1671070624345674,0.5268568328114336
FTC-133,44607531,1.7603587928522244,1.4572317756975874
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,0.9480371617207435
MDA-MB-157,445091,2.3343110617588785,4.459046554908221
HSC-4,16013152,3.4985623845199956,4.231670601534977
Panc 04.03,11427553,3.7212087866143433,2.8511566571047124
KMRC-1,10113978,4.2388531684480615,3.2712063518482406
A2780,10127622,1.5174517910950884,3.50380235394819
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-1.8295712808494584
NCI-H2171,89183176,2.3651641452605747,3.9754922303411364
Panc 04.03,54618771,1.7180394725494992,1.1628778665147461
NCI-H292,11485656,2.2579953762585725,2.2260578948739256
LXF 289,322968,3.971478433961818,3.8653295625223767
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,2.9088111313953426
YAPC,10385095,1.3302689043535871,1.2769914667220752
LOU-NH91,5329102,1.7122787452562382,1.9648631038130737
SNU-61,19582717,4.214212535444011,3.895746616508552
HSC-4,49850262,4.158516161733518,3.6917997690492905
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.0334138737216505
NCI-H661,123631,1.2265867761007856,2.333235040099127
KMRC-1,3062316,-0.7612421720697753,1.5183619927040386
BT-549,9936388,-4.888200161073446,-0.7354489984692623
HSC-4,24951314,1.4348411807415282,1.3994920836714624
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.3966443086147575
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-0.8562730390835438
SCC-9,9933475,1.8547363245124415,1.9651458731493472
CAL-51,9936388,-5.638746232401389,-2.455602110171498
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.9524457044248591
CA46,72734382,3.577472012209052,3.793607549112835
NCI-H661,16741245,3.244500107466936,3.7515884533770274
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.1685880919256313
HCC1143,11964036,1.1986784595252613,1.3031477797339672
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.5375886795293217
A2780,126941,-2.3178428604154746,-2.9291677746311295
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.2007074567549254
NCI-H661,24753719,3.905315348750775,4.284277155819395
SBC-5,25126798,4.2020115243555285,3.7942138627356004
NCI-H146,6917907,-6.190181636892531,-5.180105623579494
NCI-H661,1750826,-0.2904028146963975,-1.6188304056095755
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.6353734502883754
ONS-76,613753,4.08215787211526,3.0919042244821746
SBC-5,3689413,-0.1482568941323282,-0.38237109417202864
FU-OV-1,446155,2.635089718837861,2.6926659942290696
SNU-449,216345,4.054978999003172,4.13029083383746
CA46,6918328,-3.721989268042841,-1.155349081976896
CAL-51,5978,-2.6819752982341463,-1.890406873354599
MDA-MB-157,57519531,1.1252399396652772,2.6379365734916336
NCI-H1623,51037431,4.287686451446288,3.084300302847168
A4/Fukuda,5394,2.6676913787283305,3.7160107472049075
MSTO-211H,151289,1.1545674452198869,1.293879599207385
HCC1143,3825829,3.893715702367038,3.9113063940618336
MSTO-211H,374536,3.2477584475462904,1.929617516020209
NCI-H460,6610216,4.838717363885395,4.260227747235039
CAL-51,54618771,0.0049145289548569,1.1414446234572129
CA46,1239801,3.4142476342729817,3.725415430858464
A-673,9956119,3.229119212963112,3.744549570535171
NCI-H460,73707438,4.549718141383013,4.205512182558
YAPC,9936388,2.1810367621372095,-1.0436319282004602
LXF 289,4705,5.10311909598278,3.384274692842165
CAL-51,54454,2.240351559744082,2.6197363445508177
JM-1,4788,5.493172342149484,5.346267983205573
SNU-449,262093,3.0394524195162766,2.837672247210625
EFO-27,46926350,-4.056205960361391,-4.193558609429953
SNU-61,5566,2.945300560810773,3.0041196878554666
Panc 04.03,6610355,5.365295116093154,4.353829425579802
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.7559306862770427
NCI-H1623,56963564,0.7315466561739135,0.11916522207441924
HCC1143,10113978,4.851592729588868,3.1790209039172965
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,1.3073807912703177
LOU-NH91,5311281,1.0411900413843744,2.39837359776536
KMRC-1,24856436,1.3740575733249207,0.5337455900310362
SBC-5,400769,-0.0932857286492618,-0.6456672073822665
OVISE,11964036,1.5054845636014844,1.6758795592352949
JM-1,1716436,2.291915875842717,2.672885566535645
SW1463,6505803,0.5252870082270547,-0.6391953639156606
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-0.9389804196649326
CAL-51,119182,-1.323881847361974,-1.1094344936886755
A4/Fukuda,4788,3.9402862208503753,5.5090903766409545
SBC-5,9926054,3.0567796435466628,1.6784337094147785
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.2824398618195292
G-401,3634881,2.5006119442923938,3.154174205111681
NCI-H727,9911830,2.860892848593743,2.5937491099071472
G-401,9911463,2.712760379614347,3.7505651497665404
NCI-H460,15983966,-0.5601417251503862,-1.5389172014520474
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.142014673935125
NCI-H292,31703,-1.868725819699569,-0.7852272644170842
NCI-H292,11175137,3.5103695935197328,2.6653511032748383
NCI-H2009,3543504,4.270240870629309,4.545056186036439
EFO-27,702558,4.734643042503988,4.999534759163493
NCI-H292,107985,-2.5053359043606043,-3.6026323845407324
HSC-4,25154868,3.1331848354363063,4.440799360960214
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-3.813379898813088
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-1.8742348062088892
MSTO-211H,11364421,-5.484172518994792,-1.720631306785937
NCI-H460,11238147,4.460003386993959,2.9989328455122615
NCI-H2171,60700,-0.3771090207819011,-0.3842255046564611
LXF 289,1641662,3.640483694902119,3.5510154126169193
MDA-MB-157,49793307,-3.250396628323611,-2.885455038827517
A-673,3503,1.5343061624145853,2.056351956878976
LoVo,10296883,3.831816674357036,3.764904671807786
HCC1143,6917907,-6.676374133945339,-4.768903997419052
NCI-H661,44185566,2.810411867420033,2.482328467073615
NCI-H522,23725625,7.287275637495971,4.945709759831626
BT-549,11175137,0.9532540120968724,2.552225860949134
BT-549,9840324,5.7680719211185005,5.805472488901307
DMS 273,42642645,-0.2214891751848421,0.6422981531917561
LXF 289,24797083,1.462636821965973,1.4082082928503101
A2780,9887053,0.4462184617201571,3.4354927774747197
G-401,3689413,-2.428789331956376,-0.36416084716531555
NCI-H460,65064,5.803776096144955,4.976971136988743
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,1.9029569970311326
CAL-51,452548,-0.9080095532304931,0.05284848310984172
NCI-H460,54613361,2.8642714411834502,0.11519880049861683
YAPC,675434,4.582728256156342,4.542832819401152
KMRC-1,4578,4.295676817145532,4.6345558665886255
BT-549,387447,-4.9509675804959,-4.234697038219448
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.2127492811679657
EFO-27,11719255,3.4932821683662865,3.4542142737103325
OPM-2,219104,1.446566622432128,2.96069566255276
NCI-H1623,6610216,4.306736710776884,4.232664354371598
NOMO-1,23582824,0.0799476906959343,0.4231024807926431
NCI-H292,6610355,4.982353204264952,4.473451355472172
NCI-H2009,46191454,2.1369399253900347,1.7144006666881677
NOMO-1,3062316,2.517026306117631,0.1544706550506195
NOMO-1,119182,-3.695250738066314,-1.9582620131628088
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,2.4157932971062768
FU-OV-1,11364421,-3.956792545928709,-1.5328029511622503
OPM-2,17755052,0.9533058757913144,1.0039793867636422
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-1.0147252007892469
DMS 273,46199207,3.605640907411319,3.1372849675758734
NCI-H522,55508,2.4640988254574356,3.5101654731627674
NCI-H292,10385095,1.2562128411100733,1.3041709425507735
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.979918192017947
CA46,107970,1.651382626144423,2.011120783147484
EFO-27,5746,1.7615281276545924,1.102617052514504
OPM-2,24856436,-0.767009816479034,0.05392151122543179
CA46,25126798,3.582571225160254,3.624027640171651
YAPC,89928392,2.607647468641453,1.6777811515309426
MDA-MB-453,3062316,2.3886014193927285,1.2389003658382753
MDA-MB-453,387447,-4.667010811634082,-3.9505158102411815
G-401,107985,-4.394015959361378,-3.678293069033466
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,2.8211824532881513
SBC-5,135875424,3.947045576812926,3.5999230143644056
KYSE-70,24785538,1.5800117539652696,1.575922642651594
BT-549,25262965,-2.559107571112332,-1.6029568925829394
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,3.593886931454744
BxPC-3,2828334,6.44946379786602,6.257086030283357
NCI-H460,3025986,0.3909368316008428,-1.0392718797224028
DMS 273,11656518,1.6608448179793895,1.8491884446405442
EFO-27,3825829,4.213579429540561,4.174975100933085
NCI-H146,44493528,1.3818057906729433,4.29421685260311
CAL-51,73707398,0.7053044464230985,1.0573211412456858
NCI-H292,148198,-2.0841293800573446,-3.407391306262606
NCI-H460,2828334,6.134119597935603,6.217720514817987
CAL-51,439501,-2.444412450902406,-1.9720093061859472
SNU-449,73707398,1.8238531786702632,1.4459031293208042
A-673,10322450,2.1969870036583323,3.8228825738423207
NCI-H2171,71466380,3.3392440967630797,4.271092273137195
HSC-4,53392493,2.986961827224748,2.428995335190168
OPM-2,1239801,3.3443313732590543,3.7403656577754494
LoVo,9935249,1.1872155844887071,2.512914048745276
G-401,1566236,1.5621622205700352,2.3283864345056373
HSC-4,9907093,5.592562690426939,4.162597242496744
MDA-MB-453,445091,4.203535883394564,4.402410668469248
EFO-27,24821094,3.745327872256005,3.109987624433358
KMRC-1,3038522,2.3225128068669676,3.174872350589731
NCI-H2009,11427553,1.9586555200212517,2.969771258091992
SNU-449,25227462,3.4571199035251565,0.6163454260869182
CAL-51,136227924,2.079284078064279,3.0215858076180986
ONS-76,452548,1.1046001555889895,0.4721505626664441
SNU-449,25105715,3.5056666677867625,3.4700814434456566
CA46,156414,1.2808873732328336,0.8587435807779253
SNU-449,400769,-0.6000208096132458,-0.4662994719731903
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,2.024035190577819
NCI-H146,462382,-0.5302162316770459,0.6116092451475835
NCI-H460,613753,5.368273372553464,3.222750449994442
MDA-MB-453,3136844,3.6967063162994114,4.157990086283181
A-673,5281672,3.4533278359325323,4.387558741889761
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.883685379184011
EFO-27,1716436,3.5844471141038823,3.1004722753258496
SNU-449,3825829,4.613153689576251,4.202430959812689
NOMO-1,73707398,0.2786764614411772,0.48491735444363854
A2780,568763,-1.431759576680003,0.30845299631334316
HCC1143,6918878,5.533567107436573,2.5158963609222837
LoVo,11455910,2.8170443999319574,1.0967805659718848
EFO-27,23582824,2.0177544133250187,0.8068979148884102
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.8928021422609294
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.0226464040390573
MDA-MB-453,44819697,-2.6195477020037696,-0.08160273717999945
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.4509304930111298
A4/Fukuda,7326481,2.3355820774301206,2.836585044951044
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,0.3650351855398759
DMS 273,5566,3.001039957404815,3.002221016784861
MDA-MB-157,148124,-6.016678597172854,-1.7616671489506877
LoVo,11507802,0.9778049572121082,1.4621676292902805
NCI-H522,9444,4.166279980928258,3.9773957952354646
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.766220032393573
MDA-MB-157,9549297,2.7932032986762008,2.379224686799047
YAPC,3689413,3.09003195173071,-0.4353577179671458
KYSE-70,10385095,0.9665013844498838,1.1864499818247298
ONS-76,11222830,1.7336224967240552,1.5287846643144878
JM-1,11625818,3.7613008305210727,4.03398230220062
LoVo,16736978,-0.2277330125842315,1.3277480985923646
NCI-H2009,10074640,3.329342225437922,3.1505182580113185
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.2841948956956206
NCI-H460,9866186,0.4176494313944011,0.8575853272182857
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.7897638329209413
A2780,60750,-0.3844759756013921,-2.8817693217654803
MSTO-211H,5329102,1.1990183253858175,2.098482002741247
NCI-H292,60700,-1.1983388185725197,-0.22233573135430404
OPM-2,16659841,1.643311806599576,3.3448459340608405
NCI-H661,11427553,3.4193847918785782,2.6830885937704725
DMS 273,445455,4.9732665628078045,4.539020749205679
NCI-H460,9967941,4.030885542149613,3.940810633902895
NCI-H460,5281321,2.142807178276493,-1.035564962322255
HSC-4,44137675,2.9134227764609735,3.4405954495542317
HCC1143,2729026,2.66692124656069,2.689684055143515
LoVo,1566236,1.5203890875485482,2.0380530352129598
NCI-H146,2842253,3.419228107779433,4.978818648031009
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,1.8283024740288016
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.9087591123001544
NCI-H522,5311281,2.6748920868920125,2.142349020509094
NCI-H2171,2945648,2.4840683519833835,2.7811667191640623
OVISE,9840324,5.37005208850368,5.842907341450731
NCI-H522,11485656,1.866098793785005,2.308456923823667
LoVo,5280436,3.7935840263164984,3.2496344016231196
SNU-61,11152667,-1.0116802565381595,-0.3942745596266818
NCI-H460,2708,4.613368759945332,4.8854348391383215
JM-1,6918328,-3.1408711543116854,-1.016147433229513
ONS-76,1716436,4.404636467874722,2.8268050906946507
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,3.051065188780461
EFO-27,241158,4.165561573655071,3.9283438668884485
A2780,7326481,2.2466116261364215,2.9911096775192743
SNU-61,11507802,1.2021022137126776,1.631611688983665
MDA-MB-157,11404337,0.0143481506183785,-0.39598847318881203
CA46,71466445,1.6737757590775906,2.6729984548236687
NCI-H727,5329102,2.005304296489746,2.0449297795218326
HSC-4,51039095,3.5449735354798,2.8539948508550803
SNU-61,135411,1.4786327368897634,0.580214202473149
KYSE-70,23635314,-2.258343718513796,-1.96294852233799
LoVo,54619267,3.1603381625719,3.971898606666214
A4/Fukuda,71751553,4.0599050322296995,4.382137041179718
MSTO-211H,156414,0.8242215144670997,1.5706968323722175
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.772694410947951
FTC-133,44185566,3.3632936032593403,2.428697550480551
DMS 273,448949,2.08082767357287,1.9457881019415069
NCI-H2009,71466578,3.1093531088855797,4.715486069471626
G-401,44632017,0.8985354611426208,0.931968059467797
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.369406080052005
HCC1143,107970,2.31840177997234,2.3789667014068754
NCI-H661,156414,0.2928474479064595,1.2374053836146124
OVISE,216345,4.54917324344274,3.905672159358669
SCC-9,25227462,0.3695734481821194,0.5289734493970318
FTC-133,46199207,4.2182762440826576,3.218269837559277
Panc 04.03,9926054,1.9560696374821285,2.036826274895225
G-401,6918736,-2.2327850291733577,-2.112368260668424
SCC-9,44607531,1.3853072214617428,1.4253786136303832
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.8971130898981738
HSC-4,171352865,4.360447231593142,3.0744605912842466
OVISE,613753,2.681502253258482,3.325808493814643
A-673,5282054,2.3452018577417166,3.370363467229869
CAL-51,5328940,1.595278406971918,1.6587021842567669
G-401,426756,4.944025345893246,4.2411024164481175
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,3.3623667068855827
FTC-133,73707398,1.7335394908123083,1.2378284027014346
LoVo,20959075,-3.964629838563966,-2.880474396924996
LoVo,46907787,0.5340804086119918,0.9951255609744224
FU-OV-1,9907093,3.428205270837273,4.177622931008588
NCI-H146,5470400,-3.389889619220011,-0.47199144743067123
FTC-133,60750,-2.331663889988264,-2.687803413193864
NCI-H661,637858,2.3544841299222927,1.7533697306672993
NCI-H460,24772860,-0.596461213785507,-1.534940585832515
FTC-133,135999136,5.800253145127344,3.7451637293287066
SNU-61,2945648,3.4316222719918903,2.8276369969063215
SBC-5,52947716,-5.148190181120178,-1.9186359211099866
G-401,5311,0.6627378317361174,1.1855634474229917
SNU-449,25183872,-0.2769192593247403,-0.6958808513927461
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.246920058713691
A2780,444795,1.1255727490438436,4.199349107666077
HCC1143,11404337,-0.7051632820466462,-0.3801905740957001
LOU-NH91,23582824,0.7266398713670753,0.5822515042180302
JM-1,24964624,1.3785887120991174,1.3125218857364296
SCC-9,6918328,0.8244293983868239,-0.14635160523127524
SBC-5,44507138,1.9527307391432291,2.28533577192494
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.49306442049429905
HSC-4,3081361,1.976322212956416,2.273184039943887
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.3000529337210622
A4/Fukuda,73707398,-0.4328093310020208,0.6294030829354553
NCI-H146,2130404,3.7873290414593983,3.144066467435899
NCI-H522,11656518,2.6059049947054533,1.6749009008928695
A-498,11626560,2.3564203123568648,1.8463418693658076
A2780,17755052,-1.4995675278651837,1.2211257750536046
HSC-4,2841722,4.578140166849417,4.430115174399264
JM-1,44462760,2.3346005220819785,3.1275871301690152
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.070723369004504
FTC-133,4261,1.6400921135700228,1.493101581820122
LOU-NH91,54618771,2.8270991446030593,1.2541176614810412
NCI-H1623,16720766,0.9555863303424396,0.6821077239662935
BT-549,44632017,1.021144372127497,1.3022637896284186
NCI-H292,107970,2.31632347859771,2.3890932029503618
SCC-9,24753719,4.411411644196846,4.360873107068266
KMRC-1,4917,3.6746853329943248,3.158611637720564
NCI-H661,72734382,5.266471995298585,4.510624699176716
SNU-449,4578,4.5704959764236675,4.478067505887008
KYSE-70,9887053,4.5630363901990565,3.417617252106908
NCI-H460,81146,4.483282466350705,4.855747551253176
G-401,637858,0.5800115670130345,1.711852381666816
BT-549,5280436,2.325988989460079,3.0509382846853015
HSC-4,107970,2.304506496588027,2.2846459533883863
NCI-H292,421610,4.310067764922952,3.09294360110086
MSTO-211H,11175137,1.4320314455831638,2.640166140776984
BxPC-3,11175137,2.81920931641519,2.573419986897435
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.991702884182893
NCI-H292,11625818,5.668815438823822,4.528075720443408
BxPC-3,3025986,-1.3024282207469429,-0.6524881354181663
NCI-H460,11364421,0.3566052665939138,-1.7198729776463544
MDA-MB-157,3385,-0.6145392702282009,3.9611956913204587
DMS 273,44589607,2.105355871894398,2.5158637850617818
SCC-9,107970,3.0149180037966095,2.303066735007931
Panc 04.03,17755052,3.2992451395509503,1.442192524079786
LoVo,10427712,4.119455144779727,4.185595376096521
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.6954907856388549
OVISE,9825149,2.776616936788869,2.1792277440679877
DMS 273,44185566,2.401025824688418,2.4315331552473527
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,1.8292338175403091
EFO-27,5329102,3.2209933806874926,2.161514024956174
NCI-H2009,3503,2.6223022737526085,2.572169296447307
SNU-449,66577038,3.1506640300230075,3.0447228464367906
SNU-449,135999136,4.264029635041134,3.8368614015492604
MDA-MB-453,16725315,3.1590887754383847,3.995456983170474
SNU-61,6505803,-0.8091898598550518,-0.9751115737193571
Panc 04.03,6438330,3.1739512088269968,2.397276153212552
SNU-81,124202324,-1.5604837877349913,1.8931428879358776
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,1.651106339981498
FU-OV-1,49850262,3.0107305406398206,3.6655551193910423
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.3074259486420106
ONS-76,54618771,0.5276024038238057,1.3395000564518318
SNU-61,5311,1.5459052759872411,1.256687721878617
CA46,11612883,1.866301185217262,2.220678253297613
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.348014144440532
A-673,11960529,3.1772019850221054,3.9849768150913367
YAPC,400769,-0.4056066486406303,-0.5527440880280438
KYSE-70,107970,2.5727619321994353,2.3297979142889753
JM-1,5291,3.241129374385646,3.3981573556343916
KMRC-1,9444,4.31479767249553,3.9662791773697115
NCI-H727,44819697,-0.26094531007839,-0.19381160409901213
NCI-H2009,5351362,1.2372754831617516,1.622436874456549
LXF 289,53495165,1.0389398894889437,-0.1481365181198582
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,3.1092646443631367
NCI-H727,123631,2.758434269009812,2.4442569045170175
NCI-H2009,5311,0.3641463076187463,1.3671040060782238
MDA-MB-157,241158,1.407364121620741,3.595555404149425
LXF 289,24785538,0.6202102990423739,1.7738504425443702
BxPC-3,10074640,2.675443562621253,3.245991416622991
G-401,4378219,4.593157039926137,2.607599357041096
CAL-51,445643,4.334473435217703,4.10570367869177
OPM-2,2858523,3.124441680057984,2.8874629251144444
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,2.314843847967131
HSC-4,11175137,3.5997845208099797,2.485235018442561
MDA-MB-453,25126798,3.9955340419002057,3.812372468534171
SNU-81,159324,-2.5700546068481502,2.233270452528997
SNU-61,3552672,2.025857953798933,2.714594087541352
FTC-133,246676,4.92384525208296,4.096809130242878
MDA-MB-453,11364421,-1.677319267600166,-1.5521912960401922
CA46,122327,3.963727711050333,4.323538312643171
LXF 289,262093,3.4150141342974605,3.0359791262877276
NCI-H292,6918289,2.42392533304279,2.734410205871256
NCI-H661,25154868,3.681430006213129,4.20018279155031
NCI-H522,327653,3.011425661783578,3.084840394017766
KYSE-70,44202524,1.884457998669868,2.004892425355044
A-673,8515,3.2253171108003023,3.824594757382219
SNU-449,6505803,1.2866498789511422,-0.6549342914872958
FTC-133,10074640,3.79174067417729,3.0465525862609995
NCI-H522,72734382,6.037966635177564,4.238600940340991
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.8881686031472786
NOMO-1,46943432,0.592792127892358,1.0558211386419967
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.041282721415936
MSTO-211H,15953870,2.3250629767102273,3.600157865876641
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-1.3665173603295542
NOMO-1,24951314,-0.0494287054100275,0.7340105145143947
NCI-H292,6918328,0.4467511585294103,0.30476421062556136
SNU-81,72193861,-0.4444993909438327,1.069125285165293
SCC-9,9956119,4.352516606884389,3.7265492805308145
CAL-51,66577038,4.134711160885491,3.021786981292379
MSTO-211H,44489675,3.600660518296678,4.01109694777029
SNU-449,11494412,2.814472666417892,1.728461719968171
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,0.2277193943192199
NCI-H522,11364421,-6.31463288554187,-2.283767432610607
OVISE,11222830,0.6942836946088363,1.6755470755621942
LoVo,135398516,0.8347424818537327,1.838223188041694
MSTO-211H,409805,4.793476239157615,4.68096030751339
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.360899131636641
MSTO-211H,9926054,1.9546831701161536,2.011803730597278
NCI-H292,2749,1.484796478537434,2.102872152390425
OPM-2,702558,4.8466631372101725,4.694025802879844
LoVo,71466445,2.646256567071358,3.1496107233823913
BT-549,16659841,4.205377629414311,3.9776693590394183
KYSE-70,3025986,-0.3454993097331295,-0.6655327061159084
NCI-H2171,15953870,3.344319567560605,3.626493640079653
Panc 04.03,11640390,3.824707626147026,3.564161180311612
NCI-H292,5278396,3.8202006656128735,3.6199053550592657
NCI-H460,5311,2.161812802665503,1.5220713529683274
CA46,54596558,4.227379600712383,4.3093170602551965
NCI-H522,50905018,5.2003053075185734,4.261666523970191
JM-1,54596490,4.858476490911798,4.447796884697347
KMRC-1,5281672,4.43646792139098,4.491914427141536
SBC-5,46199207,3.436092011920994,2.945762055593663
NCI-H661,46907787,3.1119891404607083,1.6641271607124686
NCI-H1623,11222830,2.056201659978474,1.595408794860646
SBC-5,3038522,3.9213361824350024,3.0264116317744265
NCI-H661,9926054,1.7811448977738318,1.9108957924380936
LOU-NH91,969516,2.9922565120136944,2.7910149574187018
MDA-MB-157,5329102,3.39801486229995,2.174326430199056
SNU-449,445643,4.11461116511151,3.9167948928116574
NCI-H522,9887053,3.177768808520637,3.4085784338652694
NOMO-1,16065773,2.6012917178973405,2.0060668052373902
G-401,67291369,1.7656191364648908,1.9628355521501566
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,1.8510236704050147
MSTO-211H,11609586,2.648073114002603,2.8146694119597475
A4/Fukuda,25195348,0.8993846970771071,2.781628800462769
NCI-H2009,54649381,3.659944396907473,3.8176705989497766
CAL-51,3025986,-1.0834382414923172,-1.0426730730823712
EFO-27,52912189,5.780518526906142,1.8317171165100832
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.567063746035673
A-673,123631,1.860693828866879,2.3895588143874464
A2780,44632017,0.0856486258730489,1.222597244416513
A-673,24901704,3.0162186042420966,3.0803718843668726
OPM-2,168312962,0.8773607091058507,0.8792841967362509
NCI-H292,46398810,2.6001901820453166,2.647439747115967
SNU-449,53495165,1.8844225218094013,-0.01463316581057171
YAPC,2749,2.2394739682848512,1.8418955639725432
NCI-H460,4788,5.894567383019075,5.732949844469324
LOU-NH91,637858,2.168731257760998,1.7899811514980288
NCI-H727,11427553,2.8726920198872397,2.867753659846789
NCI-H2171,5978,-3.1305615418900468,-1.469030009300824
EFO-27,969516,2.57565712333896,2.759363643381562
SNU-81,11152667,-1.3658791794225291,-0.3208646924277747
LoVo,2858523,2.923658201852042,3.0724522302260278
FU-OV-1,56946209,-4.492733112758285,-4.155368838120047
CA46,9549297,1.0960598621603344,1.825149668239642
ONS-76,6917907,-5.751164378556486,-5.290735701110625
NCI-H460,51037431,2.104101453867928,3.280456740520666
CA46,68056272,3.136594245199668,3.119068891009336
CAL-51,54143018,-0.6388505972102335,0.6714976083400841
SNU-449,5284329,2.300938885216567,3.511147219448264
A4/Fukuda,11609586,0.4485915276425587,2.0400210734615216
NCI-H146,9933475,1.6402256772331771,1.9468098851290827
NOMO-1,9927531,5.049638663441057,4.642618021583111
A-673,148198,-7.755828732328633,-3.603993926097549
SNU-449,2113511,6.338115821615388,5.384759263122294
NCI-H522,49793307,-5.2014711504438,-3.2021964476057816
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.420404902653804
FU-OV-1,44493952,2.9850522959236883,3.525645819369657
NCI-H661,5328940,0.9675290055268168,1.512344278473907
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,3.829563100043734
NCI-H727,60700,1.7894131654495464,-0.19178162917736194
MDA-MB-157,10385095,0.7848337329764868,1.2538671144407665
DMS 273,46224516,2.6849968878024297,2.343071649433392
G-401,1641662,3.2482177517563766,3.4858634197589997
NCI-H292,448949,2.3471350598248795,2.103480100630234
ONS-76,3038522,3.87205505246704,3.0985925437834676
G-401,216468,0.7704979015554879,2.109354989425417
NCI-H727,10127622,-2.4732053445147333,4.025916347446549
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.5046421386453885
LXF 289,16722836,0.8079280065417594,1.7909702720979432
FTC-133,11167602,2.051836472120041,2.65863553590313
LXF 289,3825829,3.6707575370566534,3.9690025002126244
CA46,25150857,1.719157108492683,1.8553735049303866
NCI-H727,3025986,0.1020219293656271,-0.703824853826887
MDA-MB-453,107985,-4.386344018126506,-3.494963500893645
NCI-H1623,72193861,2.1993190803521423,1.6661059729524588
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.1344661846828488
ONS-76,12001922,1.7268373273866384,1.924520729108902
LXF 289,5460769,3.06478422280727,2.4682699557574583
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-0.934948449256761
LoVo,9967941,3.621110602900207,3.4925349043273997
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,0.915058646751604
NCI-H727,5113032,6.018394893069797,4.996397979428634
MDA-MB-157,5351362,0.7984725267524495,1.3563519849507242
JM-1,1641662,2.861679408031504,3.3021818777961762
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,0.18698348155416755
MSTO-211H,445091,2.4700472101717312,4.429434458885865
NCI-H146,11404337,-1.5914515878545687,-0.23977202055517413
CAL-51,11364421,-3.809863778172731,-2.5495304483805357
A2780,4096211,0.5297517602102724,1.8915492700574907
SW1463,23635314,0.7077124425294024,-1.827923416412938
EFO-27,9933475,2.2279721994416364,1.9340382798841935
CAL-51,135875424,4.33643967165441,3.7881564518441206
NCI-H1623,15983966,2.013058792543676,-1.65778191553569
SNU-449,3038522,2.1807259662851735,3.2758623954090664
SNU-81,969516,2.098687325749346,2.5073107648887927
SNU-449,9935249,2.650976699885872,3.3265007457890308
LoVo,10385095,1.3603816893768768,1.1235697927868482
ONS-76,322968,4.979501026393853,3.7298902172957606
DMS 273,9933475,2.0005654751864865,1.9440480084006797
CAL-51,71466578,5.340961831553399,4.34665641802736
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.7287592472131172
MDA-MB-157,1750826,-3.091616753079083,-1.6904405812482435
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.698159013727422
NOMO-1,702558,2.777027807122979,4.425098405818543
YAPC,60700,-0.2763967023007928,-0.6083141444445506
CA46,5287969,-2.5448622649608925,-2.3392483846026546
CA46,15953870,3.0438117584706164,3.0759945574150835
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,2.8067542630268476
YAPC,6610355,5.243598963135711,4.633565850466995
SNU-449,4477,0.3396527753410003,0.5663251944726263
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,1.7004325954251132
SCC-9,168312962,1.0708744032070256,1.7481681126594233
SNU-449,119607,5.345576432951938,5.335454256046724
LoVo,135999136,5.7154474843469565,4.0016043469257845
NCI-H146,984333,-0.904410626141992,0.6800314089428823
KMRC-1,54619267,4.117989845600413,4.172979826838771
A4/Fukuda,11485656,1.5130746228374388,1.9335308279393553
BxPC-3,5311,1.3160685062040935,1.604403302100377
NCI-H522,3038522,2.4524519125835473,2.9683214794138304
SNU-61,89928392,1.2163192063780537,1.5222167898106043
FTC-133,5287969,-0.5047683720981219,-1.8823652664732324
ONS-76,25062766,2.430053801867403,1.9773343716875715
NCI-H2009,44486219,4.368704582532332,3.947302270705604
NCI-H522,637858,0.9732265340904396,1.8150960338482758
NCI-H522,44632017,0.530418286591973,1.149189814645881
SW1463,11485656,1.9271812519349985,2.109657943255437
SCC-9,46843906,3.309522412048413,2.9704677819217267
A4/Fukuda,6914657,-5.308594861321554,-4.411811681947917
LOU-NH91,36462,3.2256365983613677,1.910442072222101
NCI-H1623,3825829,4.488518875119825,3.992619433680109
MSTO-211H,56946209,-4.75779739938848,-3.9481547069047696
YAPC,11427553,3.397606686380644,2.5039921597602497
JM-1,426756,3.661156723786521,3.8094874975733966
JM-1,10184653,1.3269176228991806,0.8338491459367512
NOMO-1,11497983,-3.443590431300748,0.5777744863177632
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,0.645082649736275
A2780,9952709,2.339079626269582,3.096645700234429
MDA-MB-157,9866186,-1.7048510464532898,0.5902005742199998
CA46,216239,1.3191761483145148,1.8584736609193566
MSTO-211H,176870,1.3974668510804569,3.400427330728214
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,0.6397790609709354
OPM-2,135928012,2.8826672527394956,3.9798635381256657
BT-549,9915743,2.34179420613382,1.1068443992746362
LXF 289,71304818,2.1201305139291033,2.636375507201343
HCC1143,11214940,2.1301365232114144,1.923493260560554
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.32994558598723656
KYSE-70,11404337,0.2060464556058333,-0.36967097485143774
NCI-H2171,11152667,-0.915095731247344,-0.5055694436884438
HCC1143,46191454,1.52291312584366,1.5482015510459015
SNU-449,71680916,5.959793136995753,4.864191834751006
YAPC,219104,4.027438046449075,3.675769750925935
JM-1,446155,2.7706022090916793,2.51762046382485
BxPC-3,46398810,2.2883583084835126,2.5682377661818845
OPM-2,2828334,5.82639787583413,5.8558989564862385
A-673,44137675,3.4578104481213905,3.1040801352200367
FTC-133,7251185,3.0292037228467628,2.227346840374973
KMRC-1,676352,1.883475825529446,2.2614595825101484
EFO-27,1641662,3.8267974599371417,3.502964094897633
G-401,168312962,3.2015141434031547,1.471480614801218
CAL-51,2945648,2.7250935788350064,2.8604991348819584
CAL-51,71466445,4.7818956768695715,3.8310094771573686
JM-1,5113032,4.766616079684312,4.502422388770863
SCC-9,24821094,2.906183993814488,3.205301206182814
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.7039596764867013
NCI-H292,216345,3.474677020151061,4.079270094617768
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.5708352830761245
SBC-5,9549297,3.510799485826288,1.9661728610985938
CA46,156422,3.7635879578153126,3.8158375483043416
MDA-MB-453,71466445,1.9167870178623896,3.7608206205967196
A-673,54596558,3.847043372257958,4.398322761574236
OPM-2,10231331,0.6444733525039235,1.445019448155297
HSC-4,5335621,5.235604448739508,4.581786279797793
CAL-51,11719255,2.5837610433465588,3.2947324021021576
Panc 04.03,44493528,4.362737332857046,4.3812904522277485
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.3222069801361367
NCI-H522,24821094,2.425713290484283,3.108710872512928
CAL-51,6610355,4.388066889778601,4.469270474705888
MDA-MB-453,6438330,2.0150251794967655,2.126462439878799
Panc 04.03,46199207,3.759856924739056,3.2685937604409365
SNU-61,9866186,1.5207851909017442,0.9588898349545587
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.228015729107042
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.39347306160329
Panc 04.03,71466578,5.726073349824824,4.305077239879725
NCI-H727,107970,3.133468251114326,2.382716316589148
BT-549,60700,-0.4810674620852896,-0.480332396984586
OPM-2,51037431,4.229346700902662,2.9740080522493395
MDA-MB-453,56946209,-4.730570165381635,-4.11934232465733
NCI-H460,72376,-0.5460239014371263,-1.4650861242587365
BT-549,44241473,4.976602861760902,4.834615727549172
A2780,24748573,1.2286507677110594,2.007575086473102
NOMO-1,5311,-0.031303965270056,0.8676107275889977
A-673,9927531,4.216692000672551,4.650995373860243
NCI-H1623,46199207,3.747077477678168,3.2140298233392195
NCI-H292,71304818,2.830949431838268,2.5313918547525045
NCI-H1623,9911463,3.95788841498078,3.9038472868912697
SBC-5,9825149,2.9056064620320896,2.0532352129895823
NCI-H460,11612883,2.88158995470921,2.8326630254861915
OVISE,6918878,5.066606594706477,2.69418330517779
FTC-133,5278396,3.726623182659884,3.4236797160376824
Panc 04.03,24775005,4.54660450697204,3.7872418783675874
CA46,1641662,3.144498035259472,2.8971635570809826
MDA-MB-453,16722836,1.2443221263797826,1.6497917990721438
CA46,54618771,1.203400154931592,0.28459777993523905
HCC1143,613753,3.4353326628352714,3.2859642363476125
A-673,60750,-4.61356677624384,-2.745954804590341
A4/Fukuda,1641662,2.3667755294261297,3.1109458491165487
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.6077629185535705
MSTO-211H,375860,0.0606650448750636,0.029804631249439727
BxPC-3,6184667,3.26727461265582,3.100144814218536
CA46,227681,1.829365253324193,2.8815025682099797
SW1463,11964036,0.627645429671571,1.208199762745313
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.1208718393618746
FTC-133,49766530,-1.1381086002707512,-1.091691926260535
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,4.083300774804764
NCI-H292,11364421,1.76762986564817,-1.2666539452525667
KMRC-1,44819697,1.235264283084374,-0.31037377667677796
NCI-H661,9907093,3.834837743900246,4.189013887313178
DMS 273,17755052,0.9609599247674856,1.6673928958164328
SCC-9,11364421,-0.952029021799848,-1.4860896846145675
FTC-133,135984461,4.350998124633342,3.732958851004542
JM-1,11497983,-3.7280544169699192,0.8869112950745114
MDA-MB-453,24753719,4.38597739181452,4.255328363385704
ONS-76,168313047,2.901208476511606,2.200841495406589
NCI-H460,67156097,3.7191617083219097,-0.8854581236350825
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,1.907282622871221
A2780,9866186,0.3046354439957303,0.5011787189099745
HSC-4,219104,4.150323587810277,3.85104301448795
SBC-5,168313047,3.954131669958023,2.137690005115789
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,3.967817756468562
NCI-H292,15953870,3.631273190289841,3.4506927885792185
SNU-449,5281321,-2.557888043471457,-1.2092264869455842
HCC1143,702558,5.703077608026742,5.094926064186628
EFO-27,644241,3.241988529302909,2.0415410824529836
Panc 04.03,9911830,2.4999304852863404,2.442456049495267
NCI-H522,9967941,3.44539283334302,3.4987355479152393
BT-549,44607531,1.5480457992975702,1.4828139378857605
BxPC-3,44607531,1.3275313586220698,1.5210390221406331
KMRC-1,24951314,2.7376925539969927,1.5287444132385914
JM-1,10231331,5.343116821873739,1.149408037037021
A-673,25262965,-3.9892118887375303,-1.5655466794683466
FTC-133,1716436,3.3698315146098015,2.8876394704747548
OPM-2,2733526,4.066729211955922,3.424358948112973
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,2.0422756694071533
DMS 273,3825829,3.788583241717048,3.90661223071297
KYSE-70,3825829,3.6022414485207452,3.81754802575176
BxPC-3,5351362,0.9304368738373464,1.5540700457065784
NOMO-1,6918736,-3.755126975181922,-2.27207184571832
A4/Fukuda,11977753,-3.131569873612884,-1.802949856284694
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.9356045124071761
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.5181740855025887
A2780,73707386,2.710080958425795,2.767469876518464
SW1463,44819697,-0.8614164905769626,-0.18657334034625472
YAPC,24180125,3.806846010722946,3.1627288933177873
NCI-H727,54649381,3.660865770056845,3.7404541229786954
SNU-449,2708,5.735631765174737,4.704710874777182
CAL-51,54143018,-0.6388505972102335,0.6714976083400841
LXF 289,753704,4.962227230589067,4.942355707356313
NCI-H2009,9907093,4.391694288558607,4.298214936621482
EFO-27,387447,-3.111228692284437,-3.921446635086688
NCI-H661,65064,3.46809117241053,4.896516366632165
SNU-61,5278396,3.627128978826316,3.383912616265773
NCI-H727,452548,3.7056139041011034,0.30413962912151915
NCI-H292,16720766,0.3451831901206211,0.5566330471959435
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,1.885954558674457
A4/Fukuda,100016,4.8831896191852096,5.68371525145454
G-401,25126798,3.708942608188802,3.9647006269664384
SNU-61,24951314,1.416243399270427,1.2177863805306175
CA46,89183176,2.547561715641907,3.2786678924842976
Panc 04.03,2746,3.3610494767062513,3.172788922522206
FTC-133,107970,3.2744864550719126,2.146377735933272
NCI-H661,6918878,1.4921814323330362,2.392745640317127
YAPC,24951314,2.2257819926279243,1.2348555688790779
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.03197975971511
LXF 289,216345,3.67485776854348,4.100751509663578
G-401,5287969,-2.352936827953192,-1.7352921838741997
LXF 289,5566,2.9960878643930218,3.129956217781924
JM-1,71680916,3.747509118270568,4.319249701161635
LoVo,16741245,3.141864677583783,3.895456268210114
NCI-H661,54649381,3.920223147571483,3.8371941983744606
EFO-27,25154868,5.200143123549252,4.514031223499847
SCC-9,25126798,4.663845786250664,3.932181598045986
A4/Fukuda,24964624,-0.76967256635286,1.7520760828153983
A-673,11178236,-6.344930978772708,-3.4232524912293947
SNU-81,3825829,3.873341985908314,3.6756304170286693
KMRC-1,36462,3.0698954920529324,2.459144485407956
NCI-H661,262093,3.4983141095274126,2.6862670924380643
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,1.2044374786148753
G-401,676352,1.5550652369933835,1.9078607041433306
SNU-81,11228183,0.0397441918833689,1.5566287457039274
MDA-MB-453,10385095,0.8735195901829151,1.5057685875672002
KMRC-1,16065773,3.457331493974802,2.738005653269913
CAL-51,5328940,1.595278406971918,1.6587021842567669
CAL-51,56946209,-4.496983035262223,-4.282441980754465
FU-OV-1,5329102,1.609553320034118,2.1996855931052326
YAPC,3062316,1.4892918633711576,1.4057028809814427
NCI-H661,11609586,3.2377833862635206,2.816813182070494
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,1.9984007761663962
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,2.027013400744198
JM-1,36462,-2.702351282209385,0.6308656325794207
EFO-27,55508,5.431657737658487,3.413713191034086
CAL-51,10296883,4.0377332681132305,3.767865894228109
CAL-51,123631,2.4616591372530605,2.5207129840672944
A-673,53481919,3.7180877845578073,3.8130827052349656
JM-1,107970,1.4704012549786991,2.0711830841009222
CAL-51,5278396,3.885366261927898,3.434185079428088
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,-0.13736963575864533
KYSE-70,4096211,2.254549645630953,1.9260890086075095
DMS 273,11609586,1.9163652577621844,2.5699622587376183
EFO-27,9903786,4.039986452778869,2.5802675079161794
CAL-51,6917907,-8.395782425589301,-5.250266217108673
A-498,54454,2.893611310147977,2.4274931573130822
A4/Fukuda,49793307,-5.572580515048152,-3.5919623752581
NOMO-1,4259181,0.2459758371125145,-0.32529954434222935
SNU-449,107985,-3.1392486992039235,-3.4681575689866286
FU-OV-1,5278396,3.713343254157872,3.6906662874926166
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.4770902116122255
A-673,5460769,1.3883868162718005,2.4941097527086895
SCC-9,568763,0.9120329628896908,0.35451593619267774
CAL-51,72199292,1.0008292341873897,1.1745147007371777
MDA-MB-157,8515,2.4995790404865983,3.948953457254419
NCI-H661,374536,3.546483103952357,2.0583138222936417
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,1.7535423562026282
FTC-133,53392493,3.195209876090235,2.502230767249592
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.1311388581619637
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,2.921829307150733
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,2.072128093656661
NCI-H2009,3825829,4.333180881174198,4.124958482528786
A-673,6610216,4.190818336865809,4.194315715382128
LXF 289,1750826,-0.5305094201812034,-1.6872514261989653
MDA-MB-453,44543605,3.7347256504274418,4.0716244898924465
BT-549,24964624,2.3327253679943696,2.6496767952901727
DMS 273,24797083,1.0969779553781829,1.4075847516914586
NCI-H2009,24856436,-1.037334288977755,0.7282618216235184
ONS-76,73707440,4.1934861569389845,4.407889721360774
NCI-H2009,1242560,3.090706196906407,3.629302181577336
NCI-H2009,6610355,3.511475006316147,4.676655256883672
CAL-51,51039095,2.1842093640891416,2.8736005162770515
CA46,11404337,-2.4021967063511434,-1.188086506339714
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.04331741732289051
NCI-H292,11152667,0.5464898224488388,-0.7169624557233764
CAL-51,25154868,4.656760297450745,4.37869119849742
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-1.1643224456003016
HSC-4,66577038,3.591157601556467,2.969709680029691
LoVo,11175137,1.7419612548831422,2.4336251691753468
Panc 04.03,46215462,2.9027075063139804,1.8228084472838455
G-401,1750826,-3.031444880989549,-2.0806242980194085
SCC-9,462382,0.912003027061621,0.6212044754961044
NCI-H2171,71304818,1.9125624841179896,2.390211711303173
NCI-H2171,6252,2.1051572182795,0.6560148532663646
G-401,51037431,3.9974576184013726,3.0847967002098864
SNU-61,219104,3.1068483513637033,3.681287940462906
SBC-5,60750,-3.858196401702703,-3.1071158209192107
JM-1,72734382,2.7239851923699443,4.064198925218716
EFO-27,2733526,4.707486415914075,3.714750498226036
A4/Fukuda,71466445,1.4546499284121797,2.661970866391792
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.553501999357581
NCI-H460,24797083,0.9153025805785596,1.5919557609749342
A4/Fukuda,54596558,4.022693113590735,4.313480739639207
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-1.2095441915068268
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.049489991591888
HSC-4,44202524,5.184990397771561,1.6443083184324556
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,2.9602605823494503
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,2.0328540842757326
OPM-2,9915743,0.7579871544404475,0.7383178961394097
CA46,56949517,4.303265452215328,3.9975390656356478
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-0.9684166858128757
CAL-51,24785538,0.7720267524795773,1.29846443962687
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,1.6392268502540066
CAL-51,10322450,3.881825194853649,3.7650909736228457
A2780,241158,1.61479428578643,3.7496877806754987
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,0.1515058327024189
LXF 289,10074640,2.806214579062189,3.1955951582842426
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-0.48253545475255266
NCI-H522,119607,5.115168095819997,5.19393041907084
A-498,6918638,1.620608219340894,0.5529516907777366
CA46,10302451,0.2515382956842912,2.8086772586304187
NCI-H727,11152667,-1.354343634557878,-0.011862873401415716
NCI-H292,135999136,4.360218039072087,4.139652794413769
NCI-H292,322968,4.489137987914782,3.913151049388963
KMRC-1,11238147,2.6910045327617422,2.699811370018838
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,0.8751499523008073
NCI-H522,9911463,3.273817127322074,3.7195035255453694
A4/Fukuda,26596,-3.7061252239164553,-1.6711895263495409
CAL-51,2945648,2.7250935788350064,2.8604991348819584
FTC-133,10113978,5.149340897630058,3.309187023106512
G-401,25227462,-4.354739504605027,-0.13211586787947657
CAL-51,3634881,3.319714226315486,3.2673572100322947
NCI-H522,5280436,1.9285860105900432,3.2875546301774308
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,1.5658617407792987
A-673,285033,-3.783680268063714,-2.4118840238682138
KYSE-70,11497983,4.3699696445826035,3.383997055186599
EFO-27,135423438,3.7049046399150134,2.292929491645754
CA46,26596,-3.5845712744961324,-2.3325298168547675
A2780,24785538,0.5365701421591345,1.3289486932670544
NCI-H2009,8515,4.894015987740437,3.7787170936552035
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,2.183654095349948
JM-1,387447,-6.033292615187937,-4.689269054123713
DMS 273,9956119,4.190734481617164,3.6585267173343983
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.0552416773966347
NCI-H146,36462,-0.9223549938225544,1.8061840295419358
NCI-H1623,11485656,1.644044907667622,2.188797290453324
NCI-H1623,24821094,-0.2323488781711246,3.2524663485901817
HSC-4,53301938,4.738168418112686,1.772182927605639
LOU-NH91,676352,2.464978676736505,1.982508989854737
NCI-H146,46926350,-6.324766796143129,-4.178952189153142
ONS-76,16722836,1.7132123007700326,1.6332636822740747
YAPC,327653,3.117178905090827,3.4470919545708285
OVISE,24901704,4.2849421736627615,3.443516550147287
JM-1,54618164,3.458143614246244,3.9252862453634942
A-673,445091,4.1466370846962075,4.36269477171865
OVISE,5329102,2.956482132219437,2.1052786897126468
HCC1143,5470400,2.3870928447001867,-0.35046448280048076
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.859190865818392
SNU-61,3503,2.986460298481687,2.466998156395865
DMS 273,11455910,0.4737958394902512,1.0550995794256561
NCI-H460,46907787,4.3372157131836255,1.9251204278010854
CAL-51,216345,2.9520334452605637,3.9114070149043454
A2780,6450551,0.1349302943593443,2.033751989285763
LoVo,46398810,1.578557668618055,2.157848779067624
SNU-81,15953870,1.3050219745867302,3.3899480025989135
A-673,54613361,-0.6759826855411176,-0.2672026948870174
SBC-5,11234052,4.136817608168693,3.7040846368926674
NCI-H460,36462,3.103581216464206,2.2301684053595703
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.4022902536651114
A-673,168313200,1.7801049656035806,3.0184465731859036
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.730418883257321
A2780,100016,4.757543521992015,5.839927008751178
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,3.2847218267428064
CA46,25105715,3.628482142858773,3.304154052577666
HCC1143,9911463,3.749174224015704,3.7694334566787586
LOU-NH91,4477,1.3512747052000795,0.5658285896591584
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.0566216885927762
FU-OV-1,25154868,3.6525772823030502,4.279999953946126
A2780,168313016,3.896841135664639,4.342730690615829
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,1.2814216631335051
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,3.092081578393754
NCI-H292,15547703,3.23498204624142,3.230575874726376
JM-1,5329102,1.4301495534996294,1.4723549707666785
NCI-H522,3384730,2.8239588226941104,2.6170840396233253
A2780,9911463,2.7303797257759235,3.7086756554898983
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.0146930340038076
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.203878642555304
YAPC,9887053,4.707664045043398,3.643461097627017
HCC1143,10074640,2.8253679093766104,3.125616683208853
LXF 289,11178236,-2.9660816129263297,-3.037205160986661
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.5233070258454531
KYSE-70,135398516,2.3739819683449697,2.0345555073555452
A-498,57519531,4.461574036812888,2.5776003516078667
NOMO-1,9840324,6.741383080584752,5.588813502201062
BxPC-3,10427712,4.346184062898943,4.457071039795531
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.5977664129108375
LoVo,25062766,1.8850615394111836,1.948734840931855
FTC-133,262093,3.024825063724614,2.2547946591075463
HCC1143,44819697,-2.8669414823386115,-0.3746680204784246
BT-549,5351362,2.1022372489581227,1.5237075692331876
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,1.8221502349996082
MSTO-211H,53325874,5.432400358349695,4.585475892910326
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.1342017488355447
DMS 273,7326481,3.48743847164077,2.821492267472617
JM-1,11955716,-2.692308040243548,-1.8642514851801255
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.7773661779187241
MDA-MB-157,2842253,6.170125707570699,5.2097623367518535
SNU-61,54454,3.789888893365768,2.8912436301408575
NOMO-1,5460769,4.769752092364765,2.4008424689265313
A2780,285033,-3.502152061737446,-2.3350912526492054
HCC1143,44495899,4.517503920361928,2.771742396820601
NCI-H661,31703,-1.814857416200904,-1.0329230306818866
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.143208308994311
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.7515656718710811
A2780,2729026,1.9590477988732768,2.616841862114323
JM-1,89928392,-1.0810313065311572,1.0655476094971883
JM-1,10410894,1.2527004533251185,2.75405457742773
NCI-H661,16038120,1.553795977052523,0.6658840891129502
LoVo,135421197,2.0078610802467307,1.9702536618921895
HSC-4,24901704,4.088081803824046,3.3231357003924726
HSC-4,135411,-0.261300177061483,0.8591257952177043
NCI-H522,4917,2.9130794248329392,3.101248311903303
JM-1,11364421,-7.32386861469755,-2.927969964317391
NCI-H2009,10127622,-1.471627480680591,3.837223139059525
DMS 273,4917,3.103248515982538,3.0850179816564762
OPM-2,44462760,2.3304413416808463,2.860007875023422
YAPC,9956119,3.92905072911681,3.6437302580064603
A4/Fukuda,5113032,4.450145517718883,4.3788472494757205
NCI-H1623,49793307,-1.4788317062169576,-2.9889749838161475
BxPC-3,637858,2.219072546092823,1.992036254649952
NCI-H1623,1566236,4.077529389730835,1.9968306018864341
G-401,23725625,4.115882586635449,4.874500984748959
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.5270088898586474
DMS 273,252682,6.321322886147215,6.5142398620261135
KYSE-70,135411,1.9014599224142343,0.6795800606659685
NCI-H2171,49867930,3.814749813399888,4.8830190615935125
SW1463,10302451,2.197754569420114,2.923263117359192
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,4.902914241660087
NCI-H522,71466445,4.480637973076106,3.862692001076455
NCI-H727,6610355,5.167779637611195,4.635491529771517
A4/Fukuda,613753,2.966875582154842,3.059318869845555
ONS-76,4261,2.2909626551681757,1.5301086664829027
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,1.9340162834174364
KMRC-1,31703,0.3325905755235477,-0.6106460978305548
SNU-449,445455,4.484776409201516,4.653011623576158
A-498,6918878,4.306638073301365,2.732552705469032
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,3.200204244307488
OPM-2,1750826,-5.079410714013139,-1.9217387857719954
NCI-H1623,9915743,-1.6977137550638366,1.057975279572872
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.8944954848834765
SNU-449,7251185,2.777592648573664,2.7232067973997522
NCI-H522,2733526,4.089503686239825,3.9086473744654495
LoVo,24180719,2.381979820549913,3.415332812938404
A-498,49793307,2.582548635431232,-2.7972579472918166
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.3192316281887457
NCI-H522,4788,5.8756804910396925,5.465177173635562
G-401,374536,1.448879337840406,1.9234006514503381
SBC-5,135440466,3.787084066930897,2.1105252031623163
BxPC-3,36314,4.043064497836865,-0.8225728143495503
SBC-5,11626560,2.9533832336239985,1.5658763980474393
OPM-2,613753,2.6904302784099845,2.9719976345569834
G-401,71466380,4.3225707153388,4.175317967674209
G-401,45279963,3.527434868311602,3.4429270396195677
MDA-MB-453,1239801,4.069717893467032,4.063613183325157
A2780,11719255,1.8256962189728296,3.203348605336949
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-1.1859843812996924
HSC-4,11404337,-0.2351979780524762,-0.3876811124305749
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.8326896943674984
JM-1,5978,-5.097158196512326,-2.741847132297837
BxPC-3,6917907,-5.822397614063261,-4.705500298241339
NCI-H2009,52912189,1.2519346625881922,1.9328419511891222
KMRC-1,6917907,2.5901706443444477,-5.396711473192089
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.4599375050655035
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,3.821913601914669
KYSE-70,2746,2.8005709054024224,3.128102386765038
BxPC-3,638278,3.0042450495358923,2.895199980460002
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.9127519323678007
HSC-4,31703,-2.446577735650292,-1.0039230028153314
NCI-H661,11152667,-1.7022631730770723,-0.6811773619350099
SCC-9,73707398,1.5896934234406246,1.0786353183930335
FU-OV-1,148198,-3.302287500778492,-3.7756149069309966
MDA-MB-157,5287969,-2.775456728988527,-1.7475377969673114
OVISE,6918289,3.317561176891493,2.2762614113238753
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.42695933741069103
HCC1143,10296883,4.463772522749199,3.8391091966637885
FU-OV-1,25150857,2.264135178575504,2.3184176495377202
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.7654844293617725
BxPC-3,16725315,4.1100247270568815,4.240974615328278
EFO-27,11707110,4.483747329636401,0.10667924805517132
A-673,2858523,3.068752318729834,2.97397783496678
OVISE,5280436,4.204860612632051,3.48418581141198
NCI-H727,122327,5.896927010318378,4.6573082464977835
CAL-51,448949,2.479839067238928,2.0445924577061407
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,2.026946823886427
HSC-4,72199292,2.0552941548988506,1.02881785749038
NCI-H2009,36462,0.0033291412741449,2.396995633983575
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,0.989516886409422
JM-1,71466578,1.9829041072742877,3.4158796884632694
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.8018645570524862
LXF 289,67291369,3.4412292386368746,2.6247368915266454
NOMO-1,5281321,-2.1390969134868656,-1.8347249519252156
NCI-H661,387447,-3.746079371333459,-4.3410941976282595
NCI-H460,10385095,2.2920897819597896,1.3424414559506928
EFO-27,3543504,5.270070957864149,4.526105064254342
NCI-H2009,11497983,-2.437134563400756,3.8283316306491653
NCI-H2171,4917,1.7834364774656617,3.051996258396331
MDA-MB-157,4578,4.4846224734546025,4.469145116603271
A-673,9935249,0.595201632659186,2.3969933127217757
NCI-H146,4096211,2.4692816884948856,2.072423719976035
NOMO-1,60750,-2.6028640292275567,-2.9995430777616274
NOMO-1,676352,2.3647709516043336,1.7495663615096055
SNU-81,168312962,1.078666024421789,1.14154340765684
A-673,3081361,1.7117642477526505,2.022818832628637
NCI-H460,46398810,3.30325787352206,2.601009715343801
FTC-133,24771867,3.849205905915908,2.201318573836214
KMRC-1,409805,5.852991634240623,4.871542361258416
LXF 289,2708,6.094251503540483,4.8387806587717455
A4/Fukuda,11647372,-0.68075141177871,0.6605183101450252
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.1169900036563756
NCI-H522,3025944,4.039653719751215,4.229473922659623
HSC-4,6918289,2.856015155241233,2.535026317353933
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,3.1643454285396952
MDA-MB-453,67291369,1.3466484853812946,2.3201382783936833
A4/Fukuda,11178236,-5.149024442366163,-3.9065320500912337
NCI-H661,168313200,3.81404568417466,2.722098083724166
EFO-27,219104,4.121088157278177,3.830621102694978
KYSE-70,46191454,2.1451937437577575,1.5712865845826522
SCC-9,9927531,5.254709651648818,4.843477246299866
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,0.39542639327743045
CAL-51,16038120,-0.248771562775031,0.7648726086225751
JM-1,3634881,1.559410928505107,2.7256322691079107
SCC-9,5113032,4.570528604758655,4.996060421132134
CAL-51,68056272,3.9955701948507247,3.3109465711013506
CAL-51,4521392,4.667802355757324,4.489155074875272
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.561665270697907
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.2390597527344074
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.6308592481122135
SNU-61,9887053,4.377899885829067,3.761510802535594
NCI-H2009,25102847,2.121570289721804,2.5506668529553984
NCI-H661,54454,0.5886754914082402,2.3462795791881326
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.0321760397435282
MDA-MB-157,46174525,4.215722898807237,4.135723689676822
LoVo,5978,-0.9838296745754056,-2.3996849003680163
NOMO-1,44137675,1.7607667559168472,2.8649833087992764
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,0.309181161558052
FTC-133,216468,3.7386330008080018,2.7565345966309582
NCI-H522,5284616,3.1429047752915036,2.829209476200051
A-673,6450551,1.2504532759531255,2.283363866650168
MDA-MB-453,2126,4.599537631708682,4.560923391949265
FTC-133,12001922,3.1425787892022656,1.7482227595389552
BxPC-3,6610355,3.939463034432562,4.7000738621793765
Panc 04.03,72193861,4.339971647759762,1.9515678259404705
DMS 273,984333,0.9143511576606916,0.4358092746317462
NCI-H460,126941,-2.220790788147435,-2.2110918135161084
SBC-5,11178236,-5.106449128542812,-3.30548206652419
A2780,11497983,-3.587231584220661,2.5023851480990094
EFO-27,5278396,3.98166727080577,3.636390051296845
NCI-H460,40482356,5.06381124686115,4.303906155374258
OVISE,51039095,3.497583622307714,2.6599410384573816
HCC1143,56946209,-4.25120546555742,-3.853154155426486
NCI-H2009,3025986,-0.6988289053859157,-0.8207439122033098
DMS 273,44543605,5.15097132829554,4.079686175489984
HSC-4,23635314,4.118860430098142,-1.8931859519102505
FU-OV-1,107970,2.0514231206369686,2.32433401124366
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.324923992864154
A-498,5284329,4.906845392884974,3.064240538669101
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,3.0630766593527925
A-673,11612883,1.6900414301434703,2.4608519272740046
DMS 273,11507802,0.7884214749573938,1.256609501498473
NCI-H661,44486219,4.876697308801278,4.13942018702072
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.2830159482996946
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.720041359739656
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,0.5808048956224066
SNU-449,135875424,4.841371934548395,3.9188633554411325
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,2.666110093463337
NCI-H292,72376,-2.1951743702669573,-1.798263772638335
CA46,36462,0.0715644321871689,0.3101053823092116
A2780,54678924,1.3135335490837166,2.11160465302918
JM-1,9926054,1.6867956204893688,1.568809507408537
LOU-NH91,4788,5.956614254075031,5.727008430673143
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,1.251135306838143
YAPC,9929138,5.651296587688524,5.267198682381815
CA46,613753,2.777360120502711,2.9968371095053086
BxPC-3,159324,1.5239234886257875,3.209726330631347
DMS 273,9911830,2.0619640796568848,2.2252151579416286
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,1.8872169336665912
ONS-76,17755052,2.9613727126940126,1.8488335073219628
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,0.971134795050133
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.7415964965491673
BT-549,56963564,0.7590937126260752,0.24388690691858678
A4/Fukuda,135398738,0.2588260022635366,3.2931549828964446
FU-OV-1,6918328,-0.3184221939986219,0.03914257469561297
NCI-H2171,119182,5.854927706564024,-0.4037514437054053
LXF 289,46224516,3.632609368126253,2.5111968380174763
BT-549,66577038,3.347380186099457,3.085614699469261
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.1537707892287026
NCI-H460,25183872,2.110783783288614,-0.4487817570532148
CAL-51,17759555,3.5733302595078182,3.8027220915730147
HCC1143,4788,5.8180322078124265,5.63757057766317
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,3.2646514625927963
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,1.5826965858831052
A-673,11656518,-0.6930464248114873,1.5045592633476181
NCI-H522,12003241,-1.5672925136718587,-1.1506779979426849
NCI-H2009,19582717,2.816304614086765,4.272409464809345
LXF 289,9911463,2.935801973679381,3.8304170225101837
NCI-H1623,44202524,1.6623127043604982,2.0209733563775156
NCI-H522,9952709,3.5153076410238477,3.06370659593299
EFO-27,4378219,5.419366677908557,2.3608327803465343
FU-OV-1,11404337,-0.2130364442314083,-0.19353362653576955
FU-OV-1,119607,4.651010364988691,5.356335419232795
NCI-H146,135875424,2.9115600315347057,3.5239958893948784
LOU-NH91,11152667,-0.304989451834292,-0.4439421573992846
SW1463,439501,-0.3046644173954531,-2.0892849567866336
LoVo,25022340,4.929882293123705,3.095732724736599
NCI-H1623,23725625,5.633484297207613,4.801945761435819
KMRC-1,439501,-2.7889227637684773,-2.2801437600147874
A4/Fukuda,9907093,3.513986602103764,4.013331951101557
A2780,969516,2.2684147801302155,2.8733873198526125
HCC1143,24753719,5.247680835091332,4.379718960608748
DMS 273,25183872,-1.4455230978287994,-0.8958300556594678
SNU-81,3854666,0.9917295007006844,1.7317202190932088
NCI-H522,57330099,4.380671698756577,4.168383151978798
A-673,135421197,0.3124298336996849,1.8299606441515635
NCI-H460,46398810,3.30325787352206,2.601009715343801
NCI-H661,52947716,-6.022145864838143,-1.0037033423086137
CAL-51,9907093,3.7886359098281783,4.348754703996215
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,2.987824423950617
SCC-9,11640390,4.170413196512925,3.3980219805991863
SW1463,56973724,0.8689023909239705,2.853514317538494
HCC1143,24180719,4.266131781804432,3.4714059117132052
KMRC-1,135398738,5.381791034510906,3.734662661454
BxPC-3,36462,3.4182720226712457,2.4142901174803777
MDA-MB-157,4261,1.9483424687424111,1.5337668576548416
NOMO-1,2708,4.2098167660909525,3.706460735948795
A4/Fukuda,10410894,1.64506751408979,3.0986786388879763
A2780,3384730,1.1479192192658911,2.4274782678562885
SNU-449,439501,-4.772752939359215,-1.9239465544288694
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-1.5424564623583839
DMS 273,51037431,4.4079331684726775,3.1863952460431104
A2780,16741245,2.3123767413084786,3.952943018257671
SNU-81,42642645,1.3921275935464503,0.47186570958665597
CA46,44632017,0.5480853683486498,0.7789671069727401
A-673,71304818,1.350808371963784,2.4765254374687413
SNU-449,6914657,-4.967870149056919,-3.7892504832945146
MSTO-211H,25150857,2.632878402859221,2.237204073993741
MDA-MB-157,26596,-2.8480155125253623,-1.2995841735181954
LXF 289,9929138,7.38651684018349,5.171201595118271
G-401,25183872,-1.5190566583165497,-1.2678479163301777
A-673,241158,1.6738540084680422,3.7068572555480706
SNU-61,25195348,2.878615726844662,2.9708392657317937
MDA-MB-157,53392493,1.7008245883035995,2.7263377623086735
LoVo,68056272,4.365145786196869,3.323248537795369
NCI-H2171,6918837,-5.273009588122425,-3.3292981179233823
NCI-H460,168312962,-1.8333752522095308,1.9803216121440843
CAL-51,44259,0.1826439745217317,0.9350306024092703
HSC-4,285033,-0.8602386046724618,-2.1494690307172255
EFO-27,25105715,3.778793980481446,3.4332849942829746
A-673,1641662,3.2069303925294625,3.3926255747302743
KMRC-1,3854666,2.659759078644905,2.362668248036311
DMS 273,375860,-0.4468381354972334,-0.34817980429524875
NCI-H661,10231331,4.850159308010921,1.8158483935501253
DMS 273,16725315,5.248612259787856,3.8815595913989527
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,2.106667750074971
NCI-H661,73707398,1.1965083244926786,1.1298159226212823
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.036984979915105735
NCI-H1623,135421197,3.7764453326534855,1.8451846456840706
BxPC-3,24951314,1.2340413323146109,1.5984635104237521
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.203862744788086
NCI-H146,119182,2.1823445512420308,-0.7339024122510637
G-401,4578,4.054730999265937,4.314421545790365
MDA-MB-157,6918837,-2.759774975538005,-3.009194080174987
EFO-27,9907093,4.474758252228614,4.1889749314089935
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-0.6701531188862714
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,0.8004430764579742
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,2.8740696585904617
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.33107829157595886
NCI-H460,3025944,5.476008686130055,4.300557277211372
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.9193245141025395
NCI-H292,9915743,-0.4817131806939655,0.8344211036210331
LXF 289,44202524,1.498501439362416,2.2069205823348397
OVISE,135411,0.7729741022965545,0.7414329137030699
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.285471321625125
NCI-H2009,5746,1.7505534195957702,1.1841254936866918
A4/Fukuda,10184653,1.3612642262853822,1.0916489648454684
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,1.9421552080535371
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.5991625932401574
JM-1,375860,-0.4977027167273706,-0.40818682909140513
SNU-61,46943432,3.2717403410494397,2.0527831140657007
NCI-H146,168313200,1.5894074456272884,2.9092676232000936
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,2.0861320237742005
NCI-H2171,6184667,1.4164127707768046,3.0344842785765644
DMS 273,10184653,1.3805891581139824,1.0028860755945066
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,0.5189074355706592
SNU-81,24856436,-0.0712468901893707,0.3804072427797069
LXF 289,71680916,5.339150924844951,4.656145628974332
CA46,5291,2.960224941202677,3.0830985684619203
NCI-H2009,5329102,2.1297157842750756,2.30736851500283
HCC1143,49793307,-2.279288310815399,-2.975944283081672
HCC1143,15953870,6.0969880807250085,3.303065205310976
BxPC-3,2749,2.8971498792709784,1.9227156226405793
SNU-449,12003241,0.2005365129445947,-1.0959325565202083
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,1.7937591257519783
MDA-MB-157,2733487,0.3711294020076626,6.301067786878901
NCI-H292,3025944,4.3344233170115185,4.260655365981302
FTC-133,637858,3.731185140297224,1.900751247510099
NCI-H1623,387447,-3.670338978810225,-4.078838788337815
JM-1,5394,4.3191880254190425,3.2542368503491534
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,0.7888226907630771
MDA-MB-453,24964624,0.7400526464517642,2.4558459689077043
SBC-5,637858,3.033148612268187,1.666510427075329
HSC-4,3825829,4.330540788358233,3.9980095131629296
LOU-NH91,26596,-0.8372049149458933,-1.5282442570881705
Panc 04.03,24180719,4.502790622897018,3.6607657363207062
MDA-MB-453,44486219,3.97168660448306,4.416989990872284
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,3.7962008330566097
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,0.5722932051378955
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.3602213073175584
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.103043811995269
A2780,46398810,1.6945681809511193,2.484724034679297
ONS-76,44493528,4.396938069944904,4.296723507786267
HSC-4,3854666,2.969420021692798,1.6650946901440014
SNU-449,5291,3.951163668523845,3.711282896731273
MDA-MB-453,216345,3.4613524333124337,3.825410492211914
NCI-H727,71680916,5.541731669631066,4.534081501093661
NCI-H460,4261,3.676509117184606,1.7055747110139554
NCI-H2171,10184653,0.99528741531969,1.2815740456537765
FTC-133,54626689,4.834884112239084,4.641035576116213
A2780,55283,0.78738067747292,2.5145637797129803
OPM-2,753704,3.6202062566191984,4.412260647163351
NCI-H522,53392493,1.8355339375888644,2.278585847763126
DMS 273,10127622,5.766745520319409,4.068124217483384
ONS-76,BRD-K58730230,4.314454311755605,3.688503140800597
MDA-MB-453,49766530,3.3081056054922064,-0.3333930780067489
A2780,16065773,0.67384212990199,2.3119262008598813
JM-1,241158,1.7269305863155773,3.2654328597582944
A4/Fukuda,71466380,2.851115718652883,4.127611051533897
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.129935388950094
MDA-MB-157,16722836,1.792866712111087,1.6939640802448273
NCI-H460,6852167,4.590065962834362,3.0406502638440998
SCC-9,375860,0.1694000381305893,-0.4725858346050491
CAL-51,54649381,3.902782783768603,3.9531269918714225
EFO-27,2708,5.128228617584202,4.506175938181573
G-401,6450551,1.2745400494425214,2.1029590305427863
SNU-449,168313016,5.914877518762689,4.753269308601378
NCI-H661,654092,0.3537062860674825,-0.47649459981637393
SNU-61,5284616,3.808934677012338,1.6114158837242014
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,0.6334431498925998
KYSE-70,25195348,5.534160735777195,3.1702773298549287
NCI-H2171,135421197,2.0026019926205185,1.8806538514500417
NCI-H460,4261,3.676509117184606,1.7055747110139554
DMS 273,1641662,3.247845954250749,3.50685405154154
BxPC-3,6914657,-4.023901786471393,-3.6390927584685926
CAL-51,9936388,-5.638746232401389,-2.455602110171498
A4/Fukuda,25161177,3.5710974046751804,3.793694284828459
NOMO-1,24821094,3.1222382635594967,2.686388192907046
A4/Fukuda,53232,1.4709221708336295,2.591063490166338
A-673,9840324,5.96119566119886,5.782954508526387
LoVo,613753,3.444351424595812,3.057579569903551
FTC-133,4477,0.2258553638980791,0.40680660431038956
MDA-MB-453,11214940,4.455338804672604,2.0181908121058254
A2780,56649450,-0.3009304069219352,3.573239311791086
HCC1143,89928392,0.2924123173203115,1.4022861513425884
BT-549,6852167,2.654575121453327,2.887513408618898
G-401,375860,-0.2910974790080222,-0.29351444780366726
NCI-H661,613753,3.3170674343428708,3.1240566413005695
YAPC,71304818,2.728620236586343,2.4340566289595715
NCI-H292,3503,2.756562172316919,2.322438994583743
OPM-2,44819697,-1.6539436611429392,-0.7579513453041199
HCC1143,60700,1.3373007617879429,-0.39901499378025973
MSTO-211H,446155,-0.2868964860821164,2.421835821949716
A4/Fukuda,2708,3.0461577581065007,4.179411886201294
SNU-61,126941,2.173772773827979,-2.3817945790091692
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,3.0885708515794863
HCC1143,444795,4.803024181226615,4.409638270888462
JM-1,441298,2.4952150007247393,2.4372330696533187
DMS 273,44507138,4.08877163590395,2.3755853602797194
Panc 04.03,5291,3.9842309161066063,3.693855995089387
BxPC-3,3062316,-1.891072672499,1.2098036166227077
KYSE-70,15983966,-0.1847866067827735,-1.6305648790419036
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-0.9540238148325072
DMS 273,44607531,1.5313743675110545,1.5046773473439417
NCI-H292,5746,0.9253562515034884,1.189151418503974
NCI-H146,6914657,-5.6838858588772245,-4.162217523652636
EFO-27,25150857,3.1416161415552173,2.4465323493997846
SNU-61,54618771,-0.470226071786205,1.1645892130216395
BT-549,1716436,2.964006130486385,2.9569372212767524
BxPC-3,4521392,4.6952932183187,4.410220164324373
BxPC-3,5328940,0.9544734009845622,1.7567904582473637
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,2.7640126032710755
Panc 04.03,16013152,4.359497957481629,4.227278805164132
A4/Fukuda,3062316,0.4248767517614322,1.2178524828027308
A-673,11609586,1.032418246609784,2.5102802975415073
SW1463,322968,1.9625017896764745,3.544847627223234
JM-1,11427553,0.2949480151387566,1.6389676604190273
CAL-51,11497983,2.6322425573174213,3.473191420885503
Panc 04.03,12003241,0.3752932920389255,-0.816676580753917
FU-OV-1,216345,4.02478525181321,4.030719702959714
NCI-H522,89928392,1.1479343378844449,1.5131341643783072
NCI-H460,11485656,2.6212830818798065,2.341150233338022
LOU-NH91,6438330,3.480541802748286,2.049921187964984
MDA-MB-157,11228183,0.9797898244038654,2.206292804049767
A4/Fukuda,10385095,0.4549399411675465,0.9710296156815714
G-401,241158,1.9889661714459972,3.674849708569759
MDA-MB-157,5282054,1.4096594950320644,3.431482802148488
NCI-H522,11404337,-1.4542746262182442,-0.34639653177859336
NCI-H661,322968,4.732962604670861,3.666917374460507
NOMO-1,65064,5.083490310509571,4.532410028353404
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,-0.5377772831172261
BxPC-3,1716436,3.6064873492654943,2.969877528567588
NCI-H2009,24753719,4.192950544032197,4.341607242496
BxPC-3,136227924,2.62858882862477,3.1152961944748783
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-0.5934334443281152
SBC-5,3854666,0.5257720708282073,1.2574633692614627
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.05197729639107179
NCI-H460,1750826,3.3189287492303197,-0.8952507279397814
A4/Fukuda,4705,2.104501352907832,2.9818442534544904
BT-549,24821094,3.680768028115557,3.3310044128381224
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,3.2311707092036155
A4/Fukuda,46398810,1.5683404384737003,2.155028808614496
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,0.7449866801638214
MDA-MB-157,3062316,3.257879214731084,1.4813575786593225
NCI-H727,71466380,5.170266193783112,4.449244083783475
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,2.838453151204147
HSC-4,16038120,1.7232268235274473,0.8541857822404004
FU-OV-1,53392493,2.412509849766808,2.519672825227087
NCI-H2171,3634881,2.317126021520602,3.0125931557346917
DMS 273,54618305,4.272082763698834,4.456669604773204
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.032727647359349
SNU-61,9926054,1.8929452670989917,2.060391629013797
MDA-MB-453,216239,1.9202357593604051,2.1958597711998022
A4/Fukuda,252682,6.117343290485243,6.3999963756066744
Panc 04.03,11455910,2.454958233695195,1.0511361891443842
MSTO-211H,24951314,-1.1401244239295247,1.3842534169117
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.0709978570045324
NCI-H146,67156097,-2.3396756899377595,-0.7735116822214994
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.5940972533742909
FTC-133,25150857,3.5794152247995004,2.197390202613846
KMRC-1,24797083,0.8876318381449373,1.5523181958957755
KMRC-1,5282054,4.624285853166485,3.899196716801556
MDA-MB-157,36462,0.1516360669313773,2.2489304371576977
SNU-61,11609586,2.423992088951442,2.572977916802701
MDA-MB-157,4378219,2.6716514190617104,2.2687336936913107
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,1.3325077730276802
A4/Fukuda,57519531,1.5811593813701257,1.9042322695313263
EFO-27,136227331,4.702115323060179,4.290495462382371
MDA-MB-453,9952709,3.2945084007394616,3.0905737883845803
G-401,54143018,0.971383874427432,0.3406348401963629
EFO-27,9927531,5.387402639259967,4.688047372971784
DMS 273,3025986,-1.574939205922683,-1.0211362507010007
NCI-H522,26596,-2.5500947066960276,-1.2702262422320005
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,1.8892990009842832
CAL-51,5280436,3.749440064194485,3.2329837160749024
SNU-449,25150857,3.008716268425874,2.3814466561010756
KYSE-70,23582824,2.6933165956875964,0.7840132876105007
OVISE,54454,2.25285494204451,2.725845424839542
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,2.4347564372174006
MSTO-211H,5282054,2.057664237493602,3.641567114438563
CAL-51,16720766,0.5416929462446769,0.468348391557266
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.2249333114408316
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.820881572105332
SNU-449,446155,0.8119451390236352,2.905368155857717
NCI-H146,375860,0.4213004900992469,-0.29671968524550113
CAL-51,5281321,-0.4656602142962174,-1.3231745727203839
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.340863248200188
NCI-H2171,44462760,3.915746717375186,3.6581956497891417
SNU-61,151289,1.0402759766313254,0.7696926117690363
DMS 273,24856436,0.3584417497554937,0.36667552696138794
CAL-51,71466578,5.340961831553399,4.34665641802736
HCC1143,44607530,2.3193328073886628,1.8796974557588642
SCC-9,3136844,4.895725881728452,4.243997763248606
CAL-51,148198,-3.728190383000159,-3.441624047408886
DMS 273,25126798,4.049346019168164,3.82215965309061
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.4567864893163241
A2780,9825149,2.396834344892177,2.159999929040561
CAL-51,104842,-3.020036586723177,-2.555808602150251
A-673,676352,1.522059533133182,1.8667786458350504
FTC-133,9967941,5.123707260677636,3.5394293982228366
NCI-H2171,56963564,-0.0417490265139498,0.22673843194358073
DMS 273,753704,5.000496745911757,4.821456528572736
JM-1,6918837,-6.173851145057706,-3.896318106411914
KMRC-1,285033,-1.948983558292048,-2.042395446643345
FU-OV-1,54454,4.96368280899624,2.7795094986058353
LoVo,11152667,-3.1828514843907967,-0.7109888915573418
A2780,3081361,2.3669572433114663,2.1067823635506846
CA46,11497983,3.715862022418827,2.219915815636096
EFO-27,9952709,3.7128554087131658,3.1828273455039793
SCC-9,3503,2.580691900576731,2.2247802402375014
CAL-51,42642645,0.4324607401831485,0.8312756295575534
NCI-H522,462382,-0.0152056919239,0.4937515066696282
NCI-H661,44632017,0.8459474985730225,1.2961088805608025
LXF 289,44137675,2.0502885463252665,3.60052556529771
SNU-61,11404337,-0.7844361329588494,-0.19858180440840087
FTC-133,15983966,2.5675405254421113,-1.2154101893673173
KMRC-1,56946209,-5.003023698532595,-4.2047405072678545
CA46,9866186,-0.3275085520058725,0.3446339536889842
DMS 273,23635314,-4.293922540672693,-2.314095767534232
LOU-NH91,4259181,1.0248896787271708,0.05736397266345777
SCC-9,46224516,2.803045033456012,2.31818685075019
SCC-9,6918837,-2.658799999554452,-3.1240832503326295
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.6282044392478482
LOU-NH91,15983966,2.104720476479653,-2.155722165746569
NCI-H661,285033,-2.1039671806681985,-2.2834387423873093
G-401,16722836,1.0452487365316014,1.6506841042557472
SNU-61,11964036,1.5202881054490238,1.2053596161099254
MDA-MB-157,374536,-0.5698586384338129,2.1855371772426273
OVISE,168313047,2.139797955827927,2.5394692329360495
LXF 289,400769,-1.8947060859446272,-0.5499276315749198
BxPC-3,10302451,2.105262518783424,3.210875051833365
KMRC-1,446155,2.327207673229407,2.682540904833395
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,3.812637175346901
MDA-MB-453,421610,2.7771188964172664,3.0475894345154693
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-1.5423739887674512
OPM-2,2113511,3.5660346238413565,5.137384567750272
ONS-76,31703,-1.5971524717515937,-1.3012053761531839
CA46,100016,3.773189878640827,5.72673306708241
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,2.2086141386862947
EFO-27,11167602,3.5204241483481686,2.43097776983547
SNU-81,6505803,-0.5044882096333503,-0.8017136651670917
NCI-H727,1716436,2.7605133955676178,2.925688871175063
OVISE,10302451,2.747913318530857,3.4283508931914577
NCI-H292,24772860,-1.7688616980402292,-2.3736595349386533
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,1.9510949653157654
Panc 04.03,702558,5.6133476434957,5.187403740579201
NCI-H727,24964624,2.2819429425827984,2.635359641723426
MDA-MB-157,2828334,5.757584300180036,6.100392613678288
NCI-H2009,67291369,0.975633217461442,2.4043513069421967
EFO-27,421610,3.836140121936173,3.202229023623539
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.835314028821415
LXF 289,11626560,1.452143156792952,1.8752856482668696
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,2.451393593125779
NOMO-1,9444,3.521396869825756,3.350485679594952
KYSE-70,24821094,5.190593902676824,2.9092547412538043
NCI-H292,104842,-3.713576042756873,-2.9153771289093204
CAL-51,23725625,3.781531245600544,4.896630624049336
MDA-MB-453,11175137,2.676203543730399,2.793880072707367
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-1.4113912418206656
OPM-2,3038522,1.4393753112244685,2.7153989089284374
KMRC-1,107985,-3.501321688193531,-3.646429481849274
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.9973515297302282
FTC-133,9549297,5.410509835078823,2.234802756411149
HCC1143,66577038,3.1905565845946993,2.8221587951258966
A-673,73707438,5.240927680887528,4.33047764994669
LoVo,44137675,-1.419079349485425,3.302738150458063
SNU-449,3503,2.7484718807665396,2.322118114161766
JM-1,11960529,4.3881984442046384,3.8828209581890563
FTC-133,5460769,4.281031552964228,2.7415447644628967
LoVo,3025944,2.9449078290251256,4.144636490632873
A2780,613753,3.052273906836147,3.1932443557973427
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,0.8429437875732078
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,1.164339147500864
NCI-H727,119607,4.980733327072692,5.333801131021698
A2780,15983966,-5.363621110890126,-2.217930018504894
LOU-NH91,52912189,2.021653283813576,1.3996661479013652
NCI-H2171,46926350,-4.867098709680934,-4.189597492133273
JM-1,11222830,1.159649219525665,1.3034056011100739
Panc 04.03,9887053,4.247469701197239,3.968027416122528
MDA-MB-157,6918878,0.7604288199483474,2.715075656021387
DMS 273,25150857,2.151062266440261,2.3746081757748865
NCI-H2009,637858,2.463099291034241,1.8751262138281064
A-673,89928392,0.0772153864579325,1.058176857430882
OPM-2,56646779,4.429673228200906,3.5438339024176537
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,2.0198237971109267
MDA-MB-157,104842,-7.463907387011825,-2.434421703032791
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.9662782024975308
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.7667492805875593
SBC-5,23725625,4.5493880465204235,4.854256020515183
CA46,16736978,0.453820731366511,1.1705144161127985
SNU-81,5287620,-3.371703836172312,-2.0678705219427327
OPM-2,9929138,4.40255967212205,4.576089448114228
CAL-51,107985,-4.126908547019261,-3.3587328379748893
SNU-61,4261,1.9153687598051303,1.273163316439102
KYSE-70,5311,1.3049127753558711,1.3834661537768114
A2780,2874250,4.6617329815359545,4.630628735611758
A2780,46843906,2.4977538844634637,2.6144228634003643
FTC-133,11234052,5.0298463189452445,4.045615637154658
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.2070762686849728
OVISE,5282054,4.4060399380094415,3.7871483595338735
HCC1143,4096211,1.556998125169598,2.2542833655735333
NCI-H661,11364421,-5.690348879388773,-2.123020214849638
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-3.1125152603999284
A-673,11427553,0.6536689467636717,2.1447553589751873
JM-1,6917907,-6.147483124234289,-5.655159359175653
A4/Fukuda,9926054,1.7963505717751411,1.7655465004967588
Panc 04.03,65064,5.203402541242721,5.1049082415595075
MDA-MB-157,25154868,5.338832763625219,4.38790631350956
A2780,3689413,0.5219259729031659,-0.6929680101317175
NOMO-1,2828334,5.727397129817869,5.99778452177311
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.8761686558667283
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,1.332602940094275
A-498,10385095,3.0502652475567347,1.4304827117364272
NCI-H460,5280436,4.847067650781305,3.502791138849504
NCI-H146,71304818,1.6140243095299662,2.3494096255986934
SNU-61,135398516,5.118120351018792,2.152505426171283
HCC1143,9967941,5.23006520077408,3.6656853083990906
SBC-5,51039095,3.807088636542375,2.5873246340204874
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-2.510335455881106
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.3512892280044495
HCC1143,44137675,2.963488174732173,3.4732309295025847
EFO-27,15983966,2.453959425588555,-1.7413902092535685
NCI-H1623,10184653,-1.536462891864862,1.4657581073252308
JM-1,216468,0.5768131010636649,1.863026856868891
KYSE-70,5278396,3.1929088159597656,3.5677106548926605
SW1463,216345,4.078496637973622,3.8250107277381873
MDA-MB-157,54619267,4.18775168816921,4.077071642971967
LXF 289,16065773,1.584092119185821,2.5880005084911515
Panc 04.03,107985,-4.416167995938274,-3.6114607274653134
SNU-449,11238147,4.105269625362408,2.8376337230695396
ONS-76,66577038,3.2799369572038977,3.0059921400878427
NCI-H1623,156414,-2.396664487331107,1.48356015120427
DMS 273,4578,4.680938801431088,4.336137659237509
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.329483801218933
OVISE,73707398,1.6715872061037895,1.5353454507348845
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,1.9579340207212326
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,1.6470571651678856
G-401,2945648,2.835527608429738,2.820050181899407
BT-549,89928392,1.2423762488932544,1.438535732212725
NCI-H146,107970,1.621489555747201,2.188243635306189
OPM-2,71466380,2.758760560312852,4.0455223864192575
HSC-4,15547703,3.6362413258054063,3.204046289350342
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,1.1271225335837312
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.5618398020205466
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,0.8677298523996764
HSC-4,17759555,2.4253306074953978,3.7538458354515187
FTC-133,2945648,3.116487231281591,2.8969362249245996
BxPC-3,3825829,3.4267099071969738,4.290469326866092
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.813835699525272
NCI-H1623,3025986,-1.391492623029173,-1.0070496961413768
BT-549,3025986,-1.1986125704978905,-0.9324207731635006
JM-1,25227462,-4.63830716322272,-1.2722970170907137
EFO-27,4477,1.1283660363220671,0.3472699548068468
LOU-NH91,52947716,2.984350097195249,-0.6241127484229987
CAL-51,44489367,4.725330666921359,4.572252048703535
DMS 273,2949965,2.5486766063035056,2.7555341957204793
MSTO-211H,36462,1.134601353001676,2.0833151979118933
BxPC-3,4917,2.980696163243889,3.091301934134051
CA46,9903786,1.650432742323398,2.349026933198181
CAL-51,156414,1.13799157004995,1.2349851119101052
OPM-2,6610355,3.590135914900994,4.111956356276529
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-1.5900312234079446
NCI-H661,439501,-2.903837615768139,-2.262832846488971
Panc 04.03,9952709,3.610885547265169,3.0922173305138774
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,1.1036598283938373
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.6169789300398896
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.9807020786908969
OPM-2,2708,4.148168261065231,3.93361433692421
NCI-H661,10385095,0.8549868667974337,1.08889185216226
JM-1,24785538,-0.4888535449792195,0.577844297597952
FTC-133,6610216,5.488595178062795,4.095727944295611
MSTO-211H,216468,0.7149646325927866,2.7730945727588368
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.5426450245863057
NOMO-1,5978,-2.430694050184869,-2.88902337835288
DMS 273,216345,4.389361768667068,3.9299035584145336
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.6125523347562516
LoVo,676352,2.5317553470156646,1.8928706537625064
Panc 04.03,107970,2.70125557955606,2.4464695111023196
HCC1143,11427553,3.376761154443363,2.9525893529098237
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,1.9326993382963302
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.810964650642719
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,0.6727644259917791
NCI-H292,11626560,1.446983052748098,2.0699202616457355
EFO-27,3062316,-1.351094232476051,1.5697798129472098
MDA-MB-157,2746,2.873003215594031,3.0284805490553923
LOU-NH91,24180125,2.532676427085935,3.0188568652811814
JM-1,135411,-1.048960589681706,0.17999730265689023
NCI-H146,644241,1.2089846023639548,2.285995286931797
A4/Fukuda,72199292,-0.4044306818473915,0.9352533760527946
SBC-5,135421197,2.079587314097717,1.7145664780455463
SNU-81,6918837,-2.735310336273069,-3.5721129343812383
JM-1,7326481,2.606242200480973,2.9343178699244645
LXF 289,67156097,-1.7104573080698593,-0.9045238489680537
CAL-51,89928392,1.068329558331595,1.4257749864552147
A-673,6505803,0.2745970276233078,-0.26864660663781204
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,2.275091960302488
SNU-61,15547703,3.101064478021952,3.2367570844128317
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.1007006709828475
SNU-449,16065773,2.84526561612217,2.519507612960906
MDA-MB-453,53392493,1.7017875748321412,2.5787380094362993
SW1463,11317348,3.510696959395443,2.443624747928891
MDA-MB-157,11214940,-0.245291289631715,1.889058273717336
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-0.7967648720047396
OVISE,44202524,4.183655897410181,2.242903184960527
A-673,11964036,0.9382905451812168,1.2295932003306407
LXF 289,3503,2.5386473527097837,2.426138377105715
MDA-MB-453,54678924,1.5140521677167769,2.0204700983630213
SCC-9,2749,3.600343159035071,1.8891879240376546
CA46,9840324,5.575806842573594,5.604518643104513
DMS 273,54143018,0.522600880214995,0.14876897399337025
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.9056752209979377
FU-OV-1,25102847,2.696211974787464,2.4151827733050495
KMRC-1,73707398,1.5458693028147192,1.2811494730046562
A2780,5287620,-3.13264442622338,-1.8991383546927063
NCI-H460,54619267,4.901891634717457,4.082198780121467
EFO-27,2945648,3.241602940948522,3.004278895368306
NCI-H522,25105715,3.4847863866008755,3.3941806966153085
SBC-5,638278,3.4285441526954687,3.083671400813058
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.8538069791266167
CAL-51,6918328,0.3807555589851347,-0.04137464727537921
NCI-H727,11497983,4.370504456176288,3.224794240572688
NCI-H460,4259181,-0.2054535095090753,0.2904073560210185
FU-OV-1,16741245,4.362196150231273,3.380678265623377
SNU-449,9911830,2.1326623866395487,2.4669655441819143
NCI-H727,5278396,3.8599732465447247,3.509486732599254
MDA-MB-157,44566777,-1.1276584651283623,0.5075716770553887
LXF 289,656346,1.157307128170796,0.7249684063872697
CAL-51,176870,2.9999818119422175,3.3827010559502577
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.0771444737157365
SNU-61,10184653,-0.5580603125211917,1.0562194699532828
OPM-2,25126798,3.830489811395835,3.7645732212209437
SNU-449,49793307,-2.0136733678876335,-2.875579428863341
NCI-H2009,60750,0.952457111724262,-1.9842145239734428
MDA-MB-157,60750,-2.031758614917575,-2.8062669379933816
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,3.4898695820388705
MDA-MB-453,44137675,2.41330993625909,3.6047248940569103
DMS 273,5287969,-2.213452126148289,-1.6334594548896024
LOU-NH91,11609586,3.3390226168587716,2.8679090004662102
NCI-H661,24951314,0.8780582238506052,1.089216469578387
A4/Fukuda,6852167,0.513003696591474,2.3686841332007096
CA46,5311281,1.0891225881142432,1.9707377622544757
A2780,11625818,1.819164792403796,3.839060737501474
LOU-NH91,51039095,2.9779244840652295,2.787925144719559
NCI-H661,4096211,1.4698398043308702,2.0558108353500093
LoVo,4705,1.5085236639058903,2.7032624969855545
MDA-MB-453,46926350,-4.337117227146235,-4.111689288958905
SCC-9,5738263,4.330654025732234,3.2484832293170047
YAPC,46199207,3.321634350680955,3.278044662547935
A-673,71466578,4.1904953682389,3.9555386540581825
G-401,10127622,3.1466102465201793,3.539672354582352
A-673,5311281,0.6354511881397967,2.5045998437204973
Panc 04.03,6917907,-5.49357619863333,-4.854386278861066
OPM-2,216239,1.2934585013066655,1.9473304756095118
KYSE-70,1716436,3.404085131889099,2.8894433431239714
NCI-H727,9887053,6.41036176282966,3.8213176864093423
NCI-H460,11404337,1.7201854837770862,-0.191594304671769
CA46,24901704,2.114836921018661,2.803184407644673
NCI-H292,9903786,2.498172259524573,2.7609236284697936
A4/Fukuda,9927531,3.7257201794253776,4.551684406099742
CAL-51,2113511,6.39897875596168,5.206532751712608
OVISE,409805,6.403340651497087,5.100360636770336
HCC1143,11626560,1.5863706836040057,2.019886906880273
CAL-51,26596,-1.4638590943230956,-1.5017767702191833
A-673,23725625,2.0065405091728272,4.594696769554789
DMS 273,6610355,5.006954006570411,4.4693072922031725
A2780,24901704,1.9524214470888757,2.9515586080107106
SCC-9,11494412,1.4365999648395638,1.3805965969324978
DMS 273,4788,5.897035505528926,5.584960652539977
NOMO-1,46907787,-1.215006340822028,0.30877050562608377
EFO-27,676352,2.5978940444924703,2.0656694595890115
A-673,44607530,1.766367479354274,1.8308523168912265
SW1463,9887053,1.032433665952219,3.5521030272354777
EFO-27,54619267,4.322845534804342,4.061377642977912
G-401,9907093,3.2734126555601506,3.907168787961041
NCI-H460,24772860,-0.596461213785507,-1.534940585832515
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,0.8497142866700361
FTC-133,119607,5.542629368531396,5.235475078009073
SBC-5,11364421,-4.061592659681506,-3.011293912066143
Panc 04.03,5566,3.3462548914340204,2.9994584726231737
NOMO-1,6505803,0.1224616163714439,-1.133740432442535
NCI-H146,24772860,-4.237473750878659,-1.8775964318089664
NCI-H1623,11609586,3.053283731487635,2.9118346732393245
CA46,208908,1.4900061271350116,2.026067409621774
BxPC-3,9956119,3.6276214672042975,3.5294819166192872
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,2.2204575640954074
CAL-51,10410894,3.3356149928792513,3.4597484923161925
JM-1,9927531,4.0230036766634125,4.585691411662774
FTC-133,9866186,-0.0573555179634338,0.7869682484410885
OPM-2,3136844,3.3377711403827783,3.8962005373167896
FU-OV-1,3815108,2.287889788505342,2.8952835768415075
CAL-51,10410894,3.3356149928792513,3.4597484923161925
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.2010710898508217
LoVo,5329102,1.3429054297502294,1.8656834006465806
A2780,168313047,2.060680306449853,2.2881734568909766
HCC1143,104842,-3.076711821193911,-2.53481984231347
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,1.6326446166174096
LOU-NH91,6918736,-0.749268328982244,-1.8189953574260744
LXF 289,11625818,3.3628594045115805,4.347119580114162
LXF 289,5311281,0.8902308213691446,2.3023291640367707
SNU-449,5351362,1.2849200933546208,1.4980601509178708
NCI-H522,135875424,3.5456342124976445,3.802771845640064
MSTO-211H,44185566,1.3875680654995235,2.73427146883645
BxPC-3,24964624,2.317613094015834,2.4800305290643316
HSC-4,6852167,2.6632521076475446,2.8784661402543477
NCI-H661,409805,4.01937565581764,4.792166190057617
NCI-H2009,16038120,-1.1539994385349277,0.9739763517069019
NCI-H2009,5978,-2.257242885332271,-1.7372776552515774
EFO-27,56649450,4.209581770525167,3.27343143106436
DMS 273,5287620,-2.166812480100597,-2.104838327918306
LOU-NH91,613753,3.2819891552194327,3.1903479123202745
NCI-H460,73707438,4.549718141383013,4.205512182558
LOU-NH91,24785538,0.7950573935003075,1.3547951820315256
KMRC-1,71304818,3.217910603872335,2.646928498399883
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,2.937811967433459
LOU-NH91,15953870,3.547895487506012,3.1855207488457524
SNU-81,3384730,-0.4505726212948157,2.242432957603052
SNU-61,1750826,-4.373387519590766,-1.671273170981469
MDA-MB-453,753704,5.23059705064669,4.936611685030858
A-673,119607,5.020937738944074,5.1873882040134625
KMRC-1,9907093,4.272059047954712,4.164964195787136
CA46,11640390,3.3312213559791397,3.1444505550018995
SCC-9,24771867,5.065268858490301,2.484384562252664
ONS-76,5280436,3.697781558026248,3.2233783050930294
JM-1,10427712,3.737784417116883,4.037436063825214
FTC-133,3081361,3.8958462184451697,2.611216325846107
KMRC-1,56649450,3.8757723452520136,3.38738715486401
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-2.1311827811425337
LoVo,159324,-0.9516179858777442,2.512914048745276
ONS-76,2841722,4.548555296080543,4.337847824122784
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-3.3120095933984204
SNU-449,5460769,0.9117409452183444,2.493852675406764
NCI-H460,6852167,4.590065962834362,3.0406502638440998
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-1.3179161330877844
KYSE-70,176870,5.518340217914711,3.27482681284178
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.7172874584875266
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,2.7055384825707347
FU-OV-1,15953870,3.743404981829692,3.314205224806944
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.0382587065929914
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,0.8522779692749208
LXF 289,654092,-0.8888310934038361,-0.4205762091707331
BxPC-3,9826308,0.5055656835854033,0.5577078397633904
LOU-NH91,25150857,3.1116403082593096,2.3919435946090637
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,0.4348450565407002
A2780,375860,-0.912616297645574,-0.3820239417682448
LOU-NH91,6852167,3.2671273023515934,2.7017866128496486
CA46,24753719,4.040239779097469,3.577291505974259
HCC1143,135999136,4.602247958833588,3.912538222696471
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.8091601070159016
CAL-51,11960529,3.662834723962616,4.014214685598936
SNU-81,20959075,-6.025577396301825,-2.8752085039664803
NCI-H522,57519531,3.3673050119485555,2.3300264116093024
HCC1143,135421197,0.8918606552263807,2.259689486193156
SW1463,24978538,1.1634359901262634,1.3452241323793614
HSC-4,445091,4.370395830414555,4.411045023106172
SNU-61,5329102,2.445912447276521,2.155803541349997
G-401,23582824,-0.1091259215243222,0.5594545489481206
MDA-MB-157,11485656,1.3019788320898549,2.426484009785983
NCI-H1623,11964036,0.5644570453188236,1.2471006567736245
MSTO-211H,1242560,2.686361074048806,3.385036928649174
A-673,65064,3.1048319417370775,4.592364955599016
KYSE-70,208908,2.5295165235288004,2.2111091974158787
SBC-5,2733526,3.427490731511537,3.692273534256231
ONS-76,6184667,3.7303112000686256,3.0901155694342943
A2780,23939,3.9158411595028046,3.8432617936702327
JM-1,1566236,0.6280103536338946,2.029644662780211
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.4510466742191668
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.6556649929903138
CA46,11396600,2.515122226404857,2.819857031127278
BxPC-3,262093,3.443903516481154,2.806384062148488
CAL-51,1566236,2.769525954778687,2.0802052368915698
JM-1,3025944,3.553601432401545,3.8677428373430827
CA46,31703,-2.2435350155349023,-2.3420620402549
FTC-133,25105715,3.757366730830659,3.3611081915764998
LOU-NH91,54649381,2.7277802519486514,4.041439960903315
A4/Fukuda,11364421,-5.769651092108399,-2.9144995543156558
A4/Fukuda,5978,-3.163562671527086,-3.200485423406927
NCI-H1623,969516,3.836806795163693,2.859591149913572
NCI-H2009,5113032,6.328717344861362,5.023714070590672
HSC-4,7326481,1.9301811465772087,3.0536424804334334
DMS 273,54639665,4.46621146803559,2.9332742819115896
YAPC,9926054,1.8358643335634888,2.0363119122483955
NCI-H460,11238147,4.460003386993959,2.9989328455122615
OPM-2,9887053,1.8393709016316329,3.1057497573537773
JM-1,168313016,3.8541200519849017,4.257507659632388
NCI-H1623,285033,-2.516722374910668,-1.736460205147526
KYSE-70,5351362,2.601126509135012,1.3617376826202314
NOMO-1,10113978,3.435868796737405,2.4644753468722636
HCC1143,17759555,3.749709067386792,3.677742868137532
NCI-H292,11964036,1.1514824488888922,1.4566636865942848
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.024237001818588
FU-OV-1,46943432,0.7627718951481175,2.2696256676979014
NCI-H292,4917,3.248446822462735,3.1911882519990002
FU-OV-1,452548,0.3745426606957432,0.17942634639199298
A2780,24180125,2.723679145549484,2.829339843082641
SNU-61,9911830,2.7749851076050187,2.523074702559492
DMS 273,6918837,-4.776469138555483,-3.7370895916114804
NCI-H460,54454,2.7807551042334935,2.6828087272530095
SNU-61,5978,-3.491631614089224,-1.4476867988895268
G-401,5287620,-2.7219963273379766,-2.241738773082944
ONS-76,9884685,2.079600161824297,0.6484430302945617
NCI-H460,6610216,4.838717363885395,4.260227747235039
CAL-51,51039095,2.1842093640891416,2.8736005162770515
MDA-MB-157,2871966,-0.7905554969861216,0.4474578686163963
G-401,46926350,-4.213486210672068,-4.233453788333104
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,1.7731078559281253
OVISE,10184653,1.818458167845024,1.1806600561713223
A-498,6918328,1.134294475717993,-0.20727704945216988
A-498,10302451,3.720340150939392,3.299694835670182
CAL-51,9935249,3.84795648434564,2.970144709339885
NCI-H292,24856436,1.0729923244387796,0.4384469140095759
A-498,409805,6.12415200666612,4.833367832061949
EFO-27,24889392,4.405449300162506,4.480456805395601
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.606291437495251
NCI-H460,159324,4.0462841352482855,3.117839247397618
LXF 289,16720766,0.4842655504206017,0.6427385311474754
LXF 289,54649381,3.6309892426510406,3.861858976750048
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.9779090282809496
JM-1,71751553,4.311473922741218,4.247635976498217
MDA-MB-157,2945648,2.730573332542116,2.9276004012471595
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.1306801556640815
SNU-449,67156097,3.7845495552330024,-0.7336157098907704
NCI-H2171,24951314,0.4758147687646419,1.2005877375382885
A2780,24180719,2.9021439553303026,3.3910985871285817
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.474973561320706
A2780,54454,-0.2144211598876236,2.697560820787845
A4/Fukuda,16659841,2.2699989015311437,3.1580776977618914
Panc 04.03,44137675,4.02019355498934,3.524573886084117
HCC1143,25150857,2.69660437037969,2.435811406350015
BT-549,104842,-3.414515083122074,-2.699149786810838
NCI-H146,11960529,3.5646000180725146,3.762601561921622
MDA-MB-157,11238147,1.748896698587814,2.5872985502550536
SCC-9,72376,-1.0275629780171365,-1.792123233115918
MSTO-211H,57330099,2.804758704858228,3.8340635087547787
MSTO-211H,135999136,4.2061059176098645,3.4709027111781334
LOU-NH91,46907787,1.567116016960845,1.9677802031942733
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.6020172807211822
NCI-H2009,71466445,2.5164920571758036,3.854824502608979
OPM-2,54618771,0.7318105179081044,0.566869602035117
A-673,1716436,1.8403672814357532,2.6978786449459453
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.8255750225165366
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,3.6604907549945964
FU-OV-1,327653,2.5930307991109784,3.1147485860780826
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.0711638250914428
NCI-H522,56973724,3.7409361942384183,3.0949673882964697
NCI-H146,25262965,-1.0264838155868825,-1.659823944459315
CAL-51,2749,1.4482754145936665,1.9643408588992082
MSTO-211H,4477,1.290064962685197,0.42861680773392835
NCI-H292,637858,2.5198155256882813,1.9917614364965075
DMS 273,3136844,4.133948633698644,3.933503991229644
HCC1143,654092,-0.1725481204081408,-0.2069309925122273
NCI-H727,72734382,4.575159301501077,4.356057154597928
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.732483428847391
NCI-H522,6918837,-4.666914399076351,-3.332375401987525
HSC-4,11228183,2.0585180361700313,2.249293129493924
NCI-H1623,107970,2.966658693868389,2.23494088908693
A4/Fukuda,5278396,2.678829799859676,3.472550510806837
SNU-61,25062766,2.174077685737065,2.105085025369638
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.1398853341606532
ONS-76,5460769,1.8809234095271896,2.642784809936635
BxPC-3,448949,1.967823553768285,2.093565318968048
FTC-133,42642645,4.559192948180462,1.0093957165710368
MDA-MB-453,4705,2.8938913201458583,2.978131100284731
NCI-H727,54454,4.237398664855094,2.5780889479596003
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.2887570382320566
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.0717745837076371
NOMO-1,19582717,2.563142509513499,3.1266788203351483
A2780,445643,3.2119323974162786,3.9961669980856884
MDA-MB-453,6918837,-5.413037386455184,-3.0199740458494313
BT-549,72193861,1.0619418160757952,1.6416429073664194
HSC-4,44607530,1.7156299328297433,1.5346421743865728
A-673,11455910,-0.0977898825280259,0.8955234126036876
SCC-9,262093,3.396257832039873,2.7883087704162532
JM-1,148198,-6.864264453079388,-3.873200090647885
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,0.3812878445874038
CAL-51,8515,3.5852991976047863,3.696830933034592
NCI-H292,49793307,-2.523289852336332,-2.776758249658119
NCI-H1623,2708,5.67986318014104,4.7941415041158635
SCC-9,3025944,4.376039606027409,4.180987430089239
LXF 289,24772860,-1.828128181459349,-2.0850869223091535
NCI-H1623,5287969,-1.6741359655835943,-1.8663529384334858
A-673,54454,2.1191092291244877,2.7935343994404294
HCC1143,10302451,1.8641137803790455,3.2416196262547645
NCI-H292,54649381,3.811841265663476,3.9406565479936773
FU-OV-1,44607530,1.1358438423183184,1.3560687411220462
OPM-2,5702613,2.283159730657738,2.5287708297850697
LOU-NH91,11612883,2.793800542696417,2.595311273631026
DMS 273,11214940,1.0513565801549722,1.6829808054463335
FU-OV-1,65064,4.9743661807936235,4.717318746536817
A4/Fukuda,23635314,-5.004930640559638,-2.635260936795061
NCI-H146,44137675,3.928890295501361,3.4719521000529907
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.463538451719218
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.6894573903655332
SCC-9,25105715,3.642638215460893,3.4502924087778895
HCC1143,219104,3.69834662828724,3.6254734948315726
CAL-51,46215462,0.9657515518660452,1.861247998359216
FU-OV-1,9936388,1.7648084748519457,-0.9506572711286307
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,3.9878493673115827
A2780,65628,0.1843862993724733,4.172021894984401
SNU-81,11647372,-4.046967337474091,0.8663651561548203
NCI-H460,44589607,4.73035444754351,2.8702141504105145
SNU-449,9549297,4.8793656902716345,2.3750810914282683
SCC-9,11625818,5.698343618019975,4.391969251594624
LOU-NH91,54619267,4.2625648850210665,4.1207567021698335
SNU-81,676352,1.7899908822518449,1.8352899527602968
CA46,4096211,0.9281979530192106,1.4910249890897516
FTC-133,6918638,0.7173410835371117,0.32756982490331354
A-673,10074640,2.0498537136670696,3.1452583151075237
FTC-133,9907093,5.562055210260789,3.9971898916004225
HSC-4,24775005,4.677905847548428,3.818625845695517
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.6502418699583163
CAL-51,11964036,0.7531640395115359,1.2447746276758505
NCI-H146,16736978,0.7510083752799234,1.7474168769445588
YAPC,15547703,3.1542356669454055,3.2485589260625676
NCI-H1623,25195348,2.589072393428722,3.225458555622775
JM-1,5311281,0.5908340552261697,1.987644998083931
SNU-61,9840324,5.730394861191507,5.869405164261849
CAL-51,322968,3.332930006684798,3.476788969669555
BxPC-3,613753,3.1887459622848935,3.2815542986112285
A4/Fukuda,9887053,3.945623871756388,3.2469149839163793
ONS-76,119607,5.207716304164231,5.191720107878081
G-401,11955716,-2.313708507563708,-1.3807520273756657
EFO-27,9840324,6.098788849131883,5.697036642702324
Panc 04.03,219104,4.644038290885272,3.7926361468786194
HCC1143,25262965,-0.487374364701845,-1.3463680029537877
EFO-27,25227462,1.7048102531951876,0.7501550301507943
HSC-4,10074640,3.187745953835862,3.098962033473315
SNU-449,5287969,-1.7501228923890362,-1.9307334988105893
BT-549,49836020,-1.94641857460656,3.013705913577566
BT-549,36462,2.0708174288882075,2.180180819692009
SNU-449,135421197,1.7191553190938056,1.9812254687435777
EFO-27,49867926,4.359647239344765,4.249809914725291
NCI-H727,568763,0.1873556014231215,0.5964081655047988
SCC-9,5287620,-3.0509576220001953,-2.3315956488482654
SNU-449,3543504,4.913571994290616,4.528499253799989
BxPC-3,12001922,2.0478076671218317,1.9132540753756526
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.2371316301349577
NCI-H661,54618164,4.023349318575714,4.000929056623681
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.599338752498707
OPM-2,5287620,-2.918074250075414,-2.372993879518168
SBC-5,71304818,1.011143162310159,2.2994389679261373
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.3310770128311185
CAL-51,216468,1.370586512271769,2.5609851318371915
MDA-MB-157,25150857,3.068531629493821,2.3545329985949435
ONS-76,10074640,3.173150149140259,3.239207425033168
NCI-H2009,5470400,0.3791383114910072,-0.622036181798518
CAL-51,54619267,4.1828818787298765,4.184997682774002
A4/Fukuda,5738263,2.3624425097256676,2.987277934182846
SCC-9,1239801,5.7667211168431205,3.9893203803329276
CA46,11152667,-1.1506421067609531,-1.4536834462565236
LXF 289,9444,4.020808033871241,4.013757320690193
Panc 04.03,25062766,2.3535958479396166,2.1961448079356933
MDA-MB-157,71466445,-0.8161407888171323,3.912198165795347
NCI-H661,10302451,1.6315200392387812,3.0416144516870536
NCI-H522,10385095,0.7404415633977295,1.2173555030927943
LoVo,53495165,-1.2075385636979648,-0.4133323396395555
NCI-H1623,613753,3.253043904005535,3.215602423259469
SNU-81,49836020,-3.195484765979539,3.181783671354013
A-673,73707371,5.345141037142936,4.850016518848276
JM-1,71466380,3.0146886034862885,4.0832907527568
MDA-MB-453,135659046,3.699316020945489,3.657957959616776
LXF 289,72193861,1.9781400147016948,1.7269298816953358
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.253689867537721
Panc 04.03,46843906,4.199928797005276,3.109627830658283
NCI-H460,16725315,5.407057101640495,4.390245983707344
SNU-61,375860,-0.3575080218905608,-0.16024297169826518
SNU-61,216345,4.373705885149758,3.6370359678954056
CAL-51,25154868,4.656760297450745,4.37869119849742
NCI-H146,10172275,4.247153556222009,3.6184757438803694
SBC-5,122327,4.539216274618647,4.321922170769916
A4/Fukuda,24785538,-4.18833617701787,1.1749914210368977
NCI-H727,54618305,5.896457883643312,4.337450373790594
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.6613419884372254
NCI-H727,6918736,5.488213607701973,-1.5301403638181723
NCI-H522,168313200,1.7984937800694238,3.0583097605863383
OVISE,11396600,4.241731433198166,3.9554379054006263
ONS-76,25154868,3.0856348617246048,4.350653490589006
LXF 289,135398516,1.6034740470130215,2.2013012054416543
G-401,9967941,2.755238424074781,3.2862303842719234
NCI-H2171,44493528,3.677120674941258,4.255467231291288
DMS 273,135398516,0.9081791710880508,1.9848017097354305
CAL-51,219104,3.260140555917495,3.746992945538449
SNU-449,9927531,4.924705078398161,4.549680812915984
A4/Fukuda,9840324,5.782088483619631,5.755420586523985
DMS 273,11404337,-1.7233190830375906,-0.2634467758800365
MDA-MB-157,24964624,3.531877357122639,2.680381408581053
CAL-51,44486219,4.943814728636009,4.3063893277550065
LOU-NH91,216345,4.715464564049095,3.9857148857970084
LXF 289,124202324,2.1762748500922657,2.4472191284085465
HSC-4,23582824,-0.585849233367442,0.6377062351808928
LXF 289,25126798,3.2757893610597923,3.8605207200934863
SBC-5,4788,5.245695847909484,5.424845198515419
ONS-76,24856436,1.9295271968291927,0.27097165372419557
SNU-61,24753719,3.71513491278392,4.229177458007529
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.0613393629019283
LXF 289,54618305,4.64176895308047,4.2650575334173535
CAL-51,9926054,2.2227862000004577,1.9035263931942095
DMS 273,11427553,3.72076353850383,2.5855138017890558
NCI-H460,25126798,4.092385726400508,3.8402354541754367
SNU-81,1716436,3.163180638308135,2.9210162083870745
SW1463,426756,2.2352578961733967,4.112700343067995
NCI-H1623,6918638,-0.0742651507067239,0.6041337365585945
NCI-H522,46191454,1.7170402718959707,1.4441011013352694
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.027757455325862
MSTO-211H,49766530,-4.866552298919663,-0.9787639182663834
NCI-H2171,11228183,-0.0614644470988351,1.9220538769423634
HCC1143,5311281,1.3434544130633397,2.351689026904919
ONS-76,10410894,3.505250871213463,2.948760187454848
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.3037746065748528
SCC-9,46398810,2.8303032541075455,2.555950049218345
OVISE,5351362,2.5456705040985708,1.5869785787668953
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.6936942892335545
NCI-H522,5287969,-0.7039868347543177,-1.6254969142272047
KYSE-70,9840324,6.215387239369238,5.834278925075617
G-401,2708,4.061322582720861,4.477808480664853
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.85723445935399
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,1.641009276372025
A2780,9868037,1.6123332444026346,2.8785570191039977
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.1871979698094823
NCI-H292,2708,4.789540620747355,4.8969272035503515
HSC-4,11238147,3.6589845000918504,2.7106924058190742
NCI-H2009,168313047,3.1000323585702083,2.573860255660437
OVISE,3689413,-2.3316050545360136,-0.031115060468032
NCI-H522,71751553,5.137300136027492,4.623113468614574
NCI-H661,9444,4.500292949687679,4.061661253358207
BxPC-3,54649381,3.6406106092590007,3.8704195218854327
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,3.317819366172265
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.5927399937394442
KMRC-1,10427712,4.418169957842134,4.418653607667689
FTC-133,9935249,4.194644265855045,2.8954781723745584
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.5256894097462599
SBC-5,5280436,3.662085558148715,3.137838538910899
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.362891790909308
BT-549,462382,0.0307570083617302,0.6335596546873704
Panc 04.03,445091,5.978315194185719,4.495304724838899
A4/Fukuda,3011155,4.269088750580724,3.224634748418416
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,3.14023469977089
A-673,57519531,1.198988142705803,2.0377456227218658
SNU-61,3025944,3.777150750907422,4.148822131472469
CAL-51,11497983,2.6322425573174213,3.473191420885503
JM-1,12001922,1.1772658700026328,1.5918991705900345
A4/Fukuda,375860,-1.1918610484687095,-0.43233753451820284
LXF 289,5978,0.6093029371771528,-1.7714132227873016
FTC-133,5329102,4.217502606235289,2.0180726448868604
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.2108108016263954
OPM-2,10296883,2.7550650350156474,3.3430847399466033
FU-OV-1,4259181,1.2776952629591818,0.19896332732326744
BxPC-3,100016,6.453363473458683,6.146421587669265
YAPC,168313047,2.3481335437424957,2.2123905669503428
NCI-H460,10184653,3.574651577310896,1.0673677049848966
OPM-2,3062316,1.3077504545650411,0.9942133586960282
NCI-H460,9956119,4.485375019847723,3.6310131932478127
ONS-76,3815108,3.0019527232257555,2.903010589303094
NCI-H2009,6918878,-0.4863456687538305,2.6936537942713845
NCI-H727,10302451,3.178772538514987,3.2238071134495927
NCI-H727,2945648,2.622160220955332,2.8843430658448024
SCC-9,71751553,4.89059631642312,4.566040131133533
SBC-5,36462,0.3494520767872783,1.7034850594687936
G-401,4477,0.236688812816839,0.4254292043932255
DMS 273,9926054,1.8030373867492464,1.9191122875034066
MSTO-211H,2828334,5.714930690846282,6.1747740848783295
A2780,24797083,0.8113195258872324,1.4058402599390236
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,0.8460246788137618
FTC-133,44486219,4.933137185021197,4.19917819389331
CAL-51,6918736,-2.0480142356294637,-1.9614073444790796
NCI-H522,72193861,-0.7243330419144597,1.2681797748650099
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,1.0577599263611182
ONS-76,25102847,3.483061373005376,2.6397060341570313
NCI-H727,168313016,5.705554517808247,4.783859668296099
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,1.7972791992038577
OPM-2,25161177,3.2493247866394497,3.6891792738461366
NCI-H292,374536,1.098561227965989,2.246684905602227
NCI-H522,54618771,1.252244709003548,1.301304848943669
KYSE-70,44486219,3.9722791166403657,4.231627259184654
FU-OV-1,72193861,4.196952295232924,1.5728651454351121
CA46,56973724,2.349278499068081,2.028217093078898
A4/Fukuda,2729026,2.569130626356953,2.3918892161347376
YAPC,148198,-3.117185181322903,-3.5493964030133425
A-673,24753719,3.397650756866718,4.104150011293181
NCI-H1623,16659841,4.138965758514941,3.8390465183798055
NCI-H727,637858,2.2360670355510086,1.8734892957607536
NOMO-1,31703,-1.8429032714500968,-2.5052096914747857
LoVo,65628,4.171555925906434,4.408204494469356
EFO-27,322968,2.5694057659070264,3.9442018620162322
NCI-H2009,216345,4.438201480917741,4.010022975764908
BT-549,5282054,2.5925054001589976,3.620499897341599
FTC-133,6918837,-2.2077574090678307,-2.9922401389114106
DMS 273,54626689,4.997985813086497,4.566276806278833
HSC-4,16741245,1.7716610997683242,3.656708604424026
SNU-61,6438330,3.4216884605560085,2.1933671273046507
FTC-133,9936388,3.0046059879710363,-1.777427382541295
OVISE,3815108,2.0996140723315913,3.0163777080701317
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.3989448631655736
NCI-H292,5281321,-0.9498489394799606,-1.5424264191338886
BxPC-3,25126798,3.172026591671247,3.844986022713566
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.167115274720395
BxPC-3,11213558,1.5061777503093252,2.0382944799841543
BT-549,3503,1.5652779265398058,2.2564611960088903
FU-OV-1,1716436,3.524722071533676,3.0736655489337803
MSTO-211H,15547703,3.049193057044517,3.1409616931237654
KMRC-1,11427553,3.2258060185151343,2.8801582849887994
NCI-H292,46191454,0.9903655583180804,1.6047681122787614
CAL-51,135928012,4.192641653546412,4.25268054403448
NCI-H2009,44202524,1.444691297679544,1.965475310173815
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,2.5568852161430957
SCC-9,2858523,3.190510944053216,3.0157865992708826
BxPC-3,15953870,2.831569416015373,3.5421631828801488
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.9864460350850393
SNU-449,135398516,1.5851782119809552,2.1951282245973625
SNU-81,9843750,-0.6437789188002867,4.041306231627836
SNU-449,11427553,2.8197595076352564,2.762119676500966
OPM-2,11656518,2.629079922396914,0.9757609969692232
BT-549,135398516,2.1186047788766085,2.1058456940345454
OPM-2,176870,3.9257377377060383,2.770484500188834
OPM-2,46926350,-5.934740852723627,-4.339196817895882
HSC-4,2729026,2.4603123985812276,2.842352964844468
KYSE-70,9444,4.1582482593031145,4.031063365590513
FTC-133,9933475,4.176811369298493,1.7046043532545991
MDA-MB-157,51037431,2.1321019948022046,3.075190030227528
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.3490172224829653
FTC-133,44493528,6.31419839504633,4.430790771490935
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.7086135522468069
KMRC-1,11507802,3.5140789318254426,1.492394773723274
KMRC-1,25183872,-1.331773303463366,-0.7292366804384172
OPM-2,16219061,1.6139038412518538,2.5409045913994897
LoVo,25183872,-1.0423877479811554,-0.8727070715190312
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.9807020786908969
FU-OV-1,6623618,4.441105176868704,2.368031827119263
DMS 273,4259181,0.4383145170351891,-0.06457867434026632
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-3.5275931453954628
KMRC-1,89183176,5.996613867274686,4.38932350055526
MDA-MB-453,9825149,2.3540085594050204,2.33939127007827
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,1.819896944619855
G-401,4788,4.978954455161412,5.456098575155127
MDA-MB-453,52947716,-7.0217551266009375,-0.5311395801815497
SBC-5,6918328,-0.0891350348900322,-0.14590146807778742
HCC1143,49836020,2.702530837822698,3.351051428746873
MDA-MB-453,9956119,4.182542041452956,3.5743214537333783
A-673,136227924,1.815433973878695,2.916976939580686
HCC1143,9956119,3.9159046092458785,3.625399540684841
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.8792439479291434
BxPC-3,11234052,5.706263551465742,3.807268054422114
NCI-H727,44259,1.5490626006331412,0.8412831091083003
SNU-449,24964624,2.993830455857875,2.46461713985916
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,0.5792396775636374
LXF 289,3025944,3.4981276099044134,4.277673269080763
A-498,24964624,2.395732501339878,2.4883062215969245
DMS 273,4096211,1.7794100041919845,1.8703697589983137
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.3784745775888145
SCC-9,16722836,2.261290441734353,1.6500702649848469
LOU-NH91,452548,2.191181432305291,0.04130895691711427
KYSE-70,2828334,5.886367586734188,6.092331169460096
EFO-27,6450551,4.042476340029328,2.876077008938909
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,2.8875253318548557
SCC-9,1716436,3.7585685406918783,2.9254318492050646
NCI-H2009,409805,3.859994247591149,5.111381144127289
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-1.630079887627733
SCC-9,54618164,4.4493976732458576,4.056984684596993
OVISE,5470400,-1.924229347102114,-0.03591333890631603
EFO-27,44607531,1.7985046151445,1.5173771919193022
KYSE-70,439501,-1.7979650249976522,-2.2278943911133604
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,1.1353635623302114
NCI-H460,11175137,3.7005840280640374,2.66931900580329
ONS-76,71680916,4.956248935312428,4.685952374913189
NCI-H1623,10410894,1.736668634267143,3.232340598821555
KMRC-1,6918736,4.048742051120841,-2.032933189066137
CA46,25161177,3.91788686206549,3.758804216364869
MDA-MB-157,6852167,3.8998726158787007,2.928384869117607
HSC-4,11364421,-0.0916399418549534,-2.2013407804392076
CAL-51,2746,3.539110169106334,2.8606170112405547
SNU-449,24748573,1.9316038598597545,2.2998637731285605
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.7239737324812419
KMRC-1,9926054,1.768451409600443,1.836683855231836
SNU-61,4917,3.0491510397841015,2.985014244474828
FU-OV-1,5335621,4.183078950789895,4.400555726297898
LXF 289,44607531,1.6515112206427849,1.4750237315509083
A-673,11640390,1.6795118149646189,3.316142618846763
DMS 273,51039095,3.4577395537233526,2.641345912843574
NCI-H460,126941,-2.220790788147435,-2.2110918135161084
NOMO-1,5281672,5.39154363605107,4.351499509464586
SW1463,11214940,-1.9875595606860448,1.8046487430856106
SW1463,72376,-4.419423024557842,-1.9782357371325159
OPM-2,613000,1.2483941007528057,2.2441861742237563
NCI-H292,445091,4.263425815338472,4.356825362298085
MDA-MB-157,46926350,-4.132103643787292,-4.014250216490041
Panc 04.03,10296883,4.422301293811254,3.999244976773262
SCC-9,11964036,1.807051006133268,1.1875381021520581
YAPC,11626560,1.7222365359336271,1.651614403464358
LOU-NH91,375860,-0.2088041582630222,-0.18402692018300593
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.2111753240689902
A2780,374536,0.6453837370733745,1.6638362233731965
LoVo,5351362,1.2957137522113673,1.5241648287143088
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,0.9402363396561887
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-2.0215539332260075
LOU-NH91,322968,3.304915281144932,3.8519628702714908
OPM-2,54596558,4.064764759335406,4.433545972171932
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.516558132819251
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,1.6569713344018573
MSTO-211H,44137675,1.9879298255329003,3.4335126721182325
NCI-H2171,42642645,-0.8345775302937554,0.7426544363815262
A-673,5287969,-3.109107778120567,-2.029442365973126
HSC-4,5566,3.1631957469062684,3.049701603858225
NCI-H146,5284616,1.616711114994892,2.3548179128757294
FTC-133,10184653,4.443025626482117,0.9481229969164664
BT-549,241158,3.5488750117076484,3.9482580824836884
CA46,25195348,1.4184238486273535,2.642913444836296
BxPC-3,11497983,5.307904838671978,3.378164384167405
MSTO-211H,4096211,1.4030307395810702,2.1810267856528314
CA46,11175137,1.918070959510412,2.12385965841486
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.582347052563952
NCI-H1623,5566,3.3003894636357565,2.994319192906882
SNU-449,25262965,-2.560427276701697,-1.4551201266184335
FU-OV-1,16038120,1.1817724128349547,0.9064922272194399
NCI-H460,6438330,3.783082395235063,2.304540205780148
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,1.51873399388998
LOU-NH91,12003241,-1.4006618643370652,-1.2003382502373583
NCI-H2009,89928392,1.462956527326012,1.643150872393845
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.3396010118858188
NCI-H661,53495165,0.322884771008066,-0.18318871337690446
FTC-133,16659841,4.779782303247626,3.8966324742477583
FU-OV-1,176870,2.993075468358777,3.650825966090888
MDA-MB-157,24771867,-2.9284017086321197,2.573079483154154
MSTO-211H,5328940,-0.7344582610548551,1.6773066568187656
A-498,25126798,4.108305960475203,3.8636955319068047
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,1.8296166590272833
HSC-4,5460769,1.9290612526481368,2.4653759891615743
JM-1,9826308,-1.254578223347674,0.3173651329371055
ONS-76,124202324,3.376244033970937,2.4110387012113756
YAPC,135984461,4.395865755985396,3.632435777475982
DMS 273,5746,-0.0149388723107023,0.7774660913500597
FU-OV-1,4917,3.642085139957623,3.0829597259600474
LXF 289,49793307,-1.960491877422628,-2.6632990591678776
OVISE,107970,3.0608588072726444,2.34277659897402
BxPC-3,446155,2.3080345350315015,2.7382607616289794
OPM-2,65064,2.528451354351822,4.283614034566257
SNU-81,5278396,1.9031243607798085,3.3652622075149212
NOMO-1,5351362,2.08054014163225,1.2506626669903944
A4/Fukuda,675434,3.712142385749843,4.295603727259029
ONS-76,44241473,4.684511997660941,4.944735884637036
NCI-H292,54619267,4.1033140795833445,4.097621136868951
NOMO-1,5470400,0.2862684612003833,0.10872871827874615
LXF 289,1716436,2.59582131383783,3.035440738992516
OPM-2,71680916,3.9051822114426025,4.2486801717274645
YAPC,72193861,3.178335780336401,1.7708907850449058
HSC-4,148198,-2.795908666323494,-3.454339028014255
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,1.9472513811585024
A-673,25161177,3.4603475867806788,4.104524608092107
NCI-H522,9866186,0.2313673592680447,0.8648024391296757
CAL-51,24772860,-2.425084956958233,-2.3200663024487636
KYSE-70,72734382,4.428008981499565,4.039325419967124
EFO-27,44491742,4.311239061696844,4.2375326120694465
CAL-51,322968,3.332930006684798,3.476788969669555
OPM-2,68056272,3.036834126647856,3.1741317008957926
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,2.2027323338344305
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,2.936341785151028
LoVo,11485656,1.8604760547282393,2.010201637632175
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.2352203452128707
CAL-51,10074640,3.192334769578339,3.078522769467903
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,1.2799141410214945
SNU-61,452548,0.6134547199912214,0.3378573484742143
MDA-MB-453,5311,-0.5257883568365231,1.4066846101605532
HCC1143,23582824,-0.3689859010226292,0.8629339609590548
SBC-5,7251185,3.120445126947185,2.338578292159761
NCI-H292,24901704,3.391496569820259,3.3795843599059485
NCI-H522,10410894,2.9293088965189553,3.1641174336271933
SNU-61,23582824,2.5643180100002225,0.7892901317910547
HCC1143,16065773,2.712611567173667,2.3995860889272573
MSTO-211H,46191454,1.2859626841233986,1.4871153035055218
DMS 273,72199292,5.337691921623293,0.966044892955126
LOU-NH91,46398810,3.045211454343731,2.609411071702541
HSC-4,135928012,4.241462346184107,4.171513669466225
NCI-H727,3384730,3.6794289647639737,2.8595717458515044
SNU-61,4788,5.909414847709577,5.743881543911116
A2780,5329102,1.3737092942346336,1.8716969155573546
MDA-MB-453,444795,4.759998515464953,4.545812401932979
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,3.7529860619522126
BxPC-3,11507802,0.9945684314547258,1.641872824938112
Panc 04.03,24889392,4.270107644861146,4.212316101337759
MSTO-211H,46215462,0.9168806818627014,1.8366337519495746
MDA-MB-453,11167602,2.244240898320102,2.2807423696833027
A2780,400769,-2.1774855243121425,-0.5416922630313128
ONS-76,52912189,4.881284158574923,1.6689480954310525
BxPC-3,44137675,2.990010873447489,3.6361827930405326
HCC1143,753704,4.831564496260181,4.974651573830755
SNU-61,9915743,-0.5579526190142376,0.4630798741187062
OVISE,1242560,3.5076159129293956,3.532670244874503
CAL-51,6914657,-5.067352950634086,-4.277770134215219
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,2.757684480933414
NCI-H292,9907093,4.58058164849987,4.232124632582594
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,1.2540676500438175
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.1066605599290573
EFO-27,6852167,4.289895730200754,2.720106143050103
A4/Fukuda,148124,-6.6912736941139865,-3.416914778467005
MSTO-211H,24785538,0.8010437121318222,1.6361107473390177
NCI-H661,49850262,3.557667726590132,3.4852997133194963
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,1.8609378928492775
EFO-27,4521392,4.521895501485345,4.230698163976938
A-673,65628,3.827084992759042,4.01367161739694
SCC-9,11427553,3.060791645335887,2.7211805598362706
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.290749135720006
NCI-H661,36462,2.012090600363037,1.6823234589389113
CAL-51,11625818,4.1129054868405905,4.374876013711795
SNU-449,252682,6.455952915446744,6.614463430514291
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.0915018847299724
HSC-4,2828334,6.111197262680893,6.145721564222083
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.1631431493222637
A-673,753704,3.1138845387287657,4.773070758536358
NCI-H292,409805,3.708436738901026,4.575122939115594
NCI-H2009,72376,-1.9106633783650309,-1.2408149149702612
OPM-2,24753719,4.370940438199297,3.888144410600915
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,2.8987009324151103
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.1641778928051894
LoVo,9915743,-0.8819018227786422,0.8399265412835761
BT-549,4788,5.920199401047736,5.764127599506175
CAL-51,2858523,3.1959449804225524,3.1451100270472834
OVISE,2742550,5.280611289386831,3.8879302398767845
HSC-4,5470400,-1.775367561967962,0.13874088752181218
FTC-133,3503,1.9089172693495084,2.0941059896291323
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.824434318939933
MDA-MB-453,4578,4.4862028800041545,4.350868701364359
EFO-27,16038120,2.346094356536249,1.3364255041039614
SNU-61,66577038,2.989851386241242,2.997344505031995
CAL-51,4259181,-0.5132501801478601,0.16406076746560483
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,1.2949712453300608
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.6687580222573115
SNU-449,3552672,3.5064135830435563,3.038952145125748
SNU-61,44589607,2.748444545219875,2.859096569970632
ONS-76,2945648,2.901632251679741,2.8910259364342608
ONS-76,44607531,1.762572438348297,1.6916598257734017
DMS 273,2874250,4.3291006423311025,4.604997544539778
SNU-449,9840324,5.822936489993131,5.754770596147857
NCI-H460,6610355,4.949206869720499,4.423694609604406
HSC-4,11612883,3.5946567658341197,2.416815281897197
NCI-H522,11175137,2.853962760117135,2.5521136962956485
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,2.7411956268892586
A-498,5281321,-0.4472251536664238,-1.3515504021615001
OVISE,25154868,4.508600245054991,4.174298058597288
Panc 04.03,44185566,3.115745823738928,2.475841707620526
SNU-61,49793307,-2.3504304765085573,-2.6507268349092072
CA46,44607530,1.320133740199814,1.3528786713528091
SCC-9,10385095,1.4052834583911455,1.2739228184721592
HSC-4,675434,4.235689784331333,4.522680292677834
NCI-H522,16725315,3.2253372097194752,3.928946269027603
FU-OV-1,1750826,-4.024957616345245,-0.9260612768363187
HSC-4,57519531,1.2769425534379089,2.4995344456321273
NCI-H292,9868037,4.01216306257403,3.0925063096537473
G-401,52947716,-7.497954818853376,-0.7961580943426911
EFO-27,5280436,2.3763113561475997,3.5009937523381507
SNU-449,11625818,4.573588862325648,4.434687366829529
CAL-51,135999136,4.2132345103647015,3.388333527795469
NCI-H146,19582717,2.457603508665216,3.841854331561732
HCC1143,1716436,2.8430583337953284,3.071377027307737
DMS 273,9911463,3.7655644930376257,3.7507123864163545
NCI-H460,54649381,4.173104904963283,3.976213211240164
NCI-H727,6918837,-1.02939028052569,-2.333648542619538
BxPC-3,6852167,2.5268139587107754,3.015846211750142
MSTO-211H,168312962,-1.9489367550084584,1.6576366843384642
CA46,17755052,1.7120394846678155,1.2189907984110437
ONS-76,3676137,5.654292431942107,4.502374333145189
A2780,11175137,0.1901581111291173,2.420723286848131
NCI-H727,10427712,4.338841626329874,4.250314217719042
LoVo,241158,4.012317425862525,3.725758584243307
Panc 04.03,3062316,3.5966054915380647,1.3707114664245632
SNU-81,54454,2.7601348658589,2.5406706720121774
SBC-5,3136844,4.085952663076754,4.054410714937041
BxPC-3,4261,1.8613797726144792,1.5714669106963648
YAPC,11364421,2.3126725462898508,-1.7895340140206633
NCI-H727,387447,-3.6268426938273457,-3.4425623525994973
A-673,11955716,-2.8120675934907107,-1.6599966121515042
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,2.5149734476484555
FU-OV-1,135440466,0.9480137026796296,2.359242045755075
NCI-H146,25150857,0.3973439930915976,2.1246613718473397
SNU-449,46926350,-1.1609870247475182,-4.0487036427048055
MSTO-211H,9840324,5.369584805162093,5.704184088761207
G-401,5460769,-1.872739736028161,2.007679624851504
CAL-51,568763,0.0917223714484538,0.39873040018666883
MDA-MB-453,5951923,4.303369563038856,4.326115163913083
KYSE-70,66577038,3.0162273972396005,2.857158106807164
LOU-NH91,16722836,1.148829534310261,1.4892775888528111
FU-OV-1,613753,3.071481920375854,3.130715441178681
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-1.413182232835862
CA46,49766530,-5.499020578204802,-1.505473463723675
SNU-61,11175137,3.4257878627613505,2.3005615778993063
HSC-4,969516,2.6364274978390703,2.810401112788162
A2780,10074640,2.580771204793581,3.075418603904175
EFO-27,10410894,3.5790791622635907,3.4206730301040422
SNU-81,8515,4.116210915577815,3.3926533440201228
KMRC-1,322968,4.639571189041566,3.8598961716565947
EFO-27,54626689,4.866384531477491,4.624951926561744
LOU-NH91,9911830,2.650870613913377,2.4699366219273644
OPM-2,135659046,2.7260896342727396,3.3528090477975523
OPM-2,6917907,-6.048813777211379,-5.7412068336285085
SCC-9,151289,2.789872420286255,0.870595509077225
NCI-H661,4705,2.5155315968978127,3.2202737586894044
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.3925112935351165
LOU-NH91,25154868,5.6992218929630205,4.447759822486225
NCI-H522,54619267,4.072629967998864,3.9708990569751466
BT-549,11222830,1.721965279957128,1.599855037089821
NCI-H146,53301938,3.7804038583893504,2.863969310730998
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,1.6906086490521743
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,2.331704914668527
MDA-MB-453,7326481,2.376694251985227,3.042009944458461
HSC-4,6914657,-3.070952064512468,-4.338627498261771
MDA-MB-453,72376,-2.4391350280385033,-2.117668050240911
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.0572805482062508
CA46,2130404,5.640885888744477,2.9657782677372193
G-401,216345,1.83916726924219,3.527718447907956
LXF 289,54143018,0.7636513295056184,0.4189253371538918
MDA-MB-453,246676,1.942789144720036,4.33166530374837
A-498,19582717,5.689025629434131,4.146320894692269
MSTO-211H,11964036,1.836732040985672,1.4074722710235323
A-673,3552672,1.3462933778606576,2.709443120789947
CAL-51,11152667,-1.203722258692511,-0.7307913141570788
CAL-51,67156097,-2.385254348530768,-0.7525142363232853
CAL-51,65064,3.306239750209062,4.771836972031958
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.724074551035451
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-1.2012352262053978
MDA-MB-157,6917907,-6.62909111977728,-5.255805292337618
HSC-4,64971,1.7199562834608897,2.755050711363668
NCI-H460,135440466,3.295247648571462,2.290800690682755
MSTO-211H,57519531,1.3086690033484818,2.600760181111956
G-401,9926054,1.744192331951833,1.961906310127289
OPM-2,24821094,1.5161257655930716,2.5908571506013023
NCI-H727,1641662,3.969866081416476,3.6452359371365857
YAPC,66577038,3.3954554117120224,3.0966460441960133
A4/Fukuda,36462,-0.7730347482869518,1.256290462801942
DMS 273,135440466,3.3485559592244214,2.0970032839126427
FTC-133,445455,5.178470647326205,4.3539400926274165
Panc 04.03,72376,-2.048199615123948,-1.9528787894205473
CAL-51,10302451,1.350542324147247,3.077806750412315
JM-1,11214940,0.7147440273172748,1.1461171705637063
A-498,25183872,-0.6220750954527926,-1.0840965629292318
OVISE,44607531,3.0758971794813093,1.3350212103552364
A-673,53392493,1.8369213613876785,2.3564801126047517
LoVo,11719255,3.552916809155198,3.0830751558235976
SNU-61,439501,-1.3808373898758073,-2.3145391710678904
NCI-H460,104842,-2.7771726159534773,-2.3609242024613697
CAL-51,11364421,-3.809863778172731,-2.5495304483805357
BxPC-3,71466578,5.509660254732227,4.459716697826239
NCI-H522,12001922,1.5621076115514363,1.800123443862678
KMRC-1,11626560,2.283484204530191,1.9196308987168123
MDA-MB-453,5329102,2.150481946774112,2.131605079244199
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-1.8548280993086015
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.6291494136108199
ONS-76,16720766,0.8880370259188662,0.6438311172118754
EFO-27,56949517,4.565823410262603,4.2949926586844525
DMS 273,11222830,1.4389641717758948,1.379792868748668
LoVo,36462,0.97058855741136,1.7882257552615366
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-1.3958275669867166
Panc 04.03,16038120,1.7157321990683845,0.9304590401145824
LOU-NH91,3062316,-1.7568876367320156,1.6143036389132115
A2780,9903786,1.372407357095215,2.6638530658923787
OVISE,49766530,-2.0570642495309004,-0.4969620692405497
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-1.9145574462002282
SNU-61,11427553,3.286064968901604,2.8175792149361523
A-673,72193861,0.2228627716233472,1.1539026613973185
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-1.1558804313493538
NCI-H2009,3815108,3.061482559784255,2.9196285637505865
A-673,2126,5.190382873813306,4.6107649084285525
ONS-76,10302451,3.399700001459874,3.257002890368792
G-401,9825149,1.4427851681991832,1.8331687522140052
NCI-H522,44202524,1.1337498661514331,1.5909354828136697
SNU-61,52947716,-2.831948664567002,-1.0388711914041562
A4/Fukuda,2945648,2.3216808345706035,2.6216635194366216
A-673,25105715,3.2161270828318207,3.3673338277442615
NCI-H522,11178236,-5.864645603629742,-3.5118336466648037
JM-1,216239,1.5816975151035817,2.3808139010092852
CAL-51,9903786,2.1849161121493847,2.794493230770093
SNU-449,9936388,0.4589950900054629,-0.7953963919226362
NCI-H292,9927531,4.942242070848643,4.747496382721158
NCI-H2171,25262965,-0.9052216234257174,-0.918849807815359
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,2.389686370663286
JM-1,24901704,1.786623485766962,2.7014025480810626
SBC-5,656346,0.6270929807498155,0.6593114185466646
KMRC-1,89928392,3.173061856078121,1.5179441774134168
NCI-H292,156414,1.4083938325335852,1.381085142351592
LXF 289,135875424,3.2815298243266553,3.918393394422302
A-673,11494412,0.2373053627626316,1.5275846667678155
A-673,5746,-2.085801833901771,0.20492937208259673
DMS 273,9935249,1.448801275140577,2.715027087545701
FTC-133,11404337,1.1811341910019733,-0.31933490816119425
MDA-MB-453,57519531,4.708696705883037,2.4188050262334553
FU-OV-1,11152667,-0.9879051128837576,-0.14116341090221096
A-673,44493528,4.641329710074662,4.232688262298371
NCI-H460,2828334,6.134119597935603,6.217720514817987
NCI-H2171,16659841,2.989016667138281,3.8182122641346545
FU-OV-1,73707386,2.8924737769549633,3.0073275450927093
FU-OV-1,24901704,3.02942514713799,3.297110997773968
NCI-H727,4259181,-0.7375001764594127,0.034319853938953294
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,2.315042713920261
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.9908549192040805
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.2507070606902232
MDA-MB-453,17755052,-0.3952702915340721,1.9390633383563922
DMS 273,46398810,2.5474695176149527,2.4989272683627073
G-401,5278396,3.0023073980849424,3.3390184661773827
NCI-H661,24821094,2.278259467148376,3.016677929269088
NCI-H146,11364421,-6.559818289293388,-1.569286043134155
JM-1,24797083,0.8026470280931975,1.0955830651409308
NCI-H522,168312962,3.69802370811012,1.7342661217441506
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.6720577318321606
BT-549,16736978,2.673955173636492,1.5139282307585562
A4/Fukuda,46907787,-1.6446005772830188,0.7177690618891464
ONS-76,654092,-0.1261556450149646,-0.4907859705713616
NCI-H661,6610355,4.759868911507443,4.343262724474689
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.4377447947333297
G-401,25154868,3.6071608181606063,4.142464320163098
MDA-MB-453,4788,3.7423511350995255,5.59520878080478
MDA-MB-157,11960529,3.789984251684095,3.9580180418145456
SCC-9,16720766,1.7269628893506093,0.4509148219164573
NOMO-1,753704,4.4431191000277375,4.566173760318207
A4/Fukuda,6450551,1.0528971846899622,2.1653299573045106
YAPC,24964624,2.625771283300636,2.3024424596812323
A2780,82146,3.1377115486631273,3.5707678294935032
MDA-MB-157,1566236,1.4232096904008935,2.153946615471834
LXF 289,25183872,-1.882522005728347,-0.9012427441666258
KMRC-1,24753719,4.192591897270876,4.242968797244668
LoVo,44607530,0.9946707755477716,1.3141136632664314
SBC-5,44632017,0.6241642112624288,1.1330887382671528
SBC-5,23635314,-2.6646956028329223,-2.161393834887538
LXF 289,54619267,4.7435335143288935,4.1082743195369895
BT-549,46199207,3.7007120058669623,3.247617768796638
KYSE-70,6914657,-2.943523310206574,-3.9296145662151325
A2780,89928392,-0.8241966309638568,1.4155202428139686
MDA-MB-453,54618164,4.967166731196573,4.195705033626834
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,2.293122682428458
NCI-H460,4788,5.894567383019075,5.732949844469324
DMS 273,24951314,0.5391494064850418,1.1891436719544752
NCI-H460,1750826,3.3189287492303197,-0.8952507279397814
CAL-51,2749,1.4482754145936665,1.9643408588992082
OPM-2,1566236,0.7571858740606694,1.8330721093613263
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,2.9284641757712473
EFO-27,11626560,3.0674086659258646,1.9517969607091945
BT-549,216345,4.357029009920563,3.86347372002443
KYSE-70,3081361,2.4267899196210982,2.4873240722329117
NCI-H146,156414,1.153076826996135,1.0814475712520286
NCI-H522,135411,0.5669945497970937,0.7901250962703386
BxPC-3,6438330,1.9774707221451924,2.308928240317037
MDA-MB-453,9903786,4.505035222499518,2.7492874329869528
YAPC,5281321,0.2366473375234088,-1.1897186369117678
MDA-MB-157,71304818,1.9463509570918949,2.685836246180876
BxPC-3,56946209,-3.950691768305054,-3.794445992579377
LOU-NH91,6450551,3.4853298595759687,2.8004320076984004
G-401,1242560,3.581659075050411,3.44166725780436
MSTO-211H,3854666,2.1662920246080963,1.9983419790402794
NCI-H522,25062766,2.616535601519866,1.9818359115408435
Panc 04.03,3038522,3.0958365698912154,3.1217216475281657
NCI-H460,25183872,2.110783783288614,-0.4487817570532148
SCC-9,71304818,2.8421374335972653,2.4368376323493397
SCC-9,65064,5.356580923551092,4.9521840322012345
NCI-H727,25183872,0.4102957812787974,-0.702032263602122
NCI-H460,81146,4.483282466350705,4.855747551253176
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.9060985219167488
MDA-MB-453,54765302,2.0573663082868405,4.055801061083531
KYSE-70,10302451,3.1884398798129525,3.305634854772632
LoVo,49793307,-4.412709808216002,-3.4090042683811226
SNU-81,36314,-5.848392982376778,-2.3461863336345465
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.49561975370274586
Panc 04.03,2733526,4.292486036611722,3.757809454259987
CA46,9926054,1.6892727173627182,1.6661592310146958
NCI-H522,2746,2.8917767436803414,2.9357286097621667
LOU-NH91,67156097,-3.1227398262817587,-1.4157590961916273
NCI-H146,5284329,3.6277290639514455,3.234527994305196
KMRC-1,644241,4.9037113640465035,2.133087220134003
A4/Fukuda,60700,-1.3381290141173086,-0.9749798542991935
NOMO-1,24753719,4.496099764979975,3.540224055057946
NOMO-1,9903786,1.612481289648159,2.2784149946264862
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.1691980213625213
JM-1,54618771,-0.5043757930015165,0.484003673510742
G-401,3854666,0.6606077023561356,1.3989054965575276
EFO-27,24978538,3.143555245211511,1.215961031033297
OVISE,322968,2.654176014952692,3.770915854028244
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.5420590515033478
FU-OV-1,637858,1.762395691671764,1.9552877680767033
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8081294170867823
ONS-76,11626560,1.9844806011562912,1.7427052404064551
LoVo,216345,1.1599721320761718,3.4646388599205356
SNU-449,9926054,1.9385314164963827,1.9375405077296324
HCC1143,568763,-0.6390257750571487,0.6037230269702781
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.6210006215925612
NCI-H292,72193870,4.439424680926146,2.4900634827047994
NCI-H522,11228183,3.862798460505377,1.903184377965152
CAL-51,4788,6.061217822513647,5.585386554852011
LoVo,4521392,4.145025799048703,4.243573883359382
HSC-4,11626560,2.5873766751252436,1.8867786852504198
NCI-H460,60750,-0.8382921927225392,-1.762122097056715
JM-1,44137675,3.718094845766921,2.8452284829494854
HSC-4,71304818,1.898043557267106,2.4267414334385378
CAL-51,25150857,2.2346870378683934,2.4189108591116555
CA46,2871966,-1.7971239931694716,0.27698425597586185
DMS 273,54454,3.225049529812471,2.4964145180274873
ONS-76,25183872,-0.170903852827654,-0.8170881093799413
SNU-61,984333,6.216581141210495,0.5812342395573821
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0526301109386422
A2780,71466578,2.665399831677294,3.971211810435625
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-2.5242287316900858
CA46,24797083,-0.1839530161688024,1.1758736203683993
CAL-51,135875424,4.33643967165441,3.7881564518441206
NCI-H2171,3689413,-2.7117222930063867,-0.07240928974326467
A2780,11396600,2.9320615716687564,3.2743792325092484
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,1.80615783628162
G-401,56963564,0.504836775176006,0.35775834991039246
LOU-NH91,44632017,2.871860814691948,1.244607988739086
CA46,11214940,-0.2735426892992921,1.1895073692401763
NOMO-1,67156097,-2.629595584457773,-1.6872451085467843
NOMO-1,26596,-2.074766602044621,-1.4736769998764538
JM-1,50905018,4.16446369685189,4.018803640488937
NCI-H2171,445455,3.811797523558628,4.509999546288692
EFO-27,16736978,1.8793599511128067,1.2413257073882729
JM-1,54678924,1.2599632015511184,1.6165836557115545
NCI-H460,5281321,2.142807178276493,-1.035564962322255
SNU-449,5738263,4.026622535351311,3.519324777086234
SCC-9,216239,3.331867398285969,2.216338281466629
G-401,10410894,3.279247022117546,3.0765917117528945
SNU-61,11222830,1.6415416447740467,1.451664965028252
CA46,2113511,3.5674790523720317,4.953551679198153
NCI-H146,72734382,2.9399655016804114,4.268468928567892
NCI-H522,613753,2.504960527289346,3.2326098826292338
G-401,156414,1.0662464633968871,1.2263547021017431
BxPC-3,5470400,-0.5134005920596514,0.34944614065281465
KMRC-1,1242560,3.860865345198952,3.653182949026587
BT-549,1242560,4.319126066576065,3.3976614963298606
OPM-2,66577038,2.8274271292709536,2.8439646460625925
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,2.9842726430069844
DMS 273,16013152,3.9042510131977353,4.131346872489976
NCI-H522,448949,1.6947060599097594,2.0681377611694947
MDA-MB-157,5566,3.489209385839125,3.0302983616375383
Panc 04.03,53392493,3.71782736184095,2.7109328084897464
BxPC-3,55508,4.124435576281598,3.514540365959887
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.4133308305929777
NCI-H661,4521392,4.344795346058825,4.316434572300182
JM-1,119607,3.9456515069078,4.922285691099016
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.166975289489658
NCI-H460,3385,3.2657114863965573,4.004669438567604
A2780,327653,2.026169684275287,3.0515505070290176
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.1471863098377342
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,1.9057782845248366
JM-1,4261,-0.3533034531676731,0.9524781663873776
HSC-4,135875424,3.4627713632233537,3.7705842995872714
A2780,44491742,3.4077888459991774,4.206043880370493
Panc 04.03,135999136,5.549073334475873,3.6562025977947754
SCC-9,57519531,3.918058558817349,2.2643945150604243
LoVo,3815108,2.2685826541267615,2.7447647476925545
DMS 273,71466445,2.157471967137961,3.7522718917681215
NCI-H661,44241473,4.80522256986357,4.774351747941924
ONS-76,6438330,3.0471678199579206,1.998084889553037
Panc 04.03,2949965,2.626604824548014,3.0392698702831056
OPM-2,676352,1.691725548140899,1.9093978963992304
SNU-449,16722836,2.5551835494173325,1.9022817651617376
A-673,11152667,-2.304412849002376,-0.743916647080038
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,2.637595723736691
G-401,151289,0.7906130786084481,0.8569096603991591
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.7665930698924242
LoVo,25195348,3.880726101323461,2.919254466376492
NCI-H1623,11404337,1.3417738865788873,-0.2642167297064148
BT-549,3062316,0.532185160328145,1.0550899954177146
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-1.2327426972433537
EFO-27,44185566,3.1194970070950276,2.5841719044605354
A4/Fukuda,16725315,3.095723533871789,3.967646553951697
LOU-NH91,3854666,2.9087049696787544,1.9622641287089844
NCI-H460,676352,2.985829219207002,2.172389888849909
MSTO-211H,23725625,2.234746785874409,4.710205368176987
SCC-9,5351362,1.6846115382104403,1.3746646483268188
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.6330810129781359
NCI-H522,241158,3.3210308536521156,3.806468851825341
A-673,10127622,5.418104152685571,3.7503147508289096
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.0255084476335488
G-401,53232,3.5991410971239866,2.758167651783001
OPM-2,5287969,-2.4106191892149185,-2.1094170078863765
SCC-9,637858,3.7694424070181127,1.7676113959660704
NCI-H2171,5282054,2.409902559914623,3.3700381635120893
NCI-H292,1242560,3.487131794973456,3.5977276054195566
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.6553130931968187
CAL-51,3503,3.2899889427654245,2.232833802662641
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,4.051761905684348
Panc 04.03,51039095,3.732934843851844,2.9121736196584624
NOMO-1,5329102,1.5937414073922636,1.3705068715479993
ONS-76,1242560,3.484199229378892,3.692059588692534
G-401,24180719,3.4290114124184568,3.4126954117747323
A-673,11485656,1.6006257465541904,2.2560910183619383
NCI-H460,5278396,3.885794996406102,3.639131174871788
ONS-76,4788,5.851184911612036,5.615710314252012
NCI-H661,11234052,4.193192571907383,3.739714765788254
LoVo,46174525,4.300656487428364,3.8357331271205295
CA46,135875424,2.985562686352135,3.370181863784792
SNU-81,6610355,3.7225360861185592,4.096264929906816
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.4683291652979378
A-673,1566236,1.6605846703776754,2.575886254360045
LXF 289,55283,4.7983814176360715,2.836285325989647
DMS 273,1566236,1.8001113918747356,2.1628872369572636
SCC-9,4477,0.0462068475019735,0.5942699247969064
BxPC-3,439501,-2.27553783948146,-2.216831738520062
G-401,3503,1.5245243202568906,2.052454183068208
SNU-449,5280436,2.098309971831213,3.486852974006575
LOU-NH91,119607,5.561970464467383,5.30624428400809
MSTO-211H,6918328,-0.4462053694736546,0.00016438710636831666
A2780,10231331,0.3686619766312378,1.8309554385994358
SNU-449,44137675,3.6126407514409378,3.7443694775189402
Panc 04.03,9866186,0.4755964236535121,0.9228077534742626
JM-1,40482356,5.622716652052393,3.90089152563543
CAL-51,49766530,0.4609697007955676,-0.9043892609464297
G-401,11960529,4.93979495553103,3.83560771394006
HCC1143,6505803,-0.5233928936461414,-0.5374933812576149
KYSE-70,676352,2.557270596786296,2.134132945374979
A2780,135398516,-0.3122960179418635,2.225349760079344
NCI-H292,23635314,4.8326715815763395,-2.027953277932203
SNU-449,15547703,3.400796461378631,3.194088928672436
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.6507209814042743
LXF 289,46843906,2.101940493524925,3.036241340399507
DMS 273,46174525,4.164871991455526,3.967319724399232
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,3.4816392239415
SNU-449,6917907,-5.317414756413243,-5.429128893886843
A2780,4705,2.567744201920244,3.0782999341709187
KYSE-70,73707438,4.323396479680616,4.160108995751164
NCI-H460,5329102,3.240160570329804,2.253273433572855
NCI-H661,5282054,3.5253080606128133,3.4223382335722112
NCI-H1623,119607,5.952206355872506,5.271522629789635
NCI-H522,64971,2.9291780846019413,2.5178779511380514
CAL-51,11222830,1.6762547521470548,1.6148361964374656
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,3.050146370987329
SCC-9,25062766,2.812414712404745,1.9153180299421313
YAPC,31703,-0.7401868256368748,-1.445726098948518
KYSE-70,2858523,3.054228167220651,2.9134155233510604
MDA-MB-453,1242560,3.902800159671119,3.310615361454619
MSTO-211H,71466380,4.302501611697816,4.468804908493385
NCI-H2009,3689413,0.5343246791806224,-0.2759510030453344
G-401,15547703,3.220896426279267,3.2533755949899286
NCI-H522,11719255,2.5592835843852337,3.2131790808065
LXF 289,46191454,2.351463869671111,1.620885016088596
LoVo,71304818,2.0724805960279027,2.3446645279696976
A-673,5311,0.6764453858481513,1.2010375109759792
KMRC-1,11175137,2.246406512349146,2.6780924807526882
MDA-MB-157,568763,-0.4149964884485024,0.34555111282688517
LOU-NH91,11213558,0.661761515775888,1.8086929905416451
CAL-51,2733487,8.211583338705053,6.212732390789844
LXF 289,16741245,5.010251526780332,3.8663040939044913
SNU-61,24797083,1.0556452382424049,1.4797636376015857
BT-549,44137675,4.586830027774197,3.3966392492894544
CAL-51,15547703,3.503799403292956,3.2082335593166413
JM-1,3136844,3.4340507925237307,3.9651834226568097
NCI-H460,46191454,1.6495265120274705,1.6862295538042809
CAL-51,16722836,0.8083581946159574,1.6700862887541856
FTC-133,25227462,2.318225674680384,-0.17251351821167255
A2780,51039095,0.059669762784491,2.6931086192614737
OPM-2,54613361,-1.307423897840743,-0.5143041456646454
LOU-NH91,5328940,1.6284519107294106,1.6331336240928003
HSC-4,11640390,4.10313790521596,3.35952418061866
LoVo,11222830,1.6500045227885836,1.5017163010701844
NCI-H2171,53495165,-2.473385034422452,0.04379171642329993
MDA-MB-453,5281321,-0.6344069396712416,-1.498333564857372
FU-OV-1,9926054,2.079351745951841,2.0333675905752115
G-401,36462,-0.1566510321668276,1.639595445281877
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.94491169191748
NCI-H1623,11427553,2.6307082318350132,2.9481930609067337
A-673,6918638,-0.1443248090306654,0.29946400692153885
OPM-2,54596490,4.128803973627264,4.382534313024332
G-401,24753719,3.1602445998928186,4.091652582924142
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.4957111050153644
DMS 273,637858,1.5802330029013405,1.6293207271062746
OPM-2,72199292,0.0645754970830883,0.8324668584170997
SNU-449,5328940,1.97588831229785,1.6348531857857411
OVISE,49793307,0.0210083556696064,-2.7419201779848112
A-673,11647372,1.3285775791052634,1.2957528445787228
OVISE,6918328,1.4244682512544402,0.24660173933810384
Panc 04.03,25154868,5.1819399857498025,4.428445882173998
EFO-27,17755052,1.748867275877649,2.1066486041111663
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,1.2181903267692136
SBC-5,375860,-0.6399303579455221,-0.4179951241713975
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,3.05162065923225
MDA-MB-157,451668,4.959725465812671,2.2454686070911403
YAPC,54619267,5.29132207947154,4.244629332650963
OPM-2,36462,1.377546018006998,0.5793285662759738
BxPC-3,3081361,1.7902484572067556,2.3425082041284355
SNU-449,11455910,0.8938620280411973,1.2100152021803479
NCI-H1623,25022340,5.5347014016683875,3.202306545916436
NCI-H522,409805,3.737006742854017,4.915504027692316
CAL-51,568763,0.0917223714484538,0.39873040018666883
HSC-4,12001922,2.169357927696289,1.8969438929767326
CA46,2742550,3.5037926309603944,3.433766278350759
LOU-NH91,11507802,2.1124947170440533,1.3260623803904372
LXF 289,6852167,2.2044562779321635,2.997307951365687
ONS-76,26596,0.1332187247782509,-1.3366071022905113
KYSE-70,9903786,2.353212274658888,2.6968683757102125
DMS 273,10385095,0.5027476993233067,1.1921621890917786
ONS-76,3025986,-0.4351415981508911,-0.9585576912866033
MDA-MB-453,89928392,1.7795585771799345,1.552964312766393
LXF 289,676352,2.537691956872654,2.06964361117854
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-2.277821507578197
HSC-4,135659046,3.804399419736421,3.5926923475529184
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.9805499233926317
SNU-81,6623618,-2.7236989498385733,2.1229200510775312
HSC-4,5282054,3.7951129778884822,3.7130943187178245
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,0.6428735301712876
A-673,16219061,2.4523595679466954,3.1031858632721128
SCC-9,123631,1.8109604294388877,2.3744968508583857
A-673,11364421,-5.84995188170368,-2.7881124424191857
A-673,216345,3.678855080389337,3.7592882956115505
A-673,439501,-3.092013019617277,-2.2657958599644714
NCI-H460,1566236,4.3513012021592505,2.293791798528559
LOU-NH91,25195348,3.759766884877561,2.9988506229571668
DMS 273,23725625,4.676663171220921,4.714231987894602
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.620057802237792
CAL-51,6852167,2.546662292056567,2.6775634504517645
OPM-2,5738263,2.0935625564909737,2.9180057723419086
SCC-9,5311,1.75647433259966,1.3938114249539282
SNU-81,5291,3.232691727920098,3.564853424579194
FU-OV-1,262093,2.4810055989466018,2.760854045277952
LoVo,56949517,2.258326270055845,4.328763622315815
A4/Fukuda,9825149,-2.050748608979426,2.0543961922749125
CAL-51,53392493,1.8808489153668793,2.4318240372342435
NCI-H522,4521392,3.962796694444569,4.321363175084099
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,0.03308685042270917
NCI-H2009,11612883,2.3268324416241777,2.762670551064089
NCI-H292,65064,3.148033598452649,5.007603703792534
NCI-H292,44589607,3.354505508461316,2.862937541861756
KMRC-1,462382,0.2791911345900462,0.6710469631123468
A4/Fukuda,5291,3.6218734753047226,3.379399490801081
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.6770283084723948
A-673,135440466,1.1776565801361647,2.353013107542737
Panc 04.03,60700,0.3719609401953118,-0.4195013737715236
LOU-NH91,66577038,3.4622279905398052,3.0874084105009176
A2780,24856436,-0.502193855863573,0.32993548464046674
CAL-51,6852167,2.546662292056567,2.6775634504517645
JM-1,5311037,4.072371281952103,3.6988187570976545
NCI-H460,374536,2.933441634270558,2.0665501551563055
NCI-H460,216468,4.763843832635099,3.193602964839768
SW1463,421610,3.2195561799423804,2.8785315809762393
NCI-H460,439501,-2.362377537788676,-2.049029483694157
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.4091998823688881
MDA-MB-157,24978538,3.306703195844951,1.1398449962349693
MDA-MB-453,54618795,1.052632381834858,1.1607730670797078
EFO-27,6914657,-5.685084863882177,-3.7608670652845175
NCI-H661,9866186,1.9017456959186525,0.8599858805802855
CAL-51,6623618,2.223133904662847,2.4770861076971276
OPM-2,5281672,3.1701528707347015,4.2674679670192655
CAL-51,1716436,3.275997904874087,2.970193625726084
NOMO-1,25183872,-0.6960845434284378,-1.7203785117966104
EFO-27,216239,3.3875560857040887,2.303482758611844
NOMO-1,54619267,3.207870909981956,3.7917744902231054
NCI-H460,400769,-0.4007490431715684,-0.43582573554887466
SNU-61,6610355,3.885584601382451,4.348673989127147
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.002222053040264
JM-1,10077130,2.0136903876831993,2.829434502508436
NCI-H661,81146,4.823771143587,4.434703337626732
LoVo,56946209,-4.467950537911531,-4.271433703861615
NCI-H522,5460769,0.5614535105182378,2.0678222353512608
CA46,9927531,3.0223750820915978,4.287749766579989
CAL-51,11612883,1.9359641259018452,2.646059490995201
CAL-51,11427553,2.069280384014222,2.741997284031177
NCI-H727,5746,2.1304383256196293,1.2226589068697762
MDA-MB-453,16219061,1.5030881414961583,3.1817072802256443
MDA-MB-453,68056272,3.261695748545246,3.453971632428895
A4/Fukuda,6610216,3.4719570509087445,4.06947438304899
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8702988150046584
SCC-9,107985,-2.37702169012632,-3.6028227536216537
MDA-MB-157,23939,3.513284021833553,4.107487273589103
OPM-2,262093,0.5720462757198622,1.993584916281367
NCI-H661,5351362,2.412641003608378,1.3954986139866512
BT-549,53495165,-2.465962418573161,0.06963942061464833
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,2.4783935980024894
HSC-4,1716436,3.018983829466311,3.133706656208505
A4/Fukuda,10231331,-0.0070700765814584,1.220298167930124
OPM-2,25105715,2.7306053213312027,3.2291928500114966
CAL-51,3384730,2.4775948365465905,2.4844388115027782
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,0.7848008625335534
KMRC-1,262093,3.6313310555506817,2.9982961729018434
KYSE-70,5311281,3.780874632943925,2.2918122763375437
Panc 04.03,135659046,3.760242578723066,3.63018372770675
NCI-H460,46199207,3.5033257005335163,3.119649818393566
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,0.29141195546773674
NCI-H522,285033,-5.015646919007219,-2.070648045816124
NCI-H1623,31703,-1.093718795909536,-0.7240812319761768
CA46,8515,3.648186715161825,3.4852888854878654
A-673,54618164,3.9765209939943857,4.008429794478641
MDA-MB-453,71304818,1.4463301677266325,2.4798764748045965
SNU-81,656346,0.6811147423088999,0.46234823371749373
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,0.20716957038618236
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,0.6427011976357955
OVISE,71680916,3.981894618274443,4.757960731871496
LOU-NH91,56963564,0.9665729866263152,0.1992034661511205
NCI-H661,23635314,-2.0342629068452056,-2.2451694586745803
LOU-NH91,12001922,2.55699926148122,1.91021420075566
JM-1,31703,-4.919166892515249,-2.23069606308197
EFO-27,16065773,2.8503557299543063,2.6744181739604413
DMS 273,107970,2.226748766743483,2.209330759052018
MDA-MB-157,67156097,-2.087594374926874,-1.0757337082061875
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.4031968816423128
LOU-NH91,46199207,3.3608515659177147,3.151403033716597
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,1.0106062652420411
BT-549,2871966,1.6191257261573118,0.7722723885749464
BT-549,46926350,-4.493585638609818,-4.1019411630905385
OVISE,54626689,4.712933516379989,4.477241872680789
NCI-H460,119182,0.2489341964189734,-0.577678440394839
MDA-MB-453,7251185,1.8406187352582624,2.60656665110838
JM-1,4521392,4.181937683636394,3.9544266459148734
LoVo,44589607,1.625549992230134,2.7241569359747557
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.3714519107405478
A-673,24951314,0.6400096482448101,1.0952417545071433
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.5601478725166025
A2780,11152667,-1.0749204847082217,-0.6459577622013497
BT-549,5329102,2.9790267437316285,2.0689847145258295
G-401,17755052,0.028133790527295,1.5662316578676232
CAL-51,11238147,2.100409816322544,2.551840035040733
FTC-133,16725315,5.918216987208106,3.983111867713826
HSC-4,10127622,4.548794444843462,4.017714274622925
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,1.4814932424409457
HSC-4,72376,-2.108784759313747,-2.093002973781604
HCC1143,11455910,1.411815978618001,0.8325353240775079
G-401,6610216,3.9425308150709,4.191004395030283
OPM-2,73707398,-1.391957592490296,0.503361054182002
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,1.8875673030219924
MSTO-211H,11396600,3.2938939565791765,3.6653503242514534
NCI-H2171,15983966,-6.379176066325201,-1.5771437548525113
HCC1143,9903786,3.3387804215378885,2.6467126696223993
JM-1,3385,1.6679469335870958,3.0708659271861665
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.3715420461725834
JM-1,44487872,4.651129481786086,4.569801221685714
NOMO-1,439501,-2.35226533453039,-2.3632584755146335
Panc 04.03,568763,0.8595160951448656,0.5182614003225703
A-673,15953870,2.6171812575314757,3.3857726184004324
CA46,6917907,-5.812984110767001,-4.969136714372459
A4/Fukuda,11404337,-2.650657466190433,-0.7138072426183755
MDA-MB-157,6184667,1.80494393962058,2.9178575766651034
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.2530096675542772
NCI-H522,25102847,2.0692872541383784,2.3157472118328393
EFO-27,2113511,5.820212709586459,5.4156662298429366
Panc 04.03,2729026,3.1546590032208948,2.9109957577936374
MDA-MB-453,9866186,-0.0857862406385878,1.0078514838867525
CA46,44491742,3.801952242992866,3.9295256115640553
MDA-MB-157,16720766,-3.610201854539628,0.6333648126533358
NCI-H522,168313016,4.366007701234683,4.637949346324387
JM-1,53232,3.389128909220105,2.418926037707805
ONS-76,24901704,3.4855009095109435,3.2810557066978787
FTC-133,3136844,4.271719807093853,4.1939494937219255
CAL-51,54619267,4.1828818787298765,4.184997682774002
NCI-H146,17755052,1.2442303799433287,1.8185489658629954
FU-OV-1,2858523,3.1344850445874752,3.016628664932745
NCI-H292,5280436,4.014624366310106,3.395005055350331
BT-549,15547703,2.0718927663287703,3.1406170045072686
A2780,25126798,3.236047242798602,3.5813053509662565
Panc 04.03,2945648,3.066534391812563,3.0495417546907766
SCC-9,56963564,0.633234370730304,0.0314584520447237
A4/Fukuda,11507802,0.3746235533355334,1.0412613725739281
Panc 04.03,3025944,4.694936485248253,4.244417261789
SBC-5,46398810,3.6562963267762183,2.4293641708468083
JM-1,49793307,-5.3555461291239075,-3.714295322983722
SNU-81,67156097,-1.5845934662844448,-1.2147922910158082
A2780,72376,-3.651935268939024,-2.425420715226219
CAL-51,25195348,5.6667768045179905,3.207506278985138
NOMO-1,10074640,3.0496099519927435,2.3434228054625676
FTC-133,46174525,5.692041239325808,4.07924908693817
YAPC,409805,4.253424942012428,4.729055915025588
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.6570578758635437
SNU-61,11626560,1.823906724750755,1.6114446949527461
A-498,16736978,3.6467697702535182,1.8740377420166152
JM-1,9967941,2.969647244173239,3.3579794676759
MSTO-211H,3815108,2.5678993468563913,2.8019809249137984
KYSE-70,637858,2.812350468450961,1.7827782495038726
A-673,16013152,4.069813049540754,3.999850986762124
A2780,4521392,3.924686212385386,4.2547022018093035
A2780,23635314,-2.3171748001501635,-1.8976096434277216
JM-1,3689413,-3.612287026066889,-1.1884218534609259
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.6265645366841281
OPM-2,64971,2.0053510879561296,2.3315221334868657
LXF 289,9935249,3.315625346230847,3.210231228990583
Panc 04.03,984333,1.398892433045171,0.9099982796774841
DMS 273,676352,1.7083859345894283,1.9890666015225682
MDA-MB-453,4096211,1.6956492567589403,1.85962328524599
DMS 273,9903786,1.811418424711566,3.044039361918503
BxPC-3,3634881,3.024771766376516,3.4019433605078735
ONS-76,54618305,5.4771970245541866,4.683538217657042
Panc 04.03,44491742,4.30815140156182,4.167447133509387
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,4.381437801412595
MDA-MB-453,123631,2.1950816453081545,2.4944961649221375
A4/Fukuda,426756,4.168045276817785,3.608219491188162
CA46,252682,5.8821335535914905,6.371952729749193
Panc 04.03,2828334,6.268769524950107,6.1552429380752836
EFO-27,135411,0.9008731550993504,0.7601498409695918
LXF 289,15983966,-1.3187435990338214,-1.2685408732991355
A4/Fukuda,3384730,1.825152720179272,2.067878018861634
SCC-9,11404337,-1.771041191231111,-0.43007690215860434
SNU-61,6610216,4.086517799339023,4.289600153528769
LOU-NH91,446155,1.33101507486467,2.7363117327013775
KMRC-1,71466380,4.698779777562497,4.59215268335921
SNU-61,46398810,2.7474251169458346,2.426415606257479
NCI-H2009,9826308,-0.026532071259288,0.6040652755567364
NCI-H2009,56946209,-2.630012103472263,-3.948860466917806
HCC1143,46843906,3.1964507186723305,2.9092536710219705
A-673,2742550,4.033526638201744,3.924130752004505
SNU-81,11507802,0.99367607100598,1.2412468328792983
KMRC-1,11485656,3.5314695534539045,2.5869063882055308
SBC-5,57330099,2.8388792643726295,4.152747117800511
LXF 289,219104,4.555444774518925,3.853454561548635
Panc 04.03,9907093,4.451330392346362,4.136544514529994
DMS 273,19582717,4.273838780275844,3.8833419914520153
SBC-5,3815108,2.9831729144642956,2.667736130237125
OPM-2,168313016,3.5498730155612863,4.263633213071342
ONS-76,10427712,4.642311539672088,4.305728567205883
NCI-H522,54765302,4.051221649365855,4.038722973936183
JM-1,44620216,4.114569245447781,3.7383477618022742
MDA-MB-453,9887053,5.45770037243801,3.7271215554968466
A4/Fukuda,72193861,-0.8043632874402014,0.7559429100708249
G-401,25102847,1.393287045797279,2.095019691621411
SBC-5,11507802,0.0977610232609949,0.9318133846167298
JM-1,168313200,1.89690041567587,3.069720124643338
FTC-133,3634881,3.4388146515237468,3.321608653905228
NOMO-1,10427712,4.067466468396052,3.846148730833797
SNU-61,6918328,0.4046547109968232,0.24295337648513024
NCI-H2171,23635314,-3.6505205606038382,-2.0859235845814665
SNU-449,6438330,2.777557669825017,2.209724232576255
JM-1,25161177,3.865095276574429,3.513210964802485
LOU-NH91,3025986,-0.3413799803632848,-0.7179595684374478
HCC1143,53232,5.137172207040132,2.687233419811053
LOU-NH91,53232,2.5403477328432933,2.5183280555490124
NCI-H1623,24797083,2.165751455730843,1.432447162511304
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.1642742611472543
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,1.929024024257291
SNU-449,3025986,4.266276949739511,-0.8303649687680648
NOMO-1,2858523,2.9127751570608136,2.7163112381024304
A-673,6918736,-0.9753951922870552,-1.9935060824250415
A2780,44202524,1.0300821380640774,1.959044063490634
DMS 273,25154868,4.488535380180048,4.423767682246591
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.6937502744681274
BT-549,100016,6.139281322747303,6.317549370081515
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,2.645353009812703
SCC-9,148124,-0.9222891029936632,-2.4508147253613255
DMS 273,11494412,0.2734180035919979,1.4674016520391193
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.17573719690070164
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,2.4925839070256335
EFO-27,16725315,5.151426492732951,4.220235132149946
KYSE-70,3689413,0.9447440025313596,-0.08535759274006835
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.6707255689271163
NCI-H460,285033,-0.7054560098467199,-1.5326975685037747
KMRC-1,5311,2.4483949186029794,1.6499653744157903
Panc 04.03,54618164,4.2869772681873695,4.119624272802752
NCI-H727,676352,2.629502567411482,2.0913477237051517
HSC-4,24779724,5.454925638847944,4.521393462326853
A2780,23725625,2.4195603562256873,4.557458338592978
CA46,56946209,-5.9555571874685755,-4.684093064946094
NCI-H146,6252,-1.7817409080320272,0.6028659507431491
SNU-449,44589607,3.7188226068257872,2.780405574399473
LoVo,969516,2.402995535890804,2.6170217922557257
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,3.014216645381256
CAL-51,9935249,3.84795648434564,2.970144709339885
NCI-H1623,53392493,3.831222645051568,2.611453879093868
MDA-MB-453,54596490,5.641262539800198,4.6188002646193365
A-498,42642645,1.5845020846141176,0.9776918994991384
FU-OV-1,4788,6.1006518616017615,5.607412679882075
DMS 273,6852167,2.1769146352356707,2.6404154567211573
LoVo,11612883,2.4190290931093954,2.590522212409402
A4/Fukuda,54618305,3.964460418875751,4.13213682628919
NCI-H2009,17755052,1.0629457660851225,1.7562898246910013
EFO-27,5113032,5.5462842201226925,4.889719176095669
LoVo,9907093,0.4604974674369004,4.066523548776221
SCC-9,44491742,4.764074483400304,4.222372479274535
NOMO-1,53392493,1.775943290565707,1.922546895915818
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.3273214187523017
SNU-449,16725315,5.255161508937853,4.285384266944652
SNU-81,9825149,1.815233140933264,2.0048454305428733
NCI-H522,60700,-0.5552110519793028,-0.05231699706447507
NCI-H2009,375860,-0.9754800160336818,0.18154707934603162
OPM-2,44607530,0.8834373674969361,1.3664869770830905
MSTO-211H,2708,3.2234156242084073,4.359593911149794
OPM-2,15953870,2.653227585048534,3.0966165352337316
DMS 273,11238147,3.12717198165546,2.5590977779786885
OVISE,3062316,1.3579552700407893,1.1927161573128933
NCI-H522,11955716,-2.355417617820864,-1.5466496388700428
LXF 289,44486219,3.8558224358877298,4.255135592616693
NCI-H522,4261,1.255814980012561,1.5573896015749273
SBC-5,11396600,3.6683316442381617,3.191920922668354
NCI-H727,448949,2.521247711014773,2.190280184101529
CAL-51,126941,-2.448006630223804,-2.7905945066515643
MDA-MB-157,156414,1.5733069512528617,1.4561838520958927
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.7841151950209
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,3.76984405987162
FTC-133,2871966,2.512715884905784,0.521759839727131
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.6291494136108199
KYSE-70,168313047,2.1859183661660624,2.2571627880641505
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.09747230422532
LoVo,54454,2.7172548619434025,2.6109327205691204
SNU-61,73707398,0.7144154314829279,1.1200320910451675
MSTO-211H,9866186,-1.5986440722967756,0.962427941869327
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,0.7704767505153862
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.6255183430048907
NCI-H2171,57519531,1.5586354952126105,2.56311693169333
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0526301109386422
NOMO-1,451668,-1.632426084818391,0.14181970056592788
CA46,5282054,2.3254868404716755,2.953338063798025
MDA-MB-157,54618795,2.0481333451118204,1.0484044954330114
OPM-2,11707110,-2.1571352516283113,0.021448875030054163
CA46,3136844,3.7113001526336338,3.9286084397086034
NCI-H2171,984333,-0.9596445260901963,0.633527671376774
NCI-H1623,11507802,3.5238050648518136,1.4360052639714609
NCI-H460,46191454,1.6495265120274705,1.6862295538042809
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,1.8473120098885014
MDA-MB-157,7326481,2.299098205794017,2.9071753555509368
EFO-27,1239801,4.748117996702423,3.991702327322354
NCI-H460,969516,4.1763077592827225,3.0315579509706674
G-401,44202524,1.447982360696086,1.8760479310858462
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.165874556273759
NCI-H460,2749,2.5004778765083695,2.1168908906498705
DMS 273,119607,5.531574360726778,5.083939132542556
FU-OV-1,10074640,3.835416148861087,3.218529846461538
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.5329718827464028
MSTO-211H,9911830,2.3480580098381747,2.660123590085999
SBC-5,135411,0.301348299555382,0.43723877123031224
MDA-MB-453,6610216,3.7821562137745217,4.219579151320891
SBC-5,2708,2.061546130614232,4.426432935887301
KYSE-70,11396600,3.829938839575827,3.270099794683242
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,0.49412512629492816
A4/Fukuda,11152667,-2.4230854517211977,-1.2683042972867076
SBC-5,36314,-4.885811702708602,-1.5316220778133414
DMS 273,9884685,-1.1971048738595964,0.5948886607146634
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,1.2591347094979883
NCI-H2009,439501,-2.087429471182781,-1.7149544895305542
MDA-MB-157,1716436,1.1718034720311097,3.0128857258597197
ONS-76,216239,1.6729885995968985,2.364574241232401
NCI-H460,9911830,3.1326305509826824,2.5780585904708015
A-498,2858523,3.0988346297597293,3.0925670294959775
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,2.6871072550790496
OVISE,969516,2.883429877122848,3.0769765885300533
SBC-5,3825829,3.3495967392740953,3.899351814491139
LOU-NH91,5278396,3.7974378044691495,3.5772063389298467
MSTO-211H,9935249,0.534197831206919,3.172272220720444
JM-1,9911463,2.675259516581914,3.382317276459057
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,2.812589768202617
SCC-9,60750,4.9910553033212866,-2.7035704445916298
SCC-9,387447,-4.584813930042193,-4.316721889629539
SNU-81,25062766,1.4859068805404914,1.9196290334434734
NCI-H661,2708,6.321788786635088,4.520281673588179
NCI-H460,57519531,1.7606196796007008,2.690454911489439
KMRC-1,613753,3.207263348750723,3.188152154462397
KYSE-70,67156097,-2.3379446798215127,-1.300832524345283
OPM-2,10127622,2.4771662101119194,2.8430997509948446
LOU-NH91,5291,3.971687681340124,3.8153766669111655
DMS 273,6918638,-0.6329393875591668,0.31224820949563314
A4/Fukuda,16722836,0.6102638619225811,1.2807202451382722
NCI-H1623,11175137,3.026300100874371,2.6822116522708943
SCC-9,122327,5.629849115039079,4.681326486138869
CA46,11625818,3.63093624941088,3.6337290219381453
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,0.5212308159703057
Panc 04.03,156422,4.828457411788627,4.0197178385930705
DMS 273,5278396,3.2906012116635694,3.39539657342017
HCC1143,53495165,-2.177337144630303,0.20264250534654424
OPM-2,1641662,3.0681099569104653,2.928248798229508
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.8430182655585121
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-0.7661991237582214
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,1.0437759222528264
A-498,6917907,2.9475757171512575,-5.363472105743318
G-401,10385095,0.8697787767816428,1.1519650870655405
MDA-MB-453,702558,3.1332940697725435,5.121932221955348
BxPC-3,15547703,0.9056764589340796,3.306637500611373
A-673,44632017,0.706241354368095,1.2544522548090844
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,-0.35809837889352614
NCI-H661,11626560,1.806538061239003,1.832067990955319
SBC-5,9840324,4.760330511699364,5.611785177206619
NCI-H727,46398810,3.032466795061864,2.6396702577355753
HSC-4,654092,0.2566378579351391,-0.27830385472213637
G-401,5978,-3.1887203575088727,-2.412555167000118
A4/Fukuda,11238147,1.0973923844128086,2.2739314305520666
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.4106573441703692
NOMO-1,54678924,1.1055951494804663,1.5088175430318296
JM-1,135421197,0.410328587733175,1.3685703726168086
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-2.18084283348593
BT-549,216468,4.5222519285579885,2.9047260481752493
NCI-H2009,136227924,2.9896301065010933,2.9719913652475127
SCC-9,2828334,6.128266495621781,6.144943781029752
LOU-NH91,3025944,4.356407657994756,4.213959584873434
ONS-76,5329102,2.3644433253395545,1.899097025164028
DMS 273,53495165,-0.9870251488119351,-0.059298639289946026
NCI-H1623,3634881,3.389178636612412,3.3562762682571243
NCI-H1623,446155,4.270765867841268,2.5650272365758893
ONS-76,984333,0.6472143254241693,0.43367001798929644
SBC-5,3081361,3.306292226806483,2.0832956966457323
NCI-H2009,11625818,4.7000574258268255,4.458846031384573
CA46,24775005,3.732581966598925,3.4861084161505165
SCC-9,11222830,1.8600220042192213,1.5908078393219245
KMRC-1,12003241,-1.418239320082467,-0.9826704727517847
SNU-61,613753,3.0121134483838037,3.080213070815309
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,0.49495622841522985
SBC-5,4261,2.0931810634834105,1.2710821996064694
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,2.0162933851010227
JM-1,445091,4.048660068158945,4.112496643857858
NCI-H292,44185566,2.325959343920572,2.7872367393394275
SNU-81,6918328,0.0758058419703895,-0.12070281940874084
A-498,16659841,6.0591016575330325,3.884439254043551
NCI-H460,51037431,2.104101453867928,3.280456740520666
MSTO-211H,5978,-2.861470631068365,-1.801306009836794
SBC-5,6918736,-1.7962623830849138,-2.2844320735848713
NCI-H2171,11178236,-6.134942659978268,-3.417230483679708
ONS-76,11427553,2.8550216000544695,2.605962430333435
JM-1,11234052,3.3092904099829115,3.5326342781244167
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.6158100434282434
MDA-MB-453,11719255,3.0016884563631057,3.248922859229903
HSC-4,241158,3.797905223062241,3.757189774658758
SNU-61,49766530,-2.178873950286192,-0.06830967037448833
ONS-76,54454,1.5364254879481318,2.7310230454669333
NCI-H2009,54618164,4.160237516111787,4.302389307004157
CAL-51,3136844,4.799885860604426,4.153161702236214
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,1.89499268232367
SCC-9,46926350,-4.135183666473923,-4.158888577557004
YAPC,5460769,2.316930709954587,2.9956828807182863
YAPC,135411,0.9254838530178896,0.530752526642428
A-673,11228183,1.918128583172148,1.5071498368889857
MSTO-211H,24856436,-1.8779899697418416,-0.0009996268020329012
LXF 289,44185566,2.4809324153017265,2.5904481847480305
OVISE,654092,-1.3076939787912127,-0.36826449389681537
A2780,6918328,-1.1386748973241003,-0.2860776018468131
FU-OV-1,44819697,-2.23904448126328,-0.37482332402068236
BT-549,42642645,1.6219324424635808,0.9436435455330064
JM-1,216345,2.231105973795255,3.030112908393436
G-401,73707398,0.5507155331982622,1.1073072672858002
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.9069053418158549
KMRC-1,16722836,1.9243244677044424,1.7977788711268377
NCI-H1623,135875424,3.67415188779786,3.8100824306605476
NCI-H2009,638278,3.464543124143687,3.282834163545658
NCI-H727,168313047,2.9561297907786717,2.3154879532966013
SNU-81,439501,-1.707157001292212,-2.2297874996654015
MDA-MB-157,11234052,1.0821323764870938,4.058545917667226
NCI-H727,11364421,1.2179988120980565,-1.2829498350618826
BxPC-3,2729026,2.140647578797141,2.688673727059615
NCI-H292,46224516,2.488403107417036,2.1344499372620565
MSTO-211H,5746,0.1838030897357816,0.5999782937501553
NCI-H727,5280436,4.172163827724594,3.2795175425114578
NCI-H727,9911463,4.409308573364914,3.7932890622708935
LOU-NH91,9907093,4.908801109640004,4.236154864837514
HSC-4,24772860,-3.179601965562413,-2.4456754617950662
MDA-MB-453,10302451,3.3014196832790628,3.261929491116731
A-673,2945648,0.1856393110329161,2.6558949047303844
G-401,56946209,-5.714614119541748,-4.263290390397344
MSTO-211H,452548,-2.0931551112296742,-0.32021014600203934
NCI-H2009,5280436,3.59103147994178,3.4371608788681285
CAL-51,241158,3.781489879449518,3.848887539478264
FU-OV-1,24772860,-2.86759244210788,-1.884445011459301
DMS 273,54596558,4.317274835352231,4.538964457874074
DMS 273,71466380,4.5698020131067745,4.436952785861844
ONS-76,11175137,2.2807611594224975,2.461757855968925
NCI-H522,136227331,5.948504593030567,4.267197054731431
KYSE-70,262093,3.701785722517592,2.321230398080297
KMRC-1,119607,5.885636542486439,5.400162906343995
CA46,16722836,1.2778374610309875,1.3251489370374698
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.2109255726499404
SNU-61,24772860,-2.9174361907600592,-1.849429652900652
LoVo,322968,3.2361743048313536,3.4583387229034694
NCI-H460,168313047,3.736921155938788,2.5292434521774636
LOU-NH91,123631,3.064358892537756,2.446865462959531
NCI-H146,10410894,2.10877812565835,3.154872669850489
OPM-2,107985,-4.911691484457119,-3.756908107940991
HSC-4,4917,3.66079963002401,3.058282381365542
SBC-5,72376,-1.1693945126287038,-2.3709398224336935
KYSE-70,11238147,3.36128873589197,2.7899415013860205
CA46,9935249,0.2545497442771542,1.5231031071362955
SCC-9,135421197,2.7056920215811293,1.9072347343791867
FU-OV-1,123631,2.446979601054181,2.596396016043706
MSTO-211H,12001922,2.4775669078904397,1.8873167669733533
NCI-H661,3543504,4.269759852401949,4.256955186110737
FU-OV-1,53495165,2.0201630022514263,-0.11459557770316967
NCI-H2009,448949,2.535639173937985,2.204652606724444
EFO-27,285033,-1.172211692399995,-1.8198016837267432
YAPC,5978,3.3733616775717716,-1.3505054121166873
BT-549,9911463,4.268645247281358,3.7416348132617903
NCI-H522,2113511,5.298827483301359,5.21321587882176
SNU-61,1242560,3.7603648536411622,3.5028543451748817
A2780,3503,2.123197367997407,2.095830677825907
JM-1,262093,0.3077511100871351,2.4402781526323394
DMS 273,11612883,3.047294051558191,2.5410471043420806
A-673,156414,1.4246196000990916,0.8754356601137079
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.3446942072175458
SNU-81,3385,3.194341332216005,3.629840639955792
SNU-449,44486219,4.185988120780244,4.266818758371338
SCC-9,25262965,-0.8228501050995407,-1.7356727428278902
NCI-H146,9967941,1.5373910611842192,3.5726590469731927
HCC1143,969516,2.4763079586135546,2.8673740304849105
ONS-76,12003241,-1.3579895274230906,-0.744150849062322
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.482553849570364
OPM-2,26596,-3.75281027154887,-1.9210963319463223
KMRC-1,11955716,1.3700469468180672,-2.0001725119343927
ONS-76,445091,4.207927105180806,4.462865000466823
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.9047102800534139
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,2.8619231049708067
JM-1,11964036,0.6346833811859819,0.7505852863930513
MDA-MB-453,24180719,3.640576555720147,3.5427778712669284
NCI-H146,3689413,0.5626872136369616,-0.3683396095622193
A-673,5335621,4.03269099593382,4.341840866617655
FTC-133,44491742,4.538470926749077,4.099668186645305
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.3491420065193023
LXF 289,23725625,4.938564251049365,4.774477024275745
OPM-2,11612883,1.2708799210561326,2.258989750543674
CA46,11485656,1.2289823963881294,1.8272857019295845
SNU-61,227681,2.9666568152307993,3.1625971194695968
NOMO-1,135421197,1.2386186938920458,1.4433950600155043
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.1015365619927246
BxPC-3,135421197,1.4419000032460958,2.1164380094277733
CAL-51,66577038,4.134711160885491,3.021786981292379
BxPC-3,11485656,2.0481416814216375,2.1078561376677643
LOU-NH91,3689413,0.742189593443008,-0.6578534194540205
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,1.8916366467744012
JM-1,49766530,-3.0151701370453794,-1.1193401273226735
NOMO-1,15983966,-5.011559396504552,-2.8880168496754677
HSC-4,24856436,1.7831446753384608,0.15455295723907003
OPM-2,387447,-6.258797979541162,-4.820113903771655
A-673,54765302,3.022220101838166,4.058784353186216
A-673,5479543,3.2499245267113928,3.5664237975042785
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.92704306385801
A2780,441298,1.2276441630256645,2.469978288600082
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,-0.003776340244439782
HSC-4,65064,5.180183799352401,4.944297281776099
OPM-2,3384730,1.6721258053175836,2.1300889308970947
NCI-H522,387447,-5.403881314975521,-4.225710822314078
MDA-MB-157,11640390,1.4666591993417384,3.5230327835501676
CA46,9911463,2.565133854881976,3.4020983728625542
FTC-133,227681,2.0408407851095416,2.965648661081657
JM-1,285033,-4.464347137363986,-2.9180648692078512
KYSE-70,16736978,1.1213704825993671,1.4719814813492045
MSTO-211H,2729026,1.9618514095460544,2.6623562773378247
NCI-H661,24180719,3.917772031076744,3.478934409145712
NCI-H1623,400769,-1.0076663191396935,-0.656508471101982
YAPC,9840324,5.782457936566159,5.835006350313418
Panc 04.03,57330099,4.388225142481581,4.173773426627614
G-401,135659046,3.5574575455214608,3.5168406598732407
A4/Fukuda,148198,-4.99238512913244,-3.701511093408724
CA46,126941,-4.174426911659592,-3.0974327946512235
SCC-9,6610355,5.330005746360321,4.478482692799418
KYSE-70,44185566,2.2395157674699875,2.360585118242942
NCI-H1623,462382,1.1150663609789129,0.6089472327964452
CAL-51,6914657,-5.067352950634086,-4.277770134215219
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,3.930801679999852
EFO-27,54618164,4.628305371415217,4.068074581385782
JM-1,23582824,0.2805180690676545,0.7568965798556408
NCI-H460,44185566,3.2105564381381035,2.7218093422423437
CA46,52912189,-0.9978651387823436,0.5596738416663389
NCI-H2009,9935249,4.414461781647313,3.10637412102177
NCI-H2009,135928012,4.098076343567735,4.170164928017484
CAL-51,60750,-3.4379358682898973,-2.59272476429585
MSTO-211H,8515,1.6806311840995682,3.8525027218032983
ONS-76,15983966,-3.1712265481751243,-1.237506353440394
NOMO-1,56946209,-4.862706213909506,-4.315221305888507
NOMO-1,24772860,-3.4546209155075687,-2.462498805941049
FU-OV-1,44185566,3.182046500186311,2.4480926608426543
NCI-H2171,11977753,0.3036523614034643,-1.225442758513922
FTC-133,31703,-0.768913830642622,-1.1081150250261864
EFO-27,984333,0.9554706085777084,0.8530137923067278
NCI-H292,5329102,1.7855476735914897,1.936469132263615
CA46,409805,3.3808362620175187,4.1750882198478605
MSTO-211H,25183872,0.3972499543283658,-0.9545791488605424
LOU-NH91,24180719,4.451607655435679,3.5700262632486215
A2780,44185566,1.1999498835751436,2.343702432554252
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.4870767441568211
NCI-H2171,6505803,-0.0596794204500112,-0.3642853981626356
CA46,66577038,2.896384523521911,2.67916851791214
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,1.6855621396112808
CA46,12003241,-2.799565618947511,-1.2594938882016102
NCI-H661,10427712,3.832896992750264,4.238838782144231
SNU-449,107970,2.557902386411369,2.3893243595813947
Panc 04.03,2874250,5.078270927101478,4.6454078324472095
NCI-H292,54626689,4.661071465435288,4.611418474447174
NCI-H460,23725625,5.666756485817308,5.070568668886691
CAL-51,53232,2.8018516258833395,2.811138731950899
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,0.17311472893081958
EFO-27,53495165,0.9078503906950024,-0.11401794858152005
SNU-81,65064,4.179756271690876,4.645056602029808
BT-549,3689413,-0.9397914335397376,-0.10440937290056107
NCI-H2009,66577038,3.427367822074961,2.9366311047732405
LOU-NH91,10302451,4.426232341068122,3.3739499932877393
CAL-51,168313047,1.9592520089902103,2.5108463796620892
NCI-H292,135411,0.5538002090667975,0.8144819596038537
LXF 289,2874250,5.409057432200043,4.582419493942484
EFO-27,4261,1.4655103146060633,1.7847101894275252
ONS-76,25150857,2.480326692853007,2.2043492563943605
G-401,11175137,1.9335599830838224,2.4036063991412813
OPM-2,5460769,4.223891374112808,2.371276863989803
NOMO-1,10385095,1.0593467546243338,0.7941927619421449
LOU-NH91,2126,5.273491801207327,4.675403970085821
MDA-MB-453,11625818,5.002273286989784,4.221452510708298
OPM-2,44632017,0.7121474472673729,0.8209157959794999
LoVo,135411,-0.4629764704945864,0.6673999081180635
EFO-27,16722836,2.503686118945589,1.7690346710282325
LOU-NH91,10074640,3.3386477352477715,3.1789070245276485
DMS 273,11719255,4.586791904076426,3.125008166377713
OPM-2,136227924,1.7425170628423947,2.577849540507145
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.0170507504412782
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,3.130341740770732
NCI-H522,2828334,6.021027928266713,6.107647256715492
KYSE-70,72193861,1.5917149982909504,1.382482462193169
MSTO-211H,9911463,2.6842905920893108,3.8250648889225034
MDA-MB-453,969516,2.9001694226946153,2.832378294515635
CAL-51,44632017,0.9975947899898204,1.149940023471653
LXF 289,10231331,2.4249622135671824,2.0751806719816015
A2780,25195348,2.1109786238814943,3.069558333129781
NCI-H2171,44202524,1.9759332673432517,1.9202647877204708
Panc 04.03,1641662,4.251343925322988,3.500461507075232
NCI-H292,54686904,5.52345614596139,3.710921499866113
DMS 273,7251185,2.13119393000196,2.290335562546903
LoVo,9956119,3.291456775833892,3.4830320020863645
BxPC-3,11404337,-0.6361724208993981,-0.026308678887779057
NCI-H2009,119182,-1.1305543955582442,-0.4808728361575436
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.4383039666534687
NCI-H2009,5278396,3.446569775137936,3.6801349301129935
SNU-61,327653,2.3439595497702985,3.231585481935895
Panc 04.03,11238147,2.6863632300229936,2.857223576954124
LOU-NH91,9926054,3.1176474597994908,1.9547819152802226
NCI-H727,5566,3.3170373665309416,2.994777828745905
SBC-5,25150857,3.1636616713903893,2.35972991715103
A4/Fukuda,11719255,2.014724282446697,2.9816631259341007
NCI-H460,374536,2.933441634270558,2.0665501551563055
Panc 04.03,135875424,4.739147054003967,3.849022479249945
NCI-H522,9825149,2.538976142931882,2.0084632230785333
NCI-H522,11964036,1.1738559849313974,1.5128949188382634
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-2.4160762091544887
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.7385371611563716
SCC-9,5566,3.224791432055543,2.973418434465963
NCI-H460,9936388,2.3098343611543415,-1.0281299632194045
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.936836674777566
NCI-H460,16720766,0.8258921674033131,0.769079605114927
FTC-133,54618164,4.149608396421597,3.956019412181497
NCI-H727,5281321,2.7498034475542803,-1.223571535052742
BT-549,31703,-0.610163723442028,-0.9426246790703136
JM-1,11609586,0.7887510712984062,2.074254011940528
MSTO-211H,65628,3.7458295220001,4.13997499447334
NCI-H661,9887053,5.171148908960024,3.751735902484258
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.2828777100554913
G-401,9887053,1.7608751069117703,3.441917845408863
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.48434889362860645
A-673,7251185,1.3487938120123666,2.216404203890263
ONS-76,4259181,0.68334491499701,0.23513532481617566
NCI-H292,613753,2.7114183475644857,3.2209977758590402
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,1.568949147036177
JM-1,25126798,3.029145333632086,3.585471114432656
CAL-51,3815108,3.0623029951861396,2.8470940345596847
SCC-9,16725315,5.212889946477865,4.2194410731916
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.20020697869306756
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,2.0045309975790033
LoVo,16722836,0.1488668556579147,1.4890178905556852
A4/Fukuda,25262965,-4.823082336145625,-2.328005830805804
OPM-2,53392493,1.6243275023991692,2.0697933105220554
HSC-4,9926054,2.0278633205902468,1.779926634130568
SNU-81,9936388,-6.314751034125396,-4.036739120245392
G-401,9823820,1.4384887897470693,3.7766780996279037
YAPC,24753719,5.0641073859888,4.341150590476129
OPM-2,24772860,-2.8738620885527153,-2.8563405083537132
MDA-MB-157,10427712,3.542893078297904,4.457385392111643
A-498,4259181,1.547873530266754,0.10143677738256594
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.9089946094355363
SBC-5,9927531,4.452264212548339,4.604401323769688
LXF 289,119607,4.549732560104057,5.213800192942264
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,2.208167611014033
NCI-H2009,11396600,4.054693544346837,3.6993603770975825
SNU-81,15983966,-3.5187473914136738,-2.811112439170908
Panc 04.03,11494412,3.764008563191269,1.8167848803545812
OPM-2,216345,2.3930113976289364,3.100317557710627
JM-1,66577038,2.266129645862272,2.9108926584608654
SNU-449,15953870,3.8419288275174326,3.4768325147476045
BT-549,9903786,2.513972936103366,2.946619484095697
OPM-2,44202524,1.1830318509158162,1.3685398349489126
OVISE,6623618,2.0550481440983153,2.5209302634089057
SNU-449,11657048,5.413893492178721,4.104173670774014
NCI-H2171,67291369,-0.2342814323553679,2.1112600197518727
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,1.2125312595838826
NCI-H522,11238147,3.4337502548923404,2.65282895776848
MDA-MB-453,16065773,1.7584918793826552,2.2250574290967573
LoVo,136227924,4.6796674015936075,2.7469106542943984
LXF 289,3854666,2.0847029854583377,2.1839092682956593
OVISE,984333,-1.5189255907846522,0.8222725829443358
A2780,159324,-2.166969557176003,2.8074837811245756
SCC-9,17755052,1.3521912896367647,1.4874243336544963
OPM-2,9823820,1.0965123517529505,3.7212415505353755
DMS 273,12001922,1.9670879212293255,1.820482879455916
KMRC-1,24180719,3.956198558970242,3.608302856004558
KMRC-1,637858,3.0556928718558707,2.0711773279858097
NCI-H2009,6917907,-5.363195379340594,-4.486943381919528
SBC-5,24748573,1.8248605513332548,2.045204067397535
CAL-51,452548,-0.9080095532304931,0.05284848310984172
BT-549,2858523,3.192172893232417,3.0746069283581043
KMRC-1,219104,4.439460794922528,3.9095579154009723
LXF 289,2858523,3.038787864461457,3.096481151626826
NCI-H1623,9907093,3.838952634819664,4.1655136341080015
NCI-H460,168313047,3.736921155938788,2.5292434521774636
JM-1,5287969,-2.2665073107333997,-2.321174983868715
NCI-H1623,2828334,5.745033734102683,6.086485181368391
NCI-H522,53232,3.4340993190045763,2.724666427275167
MDA-MB-157,24180719,1.846017762198611,3.6641641283658437
NCI-H727,2858523,2.9690043699309094,3.2395217445574427
HSC-4,3384730,1.6775009570022803,2.4989781483553806
MDA-MB-453,66577038,2.2210808109899687,3.1106456875246726
CA46,54619267,3.4754479185856604,3.667861500967411
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,3.2459535332850873
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.113348365494244
DMS 273,89183176,4.012998903778193,4.138535798053242
LXF 289,89183176,5.264029999533809,4.265767261529706
HCC1143,25154868,3.6479876335061863,4.372531637038307
NCI-H460,5566,3.3663694984335533,3.004494113293611
EFO-27,3384730,3.632582575012134,2.6853884343331615
YAPC,3854666,3.60977300269674,2.269806819216561
CAL-51,11960529,3.662834723962616,4.014214685598936
NCI-H522,4096211,1.7167000910654833,1.8470969533866588
LXF 289,46199207,3.0446562724495676,3.243285108159385
MSTO-211H,44507138,3.561974329612715,2.5363654339216053
BxPC-3,10127622,0.1850831315580212,3.7037328224416104
SNU-81,57519531,3.6375637578947098,2.1999268316664
NCI-H522,46926350,-4.757002390021422,-3.9510738291669223
LXF 289,675434,4.434927450149955,4.544922256731886
SBC-5,2858523,3.0625939376722147,2.9952560884942185
YAPC,3025986,-1.0818355674515514,-1.1873794121639025
G-401,753704,3.840031862409327,4.550207178397724
NCI-H2171,9933475,1.8341202855706125,1.832240960857915
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.881911921845557
BT-549,5746,2.744550621458616,1.1316309597399914
MSTO-211H,2733487,6.00734552009151,6.221275611692436
LoVo,9908783,4.437010992006648,4.933187646442251
NCI-H2009,46398810,2.5614683956162554,2.554910300763365
NCI-H292,15983966,2.054572304908195,-1.1121559186578929
G-401,46943432,1.6295589064479152,1.7157922965413475
LXF 289,54618771,-0.5375230222620658,1.1303760364619757
NCI-H2009,4261,0.1994590765469732,1.6130715540004013
NCI-H292,119182,-1.3574963176080912,-0.9054405896258345
LoVo,675434,4.114717976727459,4.276911470456297
CAL-51,613753,3.3238399640193177,3.1406767322595344
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.7396855003178127
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.508324186496086
MDA-MB-157,7251185,1.2275966709755557,2.302100702260131
LOU-NH91,168313047,3.5347026371928565,2.242745703158114
Panc 04.03,11175137,3.811547013287204,2.8637879689701795
YAPC,46191454,1.528991916080322,1.7299244672413108
Panc 04.03,246676,4.5210437514033615,4.556060525652548
LOU-NH91,107985,-2.204555775629559,-3.481559249940949
JM-1,9884685,0.5602575931973728,0.21394437070321295
KYSE-70,26596,-1.4453873864890578,-1.4905696161816906
SBC-5,11238147,3.923057921789592,2.408867761331117
CAL-51,5351362,1.1872361858703535,1.3912998900751297
CAL-51,148198,-3.728190383000159,-3.441624047408886
MSTO-211H,10074640,2.8901374693183848,3.191763565051558
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-2.9495967778474177
Panc 04.03,54618305,4.994656380487723,4.532247817819786
HSC-4,9444,4.231424733159592,4.263857692582157
ONS-76,136227924,2.542073211711186,2.9400482778029478
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,0.24361297904560683
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,1.3904264808171536
A-498,4705,4.1964696083385595,3.303074403227808
NCI-H292,4788,6.000922818610643,5.798277757288028
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,2.342593864600509
A4/Fukuda,168312962,0.589698091471745,0.4838585254995389
MSTO-211H,135421197,0.8053711662366769,1.8385715053366574
G-401,9826308,0.736562536874994,0.08797012742448439
JM-1,44202524,1.2333959484520816,1.4970457160244819
SNU-449,135984461,4.468051833024593,3.7573732684496526
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,1.6659543623354016
HSC-4,135999136,1.7584955345229645,3.8057086237310385
HCC1143,6918328,-0.4969866258783406,-0.03346436580715871
A4/Fukuda,2871966,-1.2628046939905593,0.2663848640296997
HSC-4,89928392,1.9678897287961257,1.167920208613455
CA46,7251185,0.9564015595877396,1.9249768021497795
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.5419878917307952
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.420440404123462
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.611733144018088
YAPC,9967941,3.379913520192136,3.520352156769825
Panc 04.03,119607,5.706581209982884,5.213538087001487
KMRC-1,46926350,-4.153095302049271,-4.033669585585091
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,0.31145651543235564
OVISE,5287620,-0.8119274098935182,-1.7843931418859396
NOMO-1,135440466,1.6123042261647436,1.9947528365526217
A-673,11507802,0.3878845266361032,1.237708651336898
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-1.7026562653603063
NCI-H2009,3854666,0.912328636385412,2.289547155518025
SNU-81,2749,0.983670801340458,1.7948431971321164
A4/Fukuda,25105715,3.290295740743095,3.298386975247331
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,2.9906692915141666
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.908447003310704
CAL-51,9903786,2.1849161121493847,2.794493230770093
LXF 289,5113032,5.558232749512156,4.732470093075655
NCI-H522,46224516,2.9506377913569244,2.205685550450012
FU-OV-1,56649450,4.970206677695459,3.3373016140371177
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.812580139649361
MSTO-211H,9887053,4.1066593545259975,3.529907130576069
CA46,6610355,3.575030613446337,4.04013425363102
NCI-H522,445643,3.9693726836499863,3.9181215033468093
A-673,46224516,0.8314688808424526,2.180369778988318
NCI-H661,6918736,-3.5059805921507823,-1.710035828580348
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.746487754007662
A-673,3825829,3.830298825271896,3.8851534266598753
ONS-76,11396600,3.887590392789339,3.5096804173031106
LXF 289,5282054,3.512278681739004,3.8282256154868137
A-673,54618771,0.7910545462175201,0.9622237655991972
KMRC-1,25062766,1.7411663615582824,1.9481757970943692
EFO-27,71751553,4.378478985868248,4.535708126399641
EFO-27,10074640,3.872803440374816,3.3564128328807055
ONS-76,24964624,2.710261416606334,2.4084920078574545
LOU-NH91,53392493,2.3846272258457737,2.4983411268869293
CAL-51,46199207,3.548155956826357,3.2749536761330806
DMS 273,227681,4.814934070367145,2.9694528908427085
HSC-4,9908783,6.127900398037499,4.962309644205536
HSC-4,10184653,-0.7296444895073179,0.846997976716915
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.403397434057005
NCI-H1623,44185566,3.0587688781610667,2.75724056382832
KYSE-70,6918328,0.2213620303324437,-0.048664948985543306
MDA-MB-453,327653,2.9444810987281533,3.2871216497714073
FTC-133,4259181,2.1331002918337925,-0.020230399552658592
NCI-H292,60750,-3.187051343712646,-2.8264069756318366
KYSE-70,60700,2.818490002790748,-0.35250966592272837
MDA-MB-453,24821094,0.7464785951288041,3.162692586657966
NCI-H2009,656346,1.3969032628362248,1.1038279809512042
SNU-61,24964624,2.494415785344137,2.1114962657587983
NCI-H661,4261,1.9569329914003135,1.5140769243887189
SNU-449,54618305,4.668068655096509,4.58949585755293
LoVo,135875424,3.182508442374063,3.7956360914409526
LoVo,6623618,1.7195113979524326,2.0679518518165336
A-498,135398516,3.177268179593805,2.289300565357652
BxPC-3,26596,-1.629746525957504,-0.8840044517277081
NCI-H460,2749,2.5004778765083695,2.1168908906498705
KMRC-1,46398810,3.012918063271682,2.702438396784367
NCI-H522,5291,3.860595721411624,3.610616661299647
SNU-449,36462,4.301758862194218,2.399158844596826
SNU-449,6918837,-1.494845192804234,-2.684584671153039
CA46,11955716,-2.7152267118714204,-2.0679379418904142
NCI-H1623,168313200,4.911870039242249,2.9358407726803066
NCI-H2171,10427712,3.6918148562663937,4.081039828836144
NCI-H522,262093,3.0660845932794656,2.8584783487880605
BT-549,168312962,3.315695506914068,1.890926602545328
MDA-MB-157,15953870,0.7968689532543627,3.300044199972806
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,2.9067946153315023
SNU-61,11364421,-2.983927558247801,-1.564720177008166
SNU-61,3101542,4.3555934573063695,3.643576819650792
NCI-H460,52947716,-4.997624319891589,-0.692748606366326
CAL-51,44543605,3.919885801001582,4.155708956986739
NCI-H292,12003241,-1.027467238096921,-1.030851652613417
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,0.7010880201692642
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,1.7839784158397602
NCI-H292,25154868,5.001413217408079,4.471770345964718
NCI-H292,36462,2.4286801987130486,2.216954937139283
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.8315910111490347
NCI-H292,159324,3.210621191245253,3.140122448663667
SNU-81,24978538,1.1236702452048486,0.41115515998643665
A2780,9929138,3.988043631552867,5.170922616478035
HSC-4,16065773,3.311693132411482,2.436875872577306
A4/Fukuda,400769,-1.555916482707746,-0.7435459563468466
A2780,11977753,-3.718954593203518,-2.0519658087661354
FU-OV-1,60700,0.8482129777629449,-0.2911422415221557
DMS 273,168312962,2.633531304827929,1.617805200154459
SCC-9,8515,4.77911141452934,4.006037024935252
A2780,71680916,3.658218554445846,4.307481229730135
FU-OV-1,5328940,2.1307155577669143,1.68786366433436
NCI-H661,42642645,1.2812432760018797,0.8471151085619536
A4/Fukuda,2113511,3.845432548996496,5.276607380282571
SBC-5,19582717,5.27972019168548,3.8280058666613854
HSC-4,11222830,1.068056053085511,1.7218373847048043
CAL-51,10427712,4.2973287072996085,4.262177573269403
A4/Fukuda,44185566,1.3030950937163224,2.1936492609190164
ONS-76,5278396,3.742938248744769,3.604593077100247
MDA-MB-453,46943432,1.9398007817238585,1.9896480236942213
NCI-H727,984333,1.9308701128060968,0.6884370535805764
MDA-MB-157,24889392,2.1225906954298535,4.2025701079017805
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.7978552389138437
A4/Fukuda,46843906,1.071626560517578,2.0487867708136562
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.0104173616036096
HCC1143,44241473,5.874360916813842,4.672519937090737
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.2144701862831446
EFO-27,6918878,4.955152670116511,2.818492715675985
CAL-51,5281672,3.9430830045045857,4.415237563314556
NCI-H146,9915743,-0.2957101551438801,0.9980326533605947
G-401,89928392,0.7343580800154272,1.2515673199048092
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.2694348210346162
EFO-27,6184667,5.467001643500489,2.8321170133950058
NCI-H727,3854666,3.6466691501950512,2.5788771143934124
LOU-NH91,9825149,6.244850491409518,2.36077523692277
NCI-H146,11178236,-6.140205122942071,-3.372344676341206
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.1341876997071911
ONS-76,448949,2.486443038536461,2.162603829000403
BT-549,57330099,4.335540938726609,4.197929579700985
CAL-51,44819697,-1.9765663783606575,-0.6975383328259074
SNU-449,5278396,3.499051739077657,3.5117622474715477
LXF 289,9956119,3.057634534881657,3.6737769671617637
A-498,9933475,2.3013420942123655,1.9936671267038237
DMS 273,10074640,2.948045052381196,3.1601946076808307
LOU-NH91,25102847,2.3579155704363206,2.308821609495882
G-401,5311281,1.6046025374895514,2.002180738869639
A-673,219104,2.2996165619151507,3.101699998157753
FU-OV-1,42642645,1.0692746742635495,0.7905751588277048
NCI-H460,135411,0.3374737909082799,0.7730488853411895
CAL-51,6252,-0.2076922850947726,0.7265402361028661
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.4788337174482467
LXF 289,10296883,3.609856485747645,4.002546939640137
KMRC-1,54626689,4.972873475873264,4.677960268174019
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.254437221119389
HCC1143,1750826,-1.2654463091368686,-1.4724073100614303
SNU-449,24785538,2.8069089427026346,1.6232656752533676
LOU-NH91,53495165,1.612116489462364,-0.1136889039382802
EFO-27,11609586,3.640431752283184,2.835837427230171
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-1.3793042735634164
Panc 04.03,104842,-1.0125052126256155,-2.4888598272033335
NCI-H522,6610355,5.34603712705315,4.615811580179328
NCI-H661,11656518,2.215339329496845,1.5264912999852311
NCI-H661,6505803,-0.5859050253944337,-0.42715994320302764
NCI-H292,5351362,1.0382380370911135,1.4446704615861765
EFO-27,11612883,3.4595212211892377,2.6078502317972796
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.1388273403460274
HSC-4,10302451,2.384078053411002,3.2187381778725017
NCI-H292,46199207,3.366381535989616,3.2261072370354817
LoVo,262093,2.370412929490009,2.7917782775819857
BxPC-3,445643,4.432772060189362,4.030461670586082
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,3.110414327592655
A4/Fukuda,46224516,1.3171235816864948,2.249728878372589
JM-1,3854666,0.4999957819555636,1.3074860163552442
NCI-H292,124202324,2.857386903129287,2.397311709067555
BT-549,1566236,1.7296376770428397,2.309051825557343
LXF 289,11364421,-2.6687395721676577,-1.8947465085790791
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,1.1778172482914713
FTC-133,148198,-1.6568063805549866,-3.3185275552073317
LXF 289,11640390,5.398484732926136,3.4985397581199793
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,0.967485388084576
LXF 289,2749,2.818144236178911,2.0057452162919605
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,0.9824356290811308
JM-1,135875424,2.019666731209586,3.319189844072594
SCC-9,4705,2.492131143046821,2.9090051882377326
NCI-H2171,151289,1.4157771037164255,1.0288586834537028
NCI-H522,644241,2.1349742590503427,2.2333782498496
A-673,445643,4.040507929851862,3.799296117053173
JM-1,6252,-5.0324479776154885,-1.1761183591657327
NCI-H292,208908,4.322795663590344,1.997530797448122
A-498,2871966,1.0686849145956876,0.49840789037809125
G-401,12001922,1.3873374697674952,1.721521069308576
DMS 273,44491742,3.7307306463602545,4.293607329380676
A4/Fukuda,11396600,-8.215434514364686,3.2069314772307638
HSC-4,3689413,2.5472025828962055,0.09223662799672772
MDA-MB-453,4378219,1.7417226469020404,2.2187041295725907
ONS-76,387447,-4.115404850127739,-4.290659708930237
LOU-NH91,656346,1.0077735762311986,0.6592582777421789
A4/Fukuda,3081361,1.810117399969756,2.175459591258038
NCI-H460,6505803,-0.4074860596498978,-0.6894008651564905
NCI-H146,45279963,2.8359939324557706,3.3935250914895247
OPM-2,6184667,1.6391974127027074,2.5344165483257
HCC1143,148198,-3.881060339055355,-3.493532448475465
A-673,421610,1.6759942643549426,2.979908786366029
SNU-61,4259181,0.2985440005718957,0.22069852756146954
LXF 289,44819697,0.5606163889857397,-0.38856692092532497
KYSE-70,168312962,-0.2970816131627225,1.5998771768344793
NCI-H146,11494412,-1.136229477240518,1.6101173070309585
OPM-2,2746,0.9082445461467812,2.2306385508510345
MDA-MB-157,6918736,-2.3678025624565175,-1.5734599209412503
DMS 273,135659046,3.477426326571923,3.4628868551040615
HSC-4,126941,-2.3076253927529127,-2.679190250190881
CAL-51,57519531,1.893237876741888,2.411402286902528
MDA-MB-157,3038522,4.043799431595376,3.158399897389032
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.3493059018906444
BxPC-3,54613361,-0.6294380958983512,0.22731527188011008
CA46,25102847,1.8345278315547784,2.1149249866134254
FTC-133,5746,0.3858378554684238,0.9160663212530821
BT-549,10113978,3.95693770646699,3.2555707872883533
A2780,54618771,-0.248592168161829,0.7881628917181034
SNU-61,6917907,-7.995083965311066,-5.159898234449671
ONS-76,3384730,2.185678697527176,2.5382727245197287
LOU-NH91,11228183,0.5456186750940368,1.7827449233817605
MDA-MB-157,25227462,1.286146426910961,-0.04907890071899229
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.3696519852324345
BT-549,439501,-3.1266914034371567,-2.2994013795979966
LXF 289,409805,5.2068809837223435,4.573020818786573
OVISE,148198,-3.4121309130102055,-3.1847105214529465
YAPC,262093,3.6115167721531343,2.998945383281179
NCI-H727,5738263,3.354715168796171,3.3428091195935874
A-673,6918328,-0.9424380212903694,-0.24416668986839427
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,1.5797897876013252
JM-1,445643,3.755930816022248,3.7943686449078764
A2780,25154868,3.617715738937927,4.349387520238576
Panc 04.03,81146,4.4293645850092735,4.560231151885017
MDA-MB-453,4521392,4.261545411784443,4.243684608464797
CAL-51,5460769,1.3780575552768597,2.860725777325234
SNU-81,9926054,1.3093723678717843,1.8039567689931149
CAL-51,2113511,6.39897875596168,5.206532751712608
NCI-H460,136227924,3.925006850615035,3.019448751215001
NCI-H522,24856436,0.0798065953372803,0.5026642881723038
SBC-5,9967941,3.629642521259923,3.3210186435018936
A4/Fukuda,462382,-0.2406989279082468,0.5074676133748819
OVISE,11640390,4.491956307789174,3.544245697663629
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,2.5483918053200627
CAL-51,24180125,2.8082301472193203,3.0173917970507342
LXF 289,25262965,-2.558275633709226,-1.655841376722247
NCI-H2009,9903786,1.8298580590992315,2.9145675599497793
SNU-61,54678924,1.5881868934361725,2.0875865363553046
YAPC,24785538,1.575520805381804,1.7037319116580023
NCI-H2171,676352,1.591250217642193,2.167899718304387
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.244871355047712
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,1.6081604758215748
NOMO-1,3689413,-2.5325178418163174,-0.9420885568132386
OPM-2,5284373,2.335601496737994,2.401265687387973
NCI-H661,10127622,4.958480333722226,3.7678799070939224
ONS-76,44185566,2.3053400119978735,2.4962912991504798
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,2.6388246005441482
HCC1143,11485656,1.8564802256291268,2.3015457849131598
G-401,613753,2.8041503953296187,3.1628624540921497
MDA-MB-157,11657048,4.26764748298064,4.429820461826473
ONS-76,24951314,1.2212354664419371,1.2592293585228294
A2780,36462,-2.0824592368546893,1.814358131454348
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.220567782480385
OPM-2,72376,-3.1510357921092376,-2.8978980663672997
OPM-2,6918328,-2.875264730320658,-0.9706013301981866
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,1.0363898135557803
EFO-27,168312962,3.0506772104926343,1.918817545209711
NCI-H1623,107985,-2.7226564689550488,-3.5944747205187615
MDA-MB-453,46398810,2.51328952557295,2.6132691474483045
SNU-449,49766530,-0.9876450445747244,-0.6097249205651266
OPM-2,25102847,1.4573873057147737,2.0301781066259696
G-401,3081361,2.1638535645332664,2.2310370446814978
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,3.9064636153492858
A2780,24951314,0.3580646626980762,1.0667765352477243
SCC-9,2871966,2.1501352130214695,0.6492523524913377
EFO-27,53232,3.845715413797161,2.480858508462953
A2780,5460769,-5.6757466443406575,2.060011720792056
Panc 04.03,10322450,4.721553837851545,3.9692939103771767
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.4741701718992382
SNU-449,23582824,0.6769149785817056,0.6996947329825278
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,3.318266440527462
ONS-76,3854666,0.984876663182433,1.7861301536380005
MDA-MB-453,71466578,1.854784458712459,4.089286188671574
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,1.8576226525270634
MDA-MB-453,15547703,3.861172408325267,3.0099134403180794
MDA-MB-157,252682,6.150103454129247,6.46767253232012
G-401,46398810,1.5664917458517695,2.4049429476123696
NCI-H1623,327653,3.600793829240414,3.239832182013514
SBC-5,6610355,5.221010400785003,4.231314194834555
A4/Fukuda,6918878,-0.3411937140873722,1.266340183303854
SNU-81,3062316,2.330723232319837,1.2011230436536147
OPM-2,9903786,2.6412283094975657,2.147283569298141
HSC-4,15953870,4.269670192757531,3.3333667510443465
JM-1,984333,-1.6115401451915106,0.330228204006851
Panc 04.03,46174525,5.826098059849913,4.121210599371435
NCI-H292,5460769,0.0770188109309223,2.7804900435802176
FTC-133,216345,4.490711794352075,3.4248819300943283
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.38888549637271574
FU-OV-1,5311,1.028726852721831,1.455329023917087
LoVo,9911830,1.9062113768292104,2.265543635589401
CA46,23582824,0.075225101675958,0.41270492683261223
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-0.5571394968378007
EFO-27,24797083,1.960036113572856,1.2763455995788042
NCI-H1623,5460769,3.63452416726077,2.7141367927848075
NCI-H661,5311,1.0541651051557333,1.1272894611729476
G-401,119182,-0.7625552993148171,-1.361213306809622
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,0.9754994548814748
ONS-76,11507802,1.2556507557201144,1.197329676420473
KYSE-70,6918736,-3.61435843984592,-1.8320670044038598
NCI-H2009,4788,5.716428228211685,5.624562058201795
ONS-76,54686904,4.527599605979478,3.618744485256263
CAL-51,2729026,2.5757432896171517,2.7274213383570873
ONS-76,3689413,-0.2845128895134612,-0.17571732887434194
JM-1,676352,1.381688063426603,1.7855882173198065
NCI-H2171,11238147,2.9150011478889795,2.653274837445738
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.10007291245614
Panc 04.03,5738263,4.451939152518209,3.508793335233286
HCC1143,71304818,2.928848735179534,2.401400787651842
OPM-2,9826308,-1.153894104617258,0.0027948008761137966
OVISE,73707438,4.551111956107329,4.0959231253610495
KMRC-1,448949,2.0346247593103257,2.022698258998109
NCI-H661,44589607,2.97822499860898,2.4821594803425953
YAPC,3503,2.818608145608573,2.4653420055924866
NCI-H522,3825829,3.960912701697082,3.777888430277644
NCI-H661,5738263,2.7657344337958687,3.299137674274715
CAL-51,168312962,1.4117577594763937,1.7005299444852227
CA46,4261,-0.8863355705331979,0.743482792031424
CAL-51,241158,3.781489879449518,3.848887539478264
A-673,2874250,4.616954738528679,4.580134329458017
BT-549,46191454,1.72486803708685,1.1711096423396654
JM-1,6918878,0.0294179493888284,1.0676957554736777
CAL-51,4521392,4.667802355757324,4.489155074875272
CAL-51,9915743,1.1260994347217144,0.5485045401982975
NCI-H146,46943432,1.2283557348915184,2.152614278014067
YAPC,168312962,3.6522382892319185,1.488628287959554
NCI-H522,44493528,4.173254194812623,4.3288399341696735
BT-549,10296883,4.161421407524775,4.0316316649739266
OVISE,11152667,1.81896217810704,-0.2278846557260495
G-401,6852167,1.9492633511801831,2.6590144765405177
NCI-H292,168313047,2.7678931286458974,2.3264677950238823
A-673,5329102,0.93841525470917,1.8398994391576453
A-673,11404337,-2.7698937773977033,-0.5195618928069851
BxPC-3,11222830,1.6538054387944447,1.5957764750160894
KMRC-1,25102847,3.2500467863275735,2.7476059682673815
MDA-MB-453,400769,-1.402270827463697,-0.5075023967297734
OVISE,89928392,2.0483381338479907,1.800253636902707
MDA-MB-157,136227924,3.402219650297347,3.0889569283887868
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.518403864759396
BxPC-3,5738263,3.0337675506106576,3.5730963604455392
NCI-H292,16741245,5.797273118380107,3.793868821110142
Panc 04.03,11404337,1.3784278741672673,-0.10232189634679312
HSC-4,2130404,3.512147769522711,3.286465636583855
SBC-5,5329102,3.79532117952851,1.6525112580482268
SNU-449,57519531,5.8010509150022145,2.7244941674579097
KMRC-1,1750826,-1.909836969824086,-1.7957215444622114
DMS 273,53245473,3.723579099176344,3.2893509022620826
A4/Fukuda,44137675,1.307300702935143,3.4058969377622033
LoVo,72734382,4.052668353480041,4.188033766201551
SW1463,57519531,1.6287135351441295,2.470096414770476
SNU-61,16038120,1.3103584397228891,0.9289719900041963
CAL-51,9926054,2.2227862000004577,1.9035263931942095
KMRC-1,15953870,4.40931040558564,3.5121122294845004
A4/Fukuda,46191454,-2.2780561859524457,0.6968855142299359
EFO-27,6505803,0.9411407576336728,-0.4811738056513056
A4/Fukuda,24951314,0.2081517019188384,0.8721362555796566
A-498,10184653,1.9377607214538883,1.3482953324965603
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-1.3441711116986192
NCI-H522,9911830,2.121034111225194,2.3491161598697583
YAPC,53392493,3.0834263437199705,2.908357798662324
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,1.6095101486303045
FTC-133,15547703,3.427766539334031,3.203718431499731
SBC-5,11404337,1.1992857421773124,-0.49853074217783344
NOMO-1,654092,-2.6158486127541343,-0.5436352414929189
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,1.2519788691564395
OPM-2,49793307,-4.879066461483742,-3.8841269189112477
JM-1,11717001,4.327873015149225,3.9544853033574117
MSTO-211H,969516,2.440842922513423,3.1122215499774795
NCI-H460,9926054,2.081701465030928,1.9413983054348602
LXF 289,9936388,-5.793518221083613,-0.46597059822232845
LoVo,10184653,-0.0525672628767589,0.981977684946389
G-401,9866186,0.2347893748246883,0.4987927564711654
ONS-76,BRD-K99584050,5.369990310930208,2.530663312772901
KMRC-1,168312962,3.867746451267385,2.023334413621368
YAPC,452548,0.3485834104810916,-0.1436395392600574
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.3519982001074402
FU-OV-1,6450551,4.626381712180732,2.501471042456215
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,2.875203799839024
SNU-449,5978,1.8233754703073703,-2.298534242001153
LOU-NH91,44589607,2.878199319266369,2.8019908456921225
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.46472920415297
A4/Fukuda,65628,3.8428022223998366,3.8994384937592237
A2780,42611257,2.862805810765337,3.134312214976971
FTC-133,49867930,5.271360985380777,4.249470811598806
SNU-61,56946209,-2.5026309203687314,-3.9585937537750584
FU-OV-1,3062316,-5.013660753129892,1.3246897567572433
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,1.2641005647971548
NCI-H522,123631,2.114949756755372,2.3362902038700857
NOMO-1,52912189,-0.5265680930430634,0.7117744001461049
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.365188734034802
CA46,2733526,4.193969711090682,3.498971364147262
G-401,44819697,-1.6952135460319926,-0.616091297781824
MDA-MB-453,44507138,1.496822662467132,2.4718154100549135
NCI-H2171,9825149,1.181898582623386,2.400337315762808
OPM-2,8515,3.0418796641091226,3.372582017157127
Panc 04.03,4096211,3.5665133346619684,2.015817014456934
KMRC-1,6610216,4.1544949822147,4.316957431152811
NCI-H460,25150857,3.536831166282903,2.3494814449692885
OPM-2,11977753,-4.6820583055789,-2.4216967791104107
G-401,49793307,-5.199300209786212,-3.2310913182245207
A2780,1239801,3.465676691044825,3.66702350696292
Panc 04.03,46398810,3.688960594211219,2.725013930884754
G-401,65628,4.0909837295628275,4.198541326716384
BT-549,53232,2.511840395622571,2.8572303623184467
NCI-H727,104842,-0.3454800108905812,-2.3685765321823062
NCI-H292,6852167,2.409220580223775,2.8517768037494506
KMRC-1,15547703,4.785371110425684,3.3258052709429418
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,2.8780558464483246
BxPC-3,16722836,0.8866010617403134,1.7427644330765626
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,1.2220625177297912
LXF 289,168312962,1.364587801939814,1.891872639516575
G-401,11626560,1.1843690178322546,1.9323654440089661
YAPC,3825829,4.484241364021175,4.042616343985579
NCI-H2009,46943432,2.8478796444115835,2.128150179923525
SNU-449,16038120,1.104181711259477,1.184616438768825
MDA-MB-157,72193861,0.2105280638919307,1.6179286519904843
ONS-76,46191454,1.5088295462826262,1.1190668367651562
LXF 289,439501,-1.653941874457911,-1.7969359814817714
MDA-MB-453,54649381,4.094182376460235,3.847443079729909
EFO-27,11507802,4.116687062031661,1.5404526411113517
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.7055826902330538
SNU-81,11427553,2.1196099795437733,2.4902950860464723
SNU-61,54143018,-0.3273600933762652,0.6619946594149553
HSC-4,17755052,1.8179922614483863,1.6359071432862524
EFO-27,2130404,3.4270754566369748,3.2173585037375094
FTC-133,24821094,3.776872089794721,3.109232603469615
SNU-449,44607531,1.5485785292308227,1.552518009934241
KYSE-70,24772860,-1.2328668610311222,-2.343323649336943
NCI-H522,11214940,1.077396173859641,1.988644308044229
SNU-449,1474550,4.524224948734458,3.429054955808916
LXF 289,44589607,3.4320685896186585,2.8759485912645113
OPM-2,31703,-1.5109362720248076,-2.2257503026931302
A4/Fukuda,445455,4.756694709293823,4.176390602289642
LoVo,71680916,4.224958300762603,4.7093550751750195
KMRC-1,25262965,-3.4791684180939,-1.5982206416147795
NCI-H1623,54613361,0.8976129642368637,-0.11431434738284592
DMS 273,15547703,2.68216153568037,3.088685579123131
HCC1143,5311,1.090656828429124,1.4136766243789136
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.5455702530938915
MSTO-211H,11977753,-3.756718801235006,-0.9816858861602205
NCI-H661,51037431,4.262261435001038,3.045622488400557
EFO-27,25183872,0.6822597295955183,-0.9018215167220006
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-2.938751462003586
MDA-MB-453,16659841,4.43927192393091,3.8251212061035362
SNU-449,3854666,3.254678167809475,2.0893480036455965
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,1.5723983690538526
HSC-4,46174525,4.818915916273074,4.184956368789783
NCI-H727,25062766,3.0095924827905813,2.0898267429524697
EFO-27,9823820,4.474335567240953,3.838354049795352
CAL-51,4917,3.122174268556499,3.1491126856321223
SCC-9,676352,2.0394457592349093,2.019636327121816
MSTO-211H,4259181,-0.7585521679245923,0.22246403158142625
Panc 04.03,3854666,3.6180263181428622,2.3165661233597152
A2780,11214940,1.8716907673631955,1.6414462825158393
Panc 04.03,445455,5.108054343544362,4.516773715859028
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-1.4521422775454804
DMS 273,3081361,3.0365977955778805,2.5732650172122016
BxPC-3,126941,-2.8667568441276083,-2.1960337185681595
EFO-27,6918837,-4.778560341054376,-2.9197982828679137
JM-1,9956119,1.3894298966841814,3.4094503001215384
CAL-51,60750,-3.4379358682898973,-2.59272476429585
SNU-449,12001922,2.031450773900583,2.083128220178115
SNU-81,119182,-3.3799134284972614,-0.9949431998076659
CAL-51,6918878,3.0110486558166274,2.7981334145412675
CA46,44819697,-3.819793103454841,-0.7674819011916391
OPM-2,46199207,2.048842595102616,2.838253432683487
JM-1,11977753,-2.0561747941195674,-2.173507285509454
MDA-MB-453,16038120,1.4822204990084098,1.0639611364946342
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,3.707081537883034
G-401,135928012,4.758772301459146,4.164633811355825
LoVo,445455,4.556737788306169,4.471099035541912
FU-OV-1,11964036,-0.3048537688067435,1.4778101325870059
CAL-51,3825829,3.9510679995615257,3.968284102369523
NOMO-1,66577038,2.985459327680272,2.7460444414030163
YAPC,4259181,0.8211273757017798,0.32826011680177886
BT-549,2708,5.415828272287544,4.67360129747808
OPM-2,4477,0.1075725295912922,0.46090560282809245
ONS-76,23635314,-1.3572631369234491,-2.275808302230822
Panc 04.03,168313200,2.993774278353398,3.0821757055960237
A2780,25262965,-4.532154518345387,-1.7653172471039422
LoVo,24951314,0.8531724175888866,1.3454173144984092
SNU-61,6918837,-2.02709157063253,-2.5597418698546566
LOU-NH91,6918878,5.623996708869271,2.6040454129161335
LOU-NH91,16725315,5.120050781978422,4.313587378876303
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,1.027606998122706
NCI-H661,16722836,1.177222753188902,1.7609104638063342
A-498,9935249,3.347418171794467,3.1398129627703653
NCI-H2009,44185566,3.0429431135599607,2.647116771842654
Panc 04.03,25126798,3.7756614801897377,3.766137048784275
LOU-NH91,24771867,3.0978851297923895,2.6142953155412196
Panc 04.03,10231331,4.944041434313903,2.114401808545635
Panc 04.03,9967941,5.787601223768576,3.5534228416387106
HCC1143,11497983,5.345504804401821,3.167661553699002
MDA-MB-453,6505803,-3.8322805026755806,-0.6328954809893794
LXF 289,285033,-1.4335563326434544,-1.7724897925404408
NCI-H292,3689413,1.7536313837601494,-0.21352628723923048
OVISE,54618771,1.319775250733869,1.2574417891061096
SNU-81,135411,1.0381613293566891,0.5232334510500284
NCI-H2009,451668,5.323035746604961,2.890183579609094
SNU-81,3689413,1.1974270464491454,-0.33193927397774453
FTC-133,5738263,4.07617232189308,3.0932013104412786
NCI-H1623,5291,3.880629558524794,3.8065877007815057
NCI-H727,51039095,2.7124063556691267,2.8544631456408136
DMS 273,262093,2.141936221481062,2.6145502564243674
CAL-51,6918328,0.3807555589851347,-0.04137464727537921
A-498,24951314,2.536702379510054,1.3647517910010232
OVISE,135440466,-0.9475229728449716,2.2528906878300945
A2780,11404337,-0.8981705286722745,-0.454516129097852
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,2.079337614073219
Panc 04.03,24951314,1.470760951451068,1.5019778323010982
NOMO-1,4705,2.5023829157060926,2.7658241191979154
BxPC-3,176870,2.768163283404042,3.2549233373087514
G-401,11609586,0.8694160359503889,2.468071183957322
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-1.005504234842225
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.3344125220367905
NCI-H2009,15983966,-3.9047819028388178,-0.9918507197599876
JM-1,16659841,2.088291676862089,3.2345818149913894
NCI-H146,5311,-0.0389435386139853,1.3700557995344014
A2780,72734382,3.371521062177298,4.083393650607977
A-673,2708,2.956024737310482,4.125966664098717
NCI-H460,11152667,1.2005763717636435,-0.5295217269038163
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,4.040123508695399
G-401,60700,-0.931594906554522,-0.9307674063342597
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-1.066001185478279
NCI-H146,31703,-2.278385754586821,-1.2617938487677842
KMRC-1,445643,4.4248475697731005,4.0425007563864215
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.0284188092843756
KYSE-70,54613361,0.0645626216296427,0.04469773119845086
CAL-51,444795,5.053001195278548,4.2776815158360035
KYSE-70,54619267,5.587983352589812,3.9912752802319345
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.4090705282908242
NCI-H522,135984461,5.248212763135773,3.7886728116872757
CA46,10385095,0.6992054873225039,0.9275438893480548
G-401,16038120,0.8239725572719159,0.8133412177345111
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,2.950158694874472
NCI-H1623,6918328,0.1782181011891448,0.04759271830109053
G-401,31703,-2.7567506026552904,-1.5259241992348274
OPM-2,11497983,4.2316824511311,2.231280589136842
NCI-H522,46215462,1.6065433434555243,1.902026864749789
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,2.401290352403956
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,3.9176607037853692
A-673,16741245,3.6856166817392393,3.6961194942665316
DMS 273,44486219,3.889102530118227,4.229731228366933
ONS-76,3062316,0.3527292351029743,1.6144031643134062
NCI-H1623,4521392,4.396491619301915,4.365785796766023
SBC-5,3062316,3.347274022566764,1.0801245089999925
OPM-2,374536,1.7033153768622478,1.7810734192717084
NCI-H292,5291,3.74340966649761,3.7576011788471506
G-401,123631,2.330078370852269,2.240872886200733
HSC-4,135423438,1.814117839489682,2.483443553658104
CAL-51,25126798,3.926975819986009,3.8160786551313373
NCI-H727,409805,5.9670224431598875,4.883241360155046
A-673,4917,1.8117239982797952,2.9911091424791194
DMS 273,57519531,1.9430749026869305,2.3768994987643794
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,2.8055765379886606
HSC-4,25262965,-0.4495508061813805,-1.4851060990009404
OVISE,327653,2.506626214633075,3.252410143514542
A4/Fukuda,71680916,4.641498651595925,4.339822682685097
EFO-27,104842,-1.4311942194738418,-2.4720034731512497
A-673,11626560,-0.097195247735582,1.6973682305198414
NCI-H146,3384730,2.6214971804948908,2.5634401128673163
MSTO-211H,26596,-0.5653018529577997,-1.3610199113911094
JM-1,445455,3.9843646189648863,4.109957296346474
CAL-51,11427553,2.069280384014222,2.741997284031177
SNU-61,20959075,-3.60077638491687,-2.6809033256524
LXF 289,25062766,1.8533275351899623,1.9463314783581567
LOU-NH91,24797083,1.602297413523094,1.3826805336873251
CAL-51,24771867,-0.5018492111736887,2.130339933318148
NOMO-1,44632017,0.9405041708842384,0.8973023262860689
NCI-H146,25195348,0.0229507172684141,3.3360554985700093
A-673,151289,0.5990139557366498,0.7844536348823753
JM-1,72376,-3.929922218649067,-2.6103920022275457
NCI-H727,12003241,-0.657143782776601,-1.1040686666985757
JM-1,24180125,1.1035620934920058,2.649230718097831
LoVo,24964624,-0.96112559187181,2.103065013313476
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,1.2096287131944892
OVISE,6610216,4.867128617935935,4.3478322972867325
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.725162023735653
CAL-51,11507802,1.2528060552922216,1.3601550544160788
A4/Fukuda,25227462,-5.883792654516593,-0.9784753866632377
BxPC-3,5566,2.8001360517565628,2.928798035054112
DMS 273,119182,1.6620070398785467,-0.8933725844426544
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.4870075297073353
NOMO-1,168313200,3.152434526133537,2.6156845787030862
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.5619914914920973
NCI-H727,24856436,1.7647429516878397,0.6674036468093564
KMRC-1,72734382,5.690666345136703,4.459249927528266
A-673,56949517,4.212065281653062,4.155298328112345
BT-549,135421197,3.4062158650675265,1.9481594829868425
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,3.027748519984477
NCI-H1623,10074640,3.727129107489099,3.2205722533839385
YAPC,5329102,2.676937714502371,2.0981781155423875
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-2.9557235222770033
NCI-H2009,4917,2.9963488408029417,3.052888941896587
NCI-H727,44589607,2.894616632949603,2.7340708153491993
G-401,5328940,1.7098947779411977,1.67612086445123
FTC-133,10410894,5.920528547603018,3.354619583181086
CAL-51,216468,1.370586512271769,2.5609851318371915
MDA-MB-453,227681,3.97271964535407,3.21554506200771
A4/Fukuda,5284616,3.229953451024844,0.5256671816508708
NCI-H460,753704,5.635234970240753,5.131492897516125
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,2.9431529932171916
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.5352339081515545
NCI-H1623,25150857,2.7146098705885127,2.4008352109171422
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.04062724473164
LOU-NH91,2729026,2.877851429076431,2.7683443105819685
CA46,46191454,-0.333651418813281,0.1675147597377533
FTC-133,65628,4.302527639906617,4.027537576005703
A2780,72193861,-0.1120033238626439,1.0575507145713796
SCC-9,49793307,-2.052824266331224,-3.1894678352272536
BxPC-3,135440466,1.2091890795281053,2.2761270035052656
NCI-H146,11455910,-0.4209962248823531,1.128427613812895
A-673,46398810,1.6125076634642133,2.412356319783624
SNU-81,11626927,-0.7774954189098839,3.281215140519579
JM-1,45279963,2.536030346276664,3.315163426779323
MDA-MB-157,5746,1.4435337882328911,1.2752021749380373
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.386955881413342
ONS-76,2874250,6.058821088556036,4.564746652111513
A2780,5284329,2.502098244540034,3.0290130261492982
LoVo,53232,3.084407514553567,2.757220727951108
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,1.2492272170667302
OPM-2,9927531,3.0625153090482757,4.413997432049253
SNU-449,44202524,4.173676721592596,2.027968495180589
SNU-61,124202324,2.5924607447988643,2.2559236597962364
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-1.8701089904206045
CAL-51,44819697,-1.9765663783606575,-0.6975383328259074
FU-OV-1,2708,5.501261259949465,4.7501426254034245
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,1.38566482641751
SNU-81,16722836,0.5712028725805488,1.4678528085423903
SNU-61,1716436,2.6740680266491763,2.859467688107488
OPM-2,3854666,0.6659331794855328,1.281090609283275
DMS 273,71304818,2.423766397759693,2.4697330474879235
OPM-2,44185566,1.967847411757682,1.9423154865688437
SNU-449,25154868,5.089625763576692,4.489264468318579
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.504798039810959
NCI-H661,5281321,0.7671093512543088,-1.405817080751631
SCC-9,44185566,3.0958673753547785,2.6403855456708607
MDA-MB-453,16736978,1.2653262263884038,1.4907658496094702
KYSE-70,9935249,3.427959003246725,2.579856118656029
MDA-MB-453,11178236,-5.341922221503707,-3.1050579127089084
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,4.698154217350199
EFO-27,24180719,4.15462806748021,3.4744609901172563
NCI-H727,44607531,2.33451518290986,1.6951707424683682
NCI-H292,10410894,3.620691172443616,3.0978258291043335
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.0172530234540322
MDA-MB-453,10184653,1.4947310227918462,0.6462794965597748
MDA-MB-453,11228183,3.436796326739784,2.196459682225544
DMS 273,67291369,1.8884432049214537,2.2706719538831
NCI-H2171,54619267,3.4799425585632204,4.083925254605606
MDA-MB-453,448949,2.258073743229602,1.9539262041787082
A2780,135440466,1.248320725279374,2.2460391665912907
NCI-H146,9866186,0.8123633746782326,1.0103102346955024
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.3498362639691357
A4/Fukuda,10074640,2.009206402328629,3.13237747439168
KYSE-70,31703,-0.0860185315527888,-1.1560759862647279
A-673,11497983,-0.3979292238924095,2.722978421468398
A2780,12003241,-2.743381978251489,-1.1319882658724905
A4/Fukuda,25102847,0.4372365282678318,2.311123735883637
KMRC-1,11717001,4.773123606238519,4.165313873092114
FTC-133,36462,0.6793689394766376,1.8374171961193648
SCC-9,23582824,0.351039434592286,0.9051083950795884
BT-549,2729026,3.014205222238777,2.749107412352447
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.2590662437113833
LXF 289,46943432,1.4312531154305732,2.253089467548741
NCI-H727,11625818,5.425399240643101,4.450903401425524
HSC-4,44507138,3.308450875381542,2.3442563198300688
A-673,969516,1.3043572294505754,2.7165574455233026
FTC-133,969516,2.842702479050133,2.917605188944388
HCC1143,11609586,3.6708937391840206,2.743944074579267
DMS 273,2733487,6.43119993607997,6.131720243351928
LoVo,10302451,1.0215583424111876,2.93403279192842
KYSE-70,46174525,4.613744209458669,4.096521980252754
SBC-5,65628,3.417870630997437,4.177560447780724
DMS 273,24180125,3.0640550148835812,2.904885184872214
OVISE,452548,1.282500130328104,0.2859150914155331
BxPC-3,71304818,2.4465042326182247,2.44284909972079
ONS-76,54143018,0.4309751541382265,0.4304813414039771
OVISE,24856436,2.006053298804951,0.5951772130422158
MDA-MB-453,71729975,-0.0804754192781109,1.9847694546565466
NCI-H1623,65628,4.265717950525356,4.332104084958496
DMS 273,9927531,4.953960158421894,4.646867884935086
BxPC-3,426756,6.38858222821808,4.20803267903825
NCI-H2009,49766530,0.9767616789625324,-0.4390848474376268
JM-1,2858523,2.95851246958296,2.973229196810907
YAPC,9935249,3.6850704434892823,3.083033105631376
A2780,654092,-1.3080416104753447,-0.46959268406507126
OPM-2,6918638,-1.573449675489913,-0.04325468732257293
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,0.6106583786553939
SBC-5,25105715,3.9151038194938352,3.3580503972562563
SNU-61,168313047,1.9617236271133212,2.4181564858556457
A4/Fukuda,11317348,1.1392337694005448,2.090659562332032
NCI-H522,25262965,-1.3157493467877637,-1.4676778842658487
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.1099925835353903
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-3.1195690902493607
MSTO-211H,44607530,1.4093785076150551,1.7289729482931446
HSC-4,984333,1.2474358256824072,0.4000494923280579
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.4064288748285763
ONS-76,9967941,2.912852232249919,3.6029664639489276
DMS 273,24753719,4.257561408038297,4.190164335038425
CAL-51,24772860,-2.425084956958233,-2.3200663024487636
MSTO-211H,44632017,1.2059374560785627,1.3373548836313622
NCI-H146,5978,-4.422435519224839,-2.4851167341341
G-401,2746,2.560873344661061,2.8841493523373827
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,1.6697509703633577
NCI-H2009,11152667,-0.3244172236423036,-0.2159060388367454
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.7050137310864795
MDA-MB-453,219104,3.605347452429255,3.595398481243415
KMRC-1,5280436,0.1724698964633139,3.420351027042906
A-673,25154868,2.9619598302203176,4.348744281437945
A-673,135999136,4.231524255529223,3.611359765783105
FU-OV-1,9884685,-0.2158788705773567,0.8455315863821405
NCI-H727,11626560,1.656358651993978,1.3820397091774823
CAL-51,9866186,1.45916914556855,0.6944762237746263
HCC1143,44507138,1.5952303095871043,2.2566950599383664
CA46,9823820,1.6053302041689723,3.596466710347156
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.6652276566868567
CAL-51,12001922,2.008779489179369,1.9458121909151287
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,3.6090865273981625
NCI-H292,19582717,5.466560288208149,4.137171010047499
A4/Fukuda,374536,-1.0311095755670416,1.5859750750142099
OPM-2,10113978,1.3298356496360293,2.5131536035077295
SNU-449,9903786,3.696408358539977,3.1355617537395757
JM-1,25195348,3.46638875562813,2.7484983182439646
NCI-H1623,5746,-0.5390712999232294,0.9580614279692073
KYSE-70,71466445,4.079477869375345,3.396622846763439
NCI-H460,44185566,3.2105564381381035,2.7218093422423437
MSTO-211H,6918837,-2.204195063499652,-2.5671464205876147
CAL-51,54613361,0.2180057854442524,-0.07051097320938977
A2780,216345,1.0708930445758365,3.5870398231827663
HCC1143,100016,7.122041956726765,6.116188271456113
NCI-H522,5278396,4.518604091155278,3.436913324473366
SNU-61,54619267,4.677926252875765,4.102028865460392
OPM-2,135421197,1.341685947169011,1.5254969051549798
G-401,72193861,1.057396802085585,1.119807157962691
NCI-H727,15547703,3.504014494953252,3.462396289900644
NCI-H292,11178236,-4.939590057195551,-3.175975369866517
MDA-MB-453,44241473,4.685974466458818,4.801765616651671
MSTO-211H,60700,-2.4521642225491065,-0.2866903205276663
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.322660581569035
NCI-H2171,4096211,1.8093642806404184,1.9622111061111047
NCI-H146,68056272,3.3997347898500063,3.4723165670203118
A2780,984333,-1.5561630492039429,0.37268775410064514
NCI-H2171,5479543,3.509510962528721,3.1948975491745237
ONS-76,6610355,5.379398654611739,4.489642673323131
G-401,2742550,4.179048555325354,3.6892606952361127
OPM-2,44137675,3.238695939616315,3.010830624971051
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,1.823042744280817
FU-OV-1,387447,-1.63105242136749,-4.199671570208108
LoVo,3825829,3.571391318080427,3.8734772704221485
JM-1,11404337,-2.1014875230304315,-0.9819517744403948
FU-OV-1,9929138,5.415072941349914,5.2569013580743515
SBC-5,5738263,3.46908634421933,3.29184722272577
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.8952855603523384
G-401,4917,3.172752348635073,3.0611705559146394
A-673,44589607,3.5509265356046305,2.782355672440837
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.7159758343314728
CAL-51,2828334,6.190580852669228,6.027209773139922
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,1.8743735165967188
SNU-61,67156097,-2.2274361546113854,-0.6667247535772473
OPM-2,65628,4.597670741376445,3.71155070318757
MDA-MB-453,3038522,2.334816038150176,3.168810102930432
HSC-4,2708,2.9878251305615477,4.613637531200072
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.3982389563587099
CA46,54678924,0.940253932332064,1.4525398817842723
SNU-449,11964036,1.3997299371502423,1.4590486596344854
DMS 273,54613361,-0.0987092047967699,-0.36198884300687006
SW1463,2749,1.5016847157281326,1.9009877903053185
A2780,4477,0.2147996237825641,0.5031840316129118
NOMO-1,9907093,3.6530797436282434,3.701242211704537
A-673,54618305,4.212251300263772,4.501873965731874
LOU-NH91,65064,5.187256751294022,4.885826900013909
NCI-H2171,72376,-3.3432588050758296,-1.7663608377141418
MDA-MB-453,72199292,1.3092335372039157,0.9112187652352961
NCI-H522,107970,1.611650854248594,2.34118866526952
A-673,444795,4.685959151928419,4.2650412001793745
HSC-4,6505803,0.688410933428746,-0.5410385690669852
CA46,11455910,-0.2967360934235351,0.3919854233841034
NCI-H460,6252,1.4342703041264255,0.39014306985669633
BT-549,49793307,-0.000238716840207,-2.998361512093358
CAL-51,68056272,3.9955701948507247,3.3109465711013506
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.2390542645695708
A-673,227681,3.19347186106623,3.2436798229620756
BxPC-3,54618771,0.182098153600537,1.1881800191015262
A4/Fukuda,3385,2.3595203579832553,3.0622428469770506
LoVo,36314,1.7018910931264415,-1.5805322968712852
BxPC-3,11152667,-1.4400195695513092,-0.4786530676368821
SCC-9,3025986,-0.0492814979551807,-0.9797428533457474
MDA-MB-453,4259181,0.7923345004369465,0.44365220684222884
Panc 04.03,9927531,5.313421559596226,4.787416851113263
LoVo,448949,1.89047161937067,1.9427568434120885
KMRC-1,5978,0.0310598033875183,-1.714219324174682
NCI-H292,262093,2.9868554632365556,3.015879155551986
CAL-51,9884685,-0.2528326244590672,0.4592601032390487
KMRC-1,135421197,2.781168744821282,1.9042692221370858
A2780,56973724,1.317874340119369,2.664951534666267
A4/Fukuda,46943432,-0.0927442133672991,1.47023957316856
HSC-4,50905018,4.462883747891921,4.405328567313119
JM-1,448949,0.7740790697885386,1.944329801872469
EFO-27,11964036,1.3211691780165964,1.456214513810933
A4/Fukuda,637858,0.8198578842358093,1.302698022205447
OPM-2,5282054,2.4375164125334217,2.85512670273769
ONS-76,637858,2.646425044184718,1.879253505801815
HSC-4,439501,-1.7709622187792924,-2.2327800434636456
KYSE-70,24964624,1.4483005111507754,2.373206815377331
LOU-NH91,5282054,3.3765969574471315,3.747905614559877
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,3.303380022064041
SNU-81,5281321,-4.892530389502709,-1.4674833163172358
HCC1143,168312962,3.1559735288767468,1.7107336989319981
JM-1,126941,-4.3883192692313955,-2.998333134909135
SCC-9,54143018,0.8755026739061308,0.3737863361910284
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.4498383455984527
SNU-449,1641662,3.672188762237013,3.6221905472875164
NCI-H146,54765302,2.77091239654666,4.037317272946907
NCI-H146,11427553,2.364557310661393,2.7043363081813134
CAL-51,159324,3.1794720270506307,2.970144709339885
YAPC,71466445,6.285156806731666,3.8114321483495304
ONS-76,5351362,1.281569720069414,1.299989517604194
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-1.0079933112622093
BxPC-3,6505803,-3.0514917868960767,-0.7868374729613808
A-673,45279963,3.7593508340409287,3.5527943659288246
CA46,3465537,3.345448990020783,2.0313242371700113
HCC1143,168313016,5.718985268806146,4.528081447276854
A-498,400769,-1.6101267353788036,-0.7035939853668052
NCI-H2009,10184653,1.0890186290305244,1.1820179887731197
NCI-H522,426756,6.015863149473534,4.231662965489983
NCI-H2171,44819697,-4.1780638649943675,-0.4976940680297385
DMS 273,24785538,0.640909019865508,1.3500923945912298
NCI-H146,6918638,-1.4860665745363582,0.10729048843209041
NOMO-1,3543504,4.095340640265792,4.053506904377534
NCI-H661,151289,0.3755226510544496,0.7831632522103468
G-401,53495165,-2.4189675718778516,-0.2531474321973381
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.092078490963009
YAPC,6918837,-0.3723714565085887,-2.527967246149394
BT-549,219104,4.096633484715141,3.625028100324339
LXF 289,24753719,4.56569970094865,4.327451269268411
CAL-51,25102847,1.94226811064499,2.5079221700720473
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-1.641209922549448
OPM-2,54618164,3.637238343412542,3.8485845135873795
MDA-MB-157,2733526,3.146610844933737,3.805847866891381
KMRC-1,54618164,3.981312375484732,4.1859401777821175
CA46,375860,-0.5712781411665353,-0.5934259448426183
G-401,24772860,-1.622851891505981,-2.447883086874682
NCI-H1623,119182,-1.1196330586869003,-0.8971534976766589
A-673,984333,-2.7710011035310074,-0.04991934770356885
KMRC-1,49793307,-2.5218593870176793,-2.838297271907052
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.2657377963849263
DMS 273,11152667,-1.0918930552191226,-0.7927333034794358
NCI-H460,44620216,3.8133491956675902,4.095636043255018
MDA-MB-453,19582717,2.5916230237173696,3.982368256618829
SNU-61,53495165,-0.6572534585269733,0.1936731147501624
JM-1,6505803,0.12933264701109,-0.5384277725757597
SNU-449,60700,1.1315850608054705,-0.20152126139687637
CAL-51,676352,2.3367523995253454,2.1246326993484304
LXF 289,89928392,2.4967474535679623,1.7256940165214016
LOU-NH91,11625818,5.704636625331963,4.268426515558134
MDA-MB-453,156414,0.9469838239648454,0.6915107889765584
OPM-2,462382,-0.5185214646773461,0.2058514671169437
A2780,53392493,1.4842280461046395,2.329585587886572
DMS 273,9823820,3.9764583445605006,4.01680940566613
ONS-76,24772860,-0.9083480450936676,-1.9922153260963915
KYSE-70,11612883,2.3570058511886396,2.5853406358555078
SCC-9,3854666,1.6335835525169635,1.8415265222432913
KMRC-1,375860,0.0373834100132385,-0.26951705358622247
SBC-5,9866186,-0.1944977114504531,0.6511272803902262
NOMO-1,11719255,2.6566855899212944,2.684227347489474
CAL-51,702558,3.5144984342436563,4.853006957936536
ONS-76,51039095,3.253449307143194,2.811473991664873
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.7023219038758635
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,2.6580524928581526
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,1.56121657617142
BxPC-3,216468,3.632186197150132,3.1034340870389956
SBC-5,2742550,4.323082293816951,3.6847484911204185
HSC-4,24797083,0.9836127584085878,1.4483076146448477
OVISE,4788,6.030976207458705,5.6764326209468665
LXF 289,11455910,1.909862916296106,1.048426384724221
SCC-9,16659841,4.917362195715636,3.739706999613201
G-401,49766530,-2.7444300270308113,-1.1296116529788183
HSC-4,6450551,4.030000721690881,2.5608359248910646
CAL-51,6918736,-2.0480142356294637,-1.9614073444790796
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.7594494424737535
SCC-9,4096211,2.914802879806832,1.8854193265977872
EFO-27,168313200,3.5651936579716277,3.0869364171587454
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,5.966135204058232
SCC-9,448949,2.996737074861378,2.0538599484709645
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.379187495776853
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,2.8619231049708067
NCI-H661,15953870,2.9876041506010003,3.3479068502111486
KMRC-1,6918638,1.621172594092556,0.562868433491371
Panc 04.03,44489675,4.301555650291772,3.918963077982145
HSC-4,54143018,5.46718478704898,0.4285375356754071
NCI-H661,11175137,2.5272908163527745,2.4187095304676696
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,1.9221939390616518
NCI-H292,24753719,4.2962074219620225,4.273544427183005
NCI-H146,11228183,-2.941805953111262,1.587328185943673
MDA-MB-157,65064,3.084719541991811,4.934237665736077
HSC-4,44491742,4.173988284907792,4.297999031523968
CA46,9933475,1.582522184359856,1.8095870117386306
JM-1,53245473,3.7598021769733414,3.0546896586050427
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.220704404859774
KMRC-1,702558,5.7321455674333475,5.394790593951366
EFO-27,262093,3.0007323703470896,2.867053395732201
A4/Fukuda,72734382,2.815137004147321,3.9961023530353517
NCI-H727,44185566,2.6786881549102626,2.522817763169226
OVISE,25062766,3.2029018764111896,2.1032905200992866
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.256739949394917
CA46,3825829,3.8503527939376583,3.564908309806022
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,0.26698564180594975
BxPC-3,60750,-2.6920891843690273,-1.7857768860168708
EFO-27,1566236,1.9834366009012432,2.1629894485118997
LXF 289,53392493,2.5437082258312804,2.647236099822099
NCI-H460,135421197,3.2510260026522233,2.1231866510986768
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-1.2569129906061094
Panc 04.03,44607531,1.8924568500741572,1.6014313081754676
ONS-76,15547703,3.220128707821482,3.1280973183250005
BxPC-3,123631,1.9141625570683185,2.392557693264783
NCI-H2009,24180125,3.399696031265864,3.141097022178455
A-673,19582717,3.777631654850071,4.103260071319839
FU-OV-1,12003241,-1.039273875540509,-0.9457661398102327
SNU-61,409805,4.743067556302579,5.011080421551132
DMS 273,11364421,-1.741561290091182,-1.871940017302916
Panc 04.03,11214940,1.7867172186781857,1.9426439362975247
NCI-H522,31703,-1.0005486569838078,-0.9992350436593711
KYSE-70,5287620,-1.7159794680358271,-2.0223614600115467
A2780,11507802,0.380240885087182,1.1677309578869637
ONS-76,54613361,0.8570205233962582,-0.19607372965620076
KMRC-1,2729026,3.101959850286169,2.8452514707678787
NCI-H522,136227924,2.2034936459857506,3.022637154142978
NCI-H661,52912189,3.763222756257729,1.706988957075699
ONS-76,262093,3.354802573562099,2.6507270365748394
A2780,675434,3.840840752716624,4.408048346429673
EFO-27,24771867,3.839082818590537,2.714461083068142
BT-549,44185566,3.1570730526396407,2.5327289671166877
NCI-H2009,89183176,3.352860584382055,4.3258849803792705
A2780,2949965,2.158264003903123,2.7949027275815252
MDA-MB-157,119182,-3.4496410534325093,-0.8963217801013574
MDA-MB-453,2949965,2.588847266095094,2.840025743518081
MDA-MB-453,71576739,4.365206221166654,4.175799527631962
A-498,11455910,2.747308138802023,1.1530431469881643
A4/Fukuda,448949,1.1686862984883333,1.7198886249341072
OPM-2,10385095,0.6586756349946576,0.9834062178259272
BxPC-3,52912189,1.4214477046132656,1.9538520641957815
JM-1,46907787,-1.9243382261841309,0.43505243323657694
G-401,3385,1.38862488630676,3.7346212377109036
LOU-NH91,24978538,-2.307670841327046,1.1966100094855963
BxPC-3,25262965,-1.1326145626109247,-1.372361924754697
KYSE-70,9915743,1.2522553618909642,0.9083422425900897
A4/Fukuda,42642645,-1.373677794386147,0.5352497003260518
A-673,44202524,1.1944686936342714,1.762408283067781
FU-OV-1,66577038,3.5319441468561648,2.9214375072667362
SBC-5,BRD-K99584050,5.772271611565925,2.3874005887000833
MSTO-211H,2749,1.2029234831790616,1.9332850743731824
EFO-27,2858523,3.4178086224101527,3.1996095647947556
NCI-H2009,54613361,-1.6701870677586086,0.21416741727525565
CAL-51,11626560,0.7349282975065881,1.861307241831879
YAPC,446155,3.8433351119798695,2.871929837798464
KYSE-70,3854666,1.6457032232411275,1.7829256465950223
MDA-MB-157,49836020,-4.4611089332084335,3.323417713657049
Panc 04.03,10385095,1.3607276101908192,1.3304003383186964
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.7564446868491594
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.3100419175022768
NCI-H460,31703,-0.6563705559837907,-0.366278546647064
HSC-4,135421197,2.1482643592466495,1.7789386642794756
KYSE-70,216345,3.953496119268799,3.624553946590544
NCI-H2009,44259,0.1981246725332563,0.9951749770343881
NCI-H661,24771867,2.8989054210712784,2.0444315229966055
LOU-NH91,89928392,1.577129115434841,1.6122392038206563
SBC-5,44819697,-0.6119786373907494,-0.9839336359335205
CAL-51,135398738,4.757337519270393,3.780095873672376
A2780,11234052,1.762226904306368,3.756371291737315
EFO-27,5287969,-2.249416082595734,-1.5213252492877163
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,0.8961167933724553
EFO-27,72734382,4.838814549837177,4.415489473933422
A2780,2126,3.67742533530732,4.5766553882415995
NOMO-1,656346,0.9377734591624955,0.40472885185314034
NCI-H522,439501,-5.784929410118117,-2.364029967524028
NOMO-1,4521392,4.093982124965485,3.93234786911142
NCI-H2009,452548,-0.9979896146805513,-0.08460282877274526
NOMO-1,327653,2.81345515165661,2.714659180779864
A-673,46191454,-1.7005324627981964,1.05823620113197
A2780,168312962,0.1167104942518841,1.7056614475385692
HSC-4,11214940,4.953530718305131,2.101385937154131
KYSE-70,44507138,1.8487883665285316,2.309799583716862
MDA-MB-453,5566,2.956907653722259,2.9773848495752406
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,2.771664262610278
SNU-449,24753719,4.452712705797618,4.270216387144056
HSC-4,6184667,2.683776581109496,3.0652472915917115
Panc 04.03,4477,1.027037586587599,0.48924107993971283
CA46,24951314,-0.0442972386064399,0.7637833730006246
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,0.8981351862235881
NCI-H460,637858,3.384702960830197,2.1392068446249524
MSTO-211H,54618164,3.0389284404004795,4.112913340689193
BxPC-3,135875424,4.118804534986376,3.866001486810477
LoVo,374536,3.1459286411718055,1.7787974983261383
SBC-5,65064,5.87027592575748,4.61674190832581
A2780,2708,1.6817262399506028,4.6505127085105125
NCI-H292,11427553,2.7677841547579347,3.0127461911357964
EFO-27,10184653,2.474041422726229,1.3877235967651445
LXF 289,16038120,0.5250135720403194,1.065619631274328
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.7098195331506445
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.2904244790592307
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.329753239852607
BxPC-3,10184653,-0.596247884950306,1.1035384405412225
KMRC-1,54618771,0.2036698487849761,1.6151259776184392
FTC-133,4705,5.547028107549284,3.2130210279223617
A2780,107970,2.1177540249197246,2.3222478852494217
DMS 273,15983966,-4.308041598319055,-1.4572961618648665
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,1.6815047141905963
HCC1143,637858,1.5767538824178036,1.9118881408603152
OVISE,753704,5.218614122812972,4.891963353800043
NCI-H1623,148124,4.04127286799143,-1.8617712473379944
NCI-H661,1716436,2.7606212382296205,3.0472290317593864
A2780,5328940,1.6938804432156576,1.6916484812688284
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.8183039576651029
A-673,52947716,2.7267743407084333,-0.794804650099466
LXF 289,51039095,1.6878089310027404,2.872206269006077
LoVo,24753719,4.853832341629896,4.164239294685638
FU-OV-1,16065773,3.3464590574422424,2.556656421198763
Panc 04.03,439501,0.3022334331499904,-2.0238218908221524
NCI-H2009,44137675,2.9238442509206606,3.7264851943218287
SCC-9,24964624,2.350052808289582,2.487833197639487
BT-549,56946209,-4.178729112607428,-4.176530215465957
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.643612620653609
NCI-H460,1716436,4.318712917611328,2.9767884028571387
MSTO-211H,4917,2.9904400598930088,3.1167795616758447
NCI-H2009,5282054,3.436101167626708,3.8700718110879455
FU-OV-1,53232,3.5510277872612903,2.807804880943122
NCI-H460,3503,2.4668231300278154,2.435706172992949
CAL-51,6252,-0.2076922850947726,0.7265402361028661
CA46,44607531,1.0933116261411373,1.260467811956621
NCI-H2171,44589607,1.1207968177639505,2.4319990127301407
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,3.3094165511401226
BT-549,5311,2.3943998607281314,1.610056564694158
SNU-61,44491742,3.859456688826312,4.187873607436533
JM-1,46943432,-0.1491870155181681,1.6303204258447224
HSC-4,156414,0.4374127066870092,0.9155718884039078
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,2.607304304850103
OPM-2,42611257,3.2957467857000404,3.0311206423464876
A2780,136227331,3.7351205807719863,4.278409357250162
MDA-MB-157,71751553,2.589623955944651,4.519207335243971
HCC1143,262093,2.740628946324062,2.970025064758568
NCI-H522,56946209,-5.885513086137786,-4.182147954529576
A2780,67156097,-2.4563073864206633,-0.9353913497106351
FU-OV-1,136227924,3.2834953568281597,3.0785278380078127
NCI-H1623,241158,4.3681147628536445,3.9136547185432446
ONS-76,2828334,6.172523844471339,6.032086705799444
BxPC-3,11625818,4.084435736278963,4.227507927202567
DMS 273,5281321,-3.764975659067455,-1.8303306098866747
KMRC-1,3825829,4.43742858244417,4.1522552470367255
JM-1,5280436,0.8051765864900793,2.7076323024318167
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.565604443921003
MDA-MB-157,9927531,5.35009923211275,4.682214054531478
OPM-2,56963564,0.1507827744052812,-0.12744269318319437
JM-1,9825149,1.1101255190052433,1.8353023089622624
A4/Fukuda,136227924,1.9204852137512072,2.794230713019392
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,0.9412835234610138
Panc 04.03,16065773,3.1082338307326687,2.5760142228184133
KMRC-1,148198,-3.0121915653316953,-3.5181354132203855
NCI-H727,11612883,2.6691234813665226,2.8551125126348085
A-673,25183872,-1.50300168442849,-1.1500068471571068
NCI-H292,5470400,0.7410873105484811,-0.5415122549424914
SNU-61,24771867,2.3194270269791772,2.303991901677262
ONS-76,2729026,2.9392891978845626,2.5870376945837545
NCI-H522,54618305,4.230012053256092,4.419625948222634
MDA-MB-157,6918328,-1.4439105140240134,-0.04697139047428642
SCC-9,11609586,3.4579622750703902,2.8752539154385595
NCI-H2009,73707398,1.4628489872410333,1.3769596963191504
BT-549,613753,3.1113642662223913,3.0448313824821076
NCI-H522,11396600,3.374818989992459,3.5826665491557974
A2780,227681,3.163289337051595,2.996751987003315
SNU-61,42642645,0.1547953205487765,0.8212052126702428
EFO-27,24753719,4.6250624916483405,4.211700297173918
NCI-H522,1750826,-4.884358581349171,-1.5671291338888866
NCI-H460,3854666,3.1385110084048065,2.190087331291705
Panc 04.03,16736978,2.069266987472695,1.5638128187212703
KYSE-70,135875424,3.720063911223788,3.7222829985080086
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.7676245746072955
NCI-H727,4369359,4.470803757423574,3.8366504954172793
SNU-61,10296883,3.559313583941647,3.722450126407479
MSTO-211H,24748573,5.719931334372704,2.2602309112813845
SNU-81,5479543,2.97701110816304,3.206586826411517
BT-549,2733526,4.582584043539932,3.835590822292735
A2780,135423438,1.4521240670524396,1.8820180088264957
A-673,24772860,-3.1744597884682997,-2.1646385267716606
G-401,15953870,2.2768915791068483,3.283586910892002
DMS 273,5738263,3.533950076223639,3.27920066584312
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-1.306746922438841
MSTO-211H,10385095,1.0224754227931234,1.2842916793888608
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.3813347267060216
EFO-27,25062766,1.510659268863457,2.0059666243111054
FTC-133,11612883,4.310092339589411,2.543769944743269
MDA-MB-453,11455910,-0.0078824359576409,1.1413882730528302
FTC-133,23582824,1.291713189645836,0.5930839678496195
MSTO-211H,6918289,3.158366552983379,2.3489426246296476
CAL-51,9826308,0.5677925602140103,0.14477261403283204
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.3152033052060474
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,0.9255904014446508
NCI-H292,25195348,2.925898223014509,3.1290739991692944
NCI-H661,71466380,4.502023854991524,4.340880345048044
SNU-449,17755052,1.8812917370069304,1.828401883491137
SCC-9,11977753,0.680369597029185,-2.0724889450579127
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.774713761161935
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,3.9394034534788562
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,3.268139903245973
OPM-2,56973724,2.552424788495835,2.153786576708538
ONS-76,24785538,3.425081329750359,1.544335759779588
OVISE,6914657,-4.467384055269322,-3.8681526368744477
CA46,7326481,2.91557869092902,2.6757001766743578
SNU-61,445091,3.84586130327939,4.402201089463115
SNU-81,387447,-4.728664972971387,-4.429267883125665
A4/Fukuda,613000,-0.1954730319333323,2.042354935499105
JM-1,54143018,0.7319009489566454,0.27853398941729746
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-1.0828090941248398
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.012939056015261872
NCI-H2009,11222830,1.732127254120576,1.6257269169912842
Panc 04.03,25105715,3.6014191473601236,3.4632772668261875
BxPC-3,3038522,3.5132521338876352,3.0645072590612896
SBC-5,2945648,3.183732803518487,2.814185922573281
SNU-449,6450551,3.816508101047544,2.691387172380205
A2780,4261,0.5678575604143293,1.5609662254162024
JM-1,54639665,5.005029028557516,3.1489137887424397
MDA-MB-453,55508,3.100658329893645,3.3847191448235288
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.3147814590614093
OPM-2,71466578,1.093801721105574,2.8728995953474366
DMS 273,219104,2.8685320291275276,3.2042823823584814
MSTO-211H,36314,2.7056254754018,-1.5499823058266304
NCI-H661,135999136,1.375733620998009,3.5061379281694616
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.4304162679566472
A4/Fukuda,387447,-5.631039688913266,-4.705560620659341
ONS-76,65064,5.2757302482281005,4.636025385788008
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.3277899531462358
LXF 289,613753,3.241655631161551,3.2177441236537554
NCI-H661,25262965,-2.0298208680132253,-1.9575324494001556
LXF 289,6438330,5.338014468481796,2.2481102925414893
HSC-4,51037431,1.5211622982639597,3.0828425358963756
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.6002597496033492
A-673,613000,2.3658771635142877,2.139293111911697
A4/Fukuda,135421197,1.440002399326734,1.8422782903649821
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,4.366844979783421
NCI-H522,322968,2.453472191773609,3.5093421941218765
JM-1,702558,3.1195416036187646,4.545116894535698
NCI-H1623,60700,-0.6326390393669364,-0.54479714291359
KYSE-70,71466578,3.801340757329347,3.4856721964040323
OPM-2,969516,1.7213945625906069,2.4180972082639416
FTC-133,71751553,4.47121108066688,4.533316316831213
HSC-4,4261,2.7283942469645424,1.61545015545017
DMS 273,60750,-2.8080851182888096,-2.9247848772087774
BT-549,11955716,4.243153956403502,-1.343348445449578
ONS-76,104842,-3.1760610756826826,-3.004006432269399
JM-1,54619267,3.2762986321752656,3.897016695932298
NCI-H460,11427553,3.3912724357702873,2.880538476285226
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.2301006675928188
KYSE-70,3503,4.330341802091645,2.306623023779044
LoVo,6505803,-0.2027234925460443,-0.7042221674372877
A2780,123631,2.055120977987268,2.252271714949489
CA46,216345,3.098455032375494,3.4646075521485704
SBC-5,216345,4.3270666561224935,3.656976038375186
SBC-5,104842,-4.617883126488141,-3.0259989048188345
KYSE-70,3025944,3.9400169946897226,4.1571793988904595
JM-1,16725315,3.055633956084052,3.8535256101953994
KYSE-70,3385,2.7043091028991175,4.118100504842635
SNU-61,241158,3.885428513145571,3.7640344751493675
Panc 04.03,44819697,-0.3269217472163675,-0.2873355645814274
LOU-NH91,151289,1.7382502757713727,0.7845948894748365
SW1463,72193861,2.3780707386668563,1.4000782166229242
FU-OV-1,3081361,1.2672435670761582,2.223233925095384
NCI-H2171,5311,-0.0981787470707459,1.113985722094817
OVISE,15983966,2.4746719809654474,-0.660722815601357
CA46,56649450,3.397645307363617,2.9591238606464874
G-401,135398516,1.567409789625541,1.8863143883758304
A4/Fukuda,285033,-4.063528792592557,-2.8593962788363303
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.6546573036703152
SNU-81,2113511,5.998073078967423,5.362804699555859
SBC-5,984333,1.1242620116457585,0.62088029735007
DMS 273,31703,-1.0453531837534489,-1.1569419077102128
SNU-449,11955716,-1.9372940063200903,-1.7414611917578295
JM-1,156414,0.9517000986854224,0.8923177061477048
A-498,5746,0.9967598286589636,1.0982736260789163
CAL-51,168313016,5.819136604546001,4.775844162321473
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-0.8865028179565699
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.9147878843429793
DMS 273,285033,-4.2902604104934685,-2.160970882621538
NCI-H1623,25227462,1.3835292391956049,0.7928031328761008
SNU-449,46199207,3.2102080061749665,3.233783938128281
NCI-H727,54619267,4.766187279700058,4.003299207321914
KYSE-70,2729026,2.877153539650856,2.582972261761899
JM-1,9866186,-1.392842627261666,0.5851071822356968
CA46,9956119,2.2503821303322864,3.492501340662173
NCI-H1623,10302451,3.5735543079001553,3.352800034774306
NCI-H460,119607,4.735621464768821,5.3832247411211185
LXF 289,36462,2.912637639845359,2.222502541973765
HCC1143,208908,2.564266394778906,1.9528830542195927
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-2.5792381713946275
HSC-4,10296883,4.12801319058873,3.8709381892278314
NCI-H460,44819697,0.8384181776379687,-0.3250345833315996
A-673,644241,3.265724898737132,1.9075451803125643
SBC-5,55283,1.6476943611515316,2.4192804999036897
CAL-51,60700,-0.6497243984818711,-0.6005641338701944
NCI-H460,44819697,0.8384181776379687,-0.3250345833315996
NCI-H460,2113511,6.407699041859446,5.587190333895237
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.497468906474982
NCI-H146,44819697,-3.0409273944044672,-0.8083234685208492
CAL-51,2729026,2.5757432896171517,2.7274213383570873
OPM-2,25262965,-5.528707504919602,-2.32020956031506
BxPC-3,67156097,-2.0030489961064664,-0.6179961074152697
SNU-61,11455910,1.387165489844305,1.0890674652419818
MDA-MB-157,6252,-1.2956844965038024,0.26423085878595054
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,1.6018922723957507
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.7513594604856926
MSTO-211H,5284616,-7.533473618112548,2.017362063727548
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.9047102800534139
NCI-H146,11609586,1.562173805318663,2.598131293267226
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,1.9806782529541322
KMRC-1,9908783,5.060189279561186,5.055035171182134
OPM-2,3825829,3.9075204590636226,3.6093738300815112
FTC-133,439501,-1.0725688155870328,-2.1155516728903647
MDA-MB-157,73707398,-0.5856522541525173,1.1718210539528864
YAPC,71466380,5.668462841036745,4.476786649480517
YAPC,81146,5.922853011724604,4.54050211721142
SNU-61,9935249,2.942554259952632,2.683392238333493
FTC-133,72193861,2.4976681850124516,1.5398389035443418
NCI-H2171,3025944,4.816182739912449,4.310357348244971
BT-549,6918638,1.3825585614023566,0.40818942621265736
A-673,24180125,1.1732098097274752,3.027598675090351
KYSE-70,46907787,2.9670215892594793,2.35982588779855
NCI-H2171,54678924,2.405018759443171,2.076752855624043
FU-OV-1,15547703,4.297867355017808,3.200965916028927
EFO-27,49846579,4.098108273885428,1.3898226280449197
HSC-4,24748573,1.230311327364621,2.1815328410516868
BT-549,10427712,4.3521452258648505,4.454328336079504
EFO-27,126941,-4.256911665013358,-2.4806662114623537
NCI-H2009,4096211,1.934112859371262,2.2347494551790548
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.764761777419725
NCI-H146,135999136,1.6477982136645704,3.5011914833239497
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.2995663817462457
SNU-449,2746,3.928036011173348,3.2645225031980005
CAL-51,11228183,3.6770505489909007,1.975249526224233
Panc 04.03,123631,3.678186856777378,2.4613149425867755
MDA-MB-453,6184667,2.451074325070958,2.9459974142458716
EFO-27,6438330,1.8682975687900552,2.17973772202274
NCI-H661,11497983,4.324872079299071,3.05520476026652
Panc 04.03,637858,2.9634699724220783,2.0232835961958373
SNU-61,168312962,1.49910092402229,2.2936034747924943
NCI-H522,25183872,-1.6150957585419312,-0.8452093758634642
A2780,6252,0.4918472463671758,-0.4175723129755615
A-673,15547703,3.0802315016781843,3.1963450393146475
NCI-H1623,36462,0.862958596391428,2.1136643520358787
MSTO-211H,44819697,0.327886174428457,-0.07615918225679548
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.3968584458091566
SNU-81,19582717,3.466001022974326,3.3478158646604
A2780,6610355,3.3735704633901973,4.28563727636426
SCC-9,119607,6.006958395758143,5.242324038395
NCI-H146,11625818,3.4222174762792843,3.9571952928870995
CAL-51,11178236,-3.674192911743539,-3.0797250821321303
NCI-H460,168312962,-1.8333752522095308,1.9803216121440843
NCI-H661,4788,4.879892558412017,5.5375256759526925
JM-1,4705,3.374089362448498,2.3784974265144156
LoVo,3634881,2.800959668083557,3.106217613935231
OPM-2,11178236,-3.008129792299995,-3.8385610027827126
CA46,9884685,-1.0270691788705264,0.22181840808658074
MDA-MB-453,44589607,2.562256212112598,2.7336122588016036
SBC-5,54454,2.279469523172582,2.408629095771339
LoVo,5311,0.3380696500116906,1.188654592072396
NOMO-1,100016,4.546215242968586,5.663012275268228
CAL-51,71304818,3.0248956992793565,2.3858293069508743
HCC1143,216345,3.8986832350959792,3.9684925615399913
CAL-51,54618164,4.021329289838694,4.201599595114874
NCI-H292,135398516,1.6270415918019412,2.150179076747786
HSC-4,71466445,6.061667629347064,3.7671458896715184
BT-549,51039095,3.595187367514741,2.863432687652518
MDA-MB-453,26596,-1.0726693130426117,-1.4131702263711317
CA46,4259181,0.0375174782651609,-0.2668068008881302
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,0.7715786602422153
SBC-5,9887053,2.384081187432928,3.356366878644989
FTC-133,25154868,4.81278236826852,4.4037967180671895
SNU-61,44202524,1.623676041505741,2.178304677421728
Panc 04.03,6914657,-3.724597953552904,-4.1170345348173445
EFO-27,445091,4.884678811382666,4.345157424957192
SCC-9,54619267,4.260733417129102,4.0337245516302955
LOU-NH91,3815108,3.3787088400125422,3.004547164888816
NCI-H2171,135875424,2.950178944342904,3.8554187267209015
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,3.2375504589142934
LOU-NH91,11404337,-0.9599092047687252,-0.19932618614074507
SBC-5,5746,-1.5208844717109098,0.97113967967593
NCI-H460,135440466,3.295247648571462,2.290800690682755
OPM-2,1242560,2.912152501304371,3.285646483506469
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.642942047808569
BxPC-3,11364421,-1.186359589843585,-1.8227427253123545
NOMO-1,11626560,1.0628914473501356,0.6587169632208753
MDA-MB-157,5311281,2.9465431337253065,2.3974331125929713
LoVo,753704,4.37626239298451,4.789810194694835
LoVo,1317464,3.6287749925486743,3.1345448346349984
LoVo,11626560,0.8234069861143318,1.6561005687107107
SCC-9,60700,0.6764265945588348,-0.424751469040522
YAPC,5351362,2.7486257978183812,1.574204253987441
KYSE-70,24797083,1.8843278101436565,1.3179651346002599
LXF 289,65064,4.964411921317377,4.833504014838465
SNU-449,16736978,1.6431800441666105,1.4374348620188087
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.2744314465361315
CAL-51,3062316,-2.5625958708444205,1.207599952306453
Panc 04.03,49793307,-2.352687994078586,-2.8646884404675093
MSTO-211H,10302451,2.2723798321327826,3.2092993320463172
A-673,54619267,3.9525164677601015,4.0644695011534955
G-401,448949,1.8289326894340776,1.9875929366569987
SCC-9,15983966,-4.042628093805887,-1.0001687240768924
CA46,3854666,0.2733202158609283,1.113096640518985
SBC-5,42642645,2.1700569257248734,0.47772611585904906
FTC-133,6184667,4.171777093513536,2.9590501981306074
A-673,3543504,4.433549859321033,4.26863281469606
CAL-51,409805,3.8515087112009656,4.521666876515283
SNU-61,5287620,-1.5621550618200195,-2.0731724407968013
BT-549,6610216,4.341228931549091,4.162866312525713
MDA-MB-453,44566777,-0.164341777615228,0.7060942325714434
CAL-51,219104,3.260140555917495,3.746992945538449
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-1.921054410131051
A2780,65064,4.350950935999884,4.757412886079946
G-401,9803433,5.696660690430479,4.5526675419468345
BT-549,11626560,2.6049019780447473,2.010686515034052
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.174706992584198
A-673,107970,1.5652885370840817,2.455248605946026
A-498,46199207,3.6222117747737057,3.1822028662766213
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-1.7046521378477362
BT-549,11364421,-5.683704390961643,-1.7931293507476909
G-401,25195348,3.8836243061511215,3.082417926610687
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,2.6048338822676183
LoVo,24901704,1.9806347162028537,3.3028114215845763
NCI-H2009,11485656,2.228831542035607,2.561524502088945
NCI-H2171,1750826,-2.946975931831454,-0.9547134469861459
MSTO-211H,5738263,2.0448017247583996,3.015024111283848
SBC-5,2729026,3.0750341046070933,2.5234880166364615
A-673,60700,-2.9578260017137437,-0.9956645666537806
KMRC-1,216239,3.2937854483312172,2.1916037131977926
G-401,7251185,1.5631627066286176,2.1343222103138797
NCI-H522,568763,-0.6787143148403639,0.28089176705780156
MDA-MB-453,52912189,0.0253127265648339,1.5847663459474446
NCI-H1623,637858,3.185553411157662,2.028215146264177
BxPC-3,65064,4.239552039257921,4.792332658060693
BxPC-3,44202524,1.2355479078044973,1.997405544297219
HCC1143,10231331,3.1675049490504943,1.514240550386856
NCI-H727,4917,3.0740580007272125,3.004800106626567
NCI-H522,46907787,0.5375692456309028,1.6270693318751237
G-401,4261,0.8301994759372666,1.4104503680733875
HSC-4,46398810,3.0881815243810897,2.6043344704204365
NCI-H460,16722836,2.818869820371906,1.623111013358061
CAL-51,107985,-4.126908547019261,-3.3587328379748893
EFO-27,445643,4.157223404562412,3.918612451452881
NCI-H661,327653,3.5614910429728295,3.1540897339546485
A2780,15547703,2.917961616739491,3.1699167796636942
Panc 04.03,11222830,1.7267772277517466,1.7822069378449175
NCI-H727,445455,6.030056890362138,4.697661144672909
A-673,72199292,0.9360047714765588,1.0462205722331672
DMS 273,2945648,3.171749675698132,2.962554853423664
SCC-9,6917907,-5.592045136043938,-5.640055958119227
CAL-51,72193861,0.6423702350358801,1.204990372238382
SBC-5,5281321,2.671163534426493,-1.5352118371144718
NCI-H2009,10231331,-1.9302715463885551,2.0204850723340173
SCC-9,3825829,4.24505295528646,4.067530436324113
NCI-H661,702558,4.861012061293982,5.004632881604659
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,1.812657378316474
MSTO-211H,451668,4.9569649646478515,2.3478298751112177
A2780,9908783,4.382006664554736,4.637619902545981
EFO-27,44566777,0.6667958565864378,0.7165471612925981
SNU-449,11228183,3.721594588319689,2.235869111767859
MSTO-211H,322968,3.0218271531726897,3.384800454245395
NCI-H522,135999136,4.552466214525868,3.511556491972603
BxPC-3,375860,-1.018881063070817,-0.07276913300642858
FTC-133,46398810,3.783858454202458,2.298348249466992
LXF 289,446155,3.7142968943868073,2.8298417797153532
NCI-H146,54619267,2.4574193717136663,3.9535726578396746
JM-1,400769,-1.2746733592438322,-1.0830381898926047
BT-549,5328940,1.7912058861852873,1.815169170768954
NCI-H460,15547703,4.965379127843483,3.2257824654980256
JM-1,10026128,4.426440879951995,3.8468078570063757
LoVo,327653,2.9108064375514604,2.964496544965065
HSC-4,5329102,2.7247882686097458,2.041971487286332
BxPC-3,5460769,-0.1362128387149436,2.740337578770511
SNU-449,148124,1.515559327544478,-2.12385003015459
KYSE-70,24951314,1.3178292218062186,1.1503584203656134
BT-549,11485656,2.9441987555380855,2.4999241594794173
CAL-51,9866186,1.45916914556855,0.6944762237746263
NOMO-1,5278396,3.0205756000124775,3.1375276046805043
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,0.9882155968184888
KMRC-1,42642645,1.142476115564406,0.9624562004999601
NCI-H460,100016,5.855223104671776,6.176052987831488
MDA-MB-157,25062766,0.4624374403471977,2.0841080269312995
MDA-MB-453,107970,2.0242856345207834,2.288671523763879
DMS 273,16741245,5.579276049340643,3.5396269472010373
BxPC-3,3689413,-0.056748072256038,-0.22864639094449735
KYSE-70,25126798,3.963979956832577,3.724406446466348
A-673,54678924,2.025744293137832,1.7234834883546604
HCC1143,25062766,2.2830484377909492,1.9620373445395265
NCI-H2171,11625818,4.794880990749841,4.12786640954659
MDA-MB-453,2729026,2.974469204821206,2.7951858303674832
G-401,9933475,0.0956350981602405,1.6453553235233342
NCI-H460,51039095,3.9314979002332535,2.848716427646869
NCI-H522,219104,3.343081396349963,3.6734986549590944
NCI-H661,56946209,-3.6194559692185018,-4.249465747084511
SNU-81,568763,0.5116878508289208,0.3217671649359304
A-673,67291369,2.4007963238191854,2.0407557781723105
LoVo,3854666,1.417426416420887,1.9040140901435887
MSTO-211H,439501,-1.1644309958543906,-2.3902285178451494
SNU-449,285033,1.5882926770841097,-2.1075790797307006
CA46,6918878,-0.7300256707111569,0.784174060913326
NCI-H146,71466445,0.6815814889300492,3.571908448911172
SBC-5,10385095,2.1758850118167077,1.1386194954587716
A-498,637858,3.4757595298108974,2.1104193913723397
ONS-76,11964036,2.0748582848578865,1.5940885796950481
NCI-H727,16725315,4.353817237787042,4.413326172436498
G-401,10427712,4.653472001336551,4.164187299276457
CA46,10127622,5.462644164632326,3.756459756916412
SNU-449,25161177,4.378304661297746,4.082518654683991
MDA-MB-157,49766530,-2.405889714389838,-1.0252589783959767
FU-OV-1,23582824,0.4003812349581704,0.8563807156514985
FTC-133,24180719,5.041424864241871,3.349029996882143
CA46,3689413,-3.563387503989764,-0.7584796096115922
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.9031455631114136
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.3968584458091566
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.623068934388349
NCI-H522,6918638,0.2628749411775776,0.4260327552824316
EFO-27,10127622,7.049186817655218,3.6834942780428896
MDA-MB-157,400769,-0.9429856644264992,-0.7129218022867573
CAL-51,54618164,4.021329289838694,4.201599595114874
LOU-NH91,9935249,4.429052878520747,3.0651109634554343
NCI-H727,49766530,1.5110740555461553,-0.6219306492859706
A-673,9926054,1.7717409858597033,1.9839774466579856
HCC1143,5351362,1.6023771560954885,1.5243237417386513
NOMO-1,54613361,-1.5441782746277026,-0.598357692984978
JM-1,613000,2.2697515166000355,2.4016764705884537
CAL-51,49793307,-3.2015156477281193,-2.848186133495196
NCI-H1623,1750826,-0.130863987039663,-1.4998818445616389
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,0.44632376502410276
NCI-H460,107970,2.752075604137296,2.3228966845981
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.1784475669051331
CAL-51,46199207,3.548155956826357,3.2749536761330806
NCI-H2171,10074640,2.5219754676966435,3.2011692222032684
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.9313392549466457
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.5215694491180862
JM-1,11238147,1.2374439058156688,2.4442964438942862
SNU-449,54678924,2.162306121493456,2.177587488625201
NCI-H522,3854666,0.0482767863302698,1.5286530257823918
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.5407518959771676
HSC-4,10427712,3.709601221495256,4.342605262793165
KMRC-1,10296883,4.079927671527966,3.959482328440795
A-673,46907787,1.1836850249017303,1.6202600854356564
NCI-H460,67156097,3.7191617083219097,-0.8854581236350825
Panc 04.03,11364421,2.200002813497647,-1.6555102859297373
A2780,57330099,3.934423580004946,4.2589048919382115
KMRC-1,400769,0.144742351180573,-0.5045727592773263
LOU-NH91,25062766,1.8056251936091945,2.030069811279572
NCI-H460,11175137,3.7005840280640374,2.66931900580329
HSC-4,124202324,2.961748327308983,2.281775107457195
DMS 273,46191454,0.2871755056280096,1.1338127113759837
LoVo,23582824,-0.7966748622900964,0.8715208085139469
FU-OV-1,24785538,3.56375796516153,1.5508969631219407
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.021245596026552
CAL-51,216345,2.9520334452605637,3.9114070149043454
KYSE-70,11427553,3.0124804015996185,2.379321385169477
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,1.9793411149406708
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,2.3840620991666857
A2780,54618164,3.641335469190071,4.039084683933027
SNU-61,2708,5.501133929338057,4.970427931885627
CAL-51,702558,3.5144984342436563,4.853006957936536
CAL-51,11175137,1.2330676481368064,2.551680955360009
OPM-2,119607,4.667002181538018,4.907655255203187
BxPC-3,4096211,0.9773140949236826,2.244369847945722
NCI-H146,2749,0.7789788955457625,1.9202891625376441
LXF 289,16725315,3.2486511295045677,4.278154377258089
HCC1143,4261,1.976797651434544,1.6553154705576287
SNU-449,11152667,1.3844218204303944,-0.39471730485814754
CAL-51,52947716,-4.729660133739893,-1.1559464895319584
SBC-5,4477,-0.6853772163114386,0.5626158383176253
A4/Fukuda,44819697,-1.7397384839387715,-0.714479128860804
NCI-H2009,54618771,-0.2233577251443086,1.3317427024723292
LOU-NH91,2733487,6.3296049393179485,6.334584546239615
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,2.9157623643799098
NCI-H146,89928392,0.6603214053079605,1.2675163758245234
SW1463,10231331,-1.1566445252598772,1.7436168199983715
MDA-MB-453,11977753,-1.828846421242697,-1.5751021639164307
HSC-4,445643,4.123722857917103,3.867153290493468
EFO-27,42642645,1.7670896576814532,0.9881535228063848
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,2.017722532632761
BxPC-3,5311281,3.739267965753581,2.5217456881898195
SBC-5,44185566,3.097813648169307,2.4480237972605865
LOU-NH91,5351362,1.6461408289790205,1.4383722096301366
EFO-27,50905018,5.404252445104634,4.4252996858155
MDA-MB-453,374536,3.68630764751743,1.8136161520718568
G-401,25262965,-3.9564581939856582,-1.9999820273114088
CA46,2749,1.009648399882346,1.0613120769194224
SW1463,387447,-4.88012723681038,-4.412827836154677
A4/Fukuda,8515,2.244185004641864,3.632887200136137
NCI-H1623,24901704,3.7829050158791064,3.382796266861967
HCC1143,71680916,4.5741598898507565,4.812732229244385
YAPC,54143018,2.4773688492488892,0.8974945738972555
FU-OV-1,49793307,-0.2872221589202163,-2.570845313987702
Panc 04.03,168312962,4.832441653848414,1.5820038582743106
NCI-H292,11609586,2.9930145326420146,2.8588858057239173
NCI-H727,25150857,2.574637897952517,2.2809339285233508
NCI-H292,6438330,2.681078996624105,2.282557472420108
OPM-2,12003241,-2.9738714531294232,-1.2409807561272042
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.061231672510038
NCI-H522,151289,0.0217168787144745,0.8228020457048715
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.4063126658965217
BT-549,11238147,3.2866911979765803,2.854808199339825
OVISE,9866186,0.5630702781820192,0.9038451719654702
HSC-4,6918328,0.4827098957230251,0.12347470072770354
NCI-H2009,135411,0.2253946709705592,0.8673370358623322
JM-1,10385095,0.4126425157623973,1.2077127898399933
CA46,45279963,3.66447519946476,3.354504432343382
A-673,44197249,4.247235211402652,3.7977332269816095
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,1.272205325270048
NCI-H661,135440466,2.665416885593315,2.1194550972920827
G-401,168313016,4.483065775660181,4.728025730653691
BxPC-3,168313047,2.402437406788064,2.40756208554201
NCI-H661,2746,2.7828270451310786,2.911115151901583
FU-OV-1,11612883,1.8669069183790803,2.765291857345644
DMS 273,53232,2.0931635545137266,2.568283419265666
BxPC-3,9903786,2.126136875029704,2.654482022260579
NCI-H661,11625818,4.41260734243293,4.187355185635218
NCI-H522,16659841,2.9113601324358287,3.7701579317462794
OVISE,53232,2.4849914286727426,3.0176733076276956
EFO-27,135440466,3.806006891786582,2.225924613893867
SNU-449,5746,3.348109332475853,1.3549905538276497
CAL-51,969516,2.948027689121256,2.80015374254067
FTC-133,11238147,4.273178384451577,2.7363752074736225
NCI-H522,24748573,1.6076101041751254,1.952555656780597
MDA-MB-453,46224516,2.0758190952131215,2.551609569726728
LXF 289,6918878,2.1668969721619833,2.724523513737271
OPM-2,451668,-1.14063259637223,0.3462013912131569
HCC1143,3689413,0.0716522323698814,-0.4413015269239455
SBC-5,135398744,6.447254342428179,6.3041393545043505
CAL-51,227681,3.694103991631346,3.132393418215198
CAL-51,5287620,-2.338247824560234,-2.0627533076916578
A2780,3062316,2.0817886994426704,0.9454981528573755
SNU-61,2858523,2.9582475566417195,3.0218024600420104
SNU-61,54649381,3.9147762798202863,3.740354361775857
A2780,10385095,0.5603604864283975,1.0710870886561175
MDA-MB-157,11152667,0.7570225590856333,-0.31202471802043824
ONS-76,400769,-0.3525004301248006,-0.5096161179499046
A-673,409805,3.491559756034339,4.681385598231274
SBC-5,10184653,2.5351322042771356,1.1870742360424387
NCI-H727,66577038,2.8647542032772604,2.936181849259951
A-498,6505803,4.020571046679738,-0.18891532181037887
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-3.1719139180927622
NCI-H522,2708,5.085998334781725,4.616669011617913
BT-549,45279963,4.047021813577569,3.682206919038773
LOU-NH91,25183872,2.2713164299079627,-0.7966506279549164
FU-OV-1,24797083,1.8707999880079529,1.215112271522334
SNU-449,44607530,1.456313243054954,1.852820180035801
MSTO-211H,1566236,2.167071233614174,2.586694202997482
JM-1,24951314,0.1302219808330525,0.7865732415472013
EFO-27,53392493,1.9151019076026368,2.5886599316622356
FU-OV-1,16725315,4.930691545287574,4.313982306328254
NCI-H1623,12003241,-0.4868602659209724,-0.9683282222730462
SBC-5,148198,-1.371938553790338,-3.802589203602086
BxPC-3,17755052,0.5794893802598977,1.9586694396059317
SNU-61,11485656,2.115016827038527,2.1590500474045076
LXF 289,2729026,2.289348740995074,2.8213291717709446
MSTO-211H,654092,-1.1984807631004837,-0.17423591450306017
A-673,5291,3.269854942504113,3.665528963692878
LOU-NH91,4705,2.8449970854381945,3.371838582437123
SBC-5,24753719,5.823724927288436,4.233665067761905
SNU-61,675434,4.254516948181055,4.3649638673946285
A2780,5278396,2.562980728115376,3.473343408883844
DMS 273,122327,5.509571347430681,4.662758148855984
A-673,9884685,0.1604809562987641,0.8140052751300024
NCI-H1623,16722836,1.0817030477122866,1.7470151261047755
NCI-H661,67291369,1.7470049727917394,2.0236335394092877
A4/Fukuda,135398516,0.099848878431286,1.8810551266968725
A-673,568763,-0.0608974572236531,0.2889344955922871
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.6320874674102335
SNU-81,11178236,-8.196337700198193,-2.9659055324627217
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,2.410599583861283
A4/Fukuda,46215462,1.453707580765341,1.5713078485245766
HSC-4,6252,1.1187983220422375,1.0279645168506064
HSC-4,3062316,-0.6194675763886993,0.7663817255892864
NCI-H1623,57330099,4.486652982197453,4.290958958236994
BxPC-3,23635314,-1.513116034089344,-1.536415293885136
OPM-2,46943432,-1.735277326796896,1.3021335760008284
FTC-133,11175137,3.295108533345337,2.5551214256864068
SNU-61,100016,6.106397388471953,5.960355415236761
MDA-MB-453,446155,5.408001660467943,2.6762219786207457
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.496094597558833
MSTO-211H,168313200,3.954855187852925,2.9513652048600507
LoVo,2729026,2.166128688763036,2.5824044009601868
FU-OV-1,73707398,1.0047751906041116,1.311580466086703
LOU-NH91,44241473,5.33179348194517,4.87729799791883
YAPC,135440466,2.1529261418392807,2.338015826893576
KMRC-1,568763,1.1483170277588293,0.43504309824692056
CAL-51,656346,0.8466306406200714,0.9024866397516665
MDA-MB-157,327653,1.3811083957143218,3.1491599807419224
NCI-H460,107985,-2.632533954936978,-3.3684203707447335
NCI-H460,135875424,3.211754300989152,3.9788715641062358
BT-549,119607,5.663531776682701,5.3637036542411805
KYSE-70,4261,1.9447398866595849,1.3648808798990077
CAL-51,44543605,3.919885801001582,4.155708956986739
SCC-9,44566777,0.4714703461280546,0.9173385246053235
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.6339826272758737
EFO-27,10322450,4.618987367546035,3.7276628063976704
LoVo,452548,-1.7762082467733018,0.10899045032311365
G-401,24821094,2.5559581237528097,3.0291464246117137
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-3.235570975612035
KYSE-70,135999136,5.194226724950964,3.6015330266316146
NCI-H146,6438330,-0.4558524131736901,1.9000135745648579
BxPC-3,31703,-0.5929664629875476,-0.8902218203169135
Panc 04.03,5470400,0.9135030177256964,-0.08124627830249401
KYSE-70,25150857,2.5963104301055258,2.217954560817841
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,2.8972778216859982
A4/Fukuda,439501,-3.252400391503616,-2.462557042954172
SBC-5,107985,-2.339881885950972,-3.806599312523025
NCI-H146,25227462,0.2247724046939956,0.18774993842261953
JM-1,44491742,3.590859136704876,4.038014744748741
YAPC,6505803,-0.1975849276423945,-0.6483842046135722
MDA-MB-453,10113978,3.193218839681212,3.11587857904255
A-673,16038120,-1.140194872712738,0.7196964450730349
FTC-133,675434,4.640800834602054,4.5113689422912735
MDA-MB-157,439501,-3.062684000428755,-2.012239117324678
SBC-5,10074640,3.660613951501144,3.0515609189006216
DMS 273,3689413,-1.7704206659692223,-0.9864400819921998
SCC-9,36462,2.4622585602605493,2.2118110645249915
NCI-H1623,46843906,3.212648418277938,3.050579256574549
NCI-H2009,676352,1.803439035619831,1.9467484945123517
CAL-51,387447,-3.720200693098244,-4.398953071353473
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.9857943697188132
CAL-51,44632017,0.9975947899898204,1.149940023471653
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.45931484468154404
DMS 273,9936388,3.4086707637717883,-1.9114745695684519
NCI-H1623,24180125,3.727544824819635,3.2963635335583423
NOMO-1,969516,2.327280884248625,2.377221809262691
A4/Fukuda,1750826,-3.1003590099134284,-1.4506951945824258
Panc 04.03,5281321,2.674318568781228,-1.521892705036428
FTC-133,176870,5.80195413779655,3.6190903240514114
CAL-51,10113978,3.4506321601115397,3.239946426687076
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.2459857246201964
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,0.5945877249741689
A2780,3385,2.4446535707127537,3.6716715567795712
DMS 273,45279963,3.8289869697511527,3.573214480907176
OPM-2,11609586,2.7966274513563496,2.0380021306985423
NCI-H1623,26596,-1.1542368606327895,-1.4179818116100142
SW1463,5479543,1.0422897086412093,3.2923143704040227
SNU-449,53392493,3.0071956547718113,2.698406974462592
Panc 04.03,11178236,-2.395899374087587,-2.9243945848271653
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,0.8997016221732972
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.687316816893846
NCI-H460,9866186,0.4176494313944011,0.8575853272182857
FTC-133,53232,1.7186310962422595,2.7968475202591163
BxPC-3,216345,4.279216843902863,4.077505229145017
A-673,10296883,3.758044639987347,3.9163569632193362
ONS-76,11178236,-3.26201925681368,-3.1933206557284364
CAL-51,25062766,1.9168321284868295,2.066461980281276
NCI-H522,6852167,2.4506568165817777,2.9390838326858026
SNU-61,72193861,1.1230875557226898,1.495871981887365
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.069931809850903
BxPC-3,3543504,4.240175882152398,4.489950297519956
NCI-H661,73707438,4.487630336801632,4.118089240889675
OVISE,638278,1.1296919637825429,3.1578445034352858
A4/Fukuda,36314,4.126705075384559,-2.0577191952831595
SBC-5,10127622,7.037598772691409,3.3824393098114793
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.6639745344231245
BxPC-3,49766530,0.5943123243750338,-0.49141122436346685
LoVo,54143018,-0.354466194309244,0.23566790025792705
BT-549,44589607,2.161067974853105,3.1337453283271817
LOU-NH91,3136844,4.41334270983783,4.3480698511903535
OPM-2,5311,-0.071810443528602,0.8190437040049295
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,0.9854154870290511
HCC1143,676352,2.389016147507623,2.029657627569921
Panc 04.03,11657048,4.4356176445581,4.10976321335105
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.1682441983621188
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.510249748508673
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.8394433764138691
NCI-H1623,374536,0.6337427379168257,1.967943340090532
SNU-61,3825829,4.102120147241808,3.9185782052756455
DMS 273,56649450,3.5073695444545288,3.2445288975228106
CAL-51,24785538,0.7720267524795773,1.29846443962687
OVISE,16038120,2.1825815777023965,1.0769003828972494
EFO-27,6918328,-0.3264411901724555,0.01490638649777637
FTC-133,3025944,4.352563236352026,4.350581703317568
A-673,89183176,3.363943107585485,4.190873644831237
KYSE-70,123631,1.697265417228948,2.510451488394969
MDA-MB-157,441298,1.9245422363016824,2.4683032554055524
A-673,156422,4.078876073319714,3.8648065815492627
BxPC-3,676352,2.25430531813019,2.0818529599221143
HSC-4,25150857,3.233332545340528,2.3529944177724804
G-401,24856436,-0.0141865957174665,0.3785730289722183
MSTO-211H,49793307,-4.316049670445352,-2.5363387068779026
OPM-2,11485656,1.3184852346481954,1.7342907591375805
HSC-4,208908,1.4999275809756432,1.9857969341822674
MDA-MB-453,54613361,-2.035930507333412,0.20159420436951186
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.8888022495687835
EFO-27,44589607,3.0601109795549295,2.8308214261984954
SNU-61,44493528,4.287806417412906,4.36515234607122
G-401,11152667,0.9519757620011424,-0.9252436632552987
NCI-H2009,5287620,-2.745575302534365,-1.8051176616528903
ONS-76,23725625,4.840348822045759,4.997666140451761
CAL-51,44620216,5.469091994130916,3.8737916639039707
NCI-H460,9903786,4.057661845653794,2.910143255798003
A-673,11214940,1.1675505170406824,1.146255867565635
A-673,24964624,2.426022149354347,2.166389073336906
BxPC-3,9866186,0.8001699279354296,1.0053853665056764
FTC-133,25062766,3.8237771334178903,1.9216784412398653
HSC-4,42642645,1.8060847122685193,1.0069993206645873
HSC-4,11178236,-3.2670379451965164,-3.078219741531708
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,0.9289069161621338
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.1821533105612234
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.57223580141183
NOMO-1,46843906,1.7610241193794407,2.290600821149713
NCI-H2171,6917907,-6.363958938419671,-4.869854982235808
DMS 273,11707110,5.189560989731051,-0.4237833232114353
LoVo,6918328,-0.3156299102516719,0.07114897177530692
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.081212947789796
NCI-H2009,44632017,1.0717713653211387,1.3959301993793722
DMS 273,11626560,1.283315066012986,1.8249695808714963
MDA-MB-157,11317348,1.0421206228140214,2.6172263777536835
A2780,5311281,0.918852428114819,2.1923454777684444
DMS 273,2113511,5.781557942421417,5.578115870886796
LOU-NH91,10184653,1.5324310696398793,1.3795371407759254
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,1.5390761673309867
Panc 04.03,73707398,1.757833710000806,1.3512494949511291
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,0.3506288708791791
BxPC-3,11455910,2.77826122800999,1.1841721391114892
MDA-MB-453,11955716,-2.2213534191245303,-1.6915549231952323
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.19557418299116228
NCI-H661,3634881,2.923822089210327,3.1329156924901373
NCI-H460,5281672,4.99885948312363,4.6250032565883625
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.2909711656716392
KYSE-70,4259181,-4.187670573846372,0.053443503170429146
BxPC-3,2756,5.8394588105914105,3.876959902104817
HCC1143,24901704,3.259585605807663,3.2879487694864427
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,2.3631725038227436
CAL-51,5470400,4.528848471588079,0.13424271581164773
JM-1,10296883,2.092198976716966,3.4698035912339042
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.9273316154402739
NCI-H146,46199207,1.7925573568525552,3.148467781786764
OPM-2,448949,1.278414281383,1.6152455591896107
NCI-H146,216239,1.510222966819436,1.873804997728514
HSC-4,9903786,4.262681016067309,2.786085860685179
ONS-76,57330099,4.261013423315652,4.192887094603395
NCI-H522,148124,-6.241132033807486,-2.606145154493674
SNU-449,156414,1.8120811787876097,1.5474358175801897
NCI-H2171,2746,1.1013983502046127,2.978600707685304
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.49059572700400045
LXF 289,135398744,6.087135496005038,6.450300080960289
SNU-449,3689413,-2.168376107627999,-0.4888717720096404
A4/Fukuda,5351362,0.320845740356061,1.2459916404641302
A4/Fukuda,446155,1.0805751863544764,2.5272326917956285
CA46,151289,0.6780663351050565,0.49615618837046993
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.1985442338078096
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.4710956305968512
NCI-H460,11625818,5.428588497019925,4.3605815965861225
A2780,119182,-2.871948238792312,-1.2791196036127561
ONS-76,10385095,1.1655527010487017,1.309030287891954
EFO-27,51037431,5.317639691280149,3.318488408970113
A-673,72376,-3.645473298633041,-2.0786078834423467
MDA-MB-157,24748573,1.7707431454067368,2.067098712633274
JM-1,6610355,3.6312795132079136,4.109065323836388
EFO-27,44819697,-1.290536172530674,-0.30153598199062903
A2780,5702613,3.197014181878355,2.931983296322569
A-498,25102847,3.3376740856950335,2.546775817519461
KMRC-1,3634881,3.321374403116886,3.3958780447658334
OPM-2,3081361,1.5210485339307265,1.9542417862157293
LOU-NH91,3038522,4.554088179549466,3.215175880597984
SNU-61,216239,1.9834133881004128,2.184542537846341
FU-OV-1,124202324,1.4335087059128786,2.5227905714724894
NCI-H292,72193861,2.2952018559260363,1.7401420981883777
MDA-MB-453,53495165,1.832682106227088,-0.0012127763428997729
NCI-H2171,31703,-2.460746582121975,-0.8443523992407487
NCI-H460,2729026,3.0609463870825926,2.8344549967733736
SBC-5,9868037,1.591902673624677,2.8891211054204975
LoVo,44632017,0.6073588127957028,0.9972111453992776
JM-1,25262965,-2.478831797463893,-2.0114620241070007
SCC-9,148198,-2.735497552895971,-3.493501323922564
CA46,89928392,0.0283947615438792,0.8211492930017968
OVISE,5566,3.518034595538079,3.0666838573279045
HSC-4,5278396,3.3910828172613128,3.439794956664718
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.44658195953330804
KYSE-70,4788,5.890959200463747,5.589891624065724
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.8856364903324792
Panc 04.03,374536,2.376032280196277,2.08786528216968
NCI-H661,20959075,-3.3600823520668306,-2.751430644592138
LXF 289,3543504,4.042070583449167,4.482384151722803
SNU-449,5287620,0.008240040829162,-1.8799495425927812
HCC1143,11719255,3.553533872223464,3.457658610334514
NOMO-1,54618164,3.731990472759892,3.778715233527535
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.6356744770609475
NCI-H1623,5311,1.5946462199665867,1.5049009777729128
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.4509304930111298
LOU-NH91,216468,5.562373540734892,3.1158459160254415
JM-1,9915743,0.8499678141273637,0.5249414209001197
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.744530399812277
NOMO-1,107985,-4.118574275669005,-3.9089177935005033
JM-1,135423438,1.5495237102322077,0.9999969874332028
A-673,24856436,-1.1403661815810562,0.30062334293987997
CAL-51,5282054,3.552468823116285,3.587358620723771
CAL-51,11178236,-3.674192911743539,-3.0797250821321303
G-401,6252,-0.6004387834343344,0.04397093856731696
KMRC-1,4261,3.216149224144429,2.010631373033419
MSTO-211H,54454,-0.190602208325988,2.656933156000688
CAL-51,4917,3.122174268556499,3.1491126856321223
HCC1143,54649381,3.828405406955801,3.8925111705992577
EFO-27,25262965,-3.442895730672298,-1.5050316788174856
NCI-H522,54626689,4.6269731577498066,4.632103135759639
KMRC-1,123631,2.4243478642730634,2.709283169906013
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,0.15147638362067858
MSTO-211H,6438330,1.6419113469823416,2.4088234601633434
CAL-51,446155,1.9002286289262065,2.736268605015735
MSTO-211H,25126798,3.885175037199499,3.7797707870663295
KYSE-70,54626689,6.762622459467938,4.567618158958473
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-1.3229534517538035
CA46,4705,3.1649236354970154,3.1706462724520543
LOU-NH91,36314,-6.12634068503974,-1.3220968208702077
OPM-2,49766530,-3.767684481967312,-1.065620821363777
NCI-H460,135411,0.3374737909082799,0.7730488853411895
NCI-H2009,6623618,3.0922058987418315,2.566438532873045
KMRC-1,44185566,3.110367208302614,2.7265309128783604
Panc 04.03,9933475,2.3468691227324965,1.9413608440259023
NCI-H146,25105715,3.2144396386290617,3.4785193849070457
SBC-5,25062766,3.305997596539037,1.8009736515079806
G-401,11364421,-5.069536717957333,-2.8452382665042917
OPM-2,1285940,4.143301448340403,3.33647295173888
NCI-H661,46843906,3.609730466041,2.677896684569875
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,2.050795925947296
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.3380699720498317
ONS-76,656346,2.4725060186946974,0.7858847903445308
A-498,135421197,2.4500558267656873,2.130494076008732
YAPC,5280436,4.973863444979394,3.301447522796769
NCI-H522,53481919,3.906372094667401,3.7138100377551306
CAL-51,448949,2.479839067238928,2.0445924577061407
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,0.6023962242813345
NCI-H727,15953870,3.6175866373148713,3.6135194263244785
A4/Fukuda,4378219,1.9024946719152895,1.9675038862470624
ONS-76,374536,5.32668572402577,2.041601584659896
HCC1143,387447,-2.8902460626215216,-3.9670977666860727
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.468878675960614
OPM-2,3543504,2.699241331915609,4.0441352575633935
G-401,54618305,4.431468655886698,4.46118892844803
A2780,54649381,3.634529154077109,3.6593888188982344
LXF 289,5287620,-2.3080718171081385,-1.7943125296665767
YAPC,637858,2.16601707981449,1.9484748022231668
NCI-H522,9915743,1.083108246388964,1.2498031936161502
KYSE-70,25183872,-0.2407157689495178,-0.7981599321183274
NCI-H522,56649450,4.1349782138767655,3.058062285226652
OPM-2,52947716,0.8847701060718332,-2.2301798830137725
SBC-5,124202324,2.6085939591802307,2.2855973328196755
DMS 273,2742550,3.72774264414297,3.7854650307761117
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,2.2037718539859834
NCI-H522,44491742,4.766943404170333,4.352457420449311
MSTO-211H,3503,2.7854032891391163,2.2034515575735116
FTC-133,10427712,4.710340548147587,4.293197842810277
SW1463,56946209,-2.6004240108086187,-4.274705786292442
KMRC-1,11178236,-3.5821993315226175,-3.478881339354907
NCI-H146,5281672,3.80713040102785,4.398393767162136
SBC-5,16038120,3.1431644252796835,0.6459923051388782
NCI-H522,421610,1.9391714098470076,2.7152385282036793
DMS 273,9866186,1.1265446059819233,0.7117015689614642
SNU-61,11717001,3.914635952460324,3.8273979568167498
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.3357970681040312
LOU-NH91,44137675,3.1585262513685612,3.5759221655844855
JM-1,5335621,3.4974928376934766,4.17480676580885
CAL-51,444795,5.053001195278548,4.2776815158360035
SNU-81,68056272,2.81466177200511,3.243184878921545
MDA-MB-157,23582824,1.002360199735323,0.6491439936066172
CAL-51,44185566,1.8630594392382311,2.6373096422518545
MDA-MB-453,54618771,-0.4179555738274852,1.1607730670797078
MDA-MB-157,16038120,1.7351596622267822,1.0880556821589802
OVISE,44589607,3.8530354372246394,2.917740570892612
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,1.0290559255520486
NCI-H460,400769,-0.4007490431715684,-0.43582573554887466
SCC-9,5460769,4.655053652221148,2.4246327024076026
MDA-MB-453,135398516,1.6443590350340722,1.9488427282013858
OPM-2,444795,4.04932788863876,3.678888224852429
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.0767781672886114
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.2038923348912969
HSC-4,11656518,1.5757846986297326,1.7714028564367483
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-0.8664668272410363
G-401,3062316,1.3877203939609295,1.229474437036864
SNU-61,16013152,3.3306050431250056,3.735335660753835
NCI-H292,4259181,-0.3596950747779806,0.20294357699631113
G-401,6918638,0.0373379560261908,0.39791256688179744
NCI-H460,53232,3.485336782178725,2.7049387318770526
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.6471185627525418
HSC-4,262093,2.780665409693215,2.966007123171124
LoVo,100016,6.001395250082881,5.91831831642516
OVISE,2729026,3.0624747536258843,2.8758007121895655
SNU-449,46174525,4.694645250518289,4.067114364878673
MDA-MB-453,25102847,3.185871702253412,2.410172754429542
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.200862852284365
LoVo,208908,1.8298234127328137,2.117636823248932
DMS 273,36462,2.158918041886743,1.4913767714717658
SCC-9,252682,6.244434841835944,6.514037163596454
CAL-51,3689413,0.5709426612715743,-0.5763460473871403
ONS-76,5328940,1.5304760606777814,1.8063867711927986
KYSE-70,46199207,3.0458734214111436,3.0023820051214414
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,0.9567899342753928
NCI-H727,16720766,2.0944103672723577,0.6996069894078184
CAL-51,16741245,4.222373420591208,3.932252736249592
HSC-4,23939,4.494005895197972,4.17654053237244
LoVo,60700,-0.3967380120150421,-0.7275174273814642
MDA-MB-453,25262965,-0.03783703480807,-1.6425200083018245
A-498,374536,-1.3715174839162405,2.3544411709181166
SNU-61,107970,2.0644711824277757,2.2329315186559784
G-401,702558,4.958816468985481,4.839941973219383
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-0.4038532803292346
NOMO-1,16038120,-0.1786929053902652,0.4210680350283503
HSC-4,3543504,3.922868331711394,4.478613644205934
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.144123735660438
SNU-61,10410894,3.2150759349666176,3.3086685657984702
JM-1,2746,0.8560843341026924,2.7822976307582206
NCI-H2009,15547703,2.9018345982556935,3.128250975147822
A2780,246676,4.314588687253318,4.338266489946521
CA46,135398738,2.145043320547598,2.8845032081769673
MDA-MB-157,55508,0.9028127001821934,3.4152469810256503
Panc 04.03,71304818,2.709197405012258,2.663318921896815
MDA-MB-453,53301938,4.664434739240087,2.4984869121036364
A-673,46843906,1.5511639515888018,2.756590137076856
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,0.6938172189979724
MDA-MB-453,3543504,4.170014094465671,4.447598302027109
NCI-H2171,5470400,-1.4637445210918176,-0.5018158183079131
NCI-H292,25062766,1.6798511870535655,1.91152162030591
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.5317100499326508
A4/Fukuda,16736978,-0.5754825114210159,1.1958734815815442
JM-1,2749,0.0460059123026362,1.2964603770595804
SCC-9,46215462,2.815249887965138,1.7411518708000975
SNU-61,24821094,2.5022209832597757,2.826077455970715
LXF 289,44493528,4.295099384269069,4.452242362627715
KYSE-70,54649381,4.140433754758901,3.7284649256876645
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.3387483275998518
SNU-61,9826308,1.2155896819085543,0.7042370046711021
NCI-H522,49766530,-2.92412408259348,-0.4933239020714991
HCC1143,44493528,4.485488370266477,4.379647719040872
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,0.09170124074499625
CAL-51,3081361,1.780158758130264,2.403813239792732
DMS 273,2746,1.8465116882146249,2.8912035907025473
HCC1143,5282054,3.2164949694146237,3.69317522010835
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-1.1075324570726692
SBC-5,644241,3.9213876276885458,1.621765189993604
DMS 273,702558,5.649496210085508,4.916571222356823
NCI-H661,25183872,-0.013752841490686,-0.9988313302452435
NCI-H1623,71751553,5.091527890142487,4.360781270433999
SNU-61,10322450,3.828611192492266,3.5567526457319043
YAPC,44589607,1.444383642816813,3.0042008277065775
FTC-133,426756,4.37678677221598,4.076196079318154
DMS 273,25062766,2.819032107658894,2.0871277745112264
KYSE-70,375860,-0.042936769343065,-0.331800033551427
NCI-H292,6623618,2.2662127680014708,2.335636569822202
A2780,3634881,2.2771511965432767,3.1070139943025223
FTC-133,11427553,5.52425857278767,2.5241715046516533
FTC-133,613753,3.41594619216373,3.1148276367061114
DMS 273,5978,-4.4169630962529896,-2.4638944419650084
MDA-MB-453,135398738,3.241714649843938,3.7569124430585945
G-401,252682,7.482268639703102,6.522059786272099
CAL-51,126941,-2.448006630223804,-2.7905945066515643
KMRC-1,1716436,3.642710819139985,2.887168233730812
KMRC-1,9967941,4.338887861114791,3.5948074778255115
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,1.9775836825561572
A-673,16725315,4.562355532440761,4.047453224402659
NCI-H661,54613361,-0.43407763491745,-0.051100979943958506
NCI-H727,17755052,2.165535951118127,1.910087208633132
LOU-NH91,4521392,4.279385220000522,4.267372479153358
NCI-H661,448949,1.832526735111792,2.124223337441928
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.727105426258512
JM-1,24753719,1.6485500810507543,3.7119064334743617
CA46,42642645,0.1424242949920916,0.6540841694351185
A2780,122327,3.970459431332868,4.318694078627364
LoVo,11609586,1.9215259939554383,2.3803268500239354
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,1.763876590970998
Panc 04.03,6918328,0.7116207668770654,-0.10736632674949353
YAPC,10302451,3.503177254309001,3.083468661452709
Panc 04.03,262093,3.918875507815306,3.175704968164642
Panc 04.03,4261,1.8035720705799856,1.553219134128407
HCC1143,11238147,3.6259374679037943,2.814018046466137
FU-OV-1,24951314,0.7779749033617789,1.4744175431846946
CA46,135440466,2.9995621349054007,2.0296808997925804
SNU-449,675434,6.334911868299287,4.551767188518153
G-401,568763,-0.8413074079434755,0.3421881982276717
A4/Fukuda,421610,2.9916322722523425,2.844337299093382
NCI-H727,11964036,1.415853516680377,1.2886876176864437
SBC-5,53232,3.018737473370281,2.4863507664803004
NCI-H1623,2746,3.1722069840164533,3.098733031418176
A-673,25102847,1.6240664882379,2.3965966562146783
NCI-H146,71680916,3.9962882248297182,4.601440074624491
CA46,702558,3.0016875761250383,4.414478568999055
HSC-4,3465537,2.7025414883497443,2.3298663364807415
SBC-5,15983966,-3.760719305706525,-2.38852961528362
NCI-H661,10184653,-0.0970326303224196,1.1162950156677336
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.925317937559905
MDA-MB-453,3634881,3.217596499324366,3.103500146604982
KMRC-1,54596558,4.448003654736506,4.332807125202867
SBC-5,6438330,2.801398037891768,1.9835510462338823
DMS 273,11317348,1.436395200538785,2.614767725684585
MDA-MB-453,241158,3.8848602363142697,4.084147866847383
CA46,72376,-3.3789820311778764,-3.1191942610451364
EFO-27,1242560,3.615097330539702,3.4838132724048667
BxPC-3,51039095,2.7952547650191297,2.7913318536357736
BxPC-3,71466380,5.524538311672043,4.627614620343241
A2780,49850262,3.28716577139928,3.487583187664943
EFO-27,148124,2.931737870457193,-2.160682166604164
DMS 273,65064,5.260786534928717,4.774236546559888
NCI-H727,5328940,1.5210077536616875,1.7102832293419743
SBC-5,20959075,-3.707780876124786,-2.8034608104773446
LOU-NH91,5281321,-2.3527775967876097,-1.5296577594532266
OVISE,123631,2.580734449711204,2.481684860905011
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,1.2758306410822926
OVISE,56946209,-1.506774361262591,-4.081365504022942
DMS 273,5282054,2.793045570742954,3.2461353049180897
SNU-449,11626560,2.613161578711923,1.901499842283734
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,3.263483121778439
KYSE-70,11214940,1.7563649507227177,1.9290243320106644
Panc 04.03,15953870,4.151399322633975,3.564127051622937
LXF 289,16736978,1.6084503302226174,1.985705116035486
MDA-MB-157,60700,-3.9633933148193066,0.05842239791469814
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.2061191282921557
NCI-H522,11152667,0.761836671652074,-0.648984688927748
SCC-9,1750826,-1.358939777918893,-1.7882154562243242
CAL-51,3854666,1.1494535123186709,1.6802020863322855
CA46,11656518,1.817934601803022,0.7364904605781752
CA46,46843906,1.200591966763502,1.9906197433883717
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.2559726840616889
CA46,24772860,-2.6679944090404035,-2.8552836493017395
G-401,24771867,0.701574094296253,1.9587878599192097
SBC-5,44202524,1.3408029920565403,1.604234299947004
NCI-H2009,44507138,1.543580962147717,2.5217264327142352
OPM-2,24748573,1.2641689672749945,1.7157699345910526
NCI-H661,3025986,-0.862198206140106,-0.9582838860406477
ONS-76,107970,2.339276188405755,2.226473799465289
BxPC-3,54619267,3.7277591748612866,4.120166318192813
ONS-76,4917,3.1821597264511863,3.1649687666367528
NOMO-1,44493528,4.211717002525977,4.278422830544708
SNU-449,421610,4.477929285236737,2.955143199099246
NCI-H460,4259181,-0.2054535095090753,0.2904073560210185
G-401,327653,2.827166761380022,2.9807884270337537
SNU-449,10302451,2.626140201612578,3.163019219058948
OPM-2,24964624,1.0133948666397414,1.262683723306266
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,2.92296197787789
SBC-5,441298,0.8643210359830038,2.502891464087059
NCI-H727,44489367,5.9503570299169875,4.639828007851161
HSC-4,123631,0.7882754974693414,2.287780334395367
ONS-76,24753719,3.8801096922841656,4.218494400043502
A2780,53495165,-2.5208465146636008,-0.5420226969465561
SCC-9,135411,1.0456929507985402,0.6503745181943559
A2780,6918878,0.724096247903148,2.1312030596758356
A-498,45279963,3.865048616527305,3.593325807119692
NCI-H522,51039095,-2.208127710853326,2.6095845886784574
LoVo,5335621,4.644708398315867,4.4469512679409355
HSC-4,46199207,3.2853086951025197,3.1295567811606406
KMRC-1,45279963,3.811973271229391,3.756680281310411
LXF 289,56946209,-4.292268406284497,-4.224963731449434
OPM-2,24775005,3.1759511003243532,3.5275880820786023
MDA-MB-453,11609586,2.797782394552202,3.025146804472624
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.278958776230623
A2780,53481919,3.3933560170788355,3.5418791830159826
G-401,25150857,1.6513368879801875,2.0292414331081927
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.5317100499326508
G-401,126941,-1.029913917257394,-2.9444438566456186
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.4515330943039144
MDA-MB-453,BRD-K55473186,2.6877336742225424,4.267561072825884
MSTO-211H,5311281,0.6318902138586533,2.352818454733986
CAL-51,44589607,2.4963130908502107,2.6633799903904043
KMRC-1,11234052,5.10610802043039,4.1323428818854095
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.57781905081753
HSC-4,5291,4.568554891244716,3.7931834746682425
KYSE-70,3543504,4.273044270546896,4.282267752434346
NCI-H522,54618164,3.979913879048498,4.067164499541973
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,2.855293099986147
DMS 273,439501,-3.5888564067388633,-2.4152635279117733
MDA-MB-453,122327,4.8881767020652775,4.628637837962271
A2780,6918837,-3.827695834319955,-3.169075775264608
A4/Fukuda,44489675,3.3968348796203003,3.8495372852641534
NCI-H522,25195348,4.252884841670477,2.9142581901816267
SNU-449,11404337,-0.5921655065432572,-0.047364026774217055
MSTO-211H,12003241,-2.79016034960529,-0.6350574214800419
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,3.4452695001973295
SNU-61,654092,-1.5451038120184588,-0.24237978573234245
NCI-H1623,4705,0.0935418442786881,3.236533739373923
NCI-H460,3543504,4.388423548450019,4.4983031387900505
NCI-H522,23635314,-4.582316729083318,-1.8469167018216148
LXF 289,6918837,-2.0130943060067454,-2.4077718108692334
LoVo,31703,-2.470313869470646,-1.0630084954465577
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.49558454380403627
FU-OV-1,654092,-1.6613932676517214,-0.3421116315655416
OPM-2,60750,-2.943046758118922,-3.4311145998409187
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,1.9620532039857637
A4/Fukuda,445643,2.2110077600401996,3.7868219521601354
JM-1,25105715,3.1433974364296526,3.1755700960458104
KYSE-70,9967941,5.193135802047497,3.6835722151006935
Panc 04.03,24748573,2.946919213932378,2.3087254223730636
MDA-MB-453,6918878,0.409116855324534,2.60253703053245
Panc 04.03,24901704,4.022965674422846,3.310426100834344
CAL-51,16736978,0.375988055286384,1.6169051136655437
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,0.7941509248735907
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,2.66406325724919
Panc 04.03,462382,1.207122186011881,0.6567049101660427
BxPC-3,568763,0.1839879990612418,0.584482024725173
A4/Fukuda,11640390,-1.5428779369431247,2.997418216788054
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,2.7590537512770403
NCI-H522,216239,1.926799438191183,2.2985615070118652
G-401,53392493,1.8463111416757765,2.2925449856229694
KMRC-1,241158,4.823138037217212,4.0075948340479215
A-498,5566,2.910612965628124,2.966954584530879
SNU-61,17755052,2.932810476371255,1.0167415512711089
HSC-4,49793307,-1.7279713732228117,-3.086613183277241
SW1463,49793307,-1.9541064611693424,-2.991373388014911
LXF 289,11964036,0.5627528071719251,1.5505041683241279
FU-OV-1,11228183,2.3859582400300683,2.196704331720467
EFO-27,5311,0.9089041307391243,1.596855079380317
SNU-449,44819697,-1.6819344520854818,-0.3536037912734448
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,1.3276825161100627
A-498,168313307,4.423397924448837,2.383607154740117
NCI-H522,19582717,4.722348713472889,3.7666670941577354
FU-OV-1,9903786,2.8592788804010936,2.817013147510559
DMS 273,444795,4.3404236236698495,4.341431638104082
A2780,56946209,-4.674045280410088,-4.232921666537492
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.630453216204334
A4/Fukuda,3503,1.0521499831923595,2.2749041650356405
SBC-5,6918837,-2.402107568310104,-3.1519737881101095
YAPC,23582824,3.2647123156294855,0.8001829694312482
HSC-4,159324,3.192829599869501,2.9038948601138603
ONS-76,54619238,4.4304444652836805,5.110156839460817
G-401,11228183,5.702662541402335,1.7495038564438672
JM-1,44819697,-3.7816867530650535,-0.7492396725635624
SBC-5,54143018,-0.8844414516239579,0.2897586660669495
A4/Fukuda,44589607,1.1710928843495056,2.5137939861034044
ONS-76,44543605,3.8219566402137457,4.100587320582669
YAPC,15983966,2.0827072702810847,-1.2603170585108245
SBC-5,2749,1.818007095297154,1.7802517006950698
FU-OV-1,44487872,4.488734888040304,4.463876557390349
EFO-27,44197249,3.884486906001317,4.143414156660209
NCI-H2171,10385095,0.5588950968794439,1.1272414413217358
LXF 289,5351362,2.37199640031851,1.682275262497277
OPM-2,54618305,3.930022905522119,3.6113817753185056
NCI-H146,327653,2.704686127708374,3.038733718486778
OVISE,11497983,4.4381003844097595,3.8529480169728476
NCI-H522,11977753,-0.2877362686640902,-1.5251623430372023
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1488038045300137
NCI-H522,11707110,3.8955176091352857,0.15890832873844402
HSC-4,3676137,3.997252050059137,4.516268947817746
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,0.9330290974127687
A2780,9840324,5.381878860524984,5.822942205713175
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,2.1633106116008687
FU-OV-1,6917907,-4.405886494893828,-5.001904160283064
CAL-51,71304818,3.0248956992793565,2.3858293069508743
FU-OV-1,51039095,3.5191953123451096,2.8133393285717863
SNU-449,5470400,0.6313893315276518,-0.34922068759178626
MDA-MB-157,6438330,1.1379279588809148,2.042074514310729
NCI-H727,969516,3.103754409621015,2.862836851874006
LOU-NH91,439501,-1.197324809082114,-2.21649547594661
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,0.28430780472468187
FTC-133,148124,-3.926787463073679,-2.078093617118035
NCI-H146,24901704,3.4954665576646216,3.2622782869003237
NCI-H146,6505803,-0.3489025917214021,-0.6742192293652337
BT-549,44819697,3.658602858416661,-0.3968140041326345
Panc 04.03,5278396,4.260606427966062,3.5186858907939453
G-401,11647372,0.0479330615057392,1.0360422224337003
EFO-27,71466445,6.412452895571818,3.7802567908291946
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.366985379695376
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.657801276718302
NOMO-1,1716436,2.6410194121109773,2.825480959298892
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-1.549995743269205
SNU-61,46199207,3.1956978461436014,3.0994702409344894
LXF 289,4261,1.4002862892534345,1.796653313329898
DMS 273,46843906,2.9019571008738763,2.6589879944587613
SCC-9,25150857,2.532575506870741,2.387201931007611
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9544098018494228
NCI-H727,24785538,-1.326987163467981,1.6148615066059337
NCI-H661,11404337,-0.0954545894437525,-0.3223611766518932
MSTO-211H,66577038,3.302731292752764,2.816128624645996
OVISE,126941,-1.5326684035544371,-2.097875608848437
BT-549,44566777,1.3521548270810906,0.5977776201901199
A2780,3025986,-2.2950808421603983,-1.1196426778129436
NCI-H727,16736978,4.598640955798025,1.3917426888004725
JM-1,6610216,3.7780643735318615,4.089819044649773
MDA-MB-453,168312962,-1.3854623993271444,1.7232659112482773
LoVo,2749,2.494181165729376,1.8493271558377515
OVISE,15547703,4.212246909591729,3.3291368805096773
ONS-76,16736978,2.0849164003870877,1.5549788084489282
MDA-MB-453,1714884,2.9618056579194585,3.1703162357903754
DMS 273,327653,3.1988672985426847,2.9564273745006435
YAPC,2828334,6.193046978626199,6.17705416215914
CAL-51,10184653,1.4453250777347395,1.4309072468194333
Panc 04.03,9936388,2.385451093408398,-1.5087806341033236
NCI-H2009,4477,0.2115452666376647,0.6906992395154026
A2780,322968,2.566344426002007,3.384362373885236
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.1295140762238627
EFO-27,216345,4.384346641524126,3.9394872101048724
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.4926495103856734
LOU-NH91,9956119,4.571782850484356,3.735725139948205
NCI-H661,1641662,2.9325574972427813,3.354637382981169
CA46,44493528,3.81061502276679,4.209951951565974
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.6795369828946053
A2780,11647372,-1.4335547211387447,0.966931953259443
SCC-9,176870,2.779248818408345,3.0044462156190543
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.8681332267790747
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.5302831546642889
NCI-H2009,25183872,2.394233803753281,-0.5551120626137728
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,2.9826990568318017
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.4335267652837949
NCI-H727,11222830,1.7878002384813196,1.8270206839156022
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.73498650864881
SCC-9,9823820,5.247901285797655,3.8202189959710338
FTC-133,44462760,4.267925011817446,3.318700480738679
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,4.813685338947549
DMS 273,54618164,3.989243888703328,3.947100305041683
A-673,5470400,-1.9410984929514092,-0.19483764313653176
A4/Fukuda,56973724,1.7857996527787343,2.423009278401773
NOMO-1,5311281,1.2143454060885572,2.1713336848726743
CA46,135423438,1.6657304721140649,1.465659799938765
HCC1143,5287620,-1.5012475814925117,-1.7477449907881608
EFO-27,107970,2.9901836608736883,2.330848329716194
EFO-27,7251185,1.6138148752584345,2.4849835368257245
LoVo,11214940,1.900565531770479,1.704767728418072
NCI-H2009,6450551,1.0382100121131883,2.8578661665112928
LoVo,3081361,0.9226789940369008,2.3626080049339513
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.09063831916862
Panc 04.03,2113511,7.412620584739622,5.565669893686862
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.7868134352614404
A2780,42642645,-1.071178701221225,0.5475450020077465
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.6955209857981857
G-401,72376,-2.6056367900842745,-2.3256251606053944
NCI-H460,54618771,1.6853262233131374,1.2415922083733557
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.20406597989364
NCI-H1623,60750,-5.650217340343659,-2.532174808088491
BT-549,49766530,-1.005486623843658,-0.5565440501740715
NCI-H292,10184653,1.6188231902933972,1.4957683135798479
NCI-H727,5282054,3.939726324876112,3.626388731677391
Panc 04.03,11485656,3.4698409381110435,2.2749663805370957
NCI-H522,24772860,-1.6489481573528793,-2.156358140543477
NOMO-1,136227331,3.913043208951298,3.7691314532422866
FU-OV-1,984333,0.3323688812243723,0.6674817407969705
LoVo,9911463,2.8816718818913176,3.658250955654787
NCI-H661,6917907,-5.078778116905793,-5.3503691466053365
SNU-81,25102847,1.5499571993593506,2.375315813591244
CAL-51,159324,3.1794720270506307,2.970144709339885
A-673,122327,3.9666709409894527,4.430561247424843
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.303658625034783
KMRC-1,2858523,3.233729541186922,3.1555823492338093
LOU-NH91,9823820,5.384931157369051,3.9678996986981456
NCI-H2171,5287969,-2.1635291246577286,-1.5892957049258234
A-673,426756,2.5032328390514365,3.9487743813075253
HSC-4,24964624,2.5086826728272538,2.614047851830382
NCI-H1623,176870,0.1873243677029567,3.429598915389808
KMRC-1,7251185,3.109058235493882,2.7095279296485426
NCI-H727,6610216,4.563405769903236,4.2080486774407575
BxPC-3,15983966,-3.8778410742282694,-1.706782532424375
G-401,46843906,1.9398273455018735,2.743251269355592
NCI-H661,126941,-5.16742432120375,-2.6016439109173732
FU-OV-1,5746,2.910322472492285,1.4226641429907392
CAL-51,11609586,1.5077859423552509,2.9232101224889084
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.6892778142468248
NCI-H1623,23582824,0.0165284592292431,0.8829650640992627
SNU-449,31703,3.0847938162993707,-0.988255637000023
A2780,4788,4.492604658524488,5.441538511079692
Panc 04.03,25102847,3.783052108341051,2.569572199190797
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.683021086370179
NCI-H522,5113032,5.82110442960573,4.728070876858787
KYSE-70,16038120,2.0286855638164054,0.8774514058699475
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,2.8262690249976354
JM-1,2828334,5.9839290329767945,5.842346020865822
G-401,16736978,0.7492323653316314,1.7205628207976174
CAL-51,107970,2.299284460939792,2.272930612249708
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,2.74173796258437
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,2.8704281342952607
NCI-H460,51039095,3.9314979002332535,2.848716427646869
MDA-MB-157,9903786,1.458865596348786,2.748852679252286
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.448458618918185
Panc 04.03,54678924,3.3151598744761626,2.0889614784675268
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-1.0210172518671015
ONS-76,25195348,3.7356955751438754,3.1477216134927364
MSTO-211H,71466578,5.31450298723974,4.321565813998969
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,1.0486146452155396
LOU-NH91,10385095,0.9698085069900604,1.4351372460527563
FTC-133,24856436,2.183528137346661,0.6270501704807532
A2780,54613361,-2.0737031658574043,-0.23063628989167376
CAL-51,5311,1.4183219405835503,1.4876304647237597
NCI-H522,51037431,4.989409718658752,3.081241381327412
Panc 04.03,11647372,2.0191280123179824,1.1248454937236425
NCI-H727,327653,3.8552398443183193,3.359812471606551
OPM-2,9884685,-0.7869928949425254,-0.06857158409858556
BT-549,676352,1.8104954024890367,2.1346094879326465
CAL-51,46907787,3.297361866649883,1.6966073474585133
EFO-27,11494412,4.723849828867172,1.873725760640832
A2780,60700,-2.20534635529039,-0.4697839404606855
A-673,5281321,-1.2857978730590742,-1.8837247878563448
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,1.5315304589152876
NCI-H661,6610216,4.875851858170822,4.181760447541771
NCI-H460,6917907,-4.956095121428261,-3.759428345768183
A4/Fukuda,5460769,3.0365194168079572,2.7754252618017454
BxPC-3,3025944,3.477531707151509,4.292784982727395
CAL-51,16065773,2.8749329306977853,2.373485759715808
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.3389739241216854
EFO-27,2874250,5.869363689503336,4.5652906074774435
A-673,702558,2.7000584853196936,4.807533862701401
HCC1143,107985,-3.4652614368177432,-3.613390472856924
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.01483058474554
NCI-H522,3025986,-1.0139106356663683,-0.8899942805409603
NCI-H2171,439501,-3.0635131055453924,-2.2273754023027696
NCI-H522,444795,5.191031194563041,4.317435463401947
NCI-H661,53392493,2.28152765608909,2.350048806281722
Panc 04.03,445643,3.9306423242452673,3.960736329981852
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,3.174773515454354
NCI-H292,25150857,2.3048085705836563,2.4177590561297686
NCI-H727,25126798,3.836281743476004,3.982322974641045
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,4.728211734380918
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-1.0224944519069559
ONS-76,9887053,4.335145594020597,3.9607908002574708
OPM-2,675434,4.053836549963459,4.20898269674807
KMRC-1,16725315,5.238650021868635,4.380968235185068
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,1.9308994168948717
A4/Fukuda,151289,0.1986917338936865,0.8113798829933178
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.8057076734627381
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.6160312776144785
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.8293437980290808
MDA-MB-453,56963564,1.2952259038449256,0.4093073777839312
NCI-H522,65064,5.303150406450188,4.7647634236035215
NCI-H2171,24772860,-3.209318985857815,-2.3267911427753054
KMRC-1,104842,1.0931359128213904,-2.5207337945266604
NCI-H460,16741245,2.175171044948558,3.8506598282687197
OVISE,4259181,0.909929291036465,0.14815416511063792
HSC-4,46191454,1.405754738797376,1.461973865996197
KYSE-70,2749,2.2442090130660577,1.8680056311264388
SNU-81,400769,-1.1944669265215293,-0.9962471973369056
NCI-H2009,6852167,1.9075911063810396,2.9084188151215904
SBC-5,241158,4.402731015442316,3.5570283321422322
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,1.035110107727142
HSC-4,44185566,3.0805483382503844,2.5618420578547467
FU-OV-1,17755052,0.0450390211671309,2.1040035891555293
KMRC-1,53495165,5.726132279462146,0.22490784753479684
NCI-H146,6184667,1.5836777358218528,2.8910447869145615
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,2.4204685437705313
HCC1143,55283,3.9101720152241226,2.506380538391133
OPM-2,71466445,2.165442844786418,2.421016754075891
A2780,49867926,3.0666746223408157,4.00530860988091
LOU-NH91,17755052,2.4120102833965844,1.7319883809206598
MDA-MB-453,49867926,4.180155964726801,4.260091333291488
Panc 04.03,25183872,0.1973991794911014,-0.7081694792616614
CAL-51,9967941,3.511576456928413,3.529332369524543
SBC-5,6852167,3.965917526242172,2.354339095662236
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-1.3361234788992653
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,2.8581961707629877
NCI-H522,54596558,4.342696772784201,4.248345094303614
HSC-4,2733526,3.5101027459294425,3.7522365020821264
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,4.915915072984932
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.9651588160247946
MDA-MB-453,4477,-0.2020943624975227,0.6418349648318766
NCI-H2171,72193861,0.5955631718249997,1.5803681183156753
NCI-H292,2828334,6.458495810735601,6.202305558621422
ONS-76,7326481,1.79748139254514,3.1119573280039066
A-673,44607531,1.457749077960986,1.4005298938695214
NOMO-1,73707438,4.2876330596581305,4.184510555777651
NCI-H460,60750,-0.8382921927225392,-1.762122097056715
NCI-H522,4259181,-0.2456063667287351,-0.041109165038195235
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.595552570414865
ONS-76,969516,2.910086136195903,2.766779093198289
YAPC,49850262,3.6789282041181095,3.5447438483759792
SNU-449,44491742,3.9284370838515903,4.281770275059964
MDA-MB-453,11485656,1.765591398344026,2.453015633345058
NCI-H460,44607530,3.4043015144880444,1.8792609688999722
OPM-2,56949517,5.349058842742104,4.187315132437668
SBC-5,216239,1.5582588949606833,1.9299716810282006
NCI-H661,219104,3.9372744940630646,3.343791316119546
NCI-H460,44484440,3.757520830720006,3.199444393504744
MDA-MB-453,44462760,5.00879187339522,3.834743819275059
ONS-76,5281321,-1.2480266745690851,-1.3152303813932056
LOU-NH91,5566,3.288881685822646,3.0412790792880666
MSTO-211H,72193861,1.6065459514404858,1.6580963251525223
NCI-H1623,16038120,-0.158474112921266,0.8750333335624547
BxPC-3,11238147,1.751681691561693,2.4471047840031206
YAPC,3025944,4.720838189364642,4.185809196911995
SNU-61,1239801,4.195034605110225,3.8090542179957225
NCI-H522,11640390,4.472705990017258,3.168962026574026
OPM-2,11238147,3.2386204402735874,2.1726411470087563
YAPC,16722836,1.8948218470527252,1.6955443946065338
MSTO-211H,4261,1.9115438043118669,1.5860107766748737
BxPC-3,24901704,3.2492386456059266,3.0968712871606403
A2780,2742550,2.799223861459344,3.8448116292195875
LoVo,6918736,-4.296362304597629,-1.9447562035672765
NCI-H292,3854666,3.3764205876154074,2.1078580628082837
G-401,11222830,1.5347756238466792,1.5277270887315564
CAL-51,44620216,5.469091994130916,3.8737916639039707
NCI-H146,6918328,-4.616864565737749,-0.08832409807166337
SNU-449,100016,6.350050439021361,6.158849239011759
CAL-51,6438330,3.884194225982375,2.2603332030636802
A4/Fukuda,451668,-0.3897468918932548,0.7230513636285437
NOMO-1,135875424,3.068632733482165,3.56789160652842
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,2.4308387610395683
MDA-MB-453,9907093,5.353373126975176,4.254802794637963
SNU-81,11404337,-1.7380856142345846,-0.5677397282696459
BT-549,3634881,2.142843752657143,3.4320512974148194
SW1463,6918837,-3.406571913442127,-3.3500644945953253
HSC-4,6610216,4.241818899552939,4.281915646111272
G-401,135421197,1.4306754302223277,1.8034179263395544
MSTO-211H,400769,-2.118881346037636,-0.49366757724071464
OPM-2,56946209,-6.715247823396851,-4.744772097987295
OPM-2,156414,0.898749748032719,0.9697962342268676
SCC-9,2708,5.420316309291021,5.028233147245987
BxPC-3,72376,-2.7426383250741786,-1.4949453870445921
LXF 289,44607530,1.309750089611443,1.903892160529179
A4/Fukuda,216468,0.7779788317268376,2.0588326067477984
ONS-76,9936388,2.029236983033262,-0.8764014306944358
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.3497501293630895
A4/Fukuda,15953870,2.701018205920996,3.2528413035384203
A4/Fukuda,3825829,2.918538307685252,3.8544981373734624
NCI-H522,1716436,2.601362471636894,2.9155900486821036
NCI-H460,16725315,5.407057101640495,4.390245983707344
NCI-H661,969516,2.7370069869182996,2.6313770290253022
SNU-449,9915743,1.6643053553641087,0.9359786778038395
NCI-H522,16219061,2.1788816492377054,3.0331699755197956
NCI-H1623,25126798,4.062693377799547,3.902269510183952
LoVo,46199207,2.62459096292295,3.0833574568294897
Panc 04.03,2126,5.406308275886939,4.629887423457915
NCI-H522,702558,5.065903257418961,5.109846974949469
NCI-H661,44489675,4.0470438340050086,3.8574740397816174
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,4.869899188591975
CAL-51,11175137,1.2330676481368064,2.551680955360009
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-1.2059171538940265
A-498,119607,5.756544485429512,5.180355717557708
CAL-51,89183176,3.8950338695454088,3.6948499209022803
FTC-133,2828334,5.859070513237425,6.212214832887554
KMRC-1,135440466,2.425894917183188,2.13130804179314
NCI-H2009,36314,-5.253596358515139,-1.6198278844174245
G-401,11238147,2.0802759078276853,2.5350437935736436
NCI-H661,452548,0.003417557634082,-0.4216470767003942
NCI-H292,5282054,4.085287507740134,3.7454860933417455
HCC1143,10385095,1.0799280769088206,1.3644615165077696
A4/Fukuda,11626560,-1.03034976821798,1.2122532022712347
FTC-133,65064,5.375666939367713,4.469771938251385
BT-549,753704,4.958873098850826,4.818230587480947
KYSE-70,46224516,2.993089177283032,2.3987150185629225
CA46,11707110,2.876405562319207,-0.15402561237908066
LXF 289,11609586,2.9430338892136354,2.909350098293112
KYSE-70,10296883,3.691258417269261,3.9117706651811295
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.4847419512591342
DMS 273,67156097,-2.1294955352549,-1.0813488483569862
NCI-H2171,11955716,-2.5749004703466976,-1.012481818791417
LOU-NH91,124202324,3.0671378719618283,2.2514575090330267
A2780,135659046,3.385733838662662,3.741197861982671
OPM-2,11427553,0.184758700497643,1.9778948228280522
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.0881414801357865
OVISE,11427553,3.886061021243629,2.823141827704415
A2780,24821094,2.7975033336102095,3.037139579126322
LoVo,10410894,2.092646303934145,3.1605794165090346
CA46,327653,2.398308016277815,2.87888197154539
NCI-H522,135440466,2.851321997265629,2.0579713522340684
NCI-H661,9903786,4.646166413465223,2.4650019371166327
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-3.7001521221082654
CA46,11427553,1.0834968953052575,1.842797495201765
Panc 04.03,6450551,3.8538949310121353,2.8151695570649666
A2780,644241,1.9281614760038184,1.8399479223320452
A2780,3815108,2.053113262637462,2.5780952728592
NOMO-1,71466380,3.4384411266907295,4.117083314010395
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.0818271848875374
A4/Fukuda,24821094,2.016569070962388,2.9346596907195095
LoVo,3503,2.2987332704820016,2.294180002689618
LXF 289,46398810,1.8383298322371264,2.5271902620943827
NCI-H146,42642645,1.3339409860624971,0.8327899662168281
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.3815165956884923
HCC1143,135984461,4.873829103860087,3.9580378413369073
LoVo,23725625,5.102020281972671,4.876168780647055
NCI-H2171,4477,0.0540600744484099,0.4275922680864476
Panc 04.03,24964624,3.127575767188385,2.753803958400104
CA46,676352,1.5563040092860552,1.7552060595282222
ONS-76,135440466,2.234484066901876,2.2768516355746313
EFO-27,31703,1.037291503873681,-0.845997286242378
MDA-MB-157,208908,2.741119640746793,2.0136147314986785
G-401,46191454,0.141864729037356,1.5031696270783903
LoVo,439501,-1.7683171506776545,-2.159125041558359
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.0852574535232997
A-498,36314,4.095863504824457,-1.2522171769300554
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.46932218790691055
NCI-H727,9935249,3.73205967923935,3.253120631255102
KYSE-70,53392493,3.454381994737171,2.538744705012256
HCC1143,11234052,5.229903952882612,3.994270518432017
CAL-51,4705,2.903463840875761,3.077053634742183
MDA-MB-157,56946209,-3.6171244608990905,-4.199440875289594
LoVo,3689413,-0.0015328635235731,-0.012146295485409304
NCI-H460,46199207,3.5033257005335163,3.119649818393566
BxPC-3,135411,0.8341107494370649,0.9948602264742044
NCI-H727,46191454,2.1799448668848105,1.5460329113390556
OPM-2,25195348,0.9238255530721258,2.8223608836500325
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.237896935869763
SNU-61,656346,0.8749051442535513,0.8915284996625619
JM-1,136227924,1.2038413750130548,2.5896571532050103
SNU-449,49867930,4.864159132996777,4.520462856431259
A2780,2733526,2.8794725769531997,3.879991067864186
OVISE,23725625,5.908959950408421,5.166374062537791
BxPC-3,60700,-0.122761385712052,-0.22261209051720496
OPM-2,53495165,-4.146839218250571,-0.6208706226361199
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.6657376009489145
A-673,25227462,-5.829932006274449,0.4432703597636364
KMRC-1,6918328,0.9635513821249304,0.1976270186813901
JM-1,89183176,3.1890961462334335,3.501902015284173
MSTO-211H,16038120,0.2471942161915729,1.0230062699860896
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,3.3698296138058996
ONS-76,6918878,5.0214366982824306,2.203830051348458
CA46,60750,-0.9269398092944348,-3.8705944839483006
HCC1143,42642645,1.0566197638440329,0.9493539913586662
OPM-2,3503,1.0860674816661569,1.9706876322185505
BxPC-3,11612883,2.2063280154469993,2.570948107043607
NCI-H522,16065773,1.5488087432962436,2.411439844858959
A-673,3634881,3.109333818891092,2.9801186999006894
NCI-H2171,71466445,1.378191899492029,3.6377085818228205
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,0.7702981509975961
NCI-H292,17755052,1.3393568867062529,1.7382797892867068
NCI-H522,11427553,1.733163384028149,2.6552207784520596
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,1.1659020043844146
BT-549,24797083,1.6394182791354686,1.5558095067752695
OVISE,6438330,2.2515103089504818,2.3055884896217935
LXF 289,10410894,3.939992216810496,3.5063115965061216
EFO-27,60750,5.390319994108079,-2.3951766225554754
BT-549,400769,-1.1296625579443007,-0.7663697535609311
SCC-9,2742550,4.1692460597635135,3.755808311709645
JM-1,5281321,-3.43257780081901,-1.7261465578192372
OVISE,24771867,1.656692666128474,2.5904109394856194
SBC-5,3384730,0.0954837515635063,2.047589293040234
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,1.0597739529463777
A4/Fukuda,2749,1.141581020051295,1.4904652827629474
G-401,1716436,2.4290804430946547,2.8252182640973587
NCI-H2009,23635314,-2.363129056883172,-1.2416541817454614
SNU-449,3081361,2.056588488576824,2.4736839002213666
NCI-H522,969516,2.4900188230240485,2.7781356231814858
MDA-MB-157,11626560,3.460415978238755,1.958913470061732
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.3023120235395207
HSC-4,11719255,4.924721636143113,3.3471219173019944
KYSE-70,17755052,0.9465092626724514,1.219932217511262
G-401,25062766,0.8725390828623283,2.0419309454422514
KMRC-1,4477,0.198014478122684,0.41151618246472893
SNU-81,44197249,-2.185783961489413,3.593622163001628
A-673,10410894,2.502904420433103,3.26769606920264
ONS-76,6914657,-4.101072641720643,-3.9409023743790397
MDA-MB-157,53495165,-1.8622859982145463,-0.38929461748012917
Panc 04.03,72734382,5.165438336919353,4.580277310874009
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.587686268747515
CA46,613000,1.1767209163070167,2.2166668460970937
EFO-27,3503,2.721888959468924,2.3532832944744713
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.3627149002026595
MSTO-211H,6917907,-6.416473568686441,-4.887649111534092
CAL-51,675434,4.354107922133551,4.597158240780125
CA46,5278396,3.312720557512005,3.034303937024072
FU-OV-1,9911463,4.1305925074662575,3.7782873978630254
DMS 273,5328940,1.9629216769229116,1.5686388444254304
LXF 289,54454,1.7599180903835134,2.5692040028157255
A2780,446155,3.1527811730433366,2.628515312069913
CA46,11222830,0.90552754986452,1.237823205752943
MDA-MB-157,15547703,2.7177027433879912,3.184488695595201
A-673,9915743,0.6829950735134661,0.9626755234265844
Panc 04.03,50905018,4.96616490546014,4.315756660757852
NCI-H146,50905018,3.857703749758686,4.033127340126274
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,1.4074455995342026
CA46,148198,-5.7845042531785,-3.842483645228736
BxPC-3,11427553,2.964396595429347,2.6479291468141044
JM-1,17755052,1.8568486472237824,0.45848617422904764
MDA-MB-453,135875424,2.7753375231350104,3.934207986908664
LoVo,52947716,-5.666189039665748,-1.133822792062037
SNU-81,3543504,4.205084802754879,4.150658203684888
CAL-51,9887053,4.486783389261201,3.619404779272425
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-1.2947018776329058
FTC-133,6852167,4.78859095347106,2.7662891846658435
SBC-5,46907787,3.799315463541784,1.6177687118908832
SNU-449,6918638,1.2557717528626495,0.5130912974264681
NCI-H2171,6438330,1.125878118169246,2.133885347123632
ONS-76,15953870,3.841628876209717,3.495294172148657
KYSE-70,44493528,4.735176242945038,4.398118609503731
BT-549,71751553,4.2471267374516435,4.404228532581424
NCI-H2171,46943432,3.4065574915710735,1.8910650385702723
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.3263329986351304
A4/Fukuda,135875424,2.943838777845953,3.4240729310679905
SCC-9,25154868,5.2906536290113975,4.305299643811846
A4/Fukuda,11964036,-0.0142982917472374,1.0444403411359748
NCI-H292,10302451,3.577296661602114,3.297897991076228
A2780,135999136,1.5930192405329104,3.579404609933012
NCI-H292,54618164,4.184972812062346,4.103931359043855
LXF 289,107985,-2.691798131563437,-3.5382626520532074
NCI-H522,44137675,3.8599044567005434,3.5548873189337593
CAL-51,3503,3.2899889427654245,2.232833802662641
A2780,409805,4.989244714218352,4.581826986330531
HSC-4,71466380,3.6804948915169784,4.4271565687598144
JM-1,6918638,-1.945896791217812,0.033119606655178685
SNU-449,44566777,0.6479277578392284,0.4552301523045934
MSTO-211H,387447,-3.4382078488280063,-4.172849120611421
DMS 273,9915743,1.912374780622189,0.894696393557184
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.5767886751586428
NCI-H661,16736978,1.5408428303752983,1.6614761114500416
MSTO-211H,44241473,3.911097970359605,4.682437393967181
NCI-H460,60700,-0.2314807684970784,-0.19349406765314195
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.7005319693356145
JM-1,227681,1.6891640861629382,2.887202419507819
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,0.2957071755425346
NCI-H661,656346,0.6919490200967222,0.6114189736531768
SW1463,5311,0.7635678260369684,1.2190099172315079
NCI-H460,387447,-2.436463262555682,-3.505953234140403
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,0.6941890117725577
HSC-4,9825149,2.985341504866837,2.190430307855257
NCI-H727,25262965,0.7692581364380534,-1.6209672084835125
A2780,10077130,2.5506457702723786,2.5384756720507498
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,1.4951199990341482
NCI-H661,136227924,2.7818959309662183,2.9849692412223066
SCC-9,446155,1.3937663931747788,2.835343290573014
BT-549,73707398,1.468839183930599,1.1200500646490397
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,2.1759662249685574
CAL-51,6623618,2.223133904662847,2.4770861076971276
LOU-NH91,327653,3.620861790086289,3.2190032460649047
BT-549,67291369,4.3793706620025095,2.6349679540653996
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-3.36634637627759
NCI-H460,3025986,0.3909368316008428,-1.0392718797224028
Panc 04.03,11228183,3.2874901590346934,2.1041020631955534
LoVo,25262965,-3.8912736240644694,-1.872309197697619
SBC-5,73707398,1.6541333685248465,1.011417583043266
NCI-H661,89183176,4.289155461605826,4.014421489371317
G-401,44241473,4.28251451131172,4.813619510596187
BT-549,2746,3.8188337512891137,3.042418684233295
YAPC,25062766,2.237282024435701,2.1502158285577733
LXF 289,20959075,-2.4089188058085,-2.8413163213853023
SCC-9,53232,2.1606412524830017,2.705408479969584
G-401,56649450,1.8227428945555348,3.162360484846835
MSTO-211H,11222830,1.162959487763126,1.546867084431146
JM-1,15953870,2.1778700018066144,3.300768937270697
LoVo,15953870,2.9352023189332703,3.2919673933929907
DMS 273,15953870,3.8128904638275216,3.446572171224744
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.6835411986500022
CAL-51,1750826,-0.4147302595408071,-1.7608571375470115
NCI-H522,9884685,0.1045560296672991,0.42084487382652536
HSC-4,327653,3.5197711195347434,3.2000542197076474
BxPC-3,6918328,-0.2318480121478282,-0.11404900972050944
NCI-H661,10074640,2.974634579766932,3.0071800144768326
FTC-133,11178236,-4.398882676695501,-3.010446613482306
CAL-51,6450551,1.9748462748620472,2.4899315252687786
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.4758313609734748
SCC-9,5978,-3.875351555062552,-2.344986274942201
LOU-NH91,5311,1.697115177859265,1.380734005467401
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.508355509612444
A4/Fukuda,49766530,-0.1813275565198268,-1.2165905773194141
CA46,5978,-7.34958411963843,-3.471987763234601
JM-1,15547703,2.5122126082355227,2.935916017345142
HSC-4,3038522,3.958216901800584,3.0393667594761284
MDA-MB-453,24901704,3.2296574944609735,3.293404925193684
SCC-9,23635314,-1.650613607792241,-2.1683113683455035
KMRC-1,11612883,3.608500084904783,2.826522830383652
OVISE,24772860,-1.0102375693918164,-1.274187471596011
A2780,11626560,0.43489025720173,1.8772440922316533
MDA-MB-453,51037431,1.3361098813185686,3.0462331380363916
HSC-4,4705,3.95336427523857,2.9309917957708738
A4/Fukuda,24748573,1.3032837048402657,1.5409066824037578
OPM-2,51039095,-2.6866952618976434,2.2937702195971994
KMRC-1,11609586,2.4412406506497155,3.1233226093599367
ONS-76,11609586,3.485979398565755,2.8658115808791536
LoVo,12003241,-2.8621949377385465,-0.7963589793425986
DMS 273,241158,3.177272786345067,3.7405219424769856
KYSE-70,20959075,-2.927604227069557,-2.818676235889991
SNU-61,16722836,1.3959733890222568,1.5281710870791274
SBC-5,89928392,2.3719311856170537,1.163560681584119
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.3174005702278089
A-498,4261,1.667462132250413,1.6881259978208636
SNU-449,23725625,6.429990861305722,4.994345653509737
A2780,4259181,-1.27299012623329,0.04584826159358867
ONS-76,10127622,-2.1347139098699706,4.141491212452365
A2780,1641662,2.3828094640764412,3.3507128214901574
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,1.4612516101156359
Panc 04.03,9549297,5.2530677537073975,2.302670309160688
MDA-MB-453,53481919,3.1180191774885735,3.933567283671057
JM-1,56963564,0.0249959117693502,0.2926566535030845
HSC-4,11234052,4.4583786214563865,4.036122975948095
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-1.2142664941074528
BxPC-3,119607,5.22613990212802,5.316605890571359
BxPC-3,5278396,2.866816315326302,3.508678566846765
LOU-NH91,400769,-0.4518117512524929,-0.47767237190234596
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-2.2733452519766404
FU-OV-1,16722836,-0.0099462763207794,1.533434722241956
SNU-449,46907787,4.480861537403045,2.1809397613834527
NCI-H292,24748573,1.9235457900331792,2.097308710560684
NCI-H460,2113511,6.407699041859446,5.587190333895237
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,2.863540342040727
NCI-H1623,46174525,4.205988468269685,4.264861438802354
NCI-H1623,6917907,-5.728045829659389,-5.198992039459785
MDA-MB-453,1641662,3.085427143962118,3.5329241267789433
NOMO-1,3854666,1.0231806307237967,1.1759575050181368
SNU-449,24821094,1.9429996101140543,3.135717163014092
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,1.8785479147306028
Panc 04.03,216345,4.594435961426402,3.9768850452420104
DMS 273,2708,4.711982190259564,4.345429764150005
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,0.8339583019134906
A-673,11222830,1.3107049031534492,1.3855929684727022
SCC-9,219104,4.323236898621614,3.5589091789110734
KYSE-70,11455910,0.6771697782379181,1.0673899956958182
MSTO-211H,9915743,-1.0722844498490078,0.9914359652490176
HCC1143,3062316,0.306898118520016,1.4790533850572383
NCI-H460,11427553,3.3912724357702873,2.880538476285226
NCI-H1623,675434,4.403585448845777,4.405605671380553
NCI-H1623,135928012,3.849713333151309,4.215946812019239
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.1826969789756363
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,1.9114295619418613
KMRC-1,11222830,1.6210071273597368,1.7574142707590354
NCI-H661,44607530,1.6067743901515843,1.674358530215572
HSC-4,24753719,5.996217074466553,4.162803245318749
NCI-H1623,44607530,0.6082825778474802,1.7019501826241616
G-401,409805,3.720272745750916,4.741696437095345
MSTO-211H,24771867,-1.256499005348058,2.244780538576907
LOU-NH91,100016,8.416108067142021,6.157078268815878
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-1.2345694824813085
MDA-MB-453,9911830,2.483477791354312,2.489601803070082
MSTO-211H,216345,2.6222222224733702,3.812682550617999
A-673,5738263,2.33182798743241,3.2401310064807247
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,0.9164232415662655
CAL-51,16038120,-0.248771562775031,0.7648726086225751
SNU-449,11222830,1.6348775900621026,1.597348949212255
SBC-5,11656518,1.8588197700646856,1.4935545252828746
LoVo,637858,1.5179613366947162,1.802360847493945
OPM-2,16065773,1.0643824527623371,2.1589352780885847
LoVo,17759555,2.3197484044750905,3.5956504384073535
LoVo,23635314,-2.3980395881052723,-1.8663266976674342
OVISE,241158,2.9923875981017134,3.87047788091799
LXF 289,6918736,-2.4177135652368476,-1.8579610131645392
NCI-H727,24180125,3.0565666249941015,3.058794763142794
HCC1143,72193861,2.4539335535877607,1.5574090490144386
LXF 289,17755052,1.3903450452706496,2.0363959538270855
SNU-449,24797083,1.6612369643963127,1.5488061987008712
A-673,9903786,1.5948741514342302,2.7277741031782092
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-2.7991160774063637
SCC-9,3552672,2.2159119862051355,2.7991598697859206
G-401,9903786,2.8038927126182327,2.4555779999434817
CAL-51,36314,1.3238047725901672,-1.0711158023694454
A2780,4917,2.608891014350475,2.9638776589057456
BT-549,446155,2.043062772915461,2.8663549214292217
LOU-NH91,2828334,6.123728588021327,6.1264060170837595
SCC-9,89928392,1.8759175792930969,1.186020224550977
LXF 289,54613361,1.2100808209747431,0.004547551723335836
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.7071386842822635
YAPC,4788,5.944205132488497,5.519913619450058
NCI-H661,11485656,2.0326011859644075,2.242993475514285
A4/Fukuda,56649450,0.8497740308893211,2.6426598843948126
JM-1,151289,0.6364544108799082,0.5931856922861701
SNU-449,1566236,1.8764566240908545,2.3976421257058207
NCI-H522,11234052,4.642717967560772,3.7895741220235726
MDA-MB-453,262093,2.6969191096415113,2.98180019047209
SNU-449,36314,1.881882754123643,-1.0611055948035486
FTC-133,3552672,1.929463221662531,2.771167667110512
DMS 273,44202524,0.9824733163321672,1.753138133173815
CAL-51,2708,4.939881356462198,4.788219423917167
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.3428149497233985
LOU-NH91,44507138,2.849532358816909,2.5977821869867266
A4/Fukuda,24856436,-2.105951383298443,0.1684829872265541
EFO-27,9967941,3.205966960393555,3.701778697009185
NCI-H460,24964624,3.5490884182562565,2.4619086686981704
A2780,71304818,1.3100858151797232,2.2817061283211957
LoVo,16065773,3.0239362353443195,2.2093292822809913
MDA-MB-157,19582717,3.2682056974125744,4.143736706235155
G-401,44607531,1.4405644617048554,1.3714712726026186
DMS 273,426756,5.171527401006451,4.045333170665978
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,2.130045810473286
A-673,3465537,3.0102553460613626,2.2406160376638047
KYSE-70,135398744,6.338938630156892,6.593424645854047
NCI-H727,439501,-2.2848783314382133,-1.9424220954342806
EFO-27,1750826,-2.462449966677767,-1.4397799248440066
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,1.5118688844790662
NCI-H2171,15547703,3.4091207334536717,3.078898263137159
BxPC-3,24753719,4.274594841538204,4.40184234110718
A2780,49846579,2.326369228321655,0.8249199100810025
KMRC-1,135398516,2.513650186922018,2.076975629864984
LXF 289,12001922,1.5738020993239468,2.0210879664174017
OVISE,107985,-3.603598955800668,-3.3878259294570063
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.7353345527450574
MSTO-211H,51039095,-0.728954813106199,2.471195740744341
MDA-MB-453,24856436,0.153871218683687,0.39626786859635227
OVISE,12003241,-0.8183931153803442,-1.1308465388511408
JM-1,219104,1.4868441806857289,2.804232307529337
KMRC-1,24901704,3.4724240700357414,3.3903470879107855
CAL-51,25105715,4.077363851334658,3.5014367802188815
Panc 04.03,5284616,3.514498334257777,2.1185498805856877
NCI-H2009,446155,3.3217785993510884,3.0256696369348566
NCI-H1623,66577038,3.365380490578284,2.9717143583695105
NCI-H460,72193861,2.1658883750752844,1.8432524494852636
NCI-H522,17755052,3.243909986839396,1.9560069412098327
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.866509514814297
LoVo,9936388,-7.372990206557469,-4.107335035677556
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,0.5469420761755049
A2780,46907787,0.387414270491788,1.691216430055337
A-673,25150857,0.7583223763798244,2.175403070188571
KYSE-70,11175137,2.267736133904179,2.5646199131274345
KYSE-70,6852167,2.2981101713941814,2.7399248081315086
SNU-61,3081361,2.723820700669796,2.3672161617321494
NCI-H661,6252,2.9131036022991728,0.00044096592425334257
NCI-H1623,9903786,3.0418604220511436,2.612312841569604
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.6317208403237151
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,0.7927227911756014
SNU-449,10322450,2.7236273289045942,3.680343822920567
LXF 289,4096211,2.4023988219433337,2.1421452546548
SNU-81,10026128,-0.7780702377310673,3.995868771506
KYSE-70,6610216,4.087252338732691,4.0977075962728575
MDA-MB-453,44607530,0.880863900568506,1.6139243878872755
NCI-H522,24978538,3.1859390482195216,1.0733859179052536
SBC-5,107970,3.247043743319875,2.255021885894612
DMS 273,969516,2.584462316279732,2.7298167708256464
MDA-MB-453,5284616,0.7898078062241378,1.9639778182704406
A2780,16720766,0.7344228111589829,0.599000021519873
OPM-2,25154868,3.783948059993976,4.315185060217728
DMS 273,44493528,4.2569430545307725,4.36704904124738
MDA-MB-157,25022340,3.479219964634342,2.864763879630623
LOU-NH91,15547703,3.808438680736899,3.2702427190521486
CA46,426756,4.77193452473935,3.6916033563134216
DMS 273,2858523,3.0502279484440233,3.079080533895021
EFO-27,3676137,4.310046032716647,4.459988688281135
MDA-MB-157,3025986,-1.856662168016076,-1.110616382056129
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.32288312170138894
LOU-NH91,44607531,1.3180545967249335,1.566939770701154
G-401,46215462,1.5390133747858452,1.7244424831356435
OPM-2,7251185,0.5721351512480617,2.0660842329565297
CAL-51,15953870,3.220977372988981,3.3086519008642368
YAPC,11964036,3.221056153642411,1.471434164196288
BxPC-3,208908,2.4547812946400502,2.019861155050866
MDA-MB-157,44589607,1.2787513073565453,2.6881207902034383
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,-0.5421900745105628
NCI-H727,72193861,2.684204612264405,1.4190991743339287
MDA-MB-453,5287969,-1.436813958809434,-1.8003056062557425
NCI-H727,15983966,2.109759483394555,-1.022981440199508
KMRC-1,216468,4.973373200756221,3.0173960241242153
SNU-449,52912189,4.380826008996873,1.910323205663978
SCC-9,46174525,4.3512864598075645,3.9068749106723404
A2780,3011155,5.55303778809739,3.9349708800999417
SBC-5,135999136,5.333154079184271,3.546911449544432
YAPC,322968,3.8135092450764656,3.737586074695327
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,0.9430374240738917
NCI-H146,5328940,1.6811042727449883,1.8172750432847269
CAL-51,168313200,3.900876548563449,2.8978060575469997
DMS 273,1750826,-1.913269562568005,-1.6917187020060513
A2780,54618305,3.781380565087532,4.495128173881937
NOMO-1,9936388,-6.523282887173488,-2.981718817719079
NCI-H460,5282054,4.802373462225767,3.8109253956470934
SBC-5,82146,3.3774942308101785,3.493629506184454
NCI-H727,56946209,-2.7175198163763232,-3.423057993464214
FTC-133,3062316,3.806169585149848,0.7526648877641451
A2780,9967941,1.4564169862408056,3.4335704078875353
DMS 273,5351362,1.0025978169272032,1.3140738046733282
SCC-9,16038120,1.877705535955449,1.0070312806466357
NCI-H522,6917907,-6.015261010654924,-5.0815360173977195
CA46,4477,-0.2706834990523855,0.5012574254996498
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,3.124951747912453
SNU-449,11178236,-2.056078636199096,-3.213640361775993
SBC-5,5278396,3.3013936373431996,3.1831209882726093
NCI-H1623,44493528,4.638812765070766,4.1994486341894115
NOMO-1,16720766,-1.891739380903732,-0.26973693815398786
G-401,2729026,2.5705443446476828,2.5449418709278753
G-401,6917907,-5.905222634362146,-5.050625183145518
MDA-MB-453,2858523,2.664825786894245,2.9923172048150786
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.4510466742191668
LoVo,11427553,2.604805449600099,2.6648275980292726
G-401,11234052,3.7167035951130423,3.844684885570035
FU-OV-1,168312962,3.576057642182836,1.574530681787136
JM-1,11228183,-0.9199972643114134,1.0090756133565244
ONS-76,65628,4.406189432641036,4.390322070176414
Panc 04.03,11964036,1.4501208375942458,1.232835701546209
YAPC,17759555,4.434513834785858,3.6652644855790038
Panc 04.03,5311,1.931700632460216,1.455700115764948
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.72271585522895
NOMO-1,49793307,-3.1091933140229,-3.4182492459715355
MDA-MB-453,46174525,3.691895458218128,4.006994564958818
G-401,11977753,-3.640604480016117,-1.8624472797900586
A-673,16722836,0.9037523157925,1.4617403073075212
MDA-MB-453,5494449,3.8003034085581993,2.6125045060905894
NCI-H522,25150857,1.47132219158847,2.18959574181461
OPM-2,5311037,3.4844810711382936,3.5209098383718582
LXF 289,11152667,-0.4789950074309144,-0.4451417848229113
CAL-51,9911830,2.6702149728757343,2.282222377023927
KMRC-1,4378219,2.060133570967863,2.4652856229329716
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.6601940334255656
CAL-51,156414,1.13799157004995,1.2349851119101052
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.6748444515090553
NCI-H727,89928392,1.7873251449620886,1.630449254395131
KYSE-70,6918837,-2.6267197721971582,-2.7651223222654817
JM-1,135928012,4.176764785732949,3.952683844980749
NCI-H522,10427712,4.202859541756615,4.217170693660162
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.9069053418158549
CA46,5470400,3.727677755196873,-0.09166785237845174
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-0.7888829455443036
EFO-27,9936388,3.039710224097925,-1.1394751981681086
NCI-H292,54618771,0.019803014891406,1.0682483358107095
KYSE-70,25262965,-2.1035778811550836,-1.7445050229648356
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,3.1124085458999566
MDA-MB-453,11656518,1.9818038641727111,1.6739531987277518
YAPC,5282054,4.005772938817316,3.872344353956377
SNU-449,24180719,3.8016565421464072,3.46572911625882
FU-OV-1,15983966,2.2280291717608947,-1.6088393872444728
SBC-5,11485656,2.2866280503579812,2.097087620890045
ONS-76,702558,5.821489397293988,5.217004890718312
SCC-9,9911463,4.4493328300482995,3.9069006034481877
HSC-4,72193861,2.788231918333871,1.3289194034522538
DMS 273,2126,4.20633218634453,4.569185195704963
OVISE,46199207,4.361349086507746,3.2992756440802657
Panc 04.03,241158,4.444137488799797,3.8491158693210785
NCI-H460,654092,0.4612941847378306,-0.15310971661109618
A4/Fukuda,45279963,1.9027034071047564,3.1827306659437102
NCI-H292,44259,1.4427392496176257,1.0604504150607006
FU-OV-1,17759555,4.190415677120393,3.582660869928865
SNU-81,3634881,2.620060882721275,3.065149490319609
NCI-H2009,107970,2.2954238398166344,2.351525378817441
LoVo,5278396,2.046108484267772,3.3719248908743964
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.8517700887261169
HCC1143,12003241,-0.0421467164139253,-1.0073482596225276
Panc 04.03,46926350,-3.8788763459733473,-4.107414133853716
A4/Fukuda,4578,3.815086457915261,4.213345917507448
CAL-51,9929138,6.421072450841616,5.656796118141144
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.6152900043969055
SNU-81,4259181,-0.3131255720640173,-0.256813448424752
KYSE-70,675434,4.695192974207532,4.419770953004087
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,1.8556196325015584
A-673,135659046,3.595490040408381,3.622657193448293
NCI-H522,4578,4.727447650100284,4.374349803684659
DMS 273,54765302,4.301325739041371,4.115500036985368
A4/Fukuda,135440466,-0.9873079875011114,2.1028146777340613
LXF 289,24821094,2.4128137194258215,3.028603169987258
NCI-H460,5746,0.0249012606464236,1.3233620452408204
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.1490760372141393
A-498,25062766,2.0793230877467166,2.147372629779412
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,2.787497392261464
Panc 04.03,10127622,4.886231353649791,3.6168243347510436
G-401,57330099,4.350194890812272,4.240996538809373
NCI-H1623,168312962,4.13769742192025,2.262433898590014
SBC-5,5566,3.1825236444892124,2.8297672955701567
Panc 04.03,9825149,3.055289787116955,2.3149896360696625
BT-549,11507802,2.533090965918468,1.3465662305518558
OPM-2,5951923,4.162321290800766,4.238875648805863
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.910108981566762
NOMO-1,9935249,2.770043096032674,1.8263955165412793
LOU-NH91,11640390,4.567382593568383,3.443671267883301
MDA-MB-453,135440466,2.739035638886915,2.2343226711141186
HSC-4,644241,2.6183127396598262,2.1007164535349427
MSTO-211H,17755052,-0.0733710656781619,1.5344076254057077
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,1.8909488286009053
BxPC-3,5281321,-1.5422365883768068,-1.2903756904533794
MSTO-211H,9444,4.1850544738080915,3.922388809735413
LoVo,17755052,-0.1303127354802701,1.6425746629418225
KMRC-1,44137675,2.117874577310701,3.444568897075251
A4/Fukuda,9911463,2.417745886609146,3.5326886901797376
MSTO-211H,3101542,4.302130070317232,3.7418029839942624
NCI-H146,426756,4.36191990335561,4.279752785529028
Panc 04.03,44589607,3.8783822611027454,2.878158705748386
G-401,24901704,2.2796887972749307,3.1738128875268217
MSTO-211H,285033,-3.2380358495287695,-1.7715472176950966
BxPC-3,452548,1.628130986083035,0.3501294766804539
SCC-9,9926054,1.898935947612019,1.9401955624533667
MSTO-211H,1750826,-4.930051018535606,-1.0722969651103107
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,1.5193217242989574
HSC-4,216345,4.5807127841732775,3.944858375852358
LOU-NH91,168312962,3.892175490150028,1.5892758945945433
MSTO-211H,53232,-0.5437095856797647,2.6673347533914704
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.471320379685492
EFO-27,5335621,6.264647611417884,4.386904608719183
CAL-51,1716436,3.275997904874087,2.970193625726084
NCI-H460,53232,3.485336782178725,2.7049387318770526
MDA-MB-157,54454,1.950382699789776,2.647687241190766
NCI-H292,44489367,4.492014578968512,4.634297304284452
KMRC-1,4521392,4.136909747869898,4.199756359420635
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.2615586921185535
HSC-4,56649450,2.6853332826773144,3.1604105412199095
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.648397059932913
BT-549,9926054,1.9687680834705423,1.9823284906020522
SCC-9,9911830,2.3699428367857145,2.5189073474311297
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,3.221577785896892
FU-OV-1,409805,4.026686349090877,4.870582690894271
BxPC-3,387447,-4.571753731996322,-3.983409982108727
CA46,44486219,3.6158388001945463,3.9355872950102815
EFO-27,135659046,3.7618075322397297,3.7859836499561954
NCI-H661,104842,-3.978937701952532,-2.8425161248298276
SBC-5,16741245,1.694771238369721,3.592810279597492
FU-OV-1,676352,2.7826635655764473,2.199587142521728
CA46,969516,2.1845952347247306,2.465961287336518
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,0.8938298522285985
HCC1143,9825149,3.0211594258387486,2.0856473239563837
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.6384665716804016
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.1665276508798932
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,3.0788088795024793
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,1.5228331751339015
MDA-MB-453,676352,1.703646310562033,1.9586509413717357
CAL-51,46191454,0.2698308836515951,1.4673877146521732
Panc 04.03,9823820,5.907522872650916,3.8564179123719238
SNU-81,44259,0.6272555485824429,0.7425764955772474
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.6423772884481966
EFO-27,445455,4.405247459654703,4.557364829647504
BT-549,11152667,-0.4620191787747055,-0.26565029100395826
HSC-4,23725625,4.12890848458229,4.995095694870552
BxPC-3,11640390,3.353927872983648,3.6156946465551867
HCC1143,216468,1.9778651637296407,2.8501485924287753
Panc 04.03,49766530,1.2448845141630578,-0.5396827915049246
SCC-9,10427712,3.976850957625781,4.226018531525557
HCC1143,36462,4.303888689757339,1.8916686967717755
NCI-H460,262093,3.3627537421549314,3.1289020217447474
SNU-61,56963564,0.6866306287041547,0.42220384016296947
SNU-449,2858523,3.0307383113048676,3.0956491620362323
KMRC-1,11214940,1.677559369833433,2.0481261045738153
A2780,216239,1.3949646663017006,2.0877380784871633
MDA-MB-157,89183176,3.472749903375588,4.313354876498809
NCI-H146,11152667,-0.8780602169524299,-0.4349660572942311
NCI-H460,9956119,4.485375019847723,3.6310131932478127
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.073974139101641
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,4.186581317102785
DMS 273,6450551,2.589238729256945,2.1242403643488244
NCI-H2171,5311281,0.8399284053106422,2.577822387148597
SNU-81,23635314,-3.737654632526069,-2.0101077547033857
FTC-133,119182,-0.5312905210850081,-0.7376888423669518
A2780,656346,0.4231070640442763,0.6387412645201411
HSC-4,441298,2.8371907900438535,2.4406236629944753
MDA-MB-157,285033,-2.194765851649468,-2.246326448335182
JM-1,73707398,-0.8556338999048841,0.6394898092012772
JM-1,6852167,1.3157742507093588,1.85864034514332
A2780,11364421,-5.7057574677584295,-2.5140197033730414
NCI-H522,54596490,4.410611853984333,4.313816102366663
NOMO-1,159324,1.6027654254866297,1.8263955165412793
A-673,107985,-4.827881226135439,-3.71266270029376
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,2.0257820886079183
NCI-H661,5287620,-2.104840782561513,-2.0068805014724664
LOU-NH91,119182,4.180997641513534,-1.1346712347098131
SBC-5,10113978,4.162999994539472,3.0703082039681284
A-673,252682,5.861850244558702,6.4945229458187805
NCI-H2171,5281321,-4.274427204887198,-1.640760361722215
EFO-27,3854666,3.6632128701571194,2.187526814936779
A-498,25154868,5.700321852894753,4.3951803939078085
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.0478593590384444
CAL-51,31703,-2.726607914110417,-0.8816982361769645
KMRC-1,9840324,5.892638074147807,5.76475134726642
BxPC-3,49850262,4.227475038244019,3.5568169602909148
JM-1,6450551,1.340572992486765,1.9197194217335467
KMRC-1,148124,2.1112012667960656,-1.605148584697782
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-1.4354018574802756
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,-0.3275400117436297
NCI-H522,7326481,4.603358487226629,3.055012683904966
KMRC-1,3025944,4.220614757043024,4.200124617455364
EFO-27,9935249,3.352272124535396,3.1579669465776345
SNU-449,10296883,3.939630786750968,3.923735698721866
A-673,42611257,3.360985567795572,3.2891030583919
MDA-MB-453,156422,3.699160121301749,3.816314034553664
A4/Fukuda,89928392,-0.3543848103605003,0.8941912072056291
SNU-449,10385095,1.0986031812390589,1.3226400940430036
HCC1143,6438330,1.6030228226948184,2.2735028480934703
MDA-MB-453,3854666,1.8999840682298523,1.934571205766867
SCC-9,46191454,1.8170261878735936,1.5262191995870975
OPM-2,9825149,0.9763440152106764,1.7536363008330846
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.0436514516750304
BxPC-3,25150857,2.298115585090939,2.3067986572982555
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.44430164121585
NCI-H2171,25227462,0.3993487036849301,0.07951121908895248
JM-1,24748573,1.2692721555493711,1.8889776641117646
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,1.3715575105302622
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.4541107070302175
KYSE-70,5281321,-0.9979352327108848,-1.3433129276120042
NCI-H460,11507802,2.848054270429628,1.7269076644611732
SCC-9,4259181,1.940043087837339,0.32214943103091004
ONS-76,135421197,2.4329108516652775,1.8649579656109858
CAL-51,52947716,-4.729660133739893,-1.1559464895319584
JM-1,123631,2.636256127990424,1.673147650246442
HCC1143,1641662,3.4150871228937563,3.4848541915421536
NCI-H292,8515,4.694095877434875,4.030545854492408
SNU-449,71304818,1.9790204353457292,2.5146526965585476
A2780,5566,2.7251077604344696,2.88800562959471
EFO-27,82146,5.16738023752069,3.8141632040990725
NCI-H727,107985,-2.9799734550318204,-3.4700063779471693
CAL-51,446155,1.9002286289262065,2.736268605015735
SNU-61,4378219,2.193359587578685,2.3607064760954777
NCI-H522,1641662,3.4912081270508293,3.4540124594321573
FTC-133,44607530,3.0000417574370157,1.7831586822690537
A-673,448949,0.8158812974066569,1.9357113048017547
LOU-NH91,20959075,-3.4746906487579494,-3.071176689321668
SNU-449,5113032,5.017862259712187,4.866593954355836
NCI-H522,6450551,3.1458433056927295,2.0923154291688757
SNU-449,16659841,4.200866251374559,3.994434269675214
NCI-H460,409805,5.4278006548731295,5.059365057967095
MSTO-211H,46943432,4.749068259324704,2.350332725086499
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.6627324721250334
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,0.8077641949121087
SCC-9,11455910,1.869884665357408,1.0234593215028625
Panc 04.03,613753,3.3040029053289772,3.0718394574980254
OPM-2,6918736,-1.006954953557461,-2.4714457234913536
A2780,3854666,-0.0414990172822217,1.5613661639511307
FTC-133,25183872,2.254027462535002,-1.0624537991206786
MDA-MB-157,387447,-4.079240132125457,-4.235427620312366
SNU-449,54618771,0.9697829427454708,1.333969596065168
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.315630009647679
MDA-MB-157,72376,-2.1484578807410553,-1.7902445148464718
SBC-5,5287620,-1.4097460130546278,-2.1194806376872974
FU-OV-1,54649381,4.3760479468817675,3.780785852085512
NCI-H2009,26596,-1.5885219134108934,-1.1024473206026424
A-673,66577038,2.223533674143975,3.004860700445058
SBC-5,6918878,2.928817535111611,1.880059563918422
OPM-2,11640390,0.8264429779628358,2.255013947072018
NCI-H460,3503,2.4668231300278154,2.435706172992949
SBC-5,156422,4.2102641448485345,3.999140942760617
ONS-76,216345,3.2166812322741043,3.8499233261217176
BT-549,15983966,-4.218963036377602,-0.31113467750892954
A4/Fukuda,3038522,1.5780319148667876,2.912238372485019
BT-549,23582824,0.5256314804740283,0.5645465410615965
NCI-H146,2871966,-2.058689249756004,0.16906372397981406
OVISE,17755052,3.2346427318945263,1.4716240965701084
OVISE,44819697,-1.8576377458936848,0.13845008333057496
SNU-449,46398810,3.267032406348896,2.488318906233284
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,2.839180398557486
A2780,11228183,2.2113347222865123,1.9088798195338919
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,1.8517219731418988
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-0.9368195262178706
SNU-81,46398810,0.3023493978041217,2.1761044619759375
KYSE-70,11152667,0.5949086715112851,-0.8636632415248892
LoVo,73707386,4.416344333605744,2.8998315795034246
NCI-H522,5746,0.3558137383480795,0.6942756819086917
NCI-H460,135421197,3.2510260026522233,2.1231866510986768
MDA-MB-453,11507802,1.551744908234443,1.6382371451906113
A-673,4096211,1.8222389073608836,2.1968321370192156
NCI-H727,136227924,3.2179651731130585,3.112780551565828
NCI-H460,16065773,2.454458456288103,2.5518534539473956
SNU-61,24901704,3.3171528895384115,3.121715248475999
NCI-H292,11612883,2.84187428422206,2.5928271204093547
NCI-H2171,9907093,4.086146580877247,4.129273422098486
NCI-H522,3634881,3.092168984490579,3.23119251781501
G-401,9915743,0.7240748800691799,0.9584946872171978
SNU-61,46843906,2.645147040347038,2.644490763066182
SNU-81,73707386,1.6277005390789234,2.756072550604667
NCI-H1623,4261,0.4244365105903193,1.5049492603573449
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.4366534312139065
OVISE,1750826,-3.1689535405206715,-1.6001242871290677
OVISE,25183872,-0.2641805795712313,-0.7907415269694621
MDA-MB-157,753704,5.007751734334353,4.904176922689454
CAL-51,54618771,0.0049145289548569,1.1414446234572129
NCI-H661,25195348,2.4001868352132445,2.9342953894415924
KMRC-1,3689413,-1.8207429228817171,-0.3291298280896195
HSC-4,650361,3.951915492066197,3.654743770153599
KYSE-70,10427712,2.9549225300897977,4.236422293998717
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,0.5470301217703056
OPM-2,11717001,3.8340096164502135,3.6323441351505203
NCI-H727,11214940,2.165075102098245,1.777766537151673
KMRC-1,11404337,1.3121470144090095,-0.12147400552657318
MDA-MB-453,24951314,-0.4314694021522904,1.3171528201760723
SCC-9,135398516,3.38372398158662,1.8563754983315854
KMRC-1,11977753,-0.1874629547163491,-1.958327323831429
NCI-H2009,25062766,1.439977805675878,2.1587511921022404
NCI-H2171,6918638,-1.5146784294865197,0.3615395869694131
Panc 04.03,3081361,3.5741960453568464,2.681183934137481
BxPC-3,73707398,1.0061551215696194,1.382850147424602
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-2.093447335440291
BT-549,11404337,-0.1293922368150601,-0.3286213091604149
SCC-9,5281321,1.285660121438517,-1.9500227937627972
SNU-81,104842,-4.044454085478647,-3.0971746327138963
CAL-51,6610216,4.7761200098267365,4.227666931220909
JM-1,9933475,1.5625695981291614,1.6592717661672436
NCI-H727,11485656,2.2939690780404423,2.3365112186733468
A2780,426756,4.623757394028108,4.067675958321569
A2780,5311,0.5155233924036543,1.233639098876813
NCI-H146,11707110,3.3128142773805176,-0.4447772617351057
MDA-MB-157,11977753,-1.6055696025393866,-1.836386752915412
A4/Fukuda,11494412,-1.359408079628026,0.6667750635226279
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.137823341970834
LoVo,11977753,-2.85765012298846,-1.2346607077484348
FU-OV-1,56963564,3.5833852081145836,0.28909001270018686
NOMO-1,375860,-0.5184264862355304,-0.45761194141558853
EFO-27,3136844,4.472321824110979,4.164296699718211
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,3.725482136133836
NCI-H292,168312962,3.5892294654935726,1.9484239490937352
CAL-51,44607530,2.3415901962162855,1.774742143966654
EFO-27,2949965,3.1309950522818277,3.0319934148456156
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.276313731268999
A4/Fukuda,12001922,1.2276815023009988,1.6390540754637934
CAL-51,24951314,1.3730048574034712,1.4483221974895917
A4/Fukuda,135928012,2.23734461349398,4.1158080368344905
SNU-81,10127622,-3.2164123245129095,2.672369185584218
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,1.6302665732339594
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,1.1231788983445137
OPM-2,122327,3.690232587907526,4.396797383904512
NCI-H522,5329102,1.9502496806074603,1.937585017897481
NCI-H2171,9903786,1.7901794952315444,2.7225103527573844
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-0.982567945460816
YAPC,676352,2.46422610000008,2.168039041379209
NCI-H292,44507138,1.692325111571909,2.614067958115781
SNU-449,2945648,2.540265867455936,3.083364956838748
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-1.8951634243226945
A-673,3136844,3.9161258830055736,4.1303862752516665
OPM-2,151289,0.8971834485048114,0.5195870308502795
LoVo,219104,3.1119995266948237,3.719428454591993
NCI-H1623,9936388,-4.968103162812744,-0.7489495958285669
DMS 273,11485656,2.8704893197930272,2.161774108642673
LoVo,73707398,0.5951327141059009,1.2019677053065534
NCI-H2009,135421197,1.5480281661357902,2.0859290250869544
NCI-H1623,409805,3.8984511674912943,4.843518886797825
CAL-51,1750826,-0.4147302595408071,-1.7608571375470115
MDA-MB-453,54143018,-0.7571444922765344,0.6551058097996646
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.6712364905133206
HSC-4,54619267,4.093335991980471,4.057716942577675
BxPC-3,4378219,2.0321108717651426,2.1903650578642235
NCI-H292,5978,-1.7096488796134024,-1.8664965758700405
A2780,71466380,3.7792629508428783,4.245966897231182
MSTO-211H,44589607,1.2735087838172758,2.8099605676763484
NOMO-1,54143018,-1.1216489579847602,-0.08849366463674514
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-1.4357829602336383
A-673,46174525,2.7075701285598375,4.0538980103781554
NCI-H661,3854666,2.0669995151297633,1.6584941827706619
NCI-H1623,322968,2.7878661836218863,3.9201098970186745
Panc 04.03,52947716,3.0713971775620448,-0.4359412264895306
DMS 273,9840324,6.645778367521572,5.721198725592899
NCI-H460,15547703,4.965379127843483,3.2257824654980256
FTC-133,11228183,0.2445093238012437,2.0481917809074743
NCI-H522,9935249,3.002706281912375,2.7486338601083546
NOMO-1,6610216,4.0700997553747325,3.829093479744247
A4/Fukuda,46199207,1.9027513858957976,3.0249969800498544
EFO-27,16659841,4.389988364450653,3.7571684347914305
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.339831668365504
CA46,11977753,-4.21997551918338,-2.464733824846548
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,1.8586649937300075
SBC-5,54613361,-1.7173374464522142,-0.24030733369598833
MDA-MB-157,16065773,0.9216763205067852,2.544319359726466
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,4.228429096980471
SNU-81,44137675,1.234825635215107,3.107627566558731
OVISE,9929138,5.66720682434708,5.385895213886308
Panc 04.03,16725315,5.278537246983346,4.208367033842528
A4/Fukuda,6438330,0.8804707138455458,1.877317084799616
NCI-H292,984333,1.6058463338689488,0.7488777119703659
NOMO-1,11396600,3.3888037624860674,3.1710028836161417
SNU-81,24964624,0.6434241987426411,2.168321047633777
BT-549,11964036,1.9997330886235436,1.5054362516026536
A-673,135411,0.3370419809316401,0.3936819381618482
NCI-H1623,10296883,4.489600285768525,3.92049472577223
NCI-H292,2733526,4.552154891253422,3.8938743961886995
YAPC,6914657,-3.2827547721856423,-3.707968862023819
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.4375576304794169
NCI-H2009,327653,3.1880644035572825,3.2071284361357395
CAL-51,3384730,2.4775948365465905,2.4844388115027782
FTC-133,3689413,-0.3036251064519336,-0.2214092113933445
MDA-MB-453,11964036,0.3676608059270313,1.3766593401438052
NCI-H2009,5281321,-2.3281539094269843,-1.3110568254898487
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.031107409441525
LoVo,654092,0.3814222362545946,-0.23117005809472682
MDA-MB-453,50905018,4.488581944485688,4.199956952718307
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.339294906166509
OPM-2,46215462,1.142494911690201,1.392615893604126
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,1.563633274334367
A4/Fukuda,5329102,0.822909221294871,1.6989871176767082
A4/Fukuda,11228183,1.827405863351363,1.3602337006461724
Panc 04.03,5460769,2.0457621674825224,2.451165288361498
MDA-MB-157,9933475,1.5029335433067268,1.9693735182899
A-673,12003241,-2.2168793422392103,-1.3585783915368674
NCI-H460,54618164,4.49670945938676,4.089877563755588
NCI-H292,11656518,2.099021496243428,1.8043811188654184
SCC-9,51039095,3.242385267473305,2.771526453732689
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.189099415607374
SBC-5,3634881,3.763213110876527,3.077889806250552
SCC-9,984333,1.3591962563360305,0.5501737467539192
CAL-51,72193861,0.6423702350358801,1.204990372238382
SNU-449,6610216,3.892858260461962,4.3248035483637794
HCC1143,6918837,-2.8885170378203995,-2.830168434683078
DMS 273,10427712,3.7833762157010655,4.240096256102966
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.6807803824799614
LoVo,8515,2.0502092932288543,3.629176021230813
ONS-76,5311281,3.0534152046102507,2.417512396984024
EFO-27,100016,6.711163327148508,6.111884775302485
A-498,6610216,4.284288503720797,4.283240628752731
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-3.401609556316306
G-401,71466578,3.958692091033976,4.052789603470464
A2780,2749,1.2168739363641357,1.7034434180293005
LXF 289,23635314,-2.0420734326640253,-2.1169496727591213
LXF 289,24901704,2.332916050939017,3.371623699385306
LoVo,9887053,2.8676927346989265,3.506603981133976
OPM-2,6918837,-6.102124609605729,-4.2821935417024
NOMO-1,72734382,3.160209893803666,3.8883882938297383
A2780,44507138,1.3155442648841038,2.3957246603204
NCI-H661,9915743,-0.8538809858854721,1.1620883130394766
SW1463,168313047,-3.1836020137929246,2.258706696500176
SNU-81,55283,4.080745185244615,2.4944988012937794
YAPC,159324,3.323857793241652,3.083033105631376
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,3.6756260858833123
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.1136493072521447
A-673,31703,-3.778183583095139,-1.9136423877632618
OPM-2,439501,-4.648238189793765,-2.390355606921477
A2780,452548,-4.864509732913544,-0.3248959423871786
CA46,71304818,1.9606514180280712,1.8878692487369586
LoVo,25150857,3.1045912764862056,2.3813566421481016
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.531313035926289
OVISE,446155,3.256033609420766,2.596046893716734
SBC-5,54626689,4.608121703383126,4.452722367161638
DMS 273,11497983,-3.3171386440582467,3.497275616845286
BT-549,46398810,3.037551805065761,2.4888593558769485
KYSE-70,44819697,2.67312291481412,-0.16533501318222296
DMS 273,10113978,3.3411401717417135,2.992063831098225
YAPC,11178236,-2.1853000629740342,-3.485566508759478
EFO-27,89928392,2.3405290602814586,1.583659403250205
NCI-H727,3062316,3.1124899612632135,0.9676006296830667
MSTO-211H,9825149,1.7087798179810727,2.3738357105948302
OPM-2,25062766,1.526966504091227,1.9096022311233807
LoVo,24797083,1.0858534416002044,1.3524455040944674
MDA-MB-157,11612883,1.9249665557248452,2.5439393913394897
MDA-MB-453,24978538,2.762094535978925,1.2238327991990932
A-673,55283,2.8138583621562288,2.5525081527002857
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,3.7608519631425064
OPM-2,11228183,2.227238978219669,1.4986651769681962
SNU-449,11640390,3.8548607423510384,3.5690990052601155
NCI-H522,5281321,-1.0736628447197911,-1.757584402297191
NCI-H460,25126798,4.092385726400508,3.8402354541754367
JM-1,9887053,1.8224498727300744,2.9630219694734983
MDA-MB-453,3689413,0.605092083526794,-0.22155636832993483
BT-549,322968,4.038930181616003,3.389121192382871
G-401,969516,2.4612878169829067,2.6741656965364826
FU-OV-1,10127622,2.361983631252389,3.8156991394996087
G-401,5738263,2.503403034491448,3.1802380908483885
MDA-MB-453,5328940,1.6011356292327752,1.5858792885489843
HSC-4,25105715,3.6888708464756337,3.415207241248841
G-401,5291,3.6897209629580616,3.548054924703662
SNU-81,148198,-1.0516438667772403,-3.578403629889027
FU-OV-1,25183872,1.8271723160300688,-0.568318000720684
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.5997893394277545
JM-1,9935249,0.9666917954448688,1.8530054207854345
JM-1,44607531,1.0390724505323097,1.1489605330726478
BT-549,5566,3.2694223641451887,3.052603569867878
LXF 289,637858,2.285720521187594,2.030871837806279
SNU-81,56946209,-4.781557694686043,-4.419962918921235
FU-OV-1,89928392,1.4286122200262183,1.5155197458965441
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-1.2154956680068678
CAL-51,54618359,4.544084907505638,1.2541507938562944
LoVo,15983966,-3.091518031584947,-2.4100385219984997
CA46,5746,0.6077367646083516,0.03279145735620963
CAL-51,2733487,8.211583338705053,6.212732390789844
NCI-H522,4705,3.8595388748644375,3.140689823304432
A4/Fukuda,5284329,2.3119801528783244,3.0572753435408826
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.44161410433763343
OPM-2,6505803,-0.5489645461029444,-0.3797427730655059
NCI-H146,11955716,-2.61946993472624,-1.2076658021689977
Panc 04.03,19582717,5.125237161512837,4.042002356017778
LXF 289,9926054,2.043368643335034,2.0047653756346104
BT-549,136227924,3.266068806496957,2.9059001459058083
LOU-NH91,24901704,2.9181520482303585,3.0772086976609443
A2780,11167602,1.1290528312474395,2.0720691088003447
HCC1143,15983966,0.2074313732487278,-1.7296125895637688
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.5152233173326237
JM-1,2871966,-2.1290689366468354,0.01870767878916433
FU-OV-1,6852167,2.292876265150526,2.5534757056154733
MSTO-211H,31703,-2.679199045886266,-1.1500934478216474
BxPC-3,5335621,4.830409945539455,4.3572442130205
SNU-81,6438330,3.0600940001891863,1.8921170128174025
CAL-51,6918878,3.0110486558166274,2.7981334145412675
LXF 289,6610355,4.558728947318035,4.521731308707835
KYSE-70,12001922,1.7900886800743383,1.9104665496527369
BxPC-3,60168763,4.708123265391542,3.046677314200411
CAL-51,44137675,3.485867182081199,3.6010762054954437
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.3278907935179705
NCI-H460,216345,3.827300936034388,3.642152090978483
NCI-H522,15953870,3.615553645162116,3.494331844516181
A-673,46199207,3.2534509529249176,3.3026695002796997
SCC-9,10127622,7.404435857651999,3.7410648828955457
Panc 04.03,11977753,1.829262770264154,-1.1592011907955098
HCC1143,168313047,3.0210205197435935,2.323019772366474
EFO-27,3465537,3.52414234339403,2.5296203921250675
A-498,462382,4.566729065673536,0.740698481038627
FTC-133,45279963,4.126382655862848,3.5288364426782017
G-401,71751553,4.092007605377758,4.333827189308665
MDA-MB-453,119607,3.891659451485504,5.294470413992226
MDA-MB-453,3384730,-0.7236289420344145,2.7080133443800536
SNU-61,6184667,2.8549853776409937,2.8332213693791304
NOMO-1,23635314,-2.3321691272104697,-2.1751148073033932
SNU-81,54618164,-0.3986435357924686,3.9230659930344918
NCI-H727,65064,3.1010913931031867,4.902145199834393
CAL-51,44607531,1.640429423812436,1.4618428370056136
CAL-51,72376,-2.938334648898351,-2.456953701238588
NCI-H522,126941,-2.655181013676553,-2.385839845063671
ONS-76,3025944,4.431691617199171,4.220006014234325
NCI-H460,25154868,3.4600493825904564,4.406573831667401
FTC-133,71304818,3.18789827914798,2.441621290603117
CAL-51,151289,0.6583498849401344,0.7918607039502916
LXF 289,11238147,3.4273419568352006,2.7878200868569247
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.513619263295662
KYSE-70,702558,6.39879445367054,4.9946515743275475
CAL-51,124202324,2.033990287468598,2.4474953574104714
MSTO-211H,46907787,2.574686905184434,2.4459737867871962
MSTO-211H,4521392,4.029667841571139,4.269806593102774
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.6616729038262528
A2780,9549297,1.1491610880845489,2.130811443757198
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.5238970849285054
NCI-H2009,2729026,1.97459320968498,2.8329437754337117
HSC-4,5311,1.8002123285320597,1.3624399022747873
YAPC,135398738,5.4751822545753415,3.74612108576285
Panc 04.03,285033,-1.1400173305697017,-1.4619083434620361
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,1.059534399274872
A4/Fukuda,71466578,0.6387062903604859,3.4325051484257822
CAL-51,135398738,4.757337519270393,3.780095873672376
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.246803135604706
A-498,24785538,3.3641680302296564,1.7616409853612294
HSC-4,452548,-1.2537746146037845,0.07397342615506527
NOMO-1,6918837,-4.687337521865761,-3.593898484760175
A2780,6505803,-1.803583295606165,-0.6679838137851002
YAPC,387447,-2.999100837413036,-4.097392321063856
NCI-H292,25183872,-0.4983801682636667,-0.7140765489646584
NCI-H1623,44137675,2.921297693984664,3.5555479962510956
LoVo,46843906,2.381362357237743,2.621252734514333
MDA-MB-157,5281321,-2.46264909171439,-1.4105515234075028
NCI-H292,44137675,3.1459685562862707,3.6528417613616546
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,0.7548698958110414
JM-1,5470400,3.917661049847631,-0.21077175729017586
NCI-H522,52912189,0.1662181985496506,1.6880432748339975
MDA-MB-157,15983966,-4.787780953616188,-0.8096143894385277
CAL-51,10322450,3.881825194853649,3.7650909736228457
CAL-51,6918837,-3.0563476396929703,-2.9553209826254965
NCI-H661,54639126,4.507619035006863,3.735819531818062
NCI-H661,5311281,4.526772174839299,2.1875384482272713
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.246920058713691
LXF 289,3025986,-0.453776319374568,-0.9501102313297054
Panc 04.03,25262965,-1.014076783670677,-1.8364942524010752
MDA-MB-453,5746,3.800897853250581,1.2130654847266802
SBC-5,15953870,3.487984127844562,3.1971805422666377
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,1.1603340078801456
OVISE,3025986,-0.0395702470459638,-0.7690962906206551
FTC-133,5311,2.4215013743463647,1.3538905426771393
NCI-H2171,11485656,1.3701169509015756,2.286320867471864
A4/Fukuda,5282054,2.418862118344995,3.2010598268947517
NCI-H1623,25102847,3.8675819706398418,2.392141936548002
OPM-2,984333,-0.0237710386013994,0.11836363553522414
FTC-133,387447,-3.6414317999651336,-4.025331465462182
BT-549,5311281,2.333978253730499,2.477474256474589
OVISE,16720766,3.986904391501256,0.6579154195360988
NOMO-1,11612883,1.4996443311921075,2.0703461336535147
NCI-H146,5282054,2.6062567229872924,3.2130705369964083
SBC-5,6917907,0.6114763356012877,-5.188937210274974
NCI-H727,24951314,2.050368453430269,1.5367868723987874
MDA-MB-157,613753,2.6621381248494456,3.2025033353740975
JM-1,44486219,4.06629583721778,4.188190008386804
CA46,285033,-4.358161131916293,-3.28484637410451
A-673,9952709,2.6406542482442545,2.8302768835979846
BxPC-3,124202324,2.2278087185314694,2.4717949923247007
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.6317208403237151
A-673,6852167,1.8255345198368305,2.6661019690890395
NCI-H146,6610355,3.561762383324193,4.3449927994551185
NOMO-1,46215462,1.6253213091786816,1.433765459434797
CA46,439501,-3.521132637790176,-2.3274642167177904
KMRC-1,5329102,1.6227643750477536,1.9933784826767589
MDA-MB-453,568763,0.1355288059345826,0.2575666651035374
NCI-H2009,15953870,4.632669867834425,3.338588277086864
G-401,16725315,3.2068580834321048,3.87736047346724
SNU-81,25154868,4.054299809836995,4.272101581662946
SNU-61,2742550,3.576212598776706,3.536137253317484
BxPC-3,44589607,1.722183316619471,2.698045356375418
SNU-61,3025986,-0.1307165413786875,-0.9123253322455537
NCI-H1623,3062316,1.6941172744123574,1.557094857465646
ONS-76,16115403,-5.005393778847352,-4.361995758146166
LXF 289,12003241,-2.348837864712453,-0.8052680786720368
DMS 273,168313016,5.378851860414917,4.643309739969705
CA46,54765302,3.694944477545822,4.051808850525183
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,0.9798523716291859
A2780,10113978,1.7525717433500034,3.050795751378814
OVISE,9911463,4.4041109725525525,3.9306996442434197
ONS-76,44589607,2.6985455021272573,2.823134641981907
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,3.733200539962793
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.089998617157698
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.862128423625588
A2780,26596,-4.32263985415392,-1.8021676878559125
SNU-449,53481919,3.639889931386733,3.737944459610111
A-673,135875424,2.9734448822107886,3.76431060847051
A-673,49867926,4.049605811998934,4.101804129637549
MSTO-211H,16720766,-0.9979081980160748,0.7465789586860702
MDA-MB-157,24785538,1.324170410962965,1.7876258496049031
CAL-51,107970,2.299284460939792,2.272930612249708
OVISE,11178236,-4.082767785475175,-2.811477476785788
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,1.9214572626869375
A4/Fukuda,25154868,2.544294393199085,4.271438274839633
CAL-51,46191454,0.2698308836515951,1.4673877146521732
NOMO-1,136227924,2.5449106490851263,2.590195696492215
KMRC-1,24821094,3.705597482955712,3.304275783607049
A2780,5282054,2.567919090275208,3.2614406328717247
NCI-H2009,11404337,-0.0657811746758558,0.13101159646727542
HSC-4,409805,5.399675964474335,4.652066894705249
LoVo,24772860,-3.380615847351667,-2.2792317303853293
MDA-MB-453,54626689,4.438407624810902,4.510858525870015
G-401,104842,-3.837747012299513,-2.9781555544895997
BT-549,135440466,3.2033555971359267,2.436056959493503
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-3.0086739368555238
NCI-H460,5280436,4.847067650781305,3.502791138849504
NCI-H727,10385095,1.3903964913374658,1.4541510186733555
NCI-H727,262093,2.950291125725139,2.988509804609106
CA46,25227462,-5.088225796968986,-0.9732754669713357
HCC1143,439501,-0.7374061663212956,-2.058901203829965
MSTO-211H,10113978,1.403014421240365,3.1029593503625277
SNU-449,72734382,5.7131640484247805,4.605859979867675
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.9598837309146009
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,2.955833348827569
BxPC-3,24772860,-3.1359973170310993,-1.4344988682458728
LoVo,5281321,-2.272723057934536,-1.405595726662947
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,1.8385751397357013
MDA-MB-453,10427712,3.2513664008238874,4.310622925236949
Panc 04.03,53495165,2.8699642151767746,0.33441425458361684
FU-OV-1,54619267,4.302850520300199,4.0307283369150335
MSTO-211H,24964624,0.1425074184859401,2.4670479358538664
G-401,135875424,3.147536590476696,3.7639431094836535
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,3.6851484260159366
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,2.9961089972323443
MDA-MB-157,9967941,1.858403940770751,3.5668691534484553
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.5339551940290636
NCI-H292,11497983,4.544493181272098,3.8655705226196937
HSC-4,3011155,4.427149856421904,3.590001864391088
NCI-H1623,17755052,0.7357373094762232,1.666330811697155
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,1.6510855660110666
BxPC-3,5746,0.9856415477525818,1.3393264057187333
OPM-2,24901704,1.9220236520558196,2.9496677624857
MSTO-211H,2858523,3.0747353868294627,3.0335416282076166
BT-549,107970,2.9169966931039113,2.2737021256148653
NCI-H292,135875424,4.14052752249008,3.9393224786863983
LOU-NH91,107970,2.5070848864255093,2.334000799088279
MDA-MB-453,6918328,-2.060631340343386,-0.17322928495909878
KMRC-1,44566777,-0.0538941449270197,0.8514560032980527
HCC1143,17755052,1.15684078766818,1.6381253419224453
Panc 04.03,9956119,4.202347043107845,3.674853196338593
G-401,54613361,-0.5160099475891917,-0.20655106504912127
NCI-H460,6918837,-0.9355989207233988,-2.768916135961496
SCC-9,10302451,2.205114392498864,3.408411109995032
BT-549,24856436,0.2415814283223239,0.7079733865955746
Panc 04.03,25150857,3.139734816867742,2.485832576272863
A-498,9866186,-1.262750837313692,1.0498674735665654
SW1463,11497983,4.077621288565615,2.9000976059498647
LoVo,124202324,1.6089295836770297,2.0096927268070197
JM-1,46215462,1.389060279673689,1.5516942977872383
A-673,2729026,1.806074207860909,2.4917798944131224
MSTO-211H,241158,2.290519528489604,3.73702021172863
A4/Fukuda,6917907,-6.123586781218294,-5.447461505810237
NCI-H460,11485656,2.6212830818798065,2.341150233338022
A2780,135875424,2.703796648613349,3.7592059454024023
NCI-H292,10127622,7.746640801358069,4.380462473349775
DMS 273,9887053,1.8082863610482875,3.39293011227811
EFO-27,426756,4.432789586131128,4.3474053166440925
MDA-MB-453,2749,0.298775024907787,1.8387797288641121
NCI-H460,11222830,2.8861636193629323,1.687408862371893
NCI-H460,119182,0.2489341964189734,-0.577678440394839
MSTO-211H,676352,2.2606828184976955,2.121867298358135
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.4793909178542821
SNU-81,16736978,0.587276282018702,1.2363314333611848
BxPC-3,10113978,2.7603674185652536,3.356503642835634
SCC-9,6505803,-0.8932206272709824,-0.551304124209876
HSC-4,122327,4.034102983304833,4.7526475184271195
MDA-MB-157,107985,-3.8805729202788304,-3.498245207704646
HCC1143,5566,3.096162587379626,2.895971083190818
BT-549,5738263,2.4683192628765753,3.2672292075933047
A-498,3854666,2.914304878080617,2.097072582046199
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-1.002736313063194
ONS-76,73707398,1.7098056225756528,1.0385010801967534
A2780,10322450,2.9165978660974545,3.6835507852939635
CA46,3062316,1.4079672687586804,0.8197702522507675
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.322815952493076
BT-549,71466380,5.5332032048485065,4.580368408500409
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.2838189054124793
KYSE-70,24180719,3.52071426185984,3.544112600439257
BT-549,10385095,1.777553004720717,1.3750662115600212
JM-1,4259181,-0.0762731042787348,-0.4592395436043873
BxPC-3,12003241,-1.7282705692868598,-0.8307978748253536
LXF 289,9840324,4.681234496405457,5.788071424352434
KYSE-70,17759555,3.816264723168541,3.441035124352876
NCI-H292,9911830,2.887423578139022,2.4250192822663137
HSC-4,9840324,5.223554072523372,5.744721950352597
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,2.8956376586121606
A2780,9915743,1.3754925129164983,0.7905833743567002
NCI-H2009,10302451,1.2105403110698565,3.1250034531662316
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,1.901293516620596
ONS-76,9935249,3.5330143946083874,3.077119673143248
BT-549,11427553,2.4752578658091524,2.9133881291598653
G-401,148198,-4.717755806624399,-3.716791914025789
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.5350745838719804
NCI-H460,5351362,3.0809857123464037,1.7931175351286055
BxPC-3,5978,-3.126756112961715,-1.5707315130275743
OPM-2,11396600,1.8817984525619431,2.993128165577428
A-673,5328940,0.9058407904985936,1.4759814830729352
LoVo,16720766,-0.1141862087465287,0.5727823644731808
LoVo,11404337,-0.8407014552816361,-0.2311383069243999
JM-1,11455910,-0.0097968256607179,0.7252494370957531
A2780,54686904,3.0280150906907206,2.937578134430454
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,3.5921647972534134
SNU-449,9956119,3.198924280342594,3.757811805662196
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.3870844930807387
SNU-81,60700,-1.0304958014583914,-0.7755900156139022
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,1.914140658495933
Panc 04.03,216468,3.559067681626077,3.115321797492795
OVISE,46398810,3.0089868889673426,2.590048762330237
MDA-MB-453,11494412,1.83607541398336,1.646698294687554
NOMO-1,409805,3.6617718212828874,4.219608110190333
BT-549,25062766,0.9643791751629904,2.0217353839647103
FTC-133,446155,0.3759987857405991,2.3869989118464834
KMRC-1,23635314,0.7760380281113136,-2.2967033330413775
SW1463,15953870,3.283482316204368,3.396116734267025
LoVo,46943432,3.050109964187685,1.6749472725283738
HSC-4,46907787,5.727789952108257,1.9295311116973997
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,0.701486128404918
FTC-133,135440466,5.15132472260749,2.2437116336702077
SW1463,568763,0.7789022422759734,0.5327759762795015
JM-1,25150857,0.7748927856999902,1.9567012632003304
A4/Fukuda,71304818,1.5363144884487692,2.0698174846800246
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.7229053815014445
NCI-H661,24785538,4.2805678056942,1.3922293594919213
FTC-133,5282054,4.434007222498336,3.320985349025354
A2780,613000,1.210736664046428,2.555064719120997
SNU-449,6852167,2.6501635563943977,2.637417850470969
NCI-H1623,5280436,2.3425513929901043,3.3451668589980676
SNU-61,11625818,5.738401007397874,4.241956750102867
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,3.3047798575265586
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,3.677437050951632
G-401,11396600,3.403558125152034,3.5152158024594176
LoVo,11396600,2.965288622606591,3.599654957766214
YAPC,5311,2.641039705119952,1.439349432132685
HSC-4,168313047,3.0036663016787015,2.3073813683725932
LXF 289,135440466,1.0541158239349229,2.298222851024118
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.294272428950014
SW1463,16720766,2.9834843450585193,0.7157654565029563
Panc 04.03,2708,5.3340089352485816,4.618615492727117
MSTO-211H,11612883,1.8196539401694043,2.831881462156417
G-401,219104,1.9483296496250493,3.2799497381084155
OVISE,3854666,4.260793298508907,2.101891226003988
JM-1,327653,2.4402793258430786,2.7684376598645946
SNU-449,984333,0.3609894515007521,0.6037304113128427
NCI-H146,40482356,6.02837292181762,4.137136107588043
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,1.743289124400053
HSC-4,9952709,2.643320259436509,3.0461446657665228
CA46,71680916,4.255070441315874,4.250531924819845
MSTO-211H,119182,-3.3068023354733156,-0.7897786516154874
HSC-4,4788,5.270141450772874,5.737904941917911
MDA-MB-453,11612883,2.003650622053601,2.7355603542467875
A-498,2729026,3.0720683032694827,2.8694990249320056
CAL-51,135659046,3.6035863494873137,3.6778035862638894
A-673,16736978,0.9204710311128564,1.563792566517388
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.6263138547228508
G-401,5335621,4.041162639386401,4.1450145040165305
NCI-H292,11647372,0.0082735983152987,1.5477832511442542
NCI-H661,46191454,1.844409109204796,1.19863397744385
NCI-H460,439501,-2.362377537788676,-2.049029483694157
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.3236856653707927
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,0.726784239069527
A4/Fukuda,5328940,-0.5379688872377596,1.3917155147911304
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.258912230717437
LOU-NH91,25126798,3.943021506059378,3.921682010162798
CAL-51,56963564,0.4281851677964957,0.17278295076946304
Panc 04.03,24785538,2.964340727211602,1.7453309067847191
SNU-449,56963564,1.9660320048352,0.22512653621016018
SBC-5,156414,2.5142262290401516,1.173704794125783
FU-OV-1,46398810,1.7086224401878771,2.5291980831813707
MDA-MB-157,426756,4.156862898324412,4.336537519258553
G-401,4521392,4.161493335374481,4.073194645954406
OVISE,36462,4.611657944155446,2.017548591440225
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,1.9387825930882658
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.561708738512739
CAL-51,5351362,1.1872361858703535,1.3912998900751297
CAL-51,119182,-1.323881847361974,-1.1094344936886755
NCI-H522,24753719,5.009376195679754,4.200350125370386
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.8023008722598677
HCC1143,9915743,0.7364353129897024,0.376159046891434
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.5997893394277545
NCI-H522,24889392,3.251100273050004,4.142684916687474
LoVo,11178236,-1.6059359070935737,-2.9710223007543903
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,3.4717918438419986
CA46,23725625,5.582899861703026,4.322606178153463
NCI-H460,25154868,3.4600493825904564,4.406573831667401
CAL-51,36462,0.7338920585832341,2.271243212224708
EFO-27,5281321,-1.9543223460886947,-1.1426410017919213
LXF 289,11612883,1.9814919247106189,3.0549392911252315
HCC1143,2828334,6.454192166435682,6.265123998719835
A4/Fukuda,3854666,-0.0838776105349313,1.4762763194364177
CA46,10322450,2.6264913036213606,3.4030645866167815
NCI-H2009,51039095,1.8360035457780568,2.8975112323538657
BxPC-3,10231331,0.6961573218104748,2.0425927495033687
LOU-NH91,56649450,2.5557041031897705,3.5150417376687124
G-401,216239,1.6826916037000108,2.0736077654136413
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4715398744761363
HCC1143,5281321,0.7613054606946723,-1.507127843341528
EFO-27,72376,-1.8608022629783372,-1.7276457219024175
NCI-H2171,19582717,3.772812394316534,3.850713231321862
MDA-MB-453,10074640,2.421510718072182,3.2211679686446253
G-401,11317348,2.32763680059041,2.3344254875825317
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,3.3520477555089654
NCI-H146,2729026,1.2131739481587438,2.6665290625843197
OPM-2,46907787,-3.368300500627006,0.03747298090254091
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.33801241135461
KYSE-70,15547703,3.259406085484829,3.039726096833374
NCI-H522,107985,-4.282222583037789,-3.660614022856464
A4/Fukuda,9933475,1.717973727652582,1.665058659926746
CAL-51,6505803,-1.1525670311484852,-0.660933151408849
HCC1143,5329102,2.41968992927328,2.193252149568896
MDA-MB-453,46215462,2.7539180673476986,1.8614415815483039
LoVo,151289,0.7390860710542093,0.7083581727982451
SCC-9,10296883,4.238304408621306,3.8770816083939246
LOU-NH91,54454,2.054793401572522,2.4684713206650093
A4/Fukuda,9884685,-2.10728676228506,0.47134859111579197
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.6350706690529275
JM-1,11317348,1.0457451678280252,2.39860857043064
MDA-MB-157,5287620,-1.8230093056434509,-1.8768283059787227
FU-OV-1,24821094,1.823018038350918,2.919651104573642
Panc 04.03,15547703,3.067090198790942,3.133871242172988
DMS 273,568763,0.8680081273298318,0.33948833399622735
KMRC-1,16038120,1.697027615564608,0.8960651796930647
A4/Fukuda,11214940,3.3298423014633585,1.5010673046130918
LoVo,168313016,4.599216339831628,4.464636487467209
JM-1,3011155,4.445867330482826,3.150014160535043
NOMO-1,135411,-0.3073928829727976,0.09889216443107822
A2780,24772860,-3.463956246093966,-2.03859742803079
MSTO-211H,11625818,2.0984197145893853,4.188181514291535
FU-OV-1,219104,2.911303350256359,3.595975978693172
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,0.6578506383617162
SBC-5,49793307,2.0795512515040144,-3.302446495436934
CA46,53232,2.437328600755792,2.6423058000108517
EFO-27,24901704,4.244323432217726,3.1605157545254037
CA46,2746,0.9501634288999758,2.3320062481653734
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,1.6513938970014632
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,1.6284785951745824
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,0.8003791011779653
NCI-H661,9956119,3.313685900900753,3.7352541212972894
SW1463,44185566,1.4171512734588314,2.1599626411079966
FU-OV-1,3384730,4.633609637548597,2.765368288800884
SW1463,3384730,2.9539510373394458,2.427067747533214
MDA-MB-453,3825829,3.844348445708714,4.081137818232126
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,1.0059096923800979
Panc 04.03,400769,-0.067858138339059,-0.545113156469147
CAL-51,445643,4.334473435217703,4.10570367869177
EFO-27,156414,2.3785601677308215,1.4913034041562403
NCI-H2009,4259181,1.0344432117954978,0.3286859092375626
MSTO-211H,16722836,0.7655247341289007,1.7931918129616655
SNU-81,11364421,-4.012430935720713,-2.7261179896836545
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.1548038780528502
A-673,2746,1.857945511282164,3.038629527278074
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.9179713739377229
NCI-H460,135398516,4.13019906717736,1.9713271136869905
BT-549,25183872,-0.4430920052505824,-0.8873157466419034
JM-1,49846579,-3.8749150343559498,0.5925197949721898
NCI-H522,10127622,6.598645867237379,4.003118287274436
OPM-2,446155,0.7744505725193765,2.403458821145615
G-401,10296883,3.7583450228982342,3.8452869069885987
DMS 273,1716436,3.74376938939547,3.023027196105792
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.1885025916408054
NCI-H522,44566777,-0.9754694174653856,0.5838170932650748
MDA-MB-453,53393127,2.113910519669698,4.1514788903055155
FTC-133,49793307,1.1308238833509443,-2.9895130210835363
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.861276979748217
A-673,135928012,2.926877088120134,4.203184370428413
NCI-H661,5280436,4.871704282803626,3.0509178120779668
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-3.514338118245596
JM-1,5282054,2.3244175489984573,3.2331270151383906
JM-1,9549297,1.5955396397117223,2.04381326360435
NCI-H460,11507802,2.848054270429628,1.7269076644611732
A-673,387447,-4.940230504934896,-4.18325472073761
LoVo,89928392,0.5944678691764933,1.4932611740947963
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,0.6217412451504282
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-0.597457029708233
NCI-H2171,67156097,-2.093355563734418,-0.803667737815532
CAL-51,9929138,6.421072450841616,5.656796118141144
NCI-H522,11609586,2.3447481698139545,2.708362287033873
JM-1,56946209,-6.537344033049601,-4.571434892505755
MSTO-211H,54649381,3.373909346349482,3.8930060808274867
A-673,4261,1.089626824326701,1.4506318806031198
SNU-61,56649450,4.501229591303133,2.936854277438576
EFO-27,5738263,4.449588569174732,3.4475708639075844
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-2.5181675114705784
EFO-27,462382,1.6036436678954449,0.585928376925677
BT-549,24180719,4.750015939259711,3.3577649566555565
HSC-4,73707398,0.9895931551524366,1.2245784052710893
LXF 289,52912189,-0.1394416798850269,1.857283530064526
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.6539682222431094
NCI-H2009,31703,-0.97323545782719,-0.8807098601583153
NCI-H2009,219104,3.953506929532588,3.7589335524775582
A2780,11626927,5.568414170846121,3.2867990254522628
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.7197311271350916
Panc 04.03,4788,6.095957987809042,5.68136666909501
OPM-2,4259181,-0.0185783035827133,-0.2879932853628849
LOU-NH91,9915743,1.51930479588737,0.8277275315420262
G-401,2828334,5.836351566381613,6.058809186529227
LXF 289,3689413,0.4542816941401804,-0.1364442424890611
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.5767700735354644
SBC-5,119182,0.2964340092945935,-1.3862088142251379
JM-1,2729026,2.071801783442454,2.490787800271695
SNU-81,11214940,1.7135053171337324,1.4899106776740816
SBC-5,439501,-2.4874901722547977,-2.2794657754831227
OPM-2,46174525,3.627220507837432,3.866542712672356
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,-0.45064636238086925
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.628364819785486
NCI-H2009,3062316,-2.678423554108453,0.9900115397876925
HSC-4,6438330,1.0116267584860468,2.005352836279402
A2780,1317464,4.304763369285543,3.2869064339778133
G-401,3025944,3.816605103301755,4.196963980154594
NOMO-1,9915743,0.4758643096003905,0.5118257524954053
CAL-51,9877608,5.917079709597661,3.3330244388592543
LoVo,71466380,3.017013363980257,4.238326471142249
HCC1143,53392493,2.60613854373917,2.4917157789604363
A-673,6918837,-5.129930095166698,-3.5180981032127967
SNU-61,60700,1.2670278964841577,-0.5101203808729677
OVISE,6918837,-1.5846953199834826,-2.7568136246452424
NCI-H727,11609586,3.3120945172723917,2.7145304161150086
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.912701194238518
NCI-H1623,5281672,4.562545083615407,4.486364883976259
NCI-H2009,6918328,-0.9509353973047906,-0.004890882962629363
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.2020553649431713
OVISE,16722836,2.434488476233433,1.821152792410529
JM-1,10127622,5.153041805169496,2.5113267784225872
NCI-H1623,252682,6.46254793762087,6.518011443644423
JM-1,53392493,1.8440760854554048,2.3346799814084225
MDA-MB-157,168312962,1.1798186112423137,1.760875502751212
YAPC,44819697,-1.3460219164430964,-0.27999854990185935
KMRC-1,44607531,1.585622780528836,1.5387804706192008
NCI-H2171,6918878,0.0284372668850805,2.3899927130238963
MDA-MB-453,44607531,1.359301388322155,1.4126889342070612
ONS-76,11485656,2.5953354109263262,2.312137515768788
MDA-MB-157,135398516,1.565807276365399,2.1207393051227736
A2780,24753719,3.5545225878481745,4.027026264007528
NCI-H661,6918328,-0.1140400883450083,-0.034361674780780435
JM-1,4578,4.1991230056704785,4.158922972768509
A4/Fukuda,9903786,0.7546004224414102,2.4055805531000853
CAL-51,11485656,2.6541256228973773,2.4672456739749036
NCI-H292,24964624,2.911439833663599,2.609817442046027
NCI-H661,6918837,-3.3797686305940156,-3.059734206911464
EFO-27,71304818,3.2919872626583486,2.4954967073124177
MSTO-211H,4705,2.457156821386339,3.0282586036278296
DMS 273,107985,-4.548014092027974,-3.6582632821859358
SNU-61,2729026,2.4451253635155106,2.5695113273762415
JM-1,60700,-2.9904484465209036,-1.136482051707312
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,1.4561175894807568
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.1440962850934278
SNU-449,24856436,4.072390930567189,0.40339943570674286
NCI-H460,159324,4.0462841352482855,3.117839247397618
NCI-H2009,11175137,2.49599907102206,2.7376444813073335
A-673,208908,1.851861192467165,2.1518447494201185
BxPC-3,25183872,-1.12027566647844,-0.7367788532987946
EFO-27,5328940,2.731901822530229,1.7202780113633933
HSC-4,135398516,2.2759469773851224,2.169963543824713
HSC-4,11647372,1.1815136799972823,1.1665103008849924
CA46,16038120,1.1324791438314847,0.6363776018630489
MDA-MB-453,9868037,1.568237926564538,2.9755864973745783
A-673,446155,1.1478268834845686,2.799610920276172
A2780,5479543,3.565203320915574,3.4126308809098918
MDA-MB-157,10322450,5.067042624032479,3.732890295536844
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.5734577167525006
MDA-MB-157,9915743,0.9957990206413116,1.147413187343602
A4/Fukuda,219104,2.2512696330904447,3.1072169913681362
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.3253187799833213
SBC-5,12001922,2.404615034975172,1.8193594384432712
A-673,51037431,1.861905373589415,3.147853414254949
A2780,637858,1.382423379201008,1.6391493301938338
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,1.7847144953340943
A2780,9884685,-1.5939943621043984,0.39584680205176015
JM-1,5311,-0.0672732572458771,0.9427821060410337
CA46,15547703,2.518572103836232,2.605375206567038
BxPC-3,54618164,4.016743819691475,4.055742506456232
BT-549,2749,3.5786970568950913,1.8660871971487225
SNU-81,73707398,1.1294477244846828,1.0150687299642716
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-2.5433959059036937
A-673,55508,3.3138750706926157,2.7268167956174936
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.0785000514038448
MDA-MB-453,23725625,4.029710365908802,4.866787824239705
A4/Fukuda,4261,-0.9007526332595048,0.8975684761227815
NCI-H727,446155,4.65589483782911,2.742432178296826
NCI-H1623,44486219,4.206804435599472,4.138911171446841
MDA-MB-453,441298,1.8295928982069447,2.549056748734591
SNU-449,54454,2.520106415523585,2.4778218039979536
A2780,387447,-4.368237522415053,-3.9955907769991224
MSTO-211H,11152667,-3.5300772231011703,-0.5562384338664529
SNU-449,25195348,3.622170031481097,3.2503403163673164
MDA-MB-157,322968,2.1225136411127545,3.7140664102352714
A2780,168313200,1.7543183926879495,2.9289882438247243
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.3606012233134075
SNU-449,5329102,2.0099859216843075,1.9381991569817387
NCI-H2009,322968,4.70725114827159,3.8505634650941305
KYSE-70,16722836,1.4327625680833322,1.6753520183974198
MDA-MB-157,11609586,1.0926317538630208,2.9006359453316786
FU-OV-1,10231331,3.398558944555642,2.191578724260292
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,2.9481598371472932
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-3.524238523074052
LOU-NH91,11238147,4.007302405058718,2.7092437096991504
LOU-NH91,49766530,0.361985362717411,-0.7839840145785157
YAPC,9444,4.346283036692295,3.881287547186362
NCI-H522,15547703,3.471643136947843,3.2135909137408576
NCI-H522,375860,-0.630771500248647,-0.42202989549878206
CA46,119182,-4.388833865288787,-2.4800668807164086
OPM-2,10410894,2.9147321100270593,2.847160694154562
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.642942047808569
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.4914591511925255
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-4.250867875949692
NCI-H2171,4261,0.9024779156039784,1.677694262218493
NCI-H1623,25262965,-3.228781743363827,-1.9460228249226252
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-1.1123599815759675
MSTO-211H,10427712,4.183883954719584,4.265954173230291
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.355570493327046
A-498,9967941,4.3277437867326025,3.7143270652527365
HCC1143,25183872,-1.001460572121427,-0.776710400104023
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,2.014491839725815
CAL-51,17755052,0.5283491907817935,1.7368694009183767
SW1463,44137675,3.7114847318755806,3.358769330871372
BT-549,5278396,3.375604766419473,3.6002661482228193
NCI-H292,3025986,-0.8794264876923694,-0.9236656411607406
NCI-H2171,3825829,3.727904622873516,3.8318907804629028
EFO-27,327653,2.4330037956805133,3.1059639665533534
NCI-H460,637858,3.384702960830197,2.1392068446249524
G-401,5746,-1.2143401521495898,0.8136192100790504
A2780,5281321,-0.7497434400684011,-1.4386396519179372
NCI-H460,409805,5.4278006548731295,5.059365057967095
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.42979592674006895
SNU-81,11964036,-0.3940350311201446,1.0526472709596753
OPM-2,53232,1.210133300080481,2.6037248109541036
A-498,216468,3.41587450505901,2.8463314850824357
LoVo,6852167,1.8421975016001388,2.5047110832818595
SNU-449,53325874,4.456238471946744,4.483461164355998
FU-OV-1,10296883,4.259179003182187,3.8440296315007174
LoVo,3136844,3.7568853791466608,4.145702244943354
HSC-4,637858,2.398043952194309,1.77342556800846
NCI-H522,9927531,4.749051096908956,4.770255539619104
MSTO-211H,53392493,1.8202473930982712,2.672589774403818
Panc 04.03,11626560,2.20525660125161,1.7677730680301185
EFO-27,11178236,-5.208504296414087,-2.9741272806464165
SBC-5,3503,1.24841833111282,2.085929126106823
G-401,11640390,2.8162749001609417,3.26341810757326
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,3.2342069921816505
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,2.9149070181913395
FTC-133,54454,1.7579296666098376,2.546454852020955
MSTO-211H,54613361,-0.4311183648022992,-0.0491006856105447
G-401,5282054,2.6200467258422235,3.281777401478526
NCI-H727,135440466,0.3181577925646752,2.2337094776577535
SCC-9,6852167,2.7106856908699255,2.6355900176388984
NCI-H2009,124202324,1.390796248932456,2.33339120293949
SCC-9,54618771,0.4910288003516506,0.8919974255419107
A-673,9826308,0.1905391916215918,0.2983668629849044
KYSE-70,446155,3.830415114438346,2.8034701568704925
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.0746631167898217
CA46,10296883,3.259152671675197,3.318035826663802
NCI-H661,159324,2.633762936698375,2.8686383806894082
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.6461730129219463
LXF 289,5328940,2.0490491787199687,1.6234175119809762
KYSE-70,400769,-0.6610715268602807,-0.5993198775314088
BxPC-3,9911463,3.950256717526944,3.832906707056475
MDA-MB-157,119607,5.813382396653367,5.246887550402089
NCI-H727,168312962,2.354698653601169,1.4795616041515327
G-401,67156097,-1.3508759360204068,-1.418697946735197
HSC-4,53232,3.536415160688875,2.74599192876144
BT-549,9866186,1.9395157417186848,0.722804570070861
A2780,46174525,3.809782337657401,3.8969300250030403
NCI-H661,24797083,0.8737198077858661,1.4366845347844464
OPM-2,107970,1.3408908225452507,2.1127094663022112
HCC1143,3038522,3.729990546362485,3.1600511364561283
JM-1,5746,-1.3315669786621744,0.25353572588490586
OPM-2,9935249,1.874633336412032,1.9865351706577479
A4/Fukuda,10302451,3.353566161735505,2.8887165054311588
SBC-5,1641662,2.7360117188732684,3.3130863537263924
CAL-51,25183872,-0.1080661998677032,-0.7394005245441236
HCC1143,72734382,3.642829686089203,4.317960133016923
SCC-9,67156097,-0.5297515363076177,-1.1760660300920298
LOU-NH91,17759555,3.0310153631552295,3.7623627531210104
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.4458096906403148
FTC-133,6252,3.0791801983523297,0.5996432875487056
NCI-H146,10026128,3.971012402354388,4.084231633251941
HCC1143,327653,2.9245812810780745,3.0962163887942933
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.4336918562065788
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-2.4985677898938325
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-1.545020319581491
A2780,71466445,2.121500658196736,3.48019514127365
FTC-133,11640390,4.129780643497309,3.6620517497901854
NCI-H661,66577038,3.3791675548307225,2.859628543978106
A4/Fukuda,89183176,1.286008536767452,3.2914359542516536
KYSE-70,49793307,-3.275020883815728,-2.5831540994109248
NCI-H2171,36314,-6.271125424872196,-0.7837517425058513
G-401,5351362,1.1066788885055705,1.454552502178374
NOMO-1,44507138,0.557170216692965,2.071816249237892
CAL-51,56649450,1.7310987503885624,3.0561335609379885
MDA-MB-453,100016,6.0730906594859215,6.017521651485026
NCI-H1623,6852167,1.7873387390250663,2.8582997245551276
A-673,16659841,2.6132078541729404,3.6189611125339085
OPM-2,67291369,1.773293288142809,1.2459794316122648
OVISE,374536,3.768512931442208,1.9106274052455439
CAL-51,11238147,2.100409816322544,2.551840035040733
YAPC,11175137,3.2313352651289327,2.660692251151734
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.6511551316231936
OVISE,10427712,4.5158462716299415,4.410185877256791
EFO-27,5351362,1.1790960486008195,1.5708410612657275
NCI-H292,6505803,0.1482155149138876,-0.5090741892733779
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,2.9448207956354158
DMS 273,71680916,4.789726238699708,4.490468804100192
CA46,10184653,1.13668363671425,0.8548981001576453
SBC-5,49867926,4.30527508614513,4.0746304056986675
LoVo,11238147,1.4038592423826672,2.5543258197616354
MDA-MB-157,11427553,2.127814795485051,2.8008843914266235
SNU-61,11178236,-3.475859478717308,-3.1815795843780923
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.5289709716720083
FU-OV-1,11214940,1.6800576649286882,2.039125931215569
LoVo,9903786,0.6551100591729495,2.624741184786556
NCI-H1623,135411,0.3784026464220375,0.7762605209215246
LoVo,3062316,-2.119304437973892,1.1619800739852026
NCI-H661,46174525,4.042428757819544,4.144504678525418
SBC-5,51037431,0.5420283127367359,2.654615335104376
A-498,3689413,-0.327867250415736,-0.5717498072726407
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,3.1305086758340015
CAL-51,54649381,3.902782783768603,3.9531269918714225
A4/Fukuda,16038120,-3.113498344638628,0.651414177505696
A-673,135398516,1.4288802928040978,2.046150060057754
NOMO-1,135398744,6.340708200805823,6.2638513306221775
KYSE-70,216468,2.031191966418552,2.6385979263585546
A2780,67291369,1.1130592599106983,2.0923795728919483
NCI-H2009,654092,0.0283248260105453,-0.12477300105698003
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,1.423512207956788
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,0.8542723979424067
SNU-61,11612883,3.050953505253589,2.7583731075148177
SNU-61,5746,1.3298489283886064,1.20791255457946
KYSE-70,124202324,2.186627813347476,2.335879591987199
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.436271689897367
BxPC-3,409805,3.7922849099240734,5.006740320476635
A4/Fukuda,3552672,1.9607713184754867,2.78065588941723
KYSE-70,9907093,3.6347338213446454,3.8911880765210394
SNU-61,12003241,0.1572719330395487,-0.6917801313224023
HSC-4,322968,4.636798889333657,3.6314223555243514
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.4845173328846766
CAL-51,16115403,-4.643171700082743,-4.207653471544926
LOU-NH91,2746,5.002248002286792,3.1991876212014034
A2780,3543504,4.147653095225295,4.139308522196009
NCI-H661,25126798,3.9237728184770946,3.8496715811665325
DMS 273,4521392,4.235410021964807,4.071518886014059
BxPC-3,49836020,-2.380895293574403,2.4331614431090096
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.9319696773769566
OPM-2,3689413,-4.501811354570108,-0.9596522181286565
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.017706279897157
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-1.2505026646611603
NCI-H460,5328940,3.322075361136407,1.8006338309885657
ONS-76,25126798,4.148768722347094,3.7480188650616633
OPM-2,57519531,1.419627244644159,2.0050318266983154
BxPC-3,20959075,-3.864209289368053,-2.470085082431522
OVISE,54618164,4.29678583267412,4.136418930343257
YAPC,10074640,3.068654585130056,3.249562408009185
BxPC-3,5287620,-2.837282092833542,-2.1479748558930294
SNU-81,24785538,-0.3807988804027284,0.8809078860690991
NCI-H292,5287620,-2.1513248285430997,-2.194494759171013
NCI-H146,104842,-5.965892600420639,-3.2197081994672323
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.444455439166911
KMRC-1,17755052,1.9475900469511016,1.884108232768872
NCI-H2171,24856436,-0.4096039036242957,0.6643643259831878
NCI-H2009,11364421,-4.013811791110126,-1.4705972134974403
MDA-MB-157,5470400,0.4579153499304774,-0.6302810364955679
HCC1143,51039095,3.6749130279746938,2.757608100719366
G-401,11964036,0.0453230579510409,1.3003086965246808
NOMO-1,1641662,3.174576963224712,3.0908014515302313
MSTO-211H,25102847,1.842661618149511,2.614263214221154
A-673,9908783,4.713034696547774,4.816652576663031
BT-549,71680916,6.0821013857398745,4.616037702240652
JM-1,11719255,1.4438675590466743,2.817993307513348
HSC-4,2874250,5.810325396532396,4.699458086583846
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.054745491279340905
NCI-H460,654092,0.4612941847378306,-0.15310971661109618
OPM-2,5328940,0.8145180628284293,1.2517472105923388
A4/Fukuda,44202524,1.0259860145116777,1.4727168636366614
G-401,11213558,0.7886605378704363,1.7344291626080257
OVISE,135984461,1.6429740508824469,4.103002901735718
NOMO-1,11964036,-1.1045639043109698,0.7574093682038863
CA46,6184667,1.8666466805539537,2.5006582343314996
NCI-H460,9903786,4.057661845653794,2.910143255798003
BxPC-3,25102847,2.0998558206838913,2.5961436065394934
SCC-9,5470400,0.9401931564199802,-0.2992648137491576
ONS-76,5284329,2.36276815665719,3.3086853984375013
DMS 273,25227462,-3.883072621079263,0.14559511295272995
A-673,42642645,-0.8052568071576633,0.5640503316902399
A4/Fukuda,9549297,1.6255879909683784,1.8984172132582464
FU-OV-1,11427553,3.01783779671809,2.5589206726245535
SNU-61,5328940,1.147707594205283,1.3408813215086517
HSC-4,5281321,1.7816899121848235,-1.453230875416559
KYSE-70,656346,0.9492660515895844,0.9940534223580155
NCI-H1623,72734382,4.853935764849827,4.530452037336854
MSTO-211H,67156097,-3.635314822435898,-0.35880711287753964
MDA-MB-453,637858,1.2138352699902215,1.9768249173390995
CAL-51,56963564,0.4281851677964957,0.17278295076946304
A-673,10113978,2.507382463710335,3.215392700639145
YAPC,2946601,6.339465197306548,4.436481827219432
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.7307550600437989
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,2.9309979365263024
HSC-4,65628,3.12205826618997,4.198893299160619
HCC1143,227681,3.1373347590378335,3.2226344067047763
A-673,53301938,4.3782771731899555,1.4198965947990234
G-401,66577038,2.320880294749871,2.8957316115058798
NCI-H661,9884685,0.1767392095869446,0.5120643125647032
SNU-449,6184667,3.7989058233577566,3.0399420263114045
OPM-2,24951314,0.2222837933942169,0.9413301707764963
LXF 289,56963564,0.2991276479966406,0.2902112298022239
HCC1143,11364421,-2.85203888888326,-1.9476838917426706
NCI-H292,9936388,-1.1579069678838152,-0.7353037289731903
G-401,10231331,2.894718734978725,1.7237576607435852
CAL-51,89928392,1.068329558331595,1.4257749864552147
NCI-H2171,53392493,1.8740494203136608,2.248010820026653
A-673,136227331,4.241984110268528,4.088023895384308
NCI-H727,11717001,2.7053596974758594,3.9793696875846836
A2780,16219061,2.814782356526162,3.19202831129922
SCC-9,54454,3.1137155512464596,2.3820486440113995
YAPC,12003241,-0.7644111057992425,-1.245492554622764
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.648397059932913
SNU-81,5335621,4.181800470543683,4.352417643277168
CAL-51,5329102,2.0492492410301484,2.0033005769778867
NCI-H146,10385095,0.6869778017915235,1.2382303988644823
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.4787855674234645
SCC-9,2113511,6.3303497429476625,5.524893428439604
ONS-76,2708,5.792421817961339,4.6058756056812316
SNU-449,11485656,3.58452534173841,2.3581188330148355
A-673,46215462,1.2771489946566346,1.925494054989469
FTC-133,285033,-1.2963608176743802,-2.118663753485276
SCC-9,6184667,3.279451062583292,2.878955853858624
NCI-H146,16722836,0.0677462505380894,1.5687959410286998
NCI-H661,44137675,3.7576040576240257,3.5592134630260177
NCI-H1623,11612883,1.5649574760969076,2.84929333529364
LOU-NH91,3825829,4.327670981782257,4.012623928911589
SCC-9,5287969,-2.1272191034883874,-1.942670978084164
Panc 04.03,10410894,3.886544188244091,3.478951384878277
NCI-H146,135398516,1.5035346569298091,2.0355099505438705
A-498,4096211,4.004902569915099,2.1621281319142422
OVISE,104842,-0.680714151991963,-3.1361475452628103
SCC-9,135440466,2.439160969941936,2.3005003660866388
ONS-76,10322450,3.321198163736043,3.8972167549281975
SNU-449,81146,6.119223793669881,4.6347036487646704
JM-1,148124,-7.840698833354439,-3.116092772195854
BT-549,5460769,6.35928800843138,2.9686633337684043
MDA-MB-157,969516,1.7670354115722269,2.76055188388162
LXF 289,5278396,2.6487510770020104,3.672844102740784
ONS-76,100016,6.019166856387977,6.055381197001194
A4/Fukuda,11707110,-3.666992219196893,-0.15209450222378953
JM-1,6438330,0.1685207017328377,1.4355147336707497
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.3990146330751179
BT-549,10074640,3.6929061121608577,3.1958794744259795
A4/Fukuda,46926350,-6.021657358635238,-4.208313516931108
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.14416441840382369
SNU-81,4917,2.3748179961814375,2.952725820128874
A4/Fukuda,119607,3.918640768426122,4.857537502387854
HSC-4,613753,3.3632883902358715,3.1996929402064547
DMS 273,135411,0.7219297948054574,0.5102226236316678
KMRC-1,46907787,3.729545872280723,2.2855762588372492
LXF 289,44489675,4.904101073680104,3.8628810480812104
BxPC-3,6918736,-1.9181543280529496,-1.4310269582923967
KYSE-70,65064,5.1318583658275205,4.558172286961282
HSC-4,25062766,1.8609848482730849,2.05725990630271
SW1463,15983966,1.3055923116721375,-1.9411013765016802
HCC1143,11396600,3.529486359294858,3.553191595465239
SCC-9,45279963,4.124125049817703,3.764505021868918
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-2.9309791433036874
NCI-H661,5113032,4.99918939361245,5.011563968461047
LXF 289,17759555,2.434653643868842,3.7013534918668394
DMS 273,46926350,-4.333780789364997,-4.213841621575936
OPM-2,46224516,2.1207785622277373,2.1922054639706965
A4/Fukuda,9908783,4.281950187885367,4.776956039318609
A4/Fukuda,1716436,2.785785051354721,2.7638636156878897
KMRC-1,54454,2.958009627513852,2.46450858279816
HSC-4,73707371,4.771220465805862,4.856099561359355
KYSE-70,9911830,3.1951659700149886,2.2984575080105625
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.5266611379933602
HSC-4,16720766,-1.6245250648624636,0.30642781828160554
OPM-2,11964036,0.2409704368173301,0.7118639211987836
LXF 289,3038522,4.104388560491244,3.1836219217430726
A2780,49793307,-3.5064247630527494,-3.0844991633252796
MDA-MB-157,12003241,-1.4339892472843776,-1.0749891376189984
MSTO-211H,53495165,-2.281905985837366,-0.07703540411495459
MDA-MB-453,24797083,1.319210590833939,1.3832080287429214
HSC-4,25126798,3.2488654911973196,3.79881514481197
BxPC-3,3854666,3.4835595653471167,2.2799623091099277
HSC-4,176870,2.813832788377266,3.3501263264311096
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.4033936232603604
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.4254789250175858
YAPC,135398744,6.484368053683043,6.517823201170552
MDA-MB-453,51039095,2.709903892694302,2.829780212800769
CAL-51,24821094,3.2618915388877023,3.097553334900722
NCI-H522,1239801,3.903810420887451,4.0694119642485465
KYSE-70,7251185,4.369311092923008,2.4204103810289768
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.6573113402127104
G-401,60750,-4.380742093252711,-2.9339862144592566
YAPC,11404337,0.4717703732171429,-0.4592699520794303
MDA-MB-157,9826308,-1.0851482905673768,0.2704674116009039
MDA-MB-157,25262965,0.470934001928582,-0.8688140336187906
FU-OV-1,10427712,2.3896052276409887,4.313936199045345
CAL-51,285033,-2.914004430070481,-2.029320063362928
CA46,246676,4.699933053014099,4.226447629810484
A-498,9926054,1.5026788619071982,1.9449366485625383
LXF 289,44632017,2.313535350982782,1.3560689596858344
NCI-H727,3689413,0.3749801507161196,-0.5287789195773839
SNU-449,1716436,3.0856052265463023,2.883484820036703
LOU-NH91,24951314,1.380037957351277,1.322562667994726
SNU-81,46191454,-1.5874627182763832,0.9408592339782861
KMRC-1,119182,-0.1449504353389931,-1.1241259720024452
NCI-H522,9823820,3.261618834820585,3.921971174336274
NCI-H460,11178236,-2.300904923417752,-2.77741629155319
A2780,5738263,3.096886997462696,3.1965017783408705
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.357676589870502
BT-549,5287969,-2.055370090828861,-1.8298816508602045
BT-549,11609586,2.735581966533724,2.935154439349314
OPM-2,1317464,3.5924971065959244,3.0639322435664673
NCI-H146,54639701,4.038686865533554,2.9507847869356034
LOU-NH91,3384730,3.7773271912609623,2.461403306906364
YAPC,11152667,0.3482753398657929,-0.9480252308756769
SNU-449,702558,5.257858019653286,5.260955696912789
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.31156814827645
FTC-133,6438330,2.249518605035186,1.9743846749981693
NCI-H727,12001922,1.7281936629666887,1.9241512587877856
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,2.7074149957719307
HSC-4,60750,-5.118377280037083,-2.8872025107043027
SNU-61,1566236,1.9599867850180668,2.062413875740752
NCI-H460,5282054,4.802373462225767,3.8109253956470934
DMS 273,6610216,4.172124776089646,4.204545486259886
NCI-H727,6852167,3.356078560596427,2.9344225052860495
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,1.7663855630672205
SNU-61,445455,4.539446073708065,4.725698438857619
DMS 273,3062316,3.60345807305724,1.118827010012558
MDA-MB-157,9956119,2.310937024804907,3.7444271143273085
OPM-2,135423438,0.9866001177758746,1.7542901822702377
Panc 04.03,16722836,2.845252730089092,1.475120375160735
MDA-MB-453,9936388,0.6028011486270662,-1.7246609643357973
A-673,68056272,3.7833857366006094,3.3989063035031455
HCC1143,16722836,1.2433455264432278,1.7549433917787727
DMS 273,72193861,0.4647891664131632,1.3071909492228786
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,0.6991664454984086
Panc 04.03,11396600,3.73844061007523,3.635779173338775
NCI-H522,6505803,-3.5272214952237344,-0.32431680296466037
CA46,56963564,-0.0544830399645368,-0.11773937030481432
A-673,9825149,0.7138432506885886,2.2046189382051726
NCI-H1623,2871966,1.4286416314522286,0.3155206642320565
SNU-449,4096211,1.9400565485658428,2.256641817915514
CAL-51,44137675,3.485867182081199,3.6010762054954437
MDA-MB-157,375860,0.0174110406826079,-0.37069862327723363
MSTO-211H,327653,2.467891014920142,2.9248054674613964
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.027430816088409644
CA46,11178236,-6.883102305003874,-3.8572298575322335
NCI-H661,5291,3.8370923902638063,3.593619813871646
FTC-133,25262965,1.6757685209235111,-0.991154447504128
SNU-449,24771867,3.0453458349703793,2.598839307626846
HCC1143,9911830,2.6182666070844447,2.696478382868154
SNU-61,44185566,2.430559307269213,2.1915667597440427
SNU-449,445091,4.4459202939225815,4.274882127385346
LXF 289,123631,1.612545473594554,2.6303221974215734
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.340554539823473
SNU-61,637858,1.6436621136217924,1.8220429681368742
MSTO-211H,3025944,3.596075182431598,4.335527168193509
SNU-81,11612883,1.8877401103471,2.2494361505019054
A-673,52912189,-0.9448854486243604,1.5537779072658353
NCI-H727,613753,3.184500780825273,3.2776536312358324
BxPC-3,24856436,-0.8809901773698104,0.7337872183208444
SNU-61,3038522,3.6960216122526943,3.2350318978319508
KMRC-1,374536,2.325099751463231,2.2688551533547714
CAL-51,54613361,0.2180057854442524,-0.07051097320938977
CAL-51,10385095,1.0305027810027567,1.17560889257914
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,3.570959964179832
LXF 289,5281321,-2.4870532876216487,-1.710823078076935
SNU-449,10184653,1.7910926490151993,1.4149570244576695
SNU-81,9887053,2.281153151762533,3.4126011320147644
KYSE-70,11485656,2.2230455690794404,2.3039072895873107
CAL-51,439501,-2.444412450902406,-1.9720093061859472
A4/Fukuda,72967,3.695839205584607,2.6296556813112737
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,1.1065763648978129
BT-549,57519531,1.7866000969199525,2.5257369696021827
YAPC,9911830,4.0093640169179325,2.3991971557173657
KYSE-70,54143018,-0.2928055682999507,0.37949186058885465
ONS-76,6852167,3.4771955261396252,2.8748322532576505
CA46,216468,1.7849524837603168,1.8546228037106087
KYSE-70,71304818,1.8226881659751617,2.4758178366131633
SNU-449,10427712,4.716616821408685,4.41564463778335
KYSE-70,11364421,-0.2598881855214042,-2.0811885708019857
SCC-9,46199207,3.715699147831311,3.265054456453214
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,2.73909272341277
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.2341224764127885
NCI-H522,45279963,2.975445810656792,3.3824195629326606
NCI-H727,44137675,3.902640688581202,3.5723954482016627
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.1769362873279792
CAL-51,3854666,1.1494535123186709,1.6802020863322855
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.418829606162826
NCI-H2009,81146,6.16166931928307,4.683765579945953
LoVo,135440466,2.5900307411888357,2.106076729312951
G-401,445455,4.8654155018395535,4.431433202255893
NCI-H1623,15547703,3.108106821400364,3.154073673307977
SCC-9,322968,4.6886309532040435,3.6074366462471086
MDA-MB-157,23635314,-3.347178711973772,-1.5660959935784757
CA46,49793307,-4.01311922110524,-3.596267614485063
CAL-51,53495165,0.3298774405260949,-0.17892662354341687
SNU-449,54618164,4.194291334344069,4.13152931825892
LOU-NH91,11178236,-2.353397629942184,-3.1437671588998226
A2780,5284616,-6.357248921927095,1.47620732960048
OVISE,11404337,1.793635825025173,-0.1789836265132048
HSC-4,216239,1.6239220207771676,2.2242513735854055
NCI-H1623,208908,0.8939149685214822,2.0661411063767763
NCI-H146,25161177,3.485806465133522,3.8884208896545704
YAPC,6918328,1.93910137978286,-0.1861956871953914
EFO-27,3038522,3.6669358154068097,3.343400570576057
DMS 273,25262965,-3.6359475061731534,-1.6820465348661042
SNU-81,9803433,4.184314019267332,4.515086859091996
SBC-5,5351362,3.2358684618056164,1.3100969008412275
NCI-H661,9826308,-0.3578866099027624,0.04054051984550906
CA46,462382,0.6475442737717811,0.31936862215044814
SNU-449,168313200,1.9091128501610053,2.960033885973421
SBC-5,613753,3.3291324843640497,3.0478815414490965
HCC1143,24797083,1.671403596818138,1.3571680165586966
NCI-H522,11625818,5.118334572164132,4.376938093352502
Panc 04.03,446155,2.4976903608369994,2.8227654018491224
NOMO-1,2733487,3.664178503465112,5.936718154312874
CA46,11494412,-0.1540181126177876,0.8548598223055108
KMRC-1,168313200,3.9547474801247455,2.8945489896417023
BT-549,12003241,-0.9663956127583828,-0.5888418690165811
MDA-MB-453,53232,4.528141583720988,2.5354802709755306
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.186385384388046
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,2.8033980333026305
BT-549,7251185,2.7032329014559555,2.4723543002750814
YAPC,72734382,4.459010686131963,4.4250422472039785
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,1.446544415871374
LoVo,10113978,1.9718639606113115,2.7934906718076813
G-401,9884685,-1.463173781220529,0.1622064827909249
NCI-H460,969516,4.1763077592827225,3.0315579509706674
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.1225486094438275
NCI-H522,10302451,3.5044820085806645,3.3513922624804495
SNU-61,10127622,0.6703048084308344,2.910794416649688
DMS 273,216239,1.7826696655906364,2.1830977637607245
NCI-H2171,24785538,-0.9958553447114444,1.3809009876167375
OPM-2,2945648,2.5610378238786367,2.6590438926732594
JM-1,5278396,3.0111139094733987,3.098451593667054
A-673,11625818,4.166556040788123,4.3968441760554136
MSTO-211H,23582824,0.616921606097025,0.7121176235695351
CAL-51,11977753,-3.094424679361229,-2.127438846588639
OPM-2,55283,2.954343465689474,2.495583591470652
SCC-9,445091,4.9115801471194365,4.391834844037457
FTC-133,11609586,3.5175505098064113,2.6567223574709984
DMS 273,16065773,2.5819171284899873,2.1079197022082594
NCI-H661,16725315,3.2574493912109315,4.175088415404134
ONS-76,3825829,4.014711164490238,4.1176004415922725
NCI-H2009,613753,3.3208706433892483,3.404420402415152
OVISE,72376,-0.0680425204905225,-1.616025470837192
Panc 04.03,1566236,3.6247050899799698,2.2124129600238147
KMRC-1,10385095,1.0697515150450725,1.4452868504674452
MDA-MB-157,6918638,0.523436976846598,0.3779862445083332
SNU-61,10231331,-0.1396530061474971,1.7545349067795946
SBC-5,67156097,-2.1260485275267684,-1.7259198992452875
HCC1143,16720766,1.508740109375584,0.4760202998156155
SNU-449,5311281,1.2425771495660034,2.4589466064578698
EFO-27,15547703,3.36481674718985,3.2020928589146744
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,3.885124881170254
HCC1143,71466445,2.406598865609875,3.8427904202943575
HCC1143,11625818,4.1599423197543395,4.1150981404043
LoVo,67156097,-2.753278115102512,-1.3361867247125856
NOMO-1,3385,1.8227638422939128,3.0543626815619467
JM-1,11494412,0.2153546786296628,0.6702421672302755
SNU-449,3384730,4.130527031297823,2.7147281048311585
KMRC-1,2871966,0.6996568641549454,0.446090528859137
MDA-MB-157,2126,3.382661447598077,4.655545126731607
SBC-5,444795,4.741830288065925,4.005431140097793
CAL-51,135398516,1.449392214756173,2.1619777476953295
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.251951307617002
FTC-133,11626560,4.477282693511418,1.678640132113141
NCI-H2171,135411,0.036573209368321,0.67714533318051
NCI-H522,5479543,3.719555600198391,3.455285996112447
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.6370749830636995
SNU-81,44494148,1.061827805146114,3.1623596309812725
OVISE,119607,5.735286818250817,5.261071341170207
CA46,4578,4.451375135730711,4.051406688226887
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.7533660524330892
MDA-MB-453,148198,-6.384072425395857,-3.2345032508013305
CAL-51,44491742,5.152478206660974,4.307499938059409
G-401,6438330,1.230579919692557,1.9658915282580525
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,2.094900115608031
KMRC-1,2746,4.901784458568857,3.2794088937150447
SW1463,3025986,0.7137013515595916,-0.7964905036956393
NCI-H727,54618164,4.079418853402711,4.02038255865592
CA46,9907093,3.753589195065423,3.6866611542093346
CA46,1750826,-4.755590130007624,-2.1929656144528566
G-401,135411,0.5966957307940325,0.38386086773761946
NCI-H727,9825149,0.533141934304371,2.550287237224251
NCI-H2009,168312962,3.455210391348572,1.944203148251058
NCI-H522,25154868,4.970187113391964,4.266662398231055
HSC-4,3503,2.6271988960037502,2.258760346855109
SNU-449,54619267,4.584813130836932,4.104307917180867
CAL-51,44507138,2.6477043136390637,2.374002628842919
CAL-51,24753719,3.9981702522006257,4.178621982179969
SBC-5,16725315,4.9617798252058165,3.9736027543507317
CAL-51,123631,2.4616591372530605,2.5207129840672944
A2780,56963564,-1.0587892817911606,0.28837581941760476
LoVo,119182,-3.2827225124554804,-1.166741511236716
A-498,3503,2.8872062971439436,2.4924263063292864
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.3511587513383845
FU-OV-1,9915743,0.5010130642537969,1.1777222876163491
LOU-NH91,6917907,-5.4115573726076125,-5.4416266822546655
A4/Fukuda,322968,1.909418940393303,2.9624882302158846
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,1.8601301776098478
HSC-4,54618164,4.183236352259565,4.038409237813079
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,0.7554387755979509
MSTO-211H,89928392,0.2675284607275224,1.6090191902416777
MSTO-211H,16741245,3.31564558456852,3.3374225494709693
FU-OV-1,969516,2.7898134338200093,2.705456907015498
FTC-133,9840324,5.72186430729165,5.680475513679934
FU-OV-1,2828334,6.23308188240882,6.111869329022455
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-4.153690599814742
NCI-H146,25062766,0.9164062509537028,2.321540449721313
MDA-MB-453,44197249,5.538441394278097,3.9371855319790763
NCI-H292,25126798,3.8121795120859865,3.9222712999071465
NCI-H2009,49793307,-2.1832388254663746,-2.6269469632000715
ONS-76,446155,1.9434822335598465,2.637515995822864
NCI-H460,613753,5.368273372553464,3.222750449994442
NCI-H1623,375860,-0.2497324332058591,-0.25182755468744467
NCI-H292,135440466,1.1809367948500966,2.3494965646713473
DMS 273,24821094,3.2786522000090974,2.9249204669145086
CA46,1566236,0.9666867201201066,1.8386566797889463
LXF 289,6914657,-2.1957863105134474,-4.167155864324886
BxPC-3,68056272,4.30573170491611,3.4115164797800133
CA46,24856436,-0.7056093623802927,-0.03910048931146198
SCC-9,136227924,3.721677265331546,2.8459086565758698
BT-549,5281672,6.431065394953252,4.506609820054679
KMRC-1,136227924,2.9529226708788734,2.9591850660564627
A2780,46224516,3.0956757820489966,2.337476351337382
OPM-2,2871966,-0.6940984937409527,0.24816935206857352
NCI-H522,44607530,1.256897748575463,1.6107715631488266
YAPC,135421197,1.6415717791988456,1.9998550147975163
Panc 04.03,11609586,3.1950022878003375,2.9758727712043918
YAPC,285033,-1.734058118132599,-1.4158936989854118
EFO-27,25161177,4.775691091389994,4.255844549046615
MDA-MB-453,285033,-3.584093663874095,-1.9193479472965844
YAPC,135398516,2.168624804585352,2.170590002866376
BT-549,10184653,2.4120945582019098,1.1660598392510173
SNU-61,322968,3.1681402320576924,3.6061716091225184
CAL-51,9911463,4.251278022142156,3.6799041667016015
NCI-H661,119607,4.8407678671423975,5.1250972566402995
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-1.0255785288179635
CA46,16720766,0.453567173389679,0.062434835004850184
CAL-51,11404337,-1.4033364127444676,-0.23618947082084446
SBC-5,9911463,4.310936662946409,3.633016133309752
NCI-H727,2828334,5.890997909388885,6.055498321656874
JM-1,104842,-7.303088314363844,-3.722213289111964
NCI-H460,5335621,5.645903220513178,4.427303778954935
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.6012969288363642
HSC-4,12003241,-0.0373048915881231,-1.3108046489552827
MDA-MB-157,53301938,4.15898814375023,2.4908438672854674
MDA-MB-453,25150857,2.1104930677980964,2.325185137012213
HSC-4,25183872,-0.8460464512297751,-0.9038256816027258
CA46,46907787,-0.8110179268567884,0.06901574744537017
LXF 289,5311,1.216776445363927,1.3967438429569983
NOMO-1,6610355,3.932739350210071,4.424153361768127
CAL-51,11222830,1.6762547521470548,1.6148361964374656
HSC-4,9915743,0.765957034876682,0.6341219346837357
SBC-5,72193861,-0.1091418694351138,1.1240628002932675
NCI-H460,60700,-0.2314807684970784,-0.19349406765314195
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.6052052891046605
SNU-449,2729026,2.998695944617882,2.8161425103787106
A-673,6914657,-9.096845778146204,-4.1265079137141
EFO-27,64971,3.389505323176025,2.7666314397159004
MDA-MB-157,44137675,2.4962707088889524,3.6945945286643744
A-673,374536,-2.1767869041067462,1.8766758936770145
NCI-H522,24951314,1.0216385721244754,1.3350606605150355
JM-1,16038120,-0.8379540118722992,0.45572769864344925
SNU-449,25126798,3.9846076439311258,3.885923193452166
JM-1,9444,3.0857992205099616,3.7648194253179543
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.634808480417899
A-673,327653,2.521292352419487,2.955772783275963
MDA-MB-453,5470400,0.9814504444661803,-0.11835674202439767
KMRC-1,71751553,4.436686890494674,4.499715372207008
FU-OV-1,52947716,3.0881190342895626,-0.5415999072924912
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,2.854350604394666
JM-1,3825829,3.3725964609251005,3.7887115762276293
G-401,6918328,-1.3062418496747916,-0.20602283187618464
OPM-2,136227331,3.7431952210756014,3.921165717096975
OVISE,5281321,-1.443802792924895,-1.2970239297808652
CAL-51,6450551,1.9748462748620472,2.4899315252687786
DMS 273,387447,-5.016212668564022,-4.254815188425581
OPM-2,5278396,3.463635489570463,3.2169427312289365
ONS-76,445643,3.769289821936489,4.002950469598311
OVISE,676352,3.019558255819343,2.1683730215178354
OPM-2,126941,-4.73900193491969,-2.843559337371987
MDA-MB-453,11404337,-0.3002498088297632,-0.11454869698291388
NOMO-1,24797083,1.0415171353084307,1.1162604592712835
NCI-H522,374536,3.894183139895475,1.9446641001952067
A-673,6252,-1.7615808961584718,-0.34355278627098085
LXF 289,9915743,1.5678711489122208,1.1813109660228245
DMS 273,72734382,4.203397510599988,4.384284125827039
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.312411579129181
A4/Fukuda,BRD-K55473186,4.020373973875239,4.021597008689187
FU-OV-1,6505803,0.8019489696335256,-0.3987732880080111
NCI-H292,10074640,3.1247192788252134,3.1094496444226576
A-673,3854666,0.8608139997201792,1.4823156053848254
EFO-27,637858,1.802850970746332,2.011383595899918
MSTO-211H,123631,1.7071024302486195,2.216362987575867
OPM-2,54619267,3.38914180731132,3.831839489395396
SCC-9,11612883,3.4111633177056992,2.597587359983373
MSTO-211H,BRD-K55473186,4.0690738661382175,4.0536224659626985
CA46,25154868,4.248651634430963,4.16668587910295
LOU-NH91,6918837,-1.6936529516603684,-3.059989245065225
OPM-2,9911830,2.101419447334853,2.222483809792213
BT-549,6438330,1.5528656655176645,2.111191524260545
EFO-27,11647372,2.575313315468432,1.3174257663509648
SNU-61,568763,-0.2886838000487807,0.4022988809290464
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,2.111309035406416
Panc 04.03,5282054,4.5317440773242925,3.7832700651463234
YAPC,53232,3.166937959197618,2.7804415578018946
SCC-9,44486219,3.972056382599232,4.156232435324402
NCI-H460,104842,-2.7771726159534773,-2.3609242024613697
BxPC-3,4788,5.831531206482249,5.65985141859769
KMRC-1,753704,4.9867166993089365,4.883137191795885
MDA-MB-157,71729975,1.9097389430207852,2.0825580523099023
MDA-MB-157,46398810,3.5828771462995666,2.6297923759790764
ONS-76,42642645,1.3507577274785498,0.9709151457187579
EFO-27,9956119,4.364890218263242,3.5644216634084933
SNU-61,49850262,3.504538311157692,3.079401893176584
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,3.720785681127818
MDA-MB-453,9967941,2.180105496017499,3.5180508007029077
OPM-2,409805,3.1459770002319023,4.354379453321377
BxPC-3,11214940,1.4945762019529478,2.0112481699396723
CAL-51,71466445,4.7818956768695715,3.8310094771573686
YAPC,44137675,4.160217990140765,3.6177116478347715
A2780,3465537,2.6217509140821247,2.301993759130697
SNU-449,135398744,6.632733291537939,6.509175964894661
A4/Fukuda,676352,1.592410759121419,1.8361105254552115
NCI-H522,5566,3.055916396278747,3.048808997521829
SBC-5,6252,1.1660150864515155,-0.3175618025568064
NCI-H460,65064,5.803776096144955,4.976971136988743
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,1.0979645887307554
KMRC-1,60700,1.5998244644110848,-0.14768793207523193
MDA-MB-453,72734382,3.580352840578633,4.361227236765195
FTC-133,BRD-K55473186,4.331616686106064,4.114754961069679
NCI-H661,3062316,-1.6378145648450078,1.0455730762665145
NCI-H661,11977753,-1.2976183269776842,-1.9166512568954286
KYSE-70,4477,1.3887255745641551,0.5585616810725366
A2780,15953870,2.2934332620703457,3.497891991460012
SBC-5,44589607,3.2873586375678627,2.468954152075038
NCI-H2009,3634881,3.6058977960867233,3.190156687044543
A2780,5951923,4.306994873236267,4.475772858511698
HSC-4,11152667,-1.532358108136572,-0.48766849507313353
OVISE,3543504,4.513312782724499,4.378392914368881
CAL-51,676352,2.3367523995253454,2.1246326993484304
LXF 289,100016,7.121965810949268,5.958477030425794
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.1768325319237398
KMRC-1,4096211,2.4789291220770053,2.207606532480909
NCI-H522,2949965,1.5154466163896825,2.8564033628450236
G-401,613000,2.0341288465268397,2.4373749684007073
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,2.988625092705273
FU-OV-1,46907787,-0.0188806347407138,2.370275264968379
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.4976761517895565
NCI-H522,9926054,1.815484319665427,1.9364978477865735
EFO-27,9866186,1.214213380462077,0.5703728381197101
DMS 273,446155,1.3230843960440628,2.264011244892875
EFO-27,136227924,3.515702384882397,2.966997541926314
NCI-H522,25161177,5.347457629837048,4.157975922902457
BT-549,107985,-4.157404914346088,-3.613713426949604
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,2.5227939921648694
CAL-51,984333,0.1261860025273146,0.5258129641343949
NCI-H2009,60700,0.1880080174398503,-0.17079409130137982
CAL-51,135421197,1.6266864976107616,1.800550106530915
MDA-MB-453,54619267,4.30313846005301,4.125248959254018
NCI-H727,72376,-1.9917966726836325,-1.8830445120868635
A4/Fukuda,54618771,0.259551202975953,0.6519378024209855
HCC1143,5280436,2.2824596389444567,3.2600780675417993
FTC-133,168313200,3.883948141330694,2.7561958445573804
LOU-NH91,11427553,1.5999683226177923,2.8033882562268406
LoVo,5287620,-2.196691557023958,-2.1293406516144975
LOU-NH91,11222830,1.619786635706389,1.5136062804717656
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.459286429337461
ONS-76,44507138,2.3475098717107685,2.566739075016882
EFO-27,12001922,2.6878207164132517,1.9635652474274323
HSC-4,25102847,2.881629074853979,2.5629880522946213
A-673,4477,0.9527863024115504,0.5504307028704261
YAPC,119607,5.457421403002251,5.293582611690997
SNU-449,11364421,1.172419453845969,-1.2371524216517649
FTC-133,1566236,2.958331107997485,2.367827848163565
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,2.0845635204592208
A2780,9956119,3.341179703016576,3.5622653241369573
A2780,421610,3.3194399172740296,2.832497139032362
MSTO-211H,11656518,-2.9147381038014095,1.5123845069047241
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,2.321502801965607
ONS-76,5282054,3.726244399490591,3.3417294876518286
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.033316340564646
SNU-449,1750826,-2.5268598200751504,-1.943302552553667
HSC-4,56949517,4.34052816497715,4.189268816917218
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,0.5490864441448547
LXF 289,11175137,1.607203821415342,2.706802763628068
LoVo,400769,-0.9988261077541156,-0.6195778363324834
SNU-449,9823820,4.446865909721317,3.6903083754308734
A2780,23582824,-1.3073183780043152,0.6029560500233242
LOU-NH91,24821094,3.1074025746804854,3.180992698262008
NCI-H2171,1566236,1.862945078393334,2.4871416198880705
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.061651725547849125
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,3.262744659970439
LXF 289,3815108,3.5075214319549683,2.946655548471899
SCC-9,6918638,0.4192666549800527,0.3869217109978003
LoVo,54626689,4.759845357486115,4.552125192679719
HSC-4,9956119,3.775946121479013,3.6615021405394357
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.408289364565297
JM-1,2708,2.6994993672471774,3.8138666433428194
A2780,151289,-0.0035192392559562,0.6826368065132489
JM-1,135440466,2.1821804764998785,1.7723596609231265
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.0820865345643649
SCC-9,100016,6.423023301160456,6.207775647710988
MDA-MB-453,24180125,2.9500133631526477,2.9255688011113143
MDA-MB-157,6610216,4.481014218943506,4.265273539668355
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.9432570688762658
MDA-MB-157,216239,2.048111671637324,2.312224636724454
ONS-76,72376,-2.745447792813742,-1.867778685332424
YAPC,56946209,-4.683971162846982,-3.9866942243219694
LXF 289,11977753,-2.1467130480879217,-1.7393473361910123
A-673,46926350,-6.171938943197618,-4.259224921303312
SNU-81,44490293,1.2258782245734428,2.865946477803755
A-673,3384730,1.4382839107098095,2.554015126506948
HSC-4,5328940,0.4436918358674775,1.7185764195029618
MDA-MB-453,15953870,2.92470748098227,3.3573332247652856
ONS-76,44487061,4.494085272908884,3.338390837041846
MSTO-211H,656346,1.1626228980727835,1.1159272026425404
NCI-H522,72376,-2.490005030905514,-1.750341124510931
A2780,2945648,2.954770875487345,2.841753412034268
OPM-2,49867926,3.883283056469906,3.911055122339116
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.7972087236068253
FU-OV-1,2729026,1.7636424043101242,2.5403379722482278
A-673,5351362,0.6290025594893434,1.4329459515012828
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.2144599069399844
NOMO-1,3384730,0.781590014898287,1.9485816953313928
A2780,753704,5.064252843259393,4.639533529963551
LOU-NH91,104842,-1.007764649763801,-2.7032820980302352
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.737069092328067
NCI-H661,135398738,5.197398941249139,3.5081480278464
OPM-2,11213558,0.5330056992590615,1.1070333552992229
SCC-9,216345,4.596520649168519,4.010019355689828
LXF 289,73707398,1.5723760999376108,1.3810239445565151
KYSE-70,148198,-2.193158047226166,-3.6417925822172896
LoVo,5281672,4.34355838965171,4.466513418533381
NCI-H292,3081361,1.6323755734101046,2.7123997298155933
NCI-H292,969516,2.7034021602074207,2.7770242181638425
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.3450783204473833
DMS 273,56963564,0.2331753873879126,0.21574248754520473
CAL-51,168313047,1.9592520089902103,2.5108463796620892
CA46,2949965,2.263314804434843,2.5663541265536196
G-401,135423438,1.541142645334712,1.9155456736061707
OVISE,16741245,2.37455837119256,3.383911666300065
CA46,3634881,2.7183374991781903,2.749162802532058
HSC-4,11427553,3.1625220487182193,2.8716545784522673
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,3.1505966801770433
G-401,168313200,3.793890782777564,2.717482808639708
A-673,3689413,-2.493408888485536,-0.37961073942028617
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,1.2177673474927047
A-673,3062316,1.882423163055416,0.7620172742894716
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.2946653706635916
FU-OV-1,49766530,-1.0180111021842635,-0.9348686187454982
NCI-H1623,4259181,0.7011384719609343,0.31478117813480444
NOMO-1,11427553,1.1686106553832942,1.2912135535832063
JM-1,25102847,1.7356230100982195,2.0756681527187473
A2780,219104,2.8403974518726938,3.4063700701989292
SBC-5,2113511,4.3346082595960045,5.175718668759055
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.1716457585816782
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.244727346117145
BT-549,44607530,1.0072782741331217,1.796944335455703
FTC-133,56946209,-2.082875590070058,-3.8106626278748155
SBC-5,49766530,2.674414744921775,-0.9761371786904942
NCI-H727,1750826,-0.0055354600789778,-0.8493556276166163
SNU-449,2749,2.680740017346485,2.1297360375978434
YAPC,46843906,3.8406256643083214,2.9451126709586934
OVISE,3503,3.051689922997692,2.40032093973604
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.7065678727235618
A4/Fukuda,24901704,2.035809268681581,3.0838884093860632
SNU-449,2949965,2.551789087127138,2.9978696370833346
MSTO-211H,65064,5.509158922836103,4.842494201853006
NCI-H460,753704,5.635234970240753,5.131492897516125
BT-549,9907093,5.687861442777729,4.060375766345337
SNU-449,89928392,1.7008506784074908,1.6935395190687874
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.8077285015895117
LOU-NH91,675434,4.5447066201437325,4.466504832137963
CA46,5351362,0.7524287969492447,0.9305975374149316
BT-549,3025944,4.080638158593822,4.358748296671779
SW1463,57330099,3.693611547578868,4.2413905011817095
HSC-4,16722836,1.7684769334825834,1.6719191651647378
G-401,4096211,1.4243357241965535,1.9388725138007539
Panc 04.03,6610216,4.328711123736605,4.3531663525833055
KMRC-1,5287620,-2.779883294896464,-2.0196224950970647
BxPC-3,119182,-1.1309049402050737,-0.6455105017031052
G-401,135999136,2.1711954992798987,3.6360763198482573
KYSE-70,285033,-2.195981319752621,-2.0214098718285145
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.7198224743177546
KYSE-70,44607531,3.0404164934883733,1.6634754443587787
SCC-9,6918878,3.402250236896725,2.672955770739774
MDA-MB-453,5282054,2.7696083041072237,3.56433979930472
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.4380892676338854
BxPC-3,57519531,2.3630144255947045,2.550081356434549
NCI-H2171,56949517,4.289308734480345,4.38409269300007
Panc 04.03,54619267,4.1321899610425215,4.126576288970271
G-401,11485656,1.708547873036538,2.013815682498704
A-673,6917907,-5.646852280462545,-4.635881742492353
NOMO-1,71304818,2.372593058500035,1.8349368733298692
MSTO-211H,11214940,0.3292815706978371,1.748700933101955
HSC-4,1750826,0.4564084690350189,-1.4141165942153235
HSC-4,426756,6.131320111521982,4.461096716122101
SCC-9,12001922,2.463166865850559,1.923597747295533
CAL-51,656346,0.8466306406200714,0.9024866397516665
NCI-H661,49793307,-1.6947898398784864,-3.0427886386661247
MSTO-211H,6450551,1.5186693992042568,2.5791256501397286
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.78052617532817
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,0.8512120391731125
NCI-H460,73707398,3.251551904382877,1.4542429875562923
CAL-51,168313016,5.819136604546001,4.775844162321473
NCI-H292,119607,5.8072644572840915,5.379430400960115
SNU-81,31703,-2.2099083949209715,-1.288577334302249
A-673,11719255,3.0296971336672627,3.2723943983304
HSC-4,9911830,2.7717739782698563,2.5555642609830964
CAL-51,44589607,2.4963130908502107,2.6633799903904043
FU-OV-1,24180125,2.037807307003979,2.9826654307373577
EFO-27,3634881,3.530057446917586,3.182574867829517
MSTO-211H,25262965,-3.426128826799908,-1.6585370101998262
LOU-NH91,3543504,4.266458043071255,4.302514331346312
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.7673916028477494
NCI-H2171,23582824,0.048802245172864,0.9528590701683102
SCC-9,11507802,1.3688807961315366,1.339943408361617
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,3.6302806960776324
CAL-51,65628,4.560195683913681,4.460813926085269
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,2.90696617401235
CA46,6505803,0.7805822725654986,-0.7173483948740553
KYSE-70,327653,3.7336437717951103,2.921431769433253
NCI-H2171,11494412,-0.1110474347644453,1.5293272560342985
LXF 289,6918328,-0.239589445073231,0.1315670841232236
CAL-51,24951314,1.3730048574034712,1.4483221974895917
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.626807578711513
A4/Fukuda,2858523,2.415383768636832,2.93492478221363
NCI-H522,753704,4.098243268802601,4.869739834857489
A4/Fukuda,11625818,2.700159842549232,3.7279881470900595
MDA-MB-157,2949965,2.5406478696331587,3.0147488209193214
ONS-76,409805,3.962852167855045,4.6772808304240066
NCI-H146,439501,-3.5641402563292393,-2.395308194465019
CAL-51,24856436,-0.3083697359271743,0.32937269379495765
SBC-5,31703,-1.5086983052531706,-1.4921403353712401
NCI-H522,10184653,0.5663226513641079,1.3562339511510801
NCI-H522,135421197,1.9700795220087195,1.6753365929677952
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-0.3290957656821783
NCI-H1623,46398810,3.5623335184860196,2.484389912388965
A-673,216468,-1.1121166448103192,2.1324507455518735
BxPC-3,2708,4.650566781622339,4.884704348825589
SNU-81,6184667,-0.6614889419446587,2.8348954293030095
NOMO-1,168312962,2.6221164331885003,0.8326888639894452
MDA-MB-453,16720766,-0.5495005772629474,0.811615244086453
NCI-H522,9956119,4.024745164263863,3.7742714491945737
NCI-H1623,135440466,0.8012621152288821,2.315757809431552
CA46,3025944,4.264528242833472,3.9202381229224854
CAL-51,71466380,3.802692276073616,4.617862574676213
Panc 04.03,11656518,3.295682085422899,1.9497758647196906
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.6129997271056609
LOU-NH91,16720766,0.888730139062919,0.6991419234409736
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.2130028608405046
JM-1,57519531,1.1574190263295916,2.236453619765879
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.0746631167898217
MSTO-211H,148198,-2.180219295506665,-3.501180890543757
SCC-9,4521392,4.43257578464979,4.414812737810435
FTC-133,2746,3.487652314498242,2.9217750893122183
LoVo,44819697,3.398153390084315,-0.5307709209751542
Panc 04.03,122327,5.490637645011104,4.668494474603326
BxPC-3,25154868,5.007679584209566,4.335287025802298
NCI-H661,3503,2.324538290067321,2.2078634527083216
NCI-H727,54618771,2.7901712320729333,1.4654842321155466
A2780,10302451,4.067201499125142,2.959040033806133
A4/Fukuda,5281321,-4.090150251628595,-1.4195042844766268
Panc 04.03,24771867,4.398084543376112,2.5830330879841203
CA46,241158,1.6221144264981358,2.812038017858207
SBC-5,26596,-2.1907470722084414,-1.5281745322268196
A-498,11625818,3.6553151033235904,4.455217004400217
G-401,9911830,0.6760173642929876,2.3069559259033188
CA46,123631,1.9024335998312112,2.190785224806978
LoVo,104842,-3.39586805089817,-2.496380046673933
OPM-2,5479543,3.226492982806864,2.7223588051306757
HCC1143,6623618,3.4930934009716226,2.278828443490024
NCI-H2009,46199207,3.041674504763304,3.106984655142823
NCI-H661,49766530,1.1318827683023138,-0.7968842676322295
CAL-51,1641662,3.5457804017420744,3.5046301705864016
ONS-76,44819697,-0.7397391051726983,-0.7388490942916484
BxPC-3,57330099,4.21152658046839,4.269333456579183
MSTO-211H,3038522,3.865174160499475,3.135562256498034
LXF 289,71466380,3.888647536265504,4.488690434155092
CA46,5479543,2.004846411807367,3.0493830233638137
OPM-2,9907093,3.786753386665246,3.7451370301536624
NCI-H522,54613361,-1.014694822148615,-0.1451512272271639
NCI-H2171,25195348,2.4042641753284872,3.235983541717715
LOU-NH91,9911463,4.226439837654448,3.811622052944273
JM-1,6918736,-2.112176013423493,-2.425669489413977
OPM-2,89183176,2.1177805080987633,2.706444079027621
OPM-2,135875424,2.796643273298537,3.3188907193627393
HCC1143,24964624,2.836653438175677,2.576052549206178
DMS 273,44566777,1.254196350489733,0.5400065108792326
NCI-H522,49867926,4.17523654199276,4.312237256252157
LoVo,72193861,-0.0557430791680942,1.0969763884626447
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.4106903654493477
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.6749970302548363
SNU-61,374536,-1.8297483787291275,1.737277509335014
CA46,44566777,-1.0409480025289963,0.11435977555704287
JM-1,54613361,-0.7111924625528845,-0.4931520965547553
LoVo,25154868,3.829103546750207,4.194177390413936
A4/Fukuda,15547703,2.4441609561923547,2.7670240849767924
KMRC-1,10074640,3.6694615069556886,3.339898830807744
NCI-H2171,2729026,2.1337054337121466,2.4191067816646887
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,0.012075609408497256
HCC1143,68056272,4.744387863321378,3.38430427054856
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.0382587065929914
NCI-H2009,44607531,0.9822487023795796,1.4110642888002303
KYSE-70,89183176,4.766828638924323,3.4524291537195064
SBC-5,25154868,3.0138435145006155,4.251269964786465
A-498,11719255,3.5352993104723245,3.3325098479023523
SCC-9,208908,2.838235608451249,1.9235974622487546
SW1463,2126,3.781949624288532,4.336766126172676
SBC-5,5311,0.7694897344457827,1.2597412207587098
BxPC-3,11609586,2.766108761160721,2.9032416199664577
CA46,71466380,3.212448709653588,3.8856577273899937
FTC-133,25126798,4.495223588633032,3.8436475621570567
JM-1,44632017,0.8586744690995054,0.9785926396818817
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,0.8191765007628211
SNU-449,4917,3.4001304631059965,3.23613167268658
JM-1,135984461,1.552881480804892,3.324693715538932
NCI-H2009,969516,2.7623608328977314,2.952182563845345
SCC-9,104842,-1.437225086828998,-3.089858002515852
CAL-51,73707398,0.7053044464230985,1.0573211412456858
KMRC-1,67156097,2.0694443843024173,-0.9039671532070923
SNU-449,135411,1.1071215925884743,0.7611896635534673
A4/Fukuda,72376,-3.4342601152101473,-2.4712100134827693
CAL-51,54619238,5.308906879487735,4.838217791355249
SBC-5,5282054,4.370273963099393,3.3521334532281832
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.63412043099338
OVISE,5328940,2.3935755372069676,1.747267547594794
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.173278071602844
A2780,24779724,4.3340331177123765,4.262826437527081
A-673,400769,-0.9976419565742564,-0.6615392034759283
MDA-MB-453,3081361,2.1431734647577496,2.5871695266533914
A4/Fukuda,123631,1.573225246333458,2.1196451729918064
A-498,46224516,5.193995490382977,2.3923995004002605
CA46,5738263,2.2696720462337456,2.947146080618668
DMS 273,16722836,2.1308156944151833,1.5069553491699457
KYSE-70,119607,5.065055719995064,5.131776849103241
MDA-MB-157,637858,0.0650158223638603,1.748644192619552
KMRC-1,24180125,3.3952911821821052,3.1746367895000454
A4/Fukuda,9935249,-4.132944592984893,2.0419126295471273
A4/Fukuda,9915743,-0.3554458205966057,0.8427556035996504
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-4.056547520412749
FU-OV-1,11222830,1.8946229471337992,1.8033462831501825
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.2742302939258967
NCI-H522,24775005,3.057250054087749,3.8075511119662995
NCI-H522,15983966,4.053677978120726,-2.1148799827248634
DMS 273,25102847,1.54508352242066,2.3601617081367405
A4/Fukuda,44543605,3.1271044447490235,4.0990950793315
CAL-51,44507138,2.6477043136390637,2.374002628842919
SNU-61,16725315,5.215969195263621,4.301343805012417
EFO-27,448949,1.7491267397814168,2.0995749463236546
A-673,5280436,1.8974559090481808,3.139202535573535
MDA-MB-453,24779724,5.606505141806212,4.456510535590922
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,2.683335991432045
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.47901160361174105
NCI-H522,216345,3.499198551341706,3.797277034406416
BT-549,25022340,3.398199457605664,2.9820171179971426
SCC-9,23725625,6.300420686237622,5.047331650079096
MSTO-211H,54619267,2.133098694540018,4.101154043756006
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,1.4785246122446511
A-498,148198,-1.0809020747576437,-3.298438869328951
SNU-449,10127622,5.039458046327855,4.121479851593419
CAL-51,1641662,3.5457804017420744,3.5046301705864016
MDA-MB-453,5291,3.622613892398656,3.6790010447601897
A-673,168312962,-0.712468254461992,1.3054361167301372
SNU-61,52912189,0.4386789975034979,1.855368476365547
LXF 289,2828334,5.402872149224608,6.097888978763749
BxPC-3,374536,3.0351492595764347,2.505664865654131
EFO-27,9825149,3.71226874457915,2.1674912571481024
NCI-H727,216345,4.166745514794161,4.125851796882847
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.3100419175022768
A2780,156414,1.0391092981452308,1.077390170456563
BxPC-3,11647372,-0.5523773269560157,1.4749335062993862
NOMO-1,10296883,3.647443685498321,3.4892423406270026
LOU-NH91,60750,2.5426597160889823,-2.381702049319335
NCI-H460,16038120,2.547350732010626,0.9554437604529317
ONS-76,123631,2.7486777230854176,2.339061813186199
OVISE,9903786,4.69480560533159,2.727175200877454
HSC-4,168312962,-1.5337410071263893,1.4146856154402965
NOMO-1,421610,4.35383474826381,2.9211700130812357
NCI-H661,4917,2.840246866325883,3.081060014528437
LXF 289,3634881,3.11935208210029,3.4437974517611334
EFO-27,9911830,3.273850069923984,2.3634138001059104
A2780,46215462,1.4920420325768875,1.9188333355169251
MSTO-211H,11234052,3.0252233847843515,3.941280328056615
NCI-H522,2842253,4.095670069869479,5.151005648730859
A-673,3385,3.2869772752619033,3.7509391278119226
MSTO-211H,46398810,1.7478948810000858,2.55499226054353
ONS-76,49850262,3.849158291733923,3.7496367525513405
MDA-MB-157,11507802,-0.5781039838427031,1.4206169341967776
A2780,24978538,0.9309197302054482,0.6576143209028358
BxPC-3,24180719,3.164671730334926,3.6448755858653628
NCI-H146,676352,1.7139908333138,2.076206418395028
A-673,82146,3.820966427179324,3.4394712469158764
NCI-H2009,46174525,3.5250507211438107,4.154484486899508
EFO-27,10302451,6.465018307145316,3.272070633367118
A-673,135984461,3.9402009784769745,3.4027782269296707
HCC1143,4521392,4.180219407268625,4.407244341176387
A2780,5351362,1.3372825777001471,1.3037146219497426
EFO-27,10296883,4.235346466258499,3.977984446605701
SNU-61,25150857,2.1451887473522295,2.427177328756021
LXF 289,25150857,2.4132050810476,2.593927639337858
KYSE-70,135440466,2.892957215680813,2.3033888124639934
MDA-MB-453,11222830,1.1155100991132725,1.7084301223045397
A2780,6918289,-5.622064624678881,1.5940135152238317
OPM-2,445455,3.93427157933256,4.13782826175027
EFO-27,15953870,3.8448280803188233,3.561484486111348
A4/Fukuda,4917,1.915641979161103,2.8099867638238014
YAPC,44185566,2.6271326170179248,2.498908493947093
SNU-449,3634881,3.3285371967859128,3.343074944224833
OPM-2,44566777,-0.9514063433103236,0.3440597521437112
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-2.8134955767293888
MDA-MB-157,4259181,-0.4671059045276012,0.06703869112386167
SNU-81,11656518,-0.0512259493867009,1.3022475433385128
NCI-H522,11494412,-0.7022253688217924,1.5999371093722854
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,3.1565543316530404
CA46,24180719,4.114109141176105,3.3887782072240014
MDA-MB-157,82146,3.0360891700929984,3.539887000154835
G-401,23635314,-3.865618451368766,-1.8765567964795502
LoVo,42642645,0.0146125142547242,0.7896545305564437
HSC-4,9826308,3.3704185574061456,0.20884013868433413
NCI-H292,176870,4.643600229240446,3.688318537987647
ONS-76,44202524,1.6130278410730936,1.7610799483138766
KYSE-70,9911463,3.4914249269651307,3.459248552643918
NCI-H146,24779724,4.32606530761132,4.226923626923139
LoVo,44493528,4.114958638118981,4.173067386191131
CAL-51,44486219,4.943814728636009,4.3063893277550065
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,1.9113816312701148
MDA-MB-453,8515,4.14044832994183,3.750924688534755
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,-0.2887896114537918
FTC-133,56963564,0.7376209226585526,0.45715038705237504
MDA-MB-157,11494412,-1.4760508995443156,1.6464351329166629
SNU-449,4261,2.5462586921108197,1.7275384871634365
MSTO-211H,984333,0.926178476056404,0.6017848140931288
SCC-9,1641662,3.777884166860496,3.4241334108307693
HSC-4,2949965,3.8536489984175097,2.7652949047050863
NCI-H2009,5566,2.98031688083636,2.9007054509110013
HCC1143,16741245,3.781249389530293,3.879647065459659
CA46,67156097,-2.616833441535583,-1.926983819408158
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.057000191115085
G-401,55283,4.120501166008349,2.533950710788769
A-673,11977753,-4.8378783477247875,-1.7890949683462052
BT-549,637858,2.0216713295762614,1.815417324524617
MDA-MB-453,5287620,-1.4808110009700917,-1.9730366593312536
BxPC-3,46907787,0.03250860780982,1.869603494571053
NCI-H661,44819697,-3.610310878099198,-0.2363740729884746
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.079511876302103
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.186262332835758
BxPC-3,46191454,0.7426288337003383,1.605858389701937
MDA-MB-453,322968,3.088283756332906,3.6984273526379847
NCI-H1623,16736978,1.234327001570643,1.5214043678422493
KYSE-70,1641662,3.490090790744947,3.458762871630146
A2780,5470400,5.365026906170319,-0.4190684434098141
NCI-H522,23582824,0.9084599252004664,0.6998010530425646
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,4.273624155154865
MDA-MB-157,23725625,0.2462467633250468,4.995393053272411
SNU-61,44632017,1.0979359106396418,1.4083152716859864
ONS-76,8515,4.109060881613791,3.7424640734912744
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,2.6881987800678013
HSC-4,54626689,4.284935050666877,4.611223763874736
SCC-9,42642645,1.380036396261508,0.9014694283282054
LOU-NH91,9866186,2.5706791809917258,0.5919788320168696
MDA-MB-453,3552672,1.8646445353613752,2.65800394074277
LXF 289,11507802,1.7765111516543377,1.571688258043932
KYSE-70,107985,-3.298359335305578,-3.828978849657687
G-401,53325874,4.831157164763357,4.313270973140605
NCI-H460,5746,0.0249012606464236,1.3233620452408204
MSTO-211H,11213558,-0.8326933060339966,1.7981003250177263
KYSE-70,56963564,0.3897414986371327,0.38103665262290315
FU-OV-1,11485656,3.4521578130267336,2.4459101745252263
A4/Fukuda,56963564,-0.5107551488404702,0.22281517406446041
A-498,51039095,3.6847311434926535,2.8927287684575207
BxPC-3,44486219,3.8860987116797703,4.379295282624616
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.4387824426886135
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.3079449191974342
HSC-4,44819697,-1.3561318696958864,-0.36959547844431795
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.774345387435345
A2780,148198,-4.120801514793353,-3.735647524179059
YAPC,36462,2.246335150310725,1.557996216285356
NCI-H460,10184653,3.574651577310896,1.0673677049848966
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.220704404859774
LOU-NH91,54678924,3.1162234647683205,1.9342820176328734
ONS-76,11214940,1.2536021206371053,1.598943419059796
SCC-9,9907093,4.490912734248418,4.25945524707152
NCI-H661,11964036,1.3116184134954847,1.3015590612630643
CAL-51,135411,0.595745817277345,0.5942573061968056
EFO-27,613753,3.260816470325069,3.1498352460384718
A-673,73707398,-0.4228078892765429,0.9436490310094163
YAPC,25262965,-0.9761970914901598,-1.4452112250796205
LXF 289,31703,0.1888440469000175,-0.8579317388247303
A-673,44486219,3.969252294689724,4.29518426783355
HCC1143,135875424,3.1375636080090925,3.910748452645264
NCI-H661,241158,4.406370209729512,3.7366250449466087
A-673,17755052,1.3895683648511998,1.9548133806185048
LXF 289,4788,5.213081732847737,5.755923602970808
NCI-H522,5738263,2.340773324031017,3.0836666561586212
SCC-9,4788,5.928282303581182,5.828640833258796
JM-1,46843906,0.1108259550663182,2.1432302000454757
CAL-51,9967941,3.511576456928413,3.529332369524543
Panc 04.03,5746,1.7282227653726634,1.1532127151003309
JM-1,444795,2.4559914793227597,3.759515679755725
A2780,25183872,-0.9660294253312856,-1.1699573934134595
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.6770283084723948
A-498,12001922,2.3665933531109564,2.1308088498550246
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,3.5735653775762417
NCI-H460,3384730,3.247736649900264,2.9845920187211745
NCI-H292,9884685,1.805947993429832,0.42618285135383155
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,3.501802998353323
NCI-H2009,25126798,3.423512143516965,3.864803170242958
A-673,67156097,-2.6530750558799268,-0.9472048313007556
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,1.705685195506736
NCI-H1623,11364421,1.5638784569997608,-2.729104299064071
OVISE,65064,5.3042455172619345,4.9033257766768505
CAL-51,11485656,2.6541256228973773,2.4672456739749036
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,0.8817093131844483
G-401,135984461,4.271777659576195,3.5362203024077865
A2780,11960529,3.87105656281655,3.9504465403851823
OVISE,168312962,-1.1497759256084987,1.8453514347385083
SNU-449,25062766,2.0173338536366776,2.080702312187382
CA46,44462760,4.878030903037556,3.2530900114947907
SNU-449,126941,-4.267074342641938,-2.5285250881344523
BxPC-3,55283,0.3092833280624811,2.6723440659142934
MDA-MB-453,2708,5.180783048838842,4.8723590721301395
EFO-27,441298,3.357031616162376,2.6926736490858696
A-673,25195348,4.457358631051988,3.057863511305154
OPM-2,285033,-4.309653599496783,-2.931236072976435
FTC-133,156414,2.701071854154092,1.0867956661129892
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,0.49381493450822606
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.26492509999874336
SNU-449,219104,4.193064059209751,3.882982207062391
SNU-61,387447,-3.847354855280633,-4.195990310004134
ONS-76,89928392,2.125505613903981,1.311638008261387
DMS 273,10296883,4.130929131041443,3.7997573092019286
SCC-9,71466380,4.753733846444339,4.442797570709354
CAL-51,11234052,5.18044926966805,4.045121836761078
FTC-133,135875424,4.265925786122884,3.401894609220012
NCI-H292,135398738,5.91070825601545,4.029352108648015
NCI-H2009,24785538,-2.0037312151285462,1.782419102398074
KMRC-1,5281321,-2.040334048066586,-1.52409303204026
OPM-2,9926054,1.8132463747821628,1.5282520696504382
NOMO-1,44607530,2.1799605259844914,1.5503079076781723
BxPC-3,104842,-2.6661298782325265,-2.6287917623902253
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,1.2489486254299584
A-498,1716436,3.6890609174990057,3.0547587831636283
NCI-H522,252682,6.061888172888063,6.599671274046306
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,3.648970663316241
CAL-51,409805,3.8515087112009656,4.521666876515283
SNU-449,676352,1.7938896042567478,2.2561341801828045
NOMO-1,72193861,0.7304873005319745,0.5504819276880804
FU-OV-1,5566,3.32118213388136,2.9859853350212946
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.9555168941219419
CAL-51,5291,4.8235616489491635,3.688488240967186
NCI-H1623,73707398,1.8898657972875643,1.2940119162515722
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,1.632355213729066
A2780,54619267,2.083839750794981,3.996716760183495
A4/Fukuda,25150857,1.0832866246256998,1.9267391389441844
SCC-9,25195348,3.9019221273063858,3.0970950088175595
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.273873538081321
NCI-H2009,20959075,-3.4439076637996076,-2.70750222021157
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.675112509467101
YAPC,135875424,4.215334227700636,4.026416183455768
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,3.144935302542228
LOU-NH91,2708,7.798658787946165,4.634602992186898
MDA-MB-157,54613361,-1.9100924648361528,-0.045588130270427275
YAPC,613753,3.436227254149273,3.1854225999018877
G-401,26596,-1.5666727843222663,-1.4319671571404013
A2780,124202324,1.685811695923782,2.35742897690126
BT-549,52912189,4.655826026030035,1.6870817722319296
OPM-2,6438330,0.5735051923287856,1.5423327516680059
ONS-76,49766530,-0.8397126534273769,-1.031405479905552
A-673,24180719,3.918829940752815,3.4788060706567645
A-673,72734382,3.862779655203366,4.24725730462222
JM-1,46926350,-6.131969810114727,-4.347990594093035
A-498,216239,2.9738940537308203,2.362863962896457
NOMO-1,54618771,-0.7336388686704796,0.3919585680155253
A4/Fukuda,25126798,3.529395374343333,3.582844918769551
NCI-H522,16013152,4.870026952980287,3.9487893326611707
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.1975368264832325
ONS-76,6918328,0.1573953751573411,0.16364343298171413
LOU-NH91,1566236,3.241690914019502,2.292372406971185
HCC1143,2858523,3.0390361797055276,3.0396313145038585
BT-549,71304818,3.5849392152335713,2.4158847840578552
MDA-MB-453,49867930,4.991198207309722,4.731722372532986
LOU-NH91,4261,2.7247094190978007,1.573823969185671
NCI-H522,52947716,2.6251827866590385,-1.077519515283764
NCI-H661,6852167,3.3441449371697205,2.7456203106983246
NCI-H292,16736978,2.16203795839555,1.754313135712044
SNU-449,637858,2.172600125936458,2.132668642322588
SBC-5,16720766,-1.9276845300945755,0.5384913815761666
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.8124470177110874
NCI-H661,2828334,5.966055284777512,6.019787262388751
EFO-27,9884685,1.4230112837032636,0.5055935415943035
OPM-2,25227462,-6.0467342682230445,-1.4627707749051704
A-673,3038522,2.0400506341720237,2.7810450455124935
HSC-4,54686904,4.85379149564711,3.4509705663481482
A4/Fukuda,969516,2.117405484631732,2.448636191698942
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.442047627398578
LOU-NH91,6610216,4.701575628194421,4.349030201721008
NCI-H661,24856436,-1.6135015308236011,0.3176759962681799
LoVo,6252,1.008875569338637,0.7096857945760678
CAL-51,5281672,3.9430830045045857,4.415237563314556
YAPC,25183872,-0.4840811687838853,-0.7922296212162471
NCI-H2171,11222830,1.3474519729527985,1.4741950789789267
SBC-5,16722836,3.112579400078665,1.3810434677833245
FU-OV-1,3689413,-2.180005064661593,-0.2810522548371974
JM-1,6914657,-7.803103466538306,-4.615006395161341
A4/Fukuda,11222830,1.361211164053787,1.3693067765017364
OPM-2,24180719,3.7347961717129383,3.0454314756224465
A2780,50905018,3.503420862443992,4.105971301297273
LXF 289,168313016,5.746715572468322,4.685792727368005
MDA-MB-453,2874250,4.390759253530558,4.700092364156834
NCI-H146,3543504,3.2112662755133616,4.221642732372663
MSTO-211H,9956119,3.2798548332341246,3.6486534416495897
NOMO-1,11152667,-1.8753376491976492,-1.2041543723681216
NCI-H292,241158,3.585722962787503,4.004483823207322
SCC-9,52912189,3.371588298050412,1.6418959141437428
A-673,15983966,-8.138595470092604,-2.211099214527022
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.12665735404624423
NCI-H146,5287969,-2.632266530811145,-2.0383802436214027
A4/Fukuda,44632017,0.3391160528514481,1.0815611623236148
CA46,1242560,2.637858421223904,3.1455346022473365
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.142631313057018
NCI-H727,10184653,0.8809089143232124,1.1988532890698103
MSTO-211H,6918736,-4.031815262851263,-1.9430596767290824
Panc 04.03,54454,4.748257983656133,2.8279655946225613
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-0.898731373404121
SNU-449,6918328,2.053547134624907,0.16648395598845922
A4/Fukuda,262093,3.0357368226896178,2.2609247742398835
ONS-76,6918837,-2.636307015456442,-3.243102350573356
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-3.349483082185464
ONS-76,107985,-3.307412021608342,-3.568473753487029
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,2.858366958077292
OPM-2,42642645,-0.4905470491794313,0.650043083226861
FTC-133,16722836,3.262117509304611,1.620242465282988
SNU-449,123631,2.9179285945779183,2.5354604955459927
OPM-2,644241,1.6900050339542656,1.7472623621337227
HSC-4,1242560,3.572222416741055,3.524529510142514
NCI-H292,123631,3.5457837677726833,2.6547703216474328
HSC-4,2842253,4.76622062087716,5.054440026482184
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,3.3350590221603063
Panc 04.03,3689413,0.3957464459941977,-0.3414693684946471
NCI-H460,135398516,4.13019906717736,1.9713271136869905
NCI-H460,5311,2.161812802665503,1.5220713529683274
SNU-61,11238147,3.2212717665721375,2.651849463324649
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.759860535346901
HCC1143,44607531,1.4024247683472026,1.7227381212151756
NCI-H727,5351362,1.1476230363651536,1.7213393692689982
KMRC-1,6852167,3.0099217565414693,3.0594462453411553
MDA-MB-157,5311,0.9088479539093504,1.3888245438070397
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,4.258586084732006
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.102673133123866
SNU-449,3025944,4.153676005178765,4.329816978922941
A-673,23635314,-4.460908555858267,-2.701872413181669
JM-1,5351362,0.3312371174067021,1.3407312794709776
DMS 273,24901704,3.9468378622372264,3.2726981635651167
MDA-MB-453,9911463,3.8683390626627454,3.77955951754589
OVISE,60700,1.357326318980797,-0.3290738930695848
FTC-133,448949,3.317946341403347,1.884715765565901
LoVo,5566,2.507145044552918,2.9638745862687075
DMS 273,9967941,3.979035067958665,3.497642378662164
LOU-NH91,16038120,-0.2213795856096394,0.9949492081964596
NCI-H1623,11977753,-1.4500330036408269,-1.7160409538207821
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.3108662974123088
NCI-H460,31703,-0.6563705559837907,-0.366278546647064
A-673,9866186,-0.4052980916556575,0.43452729511476434
OVISE,31703,0.0982732174518241,-0.7191843709201724
HCC1143,124202324,1.6321362493528402,2.3362921184872243
G-401,4705,3.1032512954578415,3.101740494094808
NOMO-1,3025986,-1.4139862297409005,-1.6662035829276625
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.9127519323678007
NOMO-1,148198,-5.33573798573566,-3.8559923606943887
A2780,9907093,2.8643649893432106,4.1109020727465095
HSC-4,44607531,1.5153971496977892,1.2601995365453205
LXF 289,2746,3.190299829163617,3.190629843932709
MDA-MB-453,4261,0.3032353935433951,1.4510190879580893
BxPC-3,656346,-0.1234429100103727,0.8295690888241392
Panc 04.03,BRD-K55473186,5.259619810258457,4.0750433023013075
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.5879974753051401
CAL-51,3385,3.064238699960593,3.7146648531517865
BT-549,675434,4.287026263227802,4.5483549823801095
LOU-NH91,9868037,3.6278868560603574,3.0181640717971034
G-401,400769,-0.955062013548762,-0.5942314618408296
SNU-449,44185566,2.80206906512974,2.740829848291101
DMS 273,613753,3.2268993277161524,3.0521192395365175
FTC-133,9911830,2.8814152307979946,2.5416432311003834
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.072549890341527
FTC-133,462382,1.2436445575195818,0.6268454632549902
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.3542631926475206
NOMO-1,9884685,0.4754269892492985,0.1332217989862636
FU-OV-1,44589607,2.6910555486326397,2.7077185161432773
CA46,11228183,3.2150932794291975,1.7890867912375839
G-401,24797083,1.4378353960151609,1.2673329502711055
OPM-2,4705,3.10353547990691,2.6215549581712683
SCC-9,49766530,0.4117706354329887,-0.7138961186706289
DMS 273,44819697,-0.9932488797546292,-0.5972898063941772
NCI-H661,56963564,-1.1338494929069671,0.15478062670188414
NCI-H727,25154868,4.680199730171404,4.471806277177727
MDA-MB-453,56649450,1.3470223737131497,3.6115080278278646
CAL-51,54678924,3.225490994604415,2.0929182898018697
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,0.9981744095050685
NCI-H522,56963564,-0.3134921987801757,0.35577131636185755
JM-1,10322450,2.576608882705072,3.6942776821872148
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.6508999845560846
A-673,24748573,1.962021648564739,1.9659276825211638
LoVo,24785538,0.3940436885335026,1.603724826326821
NCI-H292,135421197,1.1571557888211337,1.740271261446844
SCC-9,19582717,4.601399638975327,3.994794961030319
NCI-H2009,5311281,-0.1357038590739554,2.3854381265360196
BT-549,24951314,1.7605147679012945,1.5067948086697216
CAL-51,10302451,1.350542324147247,3.077806750412315
HCC1143,10127622,3.54698748679943,3.3852727549109023
NCI-H460,44589607,4.73035444754351,2.8702141504105145
LXF 289,10113978,1.6721223719755247,3.471429820011851
YAPC,5566,3.1204203259985044,3.08050364009254
NCI-H522,135423438,2.202740699610144,1.9557256765974305
MDA-MB-453,5280436,1.8692407341233208,3.356002307790968
BxPC-3,400769,-1.094495387384235,-0.4531775877060727
MDA-MB-453,57330099,4.336922942952946,4.283591652323453
DMS 273,24964624,-0.4885915334424611,2.382316731216454
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.5388918395697722
A2780,11964036,-0.2399638951327319,1.269243953612537
BxPC-3,56963564,-0.5407215297938537,0.5791633255034128
A-673,9907093,4.212541297476806,3.928037745868606
EFO-27,11427553,3.591439679350591,2.959292505808333
MDA-MB-453,439501,-3.002845657836036,-2.0643069379586363
LOU-NH91,11485656,3.2972382499502935,2.4128771059291316
MDA-MB-453,25161177,4.057301598200359,4.0147992404651465
NCI-H460,54143018,2.5592633032091956,0.7343681879887284
MDA-MB-453,53325874,4.468628295310174,4.317811974626304
CAL-51,71466380,3.802692276073616,4.617862574676213
NCI-H1623,4788,5.98570816019398,5.756038081525003
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,1.9967923007943709
Panc 04.03,11707110,4.882480457753906,-0.3534074647003561
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.4724340066036454
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.3543284756675231
SNU-61,285033,-2.2323165928541746,-1.7811606335084693
A2780,25150857,2.724824774969284,2.1032588812486566
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.30307801632349546
SW1463,36314,3.0951531870893523,-1.3260426626025135
A2780,2858523,2.134868506415456,3.0011935933991145
NCI-H460,3825829,4.446795399525052,4.130631761683094
A2780,1750826,-0.9954774428329844,-1.7390767418314637
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.327421308548044
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.252030825521407
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.275479589009901
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.7452771350239601
MSTO-211H,107985,-3.699787970340743,-3.519305316361494
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,1.1216820930035425
DMS 273,10302451,4.121656528900648,3.185777015941466
CAL-51,262093,2.862241975448649,3.001538339893101
DMS 273,4261,-0.2104746005525494,1.6542030396051546
MDA-MB-453,148124,-4.8335014079709975,-2.265807580767123
G-401,11178236,-6.653209761704985,-3.43177926688788
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.092843911236556
MDA-MB-157,262093,2.565616950913742,2.888938817176591
MSTO-211H,9868037,1.9157833543052896,3.1622016969893902
HSC-4,5280436,3.1415705358429884,3.490524453395685
MSTO-211H,10231331,1.7809441814393978,2.204475260937501
NCI-H2171,969516,2.758162928931276,2.8499657011932684
HCC1143,10184653,0.277782870066905,0.9580101131684171
A-673,4788,5.851137286094999,5.668402035814876
OVISE,11364421,1.999223974612241,-1.4608367153238242
NCI-H661,44202524,1.2385989199848235,2.0171020579774734
NCI-H460,3062316,3.704520183651484,1.199575229112319
NCI-H1623,44607531,0.8047036576600745,1.5284681502957926
OPM-2,9956119,3.674575368535915,3.2611059677919063
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.4408708296761485
NCI-H146,54618305,4.054654997899016,4.275916652561655
OPM-2,11507802,0.0988268127526858,1.0329261290684193
CAL-51,10385095,1.0305027810027567,1.17560889257914
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.5713612571919855
A-673,71466380,3.8107210551169577,4.444937980697982
A-673,10427712,3.6867963290416346,4.07913529835936
DMS 273,56946209,-5.704769625352934,-4.367351497692292
A2780,53301938,-5.924783673466769,1.648983531713524
MDA-MB-453,3025944,3.940846865776467,4.209791240119929
NCI-H146,9840324,5.546223512080725,5.699363804943059
HCC1143,3815108,2.289037887638348,2.9953541964051102
NCI-H460,11625818,5.428588497019925,4.3605815965861225
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.953124759819181
SNU-61,123631,1.7897165257078365,2.1777126515648333
HCC1143,73707398,0.6963565440176983,1.3143058097481577
FU-OV-1,24964624,0.6948307959675745,2.6123526086596573
BxPC-3,89928392,1.339609071089843,1.6670868935104262
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,2.6999897229590357
NCI-H661,46398810,2.545394900571619,2.3614916379578834
NCI-H661,17755052,1.4228000150725233,1.7793259173509244
CAL-51,10427712,4.2973287072996085,4.262177573269403
NCI-H661,208908,1.9265593878348335,2.287429387669022
LXF 289,71466578,4.726723075051965,4.483117999377303
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,2.517356911506683
KMRC-1,46224516,3.1277122869876064,2.3634037743694134
JM-1,2113511,3.632981632735763,4.957022887298533
LOU-NH91,2113511,6.175446639496144,5.537275194715835
A4/Fukuda,6918837,-6.1208599704470865,-3.6913379281389176
FU-OV-1,11640390,5.4167064390474335,3.3761554708776145
SBC-5,44607531,2.697205944866836,1.4312081849886877
OVISE,71304818,3.3064642565645572,2.4959554487755073
OPM-2,11152667,-1.3080541002664456,-1.3398657832620626
NCI-H146,3552672,1.604439194031644,2.821845301940375
CAL-51,12001922,2.008779489179369,1.9458121909151287
SBC-5,969516,3.68635139774897,2.581816894566751
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.580861832062699
CA46,53495165,-3.0280125025934495,-0.8844490651075548
SW1463,60750,0.1610513612263897,-2.017200431373647
FU-OV-1,46215462,1.830231092617303,2.1343242329843615
ONS-76,49793307,-2.5280436252167733,-2.983099330461351
NOMO-1,11404337,-0.1001889231988697,-0.8878568928619579
SW1463,123631,0.5150504925697384,1.7685324637313227
A2780,44819697,-3.3662473846109333,-0.516541197105794
A-673,44491742,3.844993574977925,4.287737153274174
NOMO-1,5280436,3.413613220161409,2.887953859226303
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.665694344922776
BxPC-3,2858523,2.8297817429760945,3.131669071224925
A2780,445091,3.798794327077476,4.370759134986413
OPM-2,11647372,1.2733466761832082,0.5810020642429031
CA46,71751553,4.222934016329145,4.258735929728267
G-401,44486219,4.1772416968228505,4.000890562017157
NCI-H522,9826308,0.3930789830124517,0.08854941708937066
CAL-51,5566,3.271951139375183,3.059974116874821
G-401,89183176,4.003742825914683,4.001286085978847
NOMO-1,12003241,-0.5951695723430065,-1.7080717033340267
MDA-MB-157,2708,2.34132544783096,4.846652135879305
YAPC,10410894,3.466680540940763,3.3585079065407886
HCC1143,65064,3.71051637258464,4.92189739852954
EFO-27,2746,3.149760082978987,3.2439266815175847
LoVo,216468,2.992200557668688,2.040378517960642
DMS 273,3025944,4.590997145359233,4.200685326998406
NCI-H661,15983966,-5.492856258402122,-1.9664819204036297
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,2.7632422101857332
CAL-51,2708,4.939881356462198,4.788219423917167
HCC1143,11175137,3.393081010308343,2.667802778161236
CA46,42611257,2.680269393096826,3.1168519685324974
ONS-76,68056272,2.9147642388168675,3.5547248857263667
Panc 04.03,2871966,2.8539977368648275,0.4205411491805004
CAL-51,25062766,1.9168321284868295,2.066461980281276
FU-OV-1,52912189,0.1271866873311006,1.7300430205881205
EFO-27,73707371,4.965139584704115,4.761695896158107
SNU-449,24951314,2.758293516562198,1.4635442780136734
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,0.5161962472789855
A4/Fukuda,135999136,4.178898868342667,3.0997143124519884
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,0.43957526283970694
HSC-4,119182,0.0150561689419209,-0.8352524470622735
LXF 289,68056272,4.660756431297166,3.6295485552145443
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.412235403199596
SNU-61,31703,0.3335579072308824,-0.7886847909563229
SCC-9,9915743,1.0040050158500469,0.737992097011929
NCI-H460,446155,3.79922347841428,2.7461156483734173
MSTO-211H,51037431,1.7350128995421004,3.378841935808772
OPM-2,73707438,4.146852269482474,4.133963435216165
MDA-MB-453,9926054,1.6596725660557576,2.060443629067348
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,3.0030839377716916
MDA-MB-157,126941,-4.13859012935224,-2.4134055560718233
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.1176504312161917
MDA-MB-453,24785538,3.5897722779252383,1.3915312569077556
JM-1,24978538,0.0218307924501431,0.7562503436608827
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,4.261643928600498
DMS 273,3503,1.4004718919159695,2.081049470671571
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1488038045300137
NCI-H2009,9926054,2.181635437582939,2.1205275115617463
KYSE-70,23725625,6.518030965677853,4.756231430559469
CA46,2729026,2.6315261399645755,2.355255899241609
OPM-2,135398516,1.2750707316498222,1.615924442011876
SNU-449,42642645,1.3579889941817174,1.1269180526729317
HCC1143,25126798,4.15297730422149,3.738005666256963
KMRC-1,9933475,1.7755712843428362,1.9495960317138545
G-401,12003241,-2.103305079214356,-0.940847692456421
A-498,5113032,5.384850868352965,4.811891704824808
NCI-H2009,6918736,-2.2815319513344896,-1.3916124821383866
NCI-H292,11455910,1.285235050416197,1.045992359024633
NOMO-1,24889392,4.281820029392572,3.7941428023259065
HSC-4,4259181,1.301377168384764,0.06482007334150003
NCI-H2171,73707371,5.940029655461802,4.997389924766877
A-498,5329102,2.2449182254359843,2.245300738500273
JM-1,51037431,4.238886241129638,3.001115586122452
A-673,56973724,1.675633920325915,2.989803096640673
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.48783330855435664
MDA-MB-157,136227331,3.870321503168366,4.386369057582653
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-2.241546965827986
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.2273045581780773
OPM-2,7326481,2.643641332780412,2.7267250798164584
NCI-H146,135423438,2.8528911509997137,2.23064071386523
BT-549,36314,1.6954100357352504,-1.2417030217555043
A2780,11717001,3.193837101204412,3.9843451619425547
NCI-H2171,136227924,2.167829841056951,2.9435761115516588
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,1.8785310076036914
NCI-H460,11152667,1.2005763717636435,-0.5295217269038163
JM-1,462382,-0.3688196944858197,0.34820351349335715
SNU-61,262093,2.836545473910542,2.842678126659696
FU-OV-1,10385095,1.480245925499038,1.2587892539157248
SCC-9,72193861,2.3270498811162508,1.4794824680203464
NCI-H661,1242560,4.217168015363727,3.522823899098627
CAL-51,984333,0.1261860025273146,0.5258129641343949
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.9112304913558339
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-1.309109075331301
BT-549,374536,3.1184462544943363,2.2481981259920163
NCI-H1623,11640390,0.1271923003977441,3.5380140256167794
HSC-4,387447,-4.060952426407354,-4.372714680971639
MDA-MB-157,5311037,2.9595373739718087,4.104454453395884
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.3807653343223025
YAPC,3543504,4.3832051547821855,4.346564694659816
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.6437223091692117
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.5199664713446766
NCI-H1623,9866186,-0.0100221274837169,0.8329703539656512
SNU-449,4788,5.842775682236554,5.60380115386667
Panc 04.03,5287620,-2.39349186702993,-2.0085180600350863
MDA-MB-157,11717001,3.389932991765854,4.276911674737349
NCI-H2009,216468,1.7077485468094884,3.092688996529513
HSC-4,24821094,3.2038955653523713,2.8715328963549123
A-673,4578,4.214026417190043,4.279111470710107
KMRC-1,135875424,5.075329697898493,3.8547397328635045
G-401,11612883,1.6387860096052431,2.335438647428091
HSC-4,156422,5.249929789072156,4.036369342523247
NCI-H522,2742550,2.7952007563166203,4.043824409524075
NCI-H522,400769,-0.9806645547005408,-0.5227297748441746
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.3204421591760167
NCI-H661,46199207,2.8133245189521054,3.0354656481184445
A2780,10184653,1.3482388837291208,1.18645439280024
SCC-9,24856436,1.519847806890015,0.32745703478979543
NCI-H460,2729026,3.0609463870825926,2.8344549967733736
LXF 289,11222830,2.2114905387790755,1.6766766269668691
KMRC-1,46215462,1.6205494448376236,2.0532110323324466
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.873707285822782
OPM-2,421610,2.2409150931042072,2.8212959294683317
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,2.212486153134637
CAL-51,119607,5.291790266428237,5.053007269685333
CAL-51,24753719,3.9981702522006257,4.178621982179969
KMRC-1,25154868,5.3943697684741805,4.437355759312618
Panc 04.03,89928392,1.6805018731496522,1.6107977747879874
SNU-61,25126798,4.129245799651812,3.886305823497685
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,2.0177247185695104
HSC-4,11977753,4.574500022269399,-1.8500727138272817
NCI-H727,4477,0.5438785176620984,0.5390411556982244
CA46,5335621,3.676802077981384,4.189274963558594
JM-1,322968,1.8634300837521185,2.7839504763863845
CAL-51,46907787,3.297361866649883,1.6966073474585133
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.7628690917227668
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.577112801382298
NCI-H522,53495165,-1.820766752755188,-0.13411052611042884
MSTO-211H,11626560,1.3885064506517848,1.9938569962820565
SBC-5,262093,2.1741934315953726,2.5782988721342472
MSTO-211H,52912189,3.1066961080068123,1.753252005475659
HSC-4,568763,1.3764913265299208,0.35691608663785773
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.3079753287238264
DMS 273,25195348,3.734209419300899,3.334174026774774
Panc 04.03,5951923,4.37213064077745,4.337913456945899
FU-OV-1,439501,-0.5556149973103641,-2.275739857402137
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,1.7088376467640611
LXF 289,168313047,4.113002678801054,2.3172156477640535
SCC-9,67291369,5.015060977849177,2.2630320464813654
OPM-2,5351362,0.2459388559982981,1.0526211254774247
FTC-133,11485656,4.087051585535102,2.454873541401889
HSC-4,46843906,4.814917111969106,2.7571530805583206
CA46,51039095,1.651262767418978,2.4365204153499307
NCI-H522,2945648,3.0823392214986343,2.84443230636557
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,2.9983721315604477
YAPC,9911463,3.901904463732921,3.9304348752133684
DMS 273,11977753,-2.475673354763999,-1.7190889595586472
SNU-449,46191454,5.774811831739998,1.7900207536448633
NCI-H661,25062766,2.1967321973268294,1.9422078714354845
A-498,53301938,4.241910990361246,1.787360113913341
Panc 04.03,10302451,3.874200048588579,3.250345931329927
A-673,16065773,1.4559751864460968,2.1086398004502254
NCI-H1623,135398516,1.607867961646436,2.055013409393
FTC-133,60700,-2.7194012548196,-0.13520762741051115
NCI-H661,3384730,1.2254103498827775,2.22101654889861
SCC-9,168313200,4.072126418899639,2.971320227542198
OPM-2,25150857,1.3601106429565517,1.9520001068955424
NCI-H292,3385,4.509781783210997,4.118011142049093
NOMO-1,227681,3.177880686522457,2.9097086180358294
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.1804033285417055
OPM-2,46191454,-0.9534482392265864,0.649939940604192
NCI-H522,3081361,1.6470006965888542,2.295301110344047
CA46,374536,0.6029387131655304,1.670383379597108
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,2.889379456050439
DMS 273,4705,3.496116762813734,3.2439920330615046
A4/Fukuda,17755052,-0.6813796549781841,1.1625768613834189
SNU-81,24180125,-1.7131691030529954,2.760724478698606
Panc 04.03,969516,3.706271998961216,2.9965263613863105
CAL-51,15547703,3.503799403292956,3.2082335593166413
NCI-H460,24951314,1.96669984187411,1.4151721180837002
SBC-5,446155,1.3486611419477716,2.6864774988291527
Panc 04.03,6184667,3.768891848670565,3.1709950023526163
MDA-MB-157,4096211,2.1957324566584715,2.1172112309189925
CAL-51,15983966,-4.387912760170627,-2.067959115850673
NCI-H2171,49793307,-5.547674326636965,-3.1844627191702624
MDA-MB-453,31703,-1.1483878700266144,-0.7759951534084926
KMRC-1,24785538,2.687509195601708,1.6252089452228988
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,1.6355606750501293
FU-OV-1,54618164,4.603510021761196,4.005168273812218
YAPC,5287620,-1.8729921135671632,-2.0390093074202764
NCI-H661,16065773,2.6852778174065435,2.348254718944501
CA46,5329102,1.3169898780971163,1.330954614272226
OVISE,66577038,3.7859124338920065,2.9346485724375446
LOU-NH91,57519531,4.764819520424852,2.2546892653380635
LOU-NH91,448949,2.461672905148464,2.092523452641092
LXF 289,10427712,4.0701965709145504,4.283405064006385
CAL-51,9915743,1.1260994347217144,0.5485045401982975
NCI-H2009,11609586,4.059888202416809,2.9924815144862524
SBC-5,60700,-1.8327808511007615,-0.6554785342747915
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-0.9628027692390623
OVISE,24951314,2.5954730551837386,1.408770695468076
KMRC-1,66577038,2.9827052655036206,3.061341082530551
LXF 289,36314,1.2391029615263165,-1.5090434004143056
NCI-H292,44607531,0.4181911293940362,1.4489693809881772
KYSE-70,219104,3.9271840577372705,3.3926380621417827
NCI-H460,71304818,2.359856693071434,2.5093267844212512
SNU-81,4477,1.0310003158688126,0.39291213629196114
A2780,1716436,1.933630716197044,2.869082320020998
LOU-NH91,11964036,1.2476019563081622,1.435090303881529
SBC-5,9936388,-5.234314033557506,-2.576447537494056
KMRC-1,24964624,2.351358467802262,2.5286490799862906
MSTO-211H,73707438,4.334782721865043,4.009513828480553
MDA-MB-453,73707438,3.778137609083601,4.048557534982332
EFO-27,49793307,-1.9052761294403429,-2.694856446544486
G-401,71680916,4.434691555895244,4.555020504216926
MSTO-211H,3634881,2.531877742135044,3.32804609983699
NCI-H292,42642645,0.8145779285410705,0.9229359759284083
OPM-2,168313200,1.8002020874491595,2.8535809468674596
NCI-H2009,53232,2.115043522086945,2.558324840139339
SNU-449,9825149,2.659052538489635,2.185831656159418
CAL-51,25105715,4.077363851334658,3.5014367802188815
MDA-MB-157,53232,1.9030895496471385,2.5441970645335577
NCI-H727,2708,6.607150814967448,4.815772775598016
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.555686767598938
NCI-H1623,44632017,1.5464636141196502,1.1074388096542662
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,0.7049721781902175
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.2484855708633056
SCC-9,3689413,-0.5284639903905319,-0.2120155897918478
NCI-H460,23725625,5.666756485817308,5.070568668886691
NCI-H460,100016,5.855223104671776,6.176052987831488
NCI-H2009,24771867,-1.6305331500245923,2.1051497159047305
SBC-5,9952709,3.0525329755213466,2.6475083756302094
SNU-449,5566,3.0151612646695822,3.151473439571558
NOMO-1,9926054,1.6113291347040215,1.6550799109910201
EFO-27,11404337,1.0583908830182924,-0.37001320832891366
A2780,54626689,3.943205764450006,4.485015385769906
A4/Fukuda,168313200,2.9572494196719723,2.764017595547335
LoVo,5460769,-2.1468642890382412,2.6667017719389374
NCI-H661,25102847,2.378632231655901,2.4197038273944065
A4/Fukuda,9866186,-0.2462641713744652,0.561122887773273
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,2.9967605821415773
KYSE-70,36314,1.2189527676950276,-1.424599800015657
BT-549,2828334,6.061535937537666,6.179095566863183
NOMO-1,25262965,-2.043358942198166,-1.6602015195537163
LXF 289,25195348,5.284501520866742,3.127846647858769
CA46,451668,2.285623139838705,0.6195883011424552
SNU-61,24856436,-0.371488374536367,0.8186541603900567
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.9468357933688893
SCC-9,44137675,3.491154886377157,3.396239619759746
BT-549,151289,0.9825598768305964,0.9725159441639631
JM-1,49836020,4.6064946369246025,3.10545365028501
YAPC,54618771,0.5686030675412354,1.184684627908582
SCC-9,24772860,-2.0717241396099473,-2.1912769178462064
A-673,10385095,1.0544598585596625,1.0771583989380646
SNU-449,216468,4.54901774756382,3.0063514391796122
SNU-61,67291369,4.2845115751683736,2.036748843442892
FU-OV-1,5291,4.051520848138153,3.609510482229985
LoVo,12001922,1.64420677630862,1.841796302700643
NCI-H661,3815108,3.885074716587427,2.6890084801878715
JM-1,374536,-1.2279479926310035,1.256211662561554
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.462666217815499
NOMO-1,4788,5.067002306940809,5.446455547986538
SNU-61,24748573,1.6967337473161408,2.0974665163489683
BxPC-3,16720766,0.4925277259578197,0.911499834796655
EFO-27,46215462,2.714023108610326,1.8709209977063146
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,1.0892083601707077
SCC-9,31703,-1.2436349312067534,-0.897183196600322
A2780,5335621,4.014990109441054,4.278176607234691
EFO-27,4917,3.7917867214450096,3.08829246462105
A2780,9926054,1.5482217772077662,1.9649661009124841
A4/Fukuda,3689413,-1.7998697854540155,-0.3122900505793794
OPM-2,6610216,3.8953919440086575,3.9262096489964518
NCI-H522,6918328,0.2751454024017333,-0.139982485793695
LoVo,60750,-4.161283305326802,-2.6479510432443054
LXF 289,15547703,4.3915240757493565,3.299236742816809
HSC-4,55283,3.529343210540244,2.756579540229229
MDA-MB-453,6436223,-6.0469700747965325,-4.442435201474378
OVISE,54619267,4.300185321056238,4.090871809381516
CA46,12001922,1.4868064190708767,1.5085313997432186
SNU-61,53392493,2.2959575452819543,2.530952592826874
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-0.5545042100087157
G-401,44137675,2.141460704144857,3.3918259089814935
NOMO-1,9825149,1.4944850939332062,1.9323795867208031
CAL-51,4788,6.061217822513647,5.585386554852011
HSC-4,119607,3.948608575005578,5.107305012237096
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,0.024499457822843886
LXF 289,4477,1.125394938272502,0.5676072417236849
JM-1,11657048,4.676495506604394,4.0041074256345714
G-401,10302451,3.1015289114526774,2.941562836703074
HCC1143,31703,-0.2055424786168501,-0.9127446537951914
HCC1143,374536,1.384467639208202,2.220996492396198
Panc 04.03,10184653,2.983159460505767,1.527430762298466
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.914974419572548
MDA-MB-453,9915743,0.2126089191242519,-0.03832215629808705
HCC1143,4477,1.746819852748151,0.5535850785089622
LoVo,44486219,3.9526381308541025,4.184205788995474
ONS-76,135875424,3.856833286433643,3.8605617190445605
SCC-9,24797083,1.144476664186746,1.3065877704672832
OPM-2,4096211,1.0315429789467454,1.521299710978103
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,2.5625429298560065
SNU-81,25262965,-1.8265758424412304,-1.75044447276817
KYSE-70,44137675,3.4677446622108925,3.39547768903127
NCI-H1623,3854666,1.505587442259218,2.0214151377870437
HSC-4,10385095,0.4573663196580717,1.2365078079886205
EFO-27,107985,-2.474640150808475,-3.5236518292482693
NCI-H2009,6610216,3.953101400309774,4.2165749748904915
SNU-61,135421197,1.1046098427392648,1.7884395869202212
HCC1143,4259181,-0.4991941409006941,-0.09565555814992281
BxPC-3,16038120,0.5924635925282854,1.091024739600712
NCI-H661,135875424,2.4725937826628006,3.8833934711180804
SCC-9,9866186,1.319539660579235,0.7160695635420954
LXF 289,24964624,1.3940062455599875,2.432026532988801
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,1.0042704903483919
HCC1143,6610216,3.638345017281011,4.191509807896617
G-401,2949965,1.5385484234582818,2.6414637228211246
BxPC-3,49793307,-3.2953922214008697,-2.7655693106507266
A4/Fukuda,5287969,-2.571307610380136,-2.271416209757515
A-673,6184667,1.935989865778159,2.958977946412369
NCI-H2171,24821094,2.9775477594317743,2.7365874766666836
NCI-H2009,67156097,-1.7347724318553324,-0.3707615537031386
A4/Fukuda,409805,3.596796639089143,4.326150226170849
JM-1,5738263,2.278112606764228,3.166363355050202
SBC-5,2828334,5.980106592077389,5.935083002642122
BxPC-3,107985,-2.51349631829315,-3.5314440727347804
G-401,11427553,1.555705840809683,2.392075833653582
G-401,10113978,1.710663554595952,2.943472717366723
NCI-H661,16013152,4.678017706607999,3.969409429397116
A4/Fukuda,11497983,-1.0595923666648657,2.242451074912777
NCI-H522,10296883,3.751667506317718,3.799114948774984
HCC1143,6610355,4.569348514461763,4.679148675142935
SCC-9,56946209,-4.978704692275232,-4.240290736493461
LOU-NH91,54613361,0.2217026048603205,0.020526330897541856
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.7876674859844567
G-401,42642645,-0.5846467586678221,0.32989573550901746
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.5576857802417379
NCI-H727,5287620,-1.579053209750056,-1.7523018432736106
FTC-133,16038120,2.9212616737408896,0.8725969885986942
SCC-9,11626560,2.4253223939520976,1.8663333961201685
Panc 04.03,2742550,4.347188786942969,3.8693267672476956
OPM-2,15547703,2.634316496996711,2.479249962749253
NCI-H522,10074640,3.1231046963753686,3.046261223287685
HSC-4,2945648,2.59041604505869,3.118037872192687
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,0.7953296699695729
MSTO-211H,10127622,2.776094640706434,3.9549460760988837
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,1.8063821958135693
NCI-H661,2858523,3.1395656938248124,2.977024406876094
A-673,56946209,-5.889509916794497,-4.171843643471506
CAL-51,44185566,1.8630594392382311,2.6373096422518545
YAPC,51039095,2.046611375354791,2.8923870622164776
OPM-2,4261,-0.9911458583810344,0.7900605192305942
BT-549,969516,2.601131538014171,2.7928840126133623
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.668861232975401
A-498,55508,4.21947279006693,3.521636268692496
SNU-449,71466380,4.63195087543953,4.59899820484739
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,3.930090422439045
A-673,11707110,3.906892758790242,0.2777902881205669
NCI-H460,54649381,4.173104904963283,3.976213211240164
KYSE-70,5282054,4.279196842795529,3.4172797426559396
G-401,119607,4.5837417334889885,5.078459786347902
YAPC,24856436,1.898811352025064,0.3735157201889544
CAL-51,5460769,1.3780575552768597,2.860725777325234
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.158585132762438
CA46,400769,-1.5476292313826252,-1.0583698707252163
SNU-449,19582717,4.423938746946012,4.10997037064154
KMRC-1,46191454,1.86757619496812,2.0117724993420008
MDA-MB-453,45279963,3.011106079512325,3.621830153079744
BT-549,25150857,2.011062957026122,2.355899682529241
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.7343872319588829
NCI-H2009,135999136,4.285465393980956,3.8800845820515377
LXF 289,984333,0.880488465949386,1.003176273839995
NCI-H146,11238147,0.964491846183422,2.7492094061296872
Panc 04.03,5287969,-1.8253556910298991,-1.6733450852079241
NCI-H292,654092,0.1209701484650686,-0.4380625795240447
MDA-MB-453,9927531,3.885109165752666,4.774448578278244
NCI-H522,44819697,-2.38793523497331,-0.38699001993903315
LOU-NH91,11364421,-1.522672653311712,-2.699313324436362
NOMO-1,4477,1.0767445259598296,0.4703191643699206
LoVo,148198,-1.1147075342847712,-3.6699284953611326
SBC-5,54619267,3.782844847718682,3.9439179978124326
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.0570596891041464
NCI-H2171,46224516,1.006764214935909,2.2974095627272324
SNU-61,55283,2.411692675664504,2.4979734214099176
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.4823449393975339
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.100853873623406
G-401,135398738,4.751845538055463,3.6069241016227243
A2780,24889392,2.5877097444926265,4.035790923109434
CAL-51,3081361,1.780158758130264,2.403813239792732
MSTO-211H,3025986,-0.6925850648320051,-0.8935223727139647
NCI-H1623,10231331,4.737119210946733,2.327876321853527
LXF 289,60750,-4.482846219959503,-2.4873489594099136
JM-1,19582717,1.6871405928140415,3.389775138379686
MDA-MB-453,24775005,1.4926368241852035,3.658905128387196
JM-1,10074640,2.5195149680920657,3.088593890450967
A-673,2749,0.4791921848862392,1.753972047085885
ONS-76,9911463,3.87028315643254,3.7613362110925106
A2780,3136844,3.626688956130205,4.1210264674933
LOU-NH91,2945648,3.130856585594597,2.8395989965404365
NCI-H146,52912189,0.5266703058361273,1.9819260012950657
A2780,156422,3.602973007130472,3.847814512235413
LXF 289,969516,2.6399649875984355,2.9066760770261713
NCI-H146,25154868,-1.0719819424572428,4.352316406377436
YAPC,1641662,3.645861677961698,3.7698687779362534
LOU-NH91,136227331,3.865245001267085,4.1724982790644685
YAPC,46224516,2.408657893134071,2.3115982123681067
JM-1,46199207,1.915427322474508,3.0169668880871536
G-401,54618164,3.8592700204433807,3.9552945262582893
A-673,53232,1.7702469915903785,2.729018586347729
SBC-5,6918289,2.991753308414544,2.244597664928987
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.283646754411445
NCI-H522,24797083,1.396487413816628,1.2867740381030952
YAPC,11238147,2.574935183805209,2.7012742977403223
BT-549,9444,3.939814284899288,4.006478311938396
NCI-H460,11364421,0.3566052665939138,-1.7198729776463544
LXF 289,23582824,0.8647594683412683,0.7628621768337913
FTC-133,89928392,1.8077600838169707,1.4238241251394783
NCI-H661,15547703,3.600649740500543,3.048299001488275
JM-1,8515,3.19981027650634,3.420836834331602
LXF 289,25102847,1.656353256373218,2.656235222282382
NCI-H1623,11626560,2.1087636260711333,1.899588593339208
NOMO-1,2729026,1.9247353379999697,2.3226454634280542
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,2.1580839080456
OPM-2,60700,-1.448416790812607,-0.681635405643499
NCI-H292,9825149,1.7347241761388297,2.3761442609945664
KMRC-1,6918878,5.2070030404450485,2.7034883007244765
SBC-5,4259181,0.3536055110585087,0.015217955118512152
KMRC-1,71466578,5.804397104747809,4.652336273363993
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.1956691649785343
SCC-9,54596490,5.620994411748341,4.535968958732795
MSTO-211H,42642645,-0.4763575861779333,0.9148463811580645
DMS 273,4378219,3.0463884183789336,2.3155080367019503
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-1.7076362086453867
MDA-MB-453,11626560,2.2881538301476696,1.9704757330567824
BT-549,46215462,1.7261150757919093,1.9646063430619978
SNU-449,45279963,4.011305658965759,3.592828056797401
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,3.7803894072829256
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,1.8122153469565803
A-673,10302451,3.0176041071951345,3.041311339953939
CAL-51,5280436,3.749440064194485,3.2329837160749024
OPM-2,23582824,0.3145394278485406,0.42383914930529926
JM-1,5287620,-0.1298713463901946,-2.2660883758671644
MDA-MB-157,3503,1.1658051797362206,2.3669656165734647
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.8576894857045188
SNU-61,16741245,4.568608723382813,3.4833944752849817
SNU-449,54626689,4.585589968636992,4.634416206607801
G-401,49867930,6.047675909857249,4.441043532322011
HCC1143,46199207,3.122692827276537,3.1285353619949103
OPM-2,445643,3.4082912819673536,3.8028608006596185
DMS 273,54618771,0.8675837195237585,1.4477413553312193
NCI-H1623,71304818,2.8160491805212615,2.5150872492730265
MDA-MB-157,16659841,3.727147143419768,3.6717081958595674
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.9487234854448998
MDA-MB-453,1750826,0.6003684780059517,-1.3788343365981697
NCI-H1623,5281321,-0.5392861044239732,-1.3992114053543319
MDA-MB-453,613753,2.5060803116052357,3.0573779775132435
MDA-MB-453,2871966,-0.7610622755396385,0.2053363374075501
MSTO-211H,5281321,-2.386258436411726,-1.6122659608255472
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,4.342977014710923
FU-OV-1,44137675,3.1043101525841377,3.5572032131799682
NCI-H2171,285033,-3.2427052076981693,-1.9872148272156707
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.14727356289214208
NCI-H727,5311,2.2708816030438816,1.6265456188764977
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.9872007220235975
A2780,5746,0.8697095475366516,0.6116657439025779
NCI-H2171,53232,2.7429596689347875,2.9632107430596233
EFO-27,5291,4.106816055599409,3.778467358869453
MDA-MB-453,9933475,1.6213532539721074,2.010369103558961
OPM-2,5281321,-3.721370442971226,-1.773955012803127
SBC-5,25183872,-1.21590268467039,-1.0561280607831636
SBC-5,452548,-1.978558467437607,-0.3887091542376361
NCI-H522,5351362,1.1598735323390523,1.3568676150189856
MSTO-211H,3552672,1.7334798735784387,2.838203615470885
A2780,10427712,3.0744297357135557,4.138667104152716
LOU-NH91,409805,5.248055334811583,4.878578228414678
JM-1,5460769,0.6255065324989537,2.229340106390512
NCI-H292,9967941,4.033073764451828,3.630115226502808
NCI-H727,16038120,-0.1646423801756905,0.857772029098792
NCI-H460,16038120,2.547350732010626,0.9554437604529317
LXF 289,241158,4.717778097263283,3.936190250471492
OPM-2,46398810,1.9487214127979129,2.157387959243017
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.2359091889734126
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.207383165334048
CAL-51,9884685,-0.2528326244590672,0.4592601032390487
LoVo,44607531,1.302221694572025,1.3147170020577363
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.7385371611563716
MSTO-211H,56963564,1.234327129960966,0.7458213258116184
MDA-MB-453,73707398,1.1537227860078607,1.3138329926352166
BxPC-3,5329102,1.9407746673909456,1.6850359216967294
HSC-4,5287620,-1.917371788332746,-1.8241174524170065
FTC-133,11152667,-0.4786534736280033,-0.46829409393535515
NCI-H146,9935249,1.0600603569941576,2.8247646984310246
YAPC,2729026,2.7496252904978293,2.816672596037933
SNU-449,71751553,4.402646349497825,4.494982413140183
HCC1143,9926054,1.808099247882512,1.9969946084328132
Panc 04.03,448949,2.534760210414342,2.1108742894330517
NCI-H661,5566,3.151274839096282,2.993841671676001
FTC-133,6610355,5.440540243356366,4.414762696359956
JM-1,16741245,4.187666128361383,3.6110971649261447
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.7092681390647835
LXF 289,107970,2.2922723928752307,2.332438857040256
Panc 04.03,54626689,4.659724899973851,4.515248838548891
MSTO-211H,16736978,0.1439838744803616,1.8145441761295928
MDA-MB-453,151289,1.613318506724072,0.9927684075832127
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.5713612571919855
CA46,6918638,-2.155597959241919,-0.04870057451456335
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.3974763295254884
A4/Fukuda,53495165,-3.058270414187161,-0.4748836800833406
DMS 273,135984461,4.327877942465965,3.564289656081886
OPM-2,89928392,0.3187576395153793,0.7803333734987759
NCI-H1623,10385095,1.1256497169747182,1.2700812787188949
ONS-76,11717001,3.327449083785458,4.250855100032498
LoVo,6610216,4.332472846182503,4.244263193227945
NCI-H292,16722836,1.3558361632896196,1.6822252040195445
MSTO-211H,135440466,1.110539790918092,2.256785054485939
BxPC-3,9868037,2.7194108471732243,2.963557748256167
CA46,2874250,4.668483912698598,4.243737935471997
MSTO-211H,11238147,2.1702387480753393,2.8618135132923586
JM-1,44607530,1.0639194271383936,1.558817863611476
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8081294170867823
ONS-76,2749,5.1102698724547375,1.893115639641318
CAL-51,36462,0.7338920585832341,2.271243212224708
CAL-51,6610216,4.7761200098267365,4.227666931220909
KYSE-70,3062316,0.8461927752800795,0.8083922512615648
LOU-NH91,285033,0.7293222441785373,-2.184292610564546
A2780,11485656,1.5628347007454235,2.2027354384592175
A-673,26596,-3.820628112159822,-1.6592660542098203
KYSE-70,44632017,1.4611535882953923,1.168650034317115
NCI-H2171,702558,3.801125308495619,5.132371095120509
MSTO-211H,23635314,-1.96294908215212,-1.626781522960354
SNU-81,5746,1.2061469752663514,0.5261233775834737
KMRC-1,4788,5.9167994505540475,5.736438195941156
CAL-51,15983966,-4.387912760170627,-2.067959115850673
CA46,49867930,4.292641096024632,4.203426929343614
HSC-4,11455910,0.337268703123225,1.0701267879466885
YAPC,5281672,4.680001258160183,4.475833648240208
SBC-5,5978,-3.632907311761228,-2.614441658610782
NCI-H460,3825829,4.446795399525052,4.130631761683094
MDA-MB-157,9444,2.0478202605503206,4.171955157738881
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.5118507655083756
SBC-5,46191454,2.9096163569547,1.2616450561051376
CA46,644241,2.374325583681648,1.4764876053022824
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,2.767830757364602
FTC-133,252682,6.679184103041344,6.510832429138125
SCC-9,56649450,2.7319907342568275,3.0242861434877404
CA46,5311,-0.1889513685103653,0.8470498030814335
OVISE,9967941,3.747669270164806,3.5243989124440147
KMRC-1,5328940,2.3844062156656256,1.7405153095874129
NCI-H146,9825149,1.1795040286889695,2.415404942018005
SNU-81,445091,-0.9408785363266468,4.170727465099944
FU-OV-1,6610216,4.742914927321441,4.184355723622306
A2780,56949517,4.37203598237815,4.106282325969844
EFO-27,119607,5.664089470896734,5.122451711631619
ONS-76,57519531,2.0495811593793105,2.43048079027913
MDA-MB-157,42642645,0.4106458170856017,1.1618846701880856
CA46,135421197,1.13174100448049,1.4190896704024452
LOU-NH91,11719255,2.9529273796726394,3.325834395179977
A-673,9967941,2.0264988474191377,3.4802115820001536
A-673,23582824,0.2073680927392712,0.6171158567535051
CAL-51,374536,3.1977545561189347,2.320850243997084
SNU-449,5311,2.373513113952619,1.580813390959848
SCC-9,11178236,-3.8920346249942264,-3.0421103570275
SNU-61,71680916,4.248107596602719,4.548589318031348
BT-549,4578,4.840393866327907,4.436808408710922
JM-1,56973724,1.572059771180543,2.4322952908181765
BT-549,6184667,4.320802676068414,2.8987722485279095
OPM-2,6918878,0.2719026340750923,1.0652737480509793
HSC-4,9967941,3.0274642479334215,3.543266221545433
G-401,6610355,3.5029306645068696,4.232286464292654
Panc 04.03,1750826,0.308709425359425,-1.1137195367589994
KYSE-70,6610355,4.961596413135767,4.539491688080363
A-673,24775005,3.310963685757038,3.7288875293485666
SNU-81,208908,2.232815974371363,1.8902750507357544
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.6823029250161698
NCI-H727,3543504,4.299187359877464,4.578730125947324
SCC-9,11152667,-0.1233430086603879,-0.7246805863828513
A2780,208908,2.5004436475537974,2.214584306711482
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.5287701512925396
A4/Fukuda,44607531,1.1783204907000706,1.304865309036137
ONS-76,54649381,4.0197495944656465,3.8976419077294198
A4/Fukuda,31703,-2.1013190360416147,-2.274865786419474
EFO-27,46398810,2.9967281863964867,2.6247785889321
JM-1,119182,-5.01139227406357,-2.2540885062396896
NCI-H2171,25183872,-2.065345244597309,-0.7540798496523914
SCC-9,53392493,3.3396857977581917,2.424800723527416
ONS-76,44259,0.6373390659589321,0.8558356608883733
NCI-H661,72376,-3.040643961037913,-2.0967802298036835
KYSE-70,11609586,2.827625452517046,2.660737704088311
NCI-H727,3025944,4.64192894764355,4.229363682640899
NCI-H460,262093,3.3627537421549314,3.1289020217447474
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.0954535642178724
NCI-H292,11396600,3.7365966834404225,3.796222678922498
OPM-2,11626560,0.8852338363333486,1.0508779629336669
MDA-MB-453,24772860,-3.354356853525474,-2.0274711554663636
BxPC-3,168312962,2.7485538585474547,2.110045806952941
KMRC-1,46199207,3.449143967158838,3.3083854786981983
MDA-MB-157,2729026,3.2437974205657816,2.8860616700510553
LoVo,4259181,0.2045859597859785,-0.018495729267156376
KYSE-70,5329102,1.9375891375175784,1.803012265827833
EFO-27,3025944,4.337116030950391,4.232589917166032
EFO-27,2742550,4.50908635993052,3.83218344550954
A2780,6610216,3.3472253004646593,4.205950339829691
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-4.098986440043487
EFO-27,24856436,4.205894943099943,0.6023765757435895
Panc 04.03,9444,4.565679465533194,3.7817097693697286
ONS-76,72193861,2.0006819721723197,1.6106105381468854
MSTO-211H,445643,1.8400808237063873,3.8332631479607624
CAL-51,8515,3.5852991976047863,3.696830933034592
OVISE,25150857,3.4132003431569524,2.519072892752695
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-0.7450123497499592
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,0.2454922458919147
OVISE,5746,2.6308159153246047,1.0199082818054332
A4/Fukuda,168313016,2.0147776130358253,4.399573917820375
LOU-NH91,54686904,4.160622905506427,3.7485646355266646
LOU-NH91,8515,5.2113767400480775,3.9038393428747695
NCI-H727,73707398,1.5620380856857303,1.5730270610287966
OPM-2,16722836,0.349034656527362,1.2990500562930989
NCI-H2009,119607,5.663513162505294,5.369369318592942
G-401,11707110,-1.5866495763270043,-0.181500790942176
SCC-9,439501,-2.6581193485563737,-2.3203985106557807
NCI-H2171,4259181,0.2390230285316857,0.16462424967419223
MDA-MB-157,45279963,1.9862312593637983,3.782754524850014
LXF 289,6610216,3.700752852024682,4.32087324520064
NCI-H2009,9936388,-6.076047204085024,-0.3505266818058949
ONS-76,11612883,3.1090836160489417,2.71748952844916
SNU-61,969516,2.346236032939849,2.65518386152665
HCC1143,3025986,-1.3091092061734078,-0.963033990769625
NCI-H146,46398810,1.4219775291726766,2.4240664418102176
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,1.8119252452354815
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.8194524263517737
HSC-4,9887053,4.087399127765092,3.911517685680248
JM-1,11178236,-8.647638887964375,-3.5439802585747326
LOU-NH91,24856436,2.045063798311017,0.3210515321613247
JM-1,4477,0.6485766089343484,0.4649272078873812
MDA-MB-157,31703,-2.5361356877609142,-0.7234968947026321
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.3418170075624825
NCI-H661,54619267,3.8937949591354486,3.9705417730908255
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,0.8757356177083322
CAL-51,135398516,1.449392214756173,2.1619777476953295
CA46,4917,3.2539126844885757,2.8997695337717833
A-673,4705,3.2416788332737454,3.0855258763463795
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,3.161501864166164
NCI-H661,107985,-3.0533673433660393,-3.408892117257441
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.9805275831964
NCI-H727,322968,3.201201930682186,3.724394511392837
MDA-MB-453,9823820,3.844639760703811,3.7831555871844427
CAL-51,44202524,1.5528850010053556,1.9557848697618068
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,1.931215890337494
NCI-H522,216468,3.814024876197808,2.324717827583711
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.4852457950993412
FTC-133,46191454,4.521976640758756,1.0556012892021973
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-0.8993690169422416
NCI-H460,3385,3.2657114863965573,4.004669438567604
SBC-5,4917,3.6947166304022465,2.888233983952647
SNU-449,241158,4.010766929552104,4.140884070133874
SBC-5,676352,1.191452976157089,1.9524969174676334
FU-OV-1,11626560,1.6217924510760422,1.6617814194204832
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,1.7466187757780327
JM-1,23635314,-4.012358401321602,-2.285975611834603
MSTO-211H,24978538,-1.489482683206989,1.045428133984166
A-673,6438330,1.8412388803722883,2.1281144326358326
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.535088193907943
SNU-449,11719255,4.899085715446655,3.2469601972877644
SBC-5,3025986,0.415316224839701,-1.3921567780912192
YAPC,439501,-1.3344819600707327,-2.264110426048477
NCI-H292,25262965,-1.3774761624707286,-1.4337774221968633
OVISE,4261,2.633875372862392,1.5518296786749104
SCC-9,24951314,2.365472705935838,1.4271493573040983
CAL-51,57519531,1.893237876741888,2.411402286902528
SNU-449,4521392,4.287622659497221,4.298606274935349
SNU-61,136227924,2.341371828887226,2.8369572372362457
HCC1143,24772860,-1.4749293698634824,-1.7588710272579693
BT-549,11178236,-2.7962989267365828,-3.354182055808723
G-401,322968,2.2957138552590264,3.3448189567060878
DMS 273,322968,3.714238246037839,3.305593830787948
NCI-H460,135875424,3.211754300989152,3.9788715641062358
SNU-449,8515,3.796953450261519,4.036657907303051
EFO-27,3689413,-2.375877948841856,-0.34087091706119915
SBC-5,46224516,4.445568719663603,2.3267803770467683
SCC-9,285033,-1.0227924755741569,-2.211038015024851
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.0873726864797388
YAPC,6610216,4.2275333940091215,4.320691013234295
DMS 273,26596,-2.1961333269229173,-1.2484302169682844
NCI-H460,15953870,5.00315267734786,3.6386635961917477
JM-1,16065773,2.0826903108024646,2.215425395244885
CA46,5280436,1.6785665289286047,2.5732586203581467
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.46736490188682667
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,0.89103067858906
NCI-H522,40482356,5.076444098213918,4.179323901222406
SNU-449,72193861,2.670314458690751,1.6099085640605286
A-673,44185566,1.862123250313604,2.390953771622356
MSTO-211H,6623618,1.8328237574963773,2.379956312908162
NCI-H661,9868037,2.6835007144938032,2.8975769829801106
NCI-H522,9903786,3.9217135447784783,2.5348814026858855
A2780,2828334,5.5086207374667175,6.130177623636501
FTC-133,9887053,4.335569761437092,3.4805178133179306
Panc 04.03,3503,2.292907505320521,2.4112004873339474
A-498,126941,-2.1438583463370495,-2.7324630571778545
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.5775544343129861
OPM-2,2130404,2.9720984033823896,3.143677313190553
HCC1143,10427712,3.6655746579836497,4.380050807628557
EFO-27,148198,-4.612142049540045,-3.2594321875206846
MSTO-211H,25195348,2.7607409792089186,3.3031359668859643
NCI-H460,11455910,1.4134750909778395,1.3543055145628349
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,3.4455229073448703
NCI-H727,11640390,0.8742840152576016,3.329658970543061
EFO-27,51039095,3.8168650627357903,2.5264844537236137
OPM-2,148198,-4.827513159673032,-3.7330134254548146
CAL-51,10113978,3.4506321601115397,3.239946426687076
NCI-H2009,71304818,2.93523377765095,2.5621194317210563
A4/Fukuda,24772860,-3.4983689572797307,-2.665233324957744
NCI-H460,6918837,-0.9355989207233988,-2.768916135961496
MDA-MB-453,3503,1.4691071846699333,2.4300846203562965
EFO-27,135398516,1.6834680726831996,2.1868551595790264
A2780,19582717,2.5113952618702102,3.484394121229032
SNU-61,6918289,4.130324820008196,1.7412915336432626
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-1.0591337842069415
MDA-MB-157,448949,1.9498713128669924,2.081713347825496
NCI-H727,675434,4.719754403481023,4.536621308126416
KMRC-1,11152667,-0.0604913513883814,-0.6156711152296659
ONS-76,9926054,2.5108803232151304,1.8239319561329297
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.5881525453685389
CAL-51,44491742,5.152478206660974,4.307499938059409
NCI-H1623,5278396,3.5068270087169022,3.5794310960541975
DMS 273,3634881,3.2856933751991844,3.319464257100041
NCI-H146,23582824,-0.1302486758765051,0.6372387738113843
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.858813473162424
A-673,11175137,1.5552265537901524,2.301134189360981
A-673,4378219,1.9880690032317576,2.6881566915155046
NCI-H661,5460769,1.0320957244219937,2.4355957996016806
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,4.25511687452067
NCI-H146,2746,0.8652413173737366,2.830821769480691
NCI-H1623,11955716,5.690110889982477,-2.0497199943644064
JM-1,46224516,0.3128269384104456,2.332687748342948
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-2.712765251099525
A2780,11317348,0.9115498056774632,2.35700838442449
NCI-H661,9911830,2.711917815790479,2.4972403116674977
CAL-51,44202524,1.5528850010053556,1.9557848697618068
BT-549,4096211,1.216432091282546,2.2329071863057477
FTC-133,6918328,0.7944971797491694,-0.1599606279429564
CAL-51,9911830,2.6702149728757343,2.282222377023927
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.2108246804760505
NCI-H146,BRD-K55473186,3.591565624419444,4.1786930150751616
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-1.454261394377909
SNU-81,16720766,0.0913844680975832,0.5469387314456623
LOU-NH91,46215462,2.06389335978863,1.9217576352799661
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.3083707808273828
CAL-51,5978,-2.6819752982341463,-1.890406873354599
CAL-51,5278396,3.885366261927898,3.434185079428088
HSC-4,4477,1.1301199037714704,0.574609719129079
HSC-4,25195348,4.125902627491381,3.038270903954641
NCI-H661,227681,4.255095664751994,3.1116564731396377
NCI-H292,24951314,1.8411912809473163,1.4941167902503798
NCI-H522,3543504,4.389197316233122,4.360307666546004
NCI-H460,452548,0.6919333948360032,0.30837133716659726
SNU-61,25105715,3.603411279706935,3.4003617392225802
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.8970474381371031
SW1463,11175137,3.4916395483032256,2.434104453215829
SBC-5,6914657,-3.351925471283153,-4.139670567517829
JM-1,65064,5.210865559450395,4.268243195208185
OPM-2,9967941,3.958466181768741,3.184829725187086
KMRC-1,969516,2.336566526495707,2.847835494154316
MSTO-211H,15983966,-3.5322347663594016,-0.9715417538190572
OPM-2,9952709,2.422518614873216,2.7149401173619676
NOMO-1,16741245,4.369418152152245,3.3735940157728486
DMS 273,16659841,4.479005871158747,3.797561625886226
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.240686124043168
JM-1,46398810,2.06860116520361,2.114815287355452
NCI-H661,12003241,-1.8871798966926587,-1.285123422567484
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-4.480689360974887
FU-OV-1,10184653,3.943218547538411,1.4908542956409183
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.8930201484651987
OPM-2,156422,3.8836640353636382,3.532628093592925
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,0.7551185855579218
SNU-449,56649450,3.812927022122559,3.408596129110434
CAL-51,119607,5.291790266428237,5.053007269685333
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.0827016587423883
BT-549,148124,3.591112191677911,-2.271098026512467
A2780,216468,0.3493873836888674,1.778676551138763
MDA-MB-453,176870,4.531738011413092,3.3050275683959165
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.679357080229592
LXF 289,24180125,2.8590757937383517,3.0781181639247426
G-401,4259181,0.5796012369716917,-0.1328095852253082
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.481000227427772
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,-0.17316416790237393
JM-1,54618305,4.117087010604098,3.992204125904405
NCI-H522,16736978,1.523319728114192,1.4090834695470646
NCI-H522,36462,3.1215227661343925,2.1069674529171385
HSC-4,400769,-0.948607557046086,-0.5199685395658633
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.8884987136556584
YAPC,20959075,1.1991758721406616,-2.6837865342306624
A-498,5328940,1.8314953095149151,1.666715229483726
YAPC,9915743,1.8269757962027744,1.027268742257376
SNU-81,54613361,-2.01246069716893,-0.6773602961957279
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-1.4512910295900558
OPM-2,1716436,2.6292767753294437,2.429268539089087
Panc 04.03,3025986,-1.5275729109481309,-0.9690314511285749
NCI-H661,25150857,2.764254958619497,2.186577774226936
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.277825525458974
LOU-NH91,5746,1.403252091596802,0.9509053113028263
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,1.6245200667241024
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.7184634944607766
NCI-H146,135398738,5.0513404057578155,3.7930947467874727
MDA-MB-453,25227462,0.3575965628816619,0.4484281561551804
NCI-H460,2858523,3.1665522277325575,3.0607290097805917
SNU-449,9866186,1.4050575476777012,0.9077440933559566
CAL-51,54686904,4.850424917483252,3.415942243592846
LoVo,53392493,2.4765619401689154,2.35436580463686
LXF 289,24951314,1.0119406639366386,1.4212544597011814
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,1.8321014387361765
NCI-H1623,5329102,1.790138577011996,2.132131727070629
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.13006021438858
NCI-H292,3815108,3.432884993584308,2.941537327249989
OPM-2,400769,-3.2268127368380215,-0.9535454022979744
MDA-MB-157,9823820,1.002295209558588,4.245285134522965
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,3.0481093493529112
YAPC,135999136,4.461108174764027,3.791547452487164
A-498,71680916,6.416494665581045,4.766131092850934
BT-549,252682,5.865498031558929,6.506953516125899
NCI-H522,2130404,2.4549438882602463,3.3009201566650126
BT-549,60750,3.345812478570961,-2.2998169246116156
A2780,55508,1.942124594025635,3.037751313333437
BT-549,3136844,5.53345832245052,4.3197740597789815
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.7438089209664402
NCI-H522,135398516,2.766899162932887,2.0812155703188533
Panc 04.03,45279963,4.427260741974604,3.739138013321108
MDA-MB-157,107970,2.1200224507121868,2.2690531043364883
DMS 273,24180719,3.915275581303962,3.713383579077551
Panc 04.03,71680916,5.172010716636655,4.6436310399941725
DMS 273,44632017,0.8019003224742934,1.068111447976782
NCI-H292,5311281,4.174884455345005,2.2430959026052353
NCI-H2171,9549297,1.2348443580878434,2.3826479461450707
NCI-H661,135398516,2.0112722508641525,1.9636128569743567
A4/Fukuda,6918328,-3.9252329494253586,-1.0247365646221713
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.3443852837788803
A-673,5284616,-2.8220877865693996,1.9324019315301415
A-498,11222830,1.898532346529896,1.7484141214275206
SNU-81,44589607,-1.0723208776906596,2.554886256031002
SCC-9,54596558,4.378159430294897,4.429893862839339
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,-0.3426705273780603
OPM-2,56649450,1.6365959554779024,2.582403506601328
JM-1,2945648,1.8231052373320176,2.520097029531614
Panc 04.03,6852167,3.6951209581653743,2.739970497911116
OPM-2,5311281,1.024044758253736,2.1702333278505384
SCC-9,9967941,4.677287493278682,3.651069019425315
CAL-51,11609586,1.5077859423552509,2.9232101224889084
SNU-61,9911463,3.407728451470452,3.4366841051295363
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,1.8810649054486521
KMRC-1,72193861,2.923138623905541,1.5202833435349665
SCC-9,168313016,4.940700460648117,4.683697361179819
NCI-H1623,46215462,1.70222177248337,1.8994883247206291
MDA-MB-157,6505803,-0.678815881739905,-0.02395694240966827
A-673,25062766,1.5933001652207863,2.2223225452537507
NCI-H522,148198,-5.538025476960186,-3.630050015122066
KMRC-1,11625818,4.222506706272698,4.502347647088581
LoVo,10074640,2.9851259451828476,3.1792667253196436
NCI-H1623,12001922,2.89915315578861,2.0011318663627047
NCI-H460,107970,2.752075604137296,2.3228966845981
HSC-4,10322450,4.749470049467763,3.749826135400944
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,0.10769984969078385
CAL-51,65628,4.560195683913681,4.460813926085269
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,2.4690886882746224
SCC-9,2746,3.644005246156997,3.039014877567854
JM-1,107985,-4.195149425063274,-3.8296979543720164
NCI-H146,119607,3.9951566487227823,4.948425227384572
JM-1,44566777,-1.1129943275867182,0.39335044369779454
SBC-5,11167602,1.6319389998554443,2.027041976022631
LOU-NH91,9936388,-6.294191236399446,-2.2072529334931215
SNU-61,135875424,3.609444893060012,3.795419293471016
NCI-H292,6917907,-6.008612763335491,-5.281345403480092
G-401,19582717,3.4233639988307623,3.751961062533239
LXF 289,46174525,4.3838011857350585,4.284784641975892
SW1463,10184653,-0.9517511422842978,1.1414472561320488
SCC-9,7251185,3.4755501931610486,2.4508133848709885
OPM-2,4788,3.799883557086963,5.383381456665153
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,2.7071961209816235
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,1.310597403175301
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,-0.1493123890248684
NCI-H460,387447,-2.436463262555682,-3.505953234140403
NCI-H522,3465537,1.2201304719285595,2.338751950297621
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,1.5883498774239846
OVISE,11228183,1.089434907795814,2.315062004884248
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,0.7724268724596237
NOMO-1,10410894,2.884775843935945,2.923472438517255
NCI-H522,3062316,1.3416096793720445,1.1898642549816698
NCI-H522,5328940,1.3898569828081493,1.66073992973132
OVISE,6917907,-2.8614664806523975,-4.795089797776089
DMS 273,53392493,1.951320459884087,2.3663980931098956
BxPC-3,44259,0.1590720374324279,0.7169415389525672
CAL-51,17755052,0.5283491907817935,1.7368694009183767
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.298584835896422
NCI-H661,676352,2.2217693895783115,1.928897541478656
LXF 289,452548,0.2436004430663324,0.09783709680473426
LoVo,6438330,1.2087527750724023,1.9773085267844375
OPM-2,16736978,1.1906517256258733,1.0163787692017876
DMS 273,89928392,1.202164769006387,1.3938042476746182
CA46,3543504,2.8823298921776717,3.839637876855784
SBC-5,11427553,4.187017651849035,2.3866980066180585
CAL-51,67156097,-2.385254348530768,-0.7525142363232853
FTC-133,23725625,5.526585624025884,4.820249277373062
BT-549,25227462,1.1552638438270102,0.5933556949575917
SNU-81,374536,-2.2172994025671877,1.5551102236817345
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-0.8781321536341514
BT-549,65064,5.372588334008338,4.9955620110595245
NOMO-1,135398738,0.7085728369009435,2.9341334692169663
A-673,44566777,0.6818018070798556,0.5443431849501392
OVISE,42642645,1.7980918591344808,0.793188137942024
CA46,637858,0.8997823848237061,1.1806577974981558
NCI-H292,9877608,5.923265260718527,3.1754555613247053
DMS 273,11964036,0.5570994002779035,1.375339406969563
FTC-133,44137675,6.176024086140045,3.466617578421571
BxPC-3,9926054,1.7603137158224154,2.056019991722408
DMS 273,5311,0.3077166337368,1.2908016051883158
SNU-61,36314,2.631499046696298,-1.215837174420104
EFO-27,6917907,-5.745836009999857,-5.031731836704465
OPM-2,11455910,0.7503761469114726,0.7206639688871767
NCI-H1623,24785538,-1.341558176424811,1.5987352941565864
SNU-449,462382,1.3667681892704822,0.4570427328062314
G-401,8515,3.316277000480566,3.6198882059781385
SNU-449,25102847,2.813788740655036,2.490082719003941
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.5966663098306617
ONS-76,11404337,-0.4259392266769182,-0.4059060520434306
KMRC-1,49766530,-0.1675164065777726,-1.0356497085012282
HSC-4,24785538,3.772420906085344,1.4069580048602577
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.127359516330266
KYSE-70,73707398,2.029692143461395,1.2052479990885159
NCI-H1623,2729026,3.210868522276231,2.8166789455612014
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,2.1456862264446084
FTC-133,56649450,4.4227260509908275,3.2145084310822956
NCI-H727,3815108,3.498449156165097,2.967343022799102
FU-OV-1,448949,2.8154029654914137,2.1389687168400555
FU-OV-1,168313200,1.721890351327649,3.1625054010040787
HSC-4,107985,-2.2656284906222144,-3.4522460211470514
NCI-H2009,44241473,6.22803294537171,4.908344515437759
CAL-51,46843906,2.776329873296567,2.8908208802714688
NCI-H1623,56946209,-3.1229213094171895,-4.206055888521805
FU-OV-1,3825829,3.720797122696784,4.122057832288091
LXF 289,10385095,0.5776298837700374,1.3105355229045483
KMRC-1,4259181,1.968851453570829,0.30140288442106994
G-401,11494412,0.2825252149996007,1.211545234866812
KYSE-70,6918878,2.8589087884624673,2.3270693365433486
CA46,44185566,1.786162700750641,2.1671032693370726
LoVo,54618164,3.038824107117225,3.993355742112955
NOMO-1,16722836,0.125485002235246,0.8639167496659234
A4/Fukuda,44486219,1.5854911698245977,4.218634263511078
LOU-NH91,10127622,4.686411868973226,4.451773971690529
KMRC-1,387447,-4.945508167403058,-4.246058811453215
NCI-H146,54618164,3.6762408834701423,3.9683245710522037
KMRC-1,5351362,3.133883590343709,1.5121889944174653
NCI-H2171,54765302,2.983840848305476,4.037123949911919
KMRC-1,16013152,4.7431155582488325,4.249764182861429
SNU-61,71304818,2.3861681407496125,2.269680678519091
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.898941338462405
SW1463,2708,3.597321448088185,4.756322510749108
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,0.35448909643021137
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.8557295842640886
SBC-5,445643,4.051401497201939,3.949751523938066
A4/Fukuda,241158,1.407426277414268,3.098576266200191
NOMO-1,6852167,1.234836949550939,2.1060330666135223
A-673,9887053,2.3565868011684956,3.349616525296077
SNU-61,6450551,3.0035817833604783,2.3929003986311095
OPM-2,24771867,-0.0082042750480303,0.7892216918299623
NOMO-1,11507802,1.1250810428603863,1.228522438567405
CAL-51,2828334,6.190580852669228,6.027209773139922
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.399619603831035
KMRC-1,44489675,3.6404436921550607,4.090292723158337
FU-OV-1,23725625,5.156277829802871,4.814292010405736
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-1.4033949917207025
OVISE,439501,-2.343202219776273,-2.0780151037122088
CAL-51,5281321,-0.4656602142962174,-1.3231745727203839
DMS 273,151289,0.7083247440682101,0.7642364820537212
MSTO-211H,9903786,1.212702371904443,2.5499798679461625
LXF 289,135421197,2.6553019911408056,2.018362313795601
NCI-H146,24771867,1.252264036368602,2.3036014254540604
CAL-51,136227924,2.079284078064279,3.0215858076180986
NCI-H522,3689413,-4.273368850016072,-0.26922911106613734
NCI-H460,46907787,4.3372157131836255,1.9251204278010854
NCI-H146,25183872,-1.3449770735764903,-0.8053582338434636
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.0104173616036096
CAL-51,9887053,4.486783389261201,3.619404779272425
NCI-H460,107985,-2.632533954936978,-3.3684203707447335
YAPC,65064,4.247853222703643,4.711105173456111
SCC-9,9884685,0.522968392230544,0.8241733945885287
SNU-61,6852167,3.859693430343892,2.3059762879451826
NCI-H292,400769,-0.4441855968341354,-0.624812653859473
EFO-27,24748573,3.2354879524418347,2.050716713495056
CA46,65628,4.372814936384242,3.6767889830743776
NOMO-1,1750826,-5.797741098147838,-2.021078226277699
LOU-NH91,135440466,0.9387697781897782,2.174175155564491
MSTO-211H,11427553,1.7459714847796464,2.5767965941168183
SNU-61,9903786,2.1391845181717373,2.7071674000785686
JM-1,9952709,2.333856130884211,2.5868102300158085
YAPC,44507138,4.423761616669373,2.5874179446372336
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,2.176859019279652
NCI-H727,10231331,-2.105430518957453,1.6242053242225547
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-1.6457942948764874
LoVo,6610355,3.962139785065475,4.296205959129971
LOU-NH91,16065773,1.5129164046929433,2.444120298224654
NCI-H292,51039095,2.62578521626359,2.8468376298927827
NCI-H2009,135398516,3.792403018557381,2.335119658799763
Panc 04.03,44566777,0.5187219827219705,0.4375375026427746
NOMO-1,285033,-2.4289999699368923,-2.8132492775176923
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-1.0734018936217726
KYSE-70,51039095,3.5490987853947247,2.6034666972701723
NCI-H460,36462,3.103581216464206,2.2301684053595703
MDA-MB-157,216345,3.882260039310166,3.9168660461621316
NCI-H522,104842,-1.8805759610000512,-3.2905797943067903
FU-OV-1,72376,-3.2802123060842283,-1.5559511635014796
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.2460661041740462
NCI-H661,5978,-4.21717720873681,-2.4556088029446546
A-498,54619267,3.764771843303345,4.123706736968547
SCC-9,53495165,0.7472636588137463,-0.4664815603794496
MSTO-211H,9823820,1.3460489687603958,3.7415759653777587
EFO-27,11222830,1.8018026478898377,1.7206505231240345
JM-1,11612883,1.345048153552996,2.0405379834201858
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,2.4053707747327637
EFO-27,12003241,-1.7336155023360622,-1.0773220651165767
SNU-449,969516,2.7263398794742972,3.009624781491161
NCI-H146,4259181,0.4591034911128469,0.04324661236746026
NOMO-1,24901704,1.738276567126731,2.762394424758211
BxPC-3,54619238,5.160880582862859,5.031547370405607
SBC-5,654092,0.9915803206550192,-0.6677042193942221
MDA-MB-453,71751553,4.5545018888168185,4.543489567694486
MDA-MB-157,5978,-4.802538048228265,-1.9322374684322583
CAL-51,24964624,1.6704816041215405,2.516417419924062
LOU-NH91,5280436,5.173335280456015,3.4438840303162506
EFO-27,53481919,4.175905541374054,3.8763162363840182
ONS-76,6610216,4.821554065133985,4.299718602868449
JM-1,53495165,-3.850144918627292,-0.2870886439658338
YAPC,16065773,2.864044457230109,2.2594657089586487
SNU-449,51039095,3.650396552732121,2.833829714207551
NCI-H661,71466445,2.1620252686029646,3.6756891623396424
A4/Fukuda,984333,-0.4165614363108865,0.29955610801774574
JM-1,4096211,0.9764948319580444,1.6631478896234007
SNU-449,44197249,4.950419501644914,4.189345742439816
NCI-H460,11178236,-2.300904923417752,-2.77741629155319
MDA-MB-453,12001922,1.470906003655458,1.7951886592029445
NCI-H460,44620216,3.8133491956675902,4.095636043255018
A-673,119182,-1.0392852637873304,-1.425871136562054
NCI-H727,11178236,-2.542459533585497,-3.2488367358594807
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,3.169063927934246
A4/Fukuda,753704,3.7176461109746897,4.581955747436643
SW1463,168312962,2.678519281942756,2.138400969508767
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.2599172362512683
OPM-2,227681,1.827584998281281,2.7054138994486165
HCC1143,3081361,2.3254724072420316,2.3464969137592435
CAL-51,44607531,1.640429423812436,1.4618428370056136
HCC1143,322968,3.187805633465504,3.5822259498758897
FTC-133,9911463,4.36756965003986,3.5255476476244048
SNU-61,159324,1.5880493113453718,2.683392238333493
NCI-H2171,5738263,2.6832104272478188,3.190545419591243
CA46,49867926,4.142181337076857,4.0554106539581625
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,1.85134190979046
HSC-4,44589607,3.345116081225748,2.8207233958329465
EFO-27,11485656,3.240498776862908,2.3632792744743316
SNU-81,23725625,1.2739024793065858,4.771700693606632
A4/Fukuda,9911830,0.8865121451383732,2.3903541658598946
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.6503676224992079
NCI-H292,9866186,0.3072921576740348,0.5762213046507504
NCI-H460,54143018,2.5592633032091956,0.7343681879887284
A2780,4378219,4.7769256594107254,2.7362853682544155
NCI-H1623,44566777,3.7111231324950102,0.7444463420742422
CAL-51,10074640,3.192334769578339,3.078522769467903
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.240243060969715
CAL-51,60700,-0.6497243984818711,-0.6005641338701944
HCC1143,12001922,1.8011931254041345,1.8471128196232056
NCI-H727,638278,3.5555642892396744,3.116534974739328
LOU-NH91,72376,-0.6247816475402558,-2.2881891846979063
EFO-27,4578,4.426476303141277,4.410914217628315
HCC1143,119607,4.074424413991316,5.155784108088175
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,1.7260541216930778
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.7504929947336604
NCI-H727,159324,3.364651085509472,3.253120631255102
NCI-H1623,5287620,-2.020641279124402,-2.2284253180705615
CAL-51,4261,2.4552246887350417,1.4093463360480194
JM-1,3543504,2.821603823672808,4.1762764248287745
SNU-81,11497983,2.4691665919847514,1.6157541557627093
G-401,5113032,4.898905985161468,4.902675388911316
MDA-MB-157,52912189,4.238554807379722,1.792438678400997
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.8892691753132624
KYSE-70,10410894,6.372300696648814,3.2733082138495626
LXF 289,54618164,3.0378434141224617,4.143634877633061
SNU-61,11214940,-0.337645985307237,1.8913904677222309
ONS-76,11364421,-0.3098764345335473,-1.4120590306252367
KYSE-70,5978,-0.772629381148284,-2.227184706392798
Panc 04.03,53232,3.444660782403792,2.857801952404606
FTC-133,46926350,-4.117104249862265,-4.061169182489263
